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General introduction and outline of the thesis 
general IntroductIon and outlIne of the thesIs
Conventional echocardiography is the most commonly used imaging technique in clinical 
cardiology, due to its non-invasive approach and wide-availability. Diagnosis, therapeutic 
management and monitoring of patients with cardiovascular diseases are mostly based on 
echocardiographic assessments 1, 2, including left ventricular (LV) volumes and ejection frac-
tion (EF), LV thickness and wall motion abnormalities, LV diastolic function measurements, 
and valvular stenosis or regurgitation severity. However, conventional echocardiography is 
characterized by several important limitations: 1) for the quantification of LV volumes and EF, 
2-dimensional (2D) echocardiography relies on significant geometric assumptions, it might 
be affected by oblique or “foreshortened” views and showed modest reproducibility 3; 2) LVEF 
and the conventional assessment of LV diastolic function have been shown to be not sensi-
tive enough to detect subtle myocardial systolic and diastolic dysfunction that may occur 
in several cardiac conditions and should be the target for an early therapeutic approach 4; 
furthermore, these conventional measurements are not sophisticated enough to describe 
thoroughly the complex LV mechanics 4; 3) 2D echocardiography permits only limited 
cross-sectional views, which make in some cases the interpretation and diagnosis of cardiac 
pathologies, and in particular of valvular disease, extremely complex and achievable only by 
experienced operators; 4) image quality is often an important issue that may significantly 
affect the accuracy of this imaging modality.
Advances in echocardiography have more recently provided novel approaches, which may 
overcome the abovementioned limitations. Real-time 3D echocardiography (RT3DE), tissue 
Doppler imaging (TDI), 2D speckle tracking imaging and contrast-enhanced echocardiog-
raphy have demonstrated their incremental value over conventional echocardiography for 
the assessment of global and regional LV function and for a better understanding of cardiac 
mechanics4–7.
In addition, non-echocardiographic imaging modalities, such as multi-detector row com-
puted tomography and magnetic resonance imaging (CMR) provide high-resolution images 
of the cardiac structures and therefore important additional information. In particular, CMR 
has emerged as the gold standard technique for the assessment of LV volumes and function 
and for the identification and quantification of myocardial scar/fibrotic tissue 8, 9.
Therefore, advanced cardiac imaging modalities may play a crucial role to improve the 
diagnosis process and the clinical management of patients with different cardiac diseases, 
including heart failure, valvular heart disease, myocardial infarction and atrial fibrillation.
Nina Book.indb   15 26-09-11   12:03
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real-time three-dimensional echocardiography
Thanks to significant technological developments, RT3DE is now readily available as a clini-
cally applicable imaging technique and allows for the assessment of the whole heart in 3 di-
mensions, including all LV segments and unlimited image plane orientations. Therefore using 
this novel modality, quantification of LV size and function (but also of left atrium and of right 
ventricle) does not rely anymore on geometric assumptions and has been shown to be more 
accurate as compared to conventional echocardiographic measurements 6.  F u r t h e r m o r e , 
regional LV function can be fully assessed based on the 3D endocardial motion of volumetric 
segments, giving the opportunity of having complete dynamic information on LV chamber 
contraction (Chapter 1, Figure 3). Therefore, accurate evaluation of LV regional motion can 
be performed in patients with ischemic cardiomyopathy. Furthermore, temporal sequence 
of regional myocardial contraction can be studied and measures of LV dyssynchrony can be 
derived and applied in patients with advanced heart failure referred for cardiac resynchroni-
zation therapy (CRT) 10.
Finally, the 3D approach permits a direct visualization of the complex anatomy and the 
sophisticated functional mechanisms of the cardiac valves (in particular of the mitral valve), 
allowing for a unique evaluation of valve morphology and for an accurate assessment of 
valvular disease severity 11, 12.
assessment of myocardial velocity and deformation
Tissue Doppler imaging and more recently 2D speckle tracking imaging have been introduced 
for the quantification of myocardial velocity and deformation (strain). These techniques have 
been largely validated against sonomicrometry and are proposed as novel approaches for a 
more sensitive and accurate assessments of global and regional LV function4, 13–15.
In particular, TDI is an echocardiographic modality characterized by high frame rate (until 
200 fps) and which is able to record myocardial velocities thanks to specific filter settings that 
exclude the blood flow high velocities 16. This modality can also be applied to a 3D dataset, 
displaying simultaneously 3 apical views (tri-plane modality) and therefore including all 
myocardial segments into account and avoiding potential problems of heart rate variability 
(Chapter 2, Figure 3). In clinical practice, TDI has been validated for the estimate of LV filling 
pressures 17, 18, measuring the early diastolic relaxation (E’) of the mitral annulus segments, 
and for the assessment of LV dyssynchrony, identifying the delay between myocardial 
peak systolic velocities of different LV segments 19,  20. However, the measure of myocardial 
velocities does not reflect only the active contraction of the myocardium but is also strongly 
influenced by the tethering of the adjacent segments or translation motion. Therefore, in 
certain cases (especially of ischemic cardiomyopathy), it might not be an accurate measure 
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of myocardial contractility. Conversely, myocardial deformation (strain) can be obtained as 
spatial derivative, integrated over time of myocardial velocity and reflects more closely the 
active component of myocardial contraction (Chapter 2, Figure 1). Therefore, it has been 
applied, together with strain rate (deformation velocity), as a promising direct measure of 
myocardial contractility 21. Being TDI a Doppler-based technique, however, makes these 
measures dependent on the insonation angle of the ultrasound beam and therefore limited 
in case of suboptimal alignment, such as in the evaluation of apical segments and of radial 
and circumferential deformation.
Two-dimensional speckle tracking imaging in turn, permits and angle-independent as-
sessment of myocardial strain (and strain rate) in multiple directions (longitudinal, radial and 
circumferential), tracking over time in standard grey-scale 2D images the presence of natural 
acoustic markers (so-called speckles), equally distributed within the myocardial wall. Using 
this technique, regional and global LV contractility can be therefore accurately quantified 
and LV dyssynchrony can be assessed looking at the time sequence of LV segmental deforma-
tion 14, 22. In addition, more complex cardiac mechanics can be studied. The human heart for 
example has a specific helical arrangement of the myofibers with a right-hand orientation 
from the base towards the apex in the endocardial layers and a left-hand orientation in the 
epicardial layers. This spiral architecture of the myofibers leads to the typical LV systolic wring-
ing motion as a result of an opposite rotation of LV apex and base. The gradient between 
apex and base in the rotation angle along LV longitudinal axis is called twist and contributes 
significantly to LV systolic function, in addition to myocardial shortening and thickening 23. 
Speckle tracking imaging allows the quantification of LV twist as the net difference between 
apical (counterclockwise) and basal (clockwise) rotations and as a novel parameter of global 
LV performance (Chapter 22, Figure1) 24.
contrast-enhanced echocardiography
In patients with suboptimal acoustic windows, intravenous echocardiographic contrast is 
normally administered to improve endocardial border delineation, to increase accuracy and 
reproducibility of regional and global LV function assessment and to detect intracavitary 
thrombus 5,  7. RT3DE image quality is highly dependent on the acoustic window, due to a 
lower spatial and temporal resolution as compared to 2D echocardiography. Accordingly, 
adequate endocardial border delineation may be difficult with this imaging modality, even 
in the presence of relatively good 2D image quality. Few studies explored the feasibility of 
RT3DE, in relation to the image quality, for the assessment of LV systolic function and reported 
a relative high prevalence of uninterpretable or poor quality RT3DE images 25. However, data 
regarding the use of contrast agents during RT3DE are scarce and only few studies evaluated 
the feasibility and accuracy of contrast-enhanced RT3DE 26.
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Contrast-enhanced echocardiography may be particularly important in the management of 
patients presenting with acute myocardial infarction, in which urgent and repeated echocar-
diographic examinations are indeed crucial in order to evaluate LV global and regional func-
tion and to exclude infarction complications. Furthermore, this approach enables evaluation 
of myocardial perfusion and microvascular integrity, providing valuable information about 
myocardial viability, which is an important prognostic factor after infarction 27. Alternative 
diagnostic imaging techniques (i.e. transesophageal echocardiography, radionuclide ven-
triculography and cardiac magnetic resonance) are conversely more invasive or expensive.
Substantial safety data already exist for the use of echocardiographic contrast in stable 
patients with known or suspected cardiac disease 28. However, safety data on contrast-echo-
cardiography in critically ill patients and particularly in patients within 24 hours of acute 
myocardial infarction are lacking. As a consequence, the use of this echocardiographic 
approach in these patients is limited, although of potential great importance. Contrast-
echocardiography could in fact provide information on the extent of infarction, which is 
crucial, together with other parameters such as LV dyssynchrony and novel measurement 
of LV mechanics, to predict LV functional recovery or development of LV remodeling, and 
long-term morbidity and mortality 27.
magnetic resonance imaging
CMR is currently considered the gold standard for the assessment of several cardiac measure-
ments, providing highly accurate and reproducible data.
In particular, it was proven to be far superior to other techniques for quantification of LV 
volumes and EF, and for the assessment of LV regional wall motion and segmental thickness. 
Therefore, it has been used as a reference technique for the quantification of LV size and 
function in validation studies of different imaging modalities, including RT3DE 6.
In addition, CMR with delayed-gadolinium enhancement is considered the gold standard 
for the assessment of myocardial infarction extent. This technique in fact offers a direct 
visualization of scar/fibrotic tissue with high spatial resolution, enabling distinction between 
subendocardial and transmural myocardial involvement (Chapter 16, Figure 1)8. Therefore, it 
is widely applied for the assessment of myocardial viability and for treatment optimization 
and risk stratification of patients with ischemic LV dysfunction.
Velocity encoded CMR is also particularly suitable for determining trans-valvular blood 
flow, providing quantitative information on moving spins, and has been recently proposed as 
a reference method for the assessment of valvular heart disease 29, 30. However, conventional 
single-slice one-directional velocity encoded CMR showed some limitations, mainly due to 
the fact that the acquisition plane can not be adapted to the systolic-diastolic motion of 
the valves. A more accurate approach is offered by the 3D 3-directional velocity encoded 
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CMR with retrospective valve tracking. This technique is able to cover the complete velocity 
vector field of the blood flow and to correct for the through-plane myocardial motion in the 
apical-basal direction (Chapter 20, Figure 1). This approach can be therefore applied for the 
assessment of all 4 cardiac valves in one acquisition and to accurately evaluate potential flow 
abnormalities (valve stenosis or regurgitation) 8, 31.
When applied for myocardial wall motion measurement, velocity encoded CMR may ob-
tain similar data to that provided by TDI, without the limitations of the acoustical window, 
and can be used for the assessment of myocardial velocities. As above-mentioned, potential 
clinical applications might be therefore in the assessment of LV diastolic function and for 
the measures of LV dyssynchrony 32, 33. More recently, CMR has also been proposed for the 
assessment of LV dyssynchrony looking at the changes in radial wall motion over time 34. With 
this approach, which includes the identification of the endocardial and epicardial border of a 
series of short axis slices, the temporal sequence of LV segments contraction can be studied 
and measures of LV dyssynchrony can be derived.
CMR therefore provides unique detailed information about cardiac morphology and 
function, as well as assessment of myocardial viability, LV dyssynchrony and quantification 
of trans-valvular flows. This comprehensive approach is particularly useful in heart failure 
patients, especially as potential candidates to CRT.
objectIves and outlIne of the thesIs
The objectives of this thesis were to investigate the incremental value of advanced cardiac 
imaging modalities for diagnosis and patient management in different cardiac disease. In 
part I, current and future applications of RT3DE will be introduced. The use of this technique 
for the quantification of LV volumes and function and for the assessment of LV dyssynchrony 
is explored in heart failure patients before and after CRT implantation (Part IA). In particular, 
different 3D measures of LV dyssynchrony, based on the full volume approach (Chapter 2, 3 
and 4) or on the tri-plane approach (Chapter 5, 6 and 7), are applied to improve candidate 
selection for CRT and to predict favorable response after implantation. In Part IB, RT3DE is 
applied in patients with atrial fibrillation or heart failure for the quantification of left atrium 
volume and for the assessment of different left atrial functions (conduit function, active 
contraction, reservoir function).
part II will discuss the additional diagnostic and prognostic value of contrast-enhanced 
echocardiography, particularly in patients within 24 hours after acute myocardial infarction. 
Safety and accuracy (in combination with RT3DE) of this modality in this specific group are 
evaluated. In addition, the incremental value of myocardial infarction extension, as assessed 
with myocardial perfusion analysis, to predict LV remodeling after infarction is explored 
together with novel measures of LV performance (LV twist).
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The use of CMR for a comprehensive assessment of patients with different cardiac disease 
will be the focus of part III. Novel CMR approaches for an accurate and reproducible measure 
of LV dyssynchrony are proposed and applied in heart failure patients in order to predict 
significant LV reverse remodeling after CRT implantation (Part IIIA). In addition, the value of 
CMR for the assessment of myocardial viability is discussed in different groups of patients 
(heart failure, LV aneurysm, ischemic cardiomyopathy, Part IIIA). Part IIIB explores the values 
of CMR in valvular heart disease, and particularly as a reference technique for the assessment 
of mitral regurgitation severity.
Finally in part Iv, novel physiopathological aspects in CRT patients will be studied using 
advanced echocardiographic imaging modalities. In particular, this part of the thesis evalu-
ates the effect of CRT on: 1) LV rotational mechanics, as assessed by speckle tracking strain 
analysis; 2) severity of mitral regurgitation, especially in patients with high operative risk; 3) 
cerebral blood flow, as measured by transcranial Doppler. Furthermore, whether the etiology 
of heart failure and biventricular pacemaker settings (when optimized) have a significant 
influence on response to CRT is further explored.
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Real-time three dimensional 
echocardiography: current and future 
clinical applications
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Real-time three dimensional echocardiography: current and future clinical applications
IntroductIon
Conventional echocardiography is the most commonly used imaging technique in clinical 
cardiology. However, the complex cardiac anatomy and the sophisticated functional mecha-
nisms of the cardiac structures require a transition from a 2-dimensional (2D) to a 3-dimen-
sional (3D) approach. In fact, conventional 2D echocardiography makes significant geometric 
assumptions for the quantification of cardiac size, and only permits cross-sectional views for 
interpretation of cardiac pathologies. Real-time 3D echocardiography (RT3DE) may over-
come most of these limitations and is now readily available as a clinically applicable imaging 
technique 1.
Early approaches to 3D echocardiography were based on off-line and time-consuming 
reconstructions of a series of 2D images obtained by either a freehand scanning or a me-
chanically driven rotating transducer 2. Current generation 3D echo-transducers consist of 
a fully sampled matrix array of more than 3000 simultaneously active ultrasound elements 
that provide a real-time volumetric scanning with rapid post-processing. Recently, this novel 
technology has also been applied to a new generation transesophageal probes, broadening 
the possibility of clinical applications 3,4. The main advantages of a 3D echocardiographic 
Table 1. Current clinical applications of real-time 3-dimensional echocardiography (RT3DE) and its advantages over conventional 
2-dimensional (2D) echocardiography.
Clinical application Advantages of RT3DE vs. 2D echocardiography
Assessment of LV volumes, mass and ejection fraction
Assessment of LA size and function
No need for geometric assumptions and no errors caused by foreshortened views:
 - more accurate
 - more reproducible
 - semi-automated procedure
Assessment of LV wall motion abnormalities The 3D dataset contains the complete dynamic information on LV contraction:
 - faster acquisition (important during stress-echo)
 - more accurate identification of wall motion abnormalities
Assessment of LV dyssynchrony  - analysis of 16 segments in 1 single acquisition
 - semi-automated procedure----more reproducible
 - angle-independent measurement of the composite effect
   of longitudinal, radial and circumferential contraction
 - combination with quantification of LV volumes and function
Assessment of RV volumes and function Advantage over 2D not yet established, accuracy of RT3DE needs further validation 
Evaluation of valve function and diseases Unlimited image plane orientation for better understanding of the complex geometry of valves 
and subvalvular apparatus:
 - MV and AV stenosis: “en face” view with more accurate 
   valve area measurement
 - MV prolapse: accurate identification of the scallop involved
 - MV and AV regurgitation: identification of the precise mechanism
   and assessment of the exact size of vena contracta area with color Doppler 
Guide for surgical or percutaneous procedures
Evaluation of congenital heart diseases Ability to display complex spatial relationship between cardiac structures
Guide for surgical or percutaneous procedures
AV: aortic valve; LA: left atrium; LV: left ventricle; MV: mitral valve; RV: right ventricle
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approach are summarized in Table 1. In this article, the role of RT3DE for the assessment of 
cardiac chambers size and function and for the evaluation of valvular and congenital heart 
diseases will be reviewed. In addition, the potential future applications of RT3DE will be 
discussed.
assessment of left ventrIcular sIze and functIon
The most common indication for performing an echocardiogram in adult patients is the as-
sessment of left ventricular (LV) size and function. Diagnostic clues, prognostic implications 
and important therapeutic decisions rest upon the results of this evaluation that conse-
quently needs to be as accurate and reproducible as possible.
Figure 1. Example of 3D left ventricular model obtained by post-processing of a full-volume 3D dataset, acquired in a normal subject. In the 
upper panel, the 3D dataset is automatically cropped (according to the interface of the software Q-Lab, Philips Medical Systems) to visualize 
the 4-chamber view (top left), the 2-chamber view (top right) and the short-axis view (bottom left). After first identifying the apex and mitral 
annulus on the end-diastolic and end-systolic frames (using 5 reference points), an automated endocardial tracing  is generated for each frame 
and may be manually adjusted as required. From this, the 3D cast (bottom right) of the LV is created and LV volumes and ejection fraction are 
obtained. In the lower panel, LV volume is plotted over time throughout the cardiac cycle.
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Quantification of lv volumes
The conventional 2D quantification of LV volumes is based on the biplane method of discs 
(Simpson’s rule) 5. This method assumes that the LV can be represented by a series of stacked 
discs with different diameters. However, this assumption may fail in the presence of an ir-
regular LV shape (in case of an LV aneurysm), wall motion abnormalities and oblique or “fore-
shortened” views of the ventricle. All these issues have important impact on the accuracy of 
this approach. In addition, it has been demonstrated that conventional 2D echocardiography 
has a relatively modest inter- and intra-observer agreement and cut-plane reproducibility in 
sequential studies 6. In contrast, RT3DE enables a largely automated analysis of LV volumes, 
based on direct endocardial surface detection (Figure 1), and therefore avoids the need for 
geometric assumptions and is not hampered by foreshortened views. Several single-center 
studies have compared RT3DE with magnetic resonance imaging (MRI) that is currently con-
sidered the gold standard for the assessment of LV volumes 7–11. These studies showed that 
conventional 2D echocardiography consistently underestimates LV volumes (mean bias with 
MRI for LV end-diastolic volume: 70±39 ml) and demonstrated the superiority of RT3DE in 
both accuracy and reproducibility (mean bias with MRI: 15±28 ml). Recently, RT3DE was also 
validated with a standardized protocol in a multi-centre setting with variable levels of experi-
ence 12. In this study, RT3DE demonstrated to be an accurate tool, with only a minimal bias 
compared to MRI. Furthermore, this bias could be optimized easily by tracing the endocardial 
border to include the trabeculae in the LV cavity.
evaluation of lv mass and shape
Several studies have demonstrated that an increased LV mass is an independent predictor 
of adverse cardiovascular outcomes, particularly in hypertensive patients 13. Calculation of 
LV mass by either M-mode or 2D echocardiography suffers from the same limitations previ-
ously described for LV volume quantification. A new method derived from the full-volume 
3D dataset is based on the identification of the LV epicardial and endocardial boundaries, 
providing the volume of LV myocardium. Next, LV mass is calculated multiplying myocardial 
volume for the specific weight of the myocardium. This method is rapid and reproducible 
and has a better agreement with MRI as compared to conventional methods 14–16. In addition, 
RT3DE may be of great value for the analysis of LV shape. This technique can be applied with 
a qualitative approach to detect more accurately the presence of aneurysmatic, hypertrofic 
or non-compacted regions. In addition, RTDE can provide a quantitative approach with a 3D 
derived sphericity index that showed to accurately reflect LV shape and to be an early and 
independent predictor of LV remodeling after acute myocardial infarction 17.
Nina Book.indb   31 26-09-11   12:03
Chapter 1
32
assessment of lv global and regional function
Assessment of global LV function is frequently performed using visual interpretation or “eye-
balling”, providing an estimate of LV ejection fraction (LVEF). This subjective interpretation 
may be comparable to the existing quantification methods derived from 2D LV volumes, and 
has limited reproducibility. In turn, RT3DE, based on 3D LV volumes, provides more accurate 
and reproducible quantification of LVEF with significant impact upon clinical decision-
making 18,19.
Similarly, evaluation of regional LV function with conventional 2D echocardiography is 
routinely performed by visually integrating endocardial motion and wall thickness. However, 
endocardial segments that are poorly visualized may be incorrectly interpreted, and discrete 
areas of hypokinesis can be missed because these are areas are not included in the standard 
2D views. Furthermore, transducer positioning errors may result in inadequate imaging 
planes. Therefore, the interpretation of wall motion abnormalities is extremely dependent 
on the experience of the reader and has a poor reproducibility. Since any possible 2D view 
is included in the 3D dataset and can be obtained by “cropping” the LV full-volume, RT3DE 
offers the opportunity of having the complete dynamic information on LV chamber contrac-
tion and to consistently reproduce the same imaging plane in sequential exams. Besides 
the conventional 2-, 4- and 3-chambers views, multiple parallel short axis slices can be used 
for systematic analysis of wall motion abnormalities. In addition, RT3DE has the potential of 
quantitative evaluation of regional LV function based on segmental analysis of 3D endocar-
dial motion 8,20. However, no studies have validated RT3DE for this specific analysis.
Figure 2. On the left panel, an example of moderate-to-poor quality RT3DE. In particular, the LV anterior and lateral walls are not visible. On 
the right panel, the improvement of endocardial border delineation with optimal LV chamber opacification in the same patient during contrast-
enhanced RT3DE. The 3D dataset is cropped to extract multiple short-axis views at different levels of the LV.
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In the subset of patients with inadequate RT3DE images, echo contrast agents could be of 
incremental value, as previously demonstrated for 2D echocardiography. Initial studies have 
shown that intravenous administration of echo contrast during RT3DE improves LV endocar-
dial border visualization, increasing the feasibility, accuracy and reproducibility of both LV 
volumes quantification and LV global and regional function assessment 21,22 (Figure 2).
rt3de during stress echocardiography
Considering the superiority over 2D echocardiography for the evaluation of LV global and 
regional function, RT3DE can be also applied in stress testing. This technique, in fact, has 
several potential advantages in this setting: 1) shorter scanning time, due to the simultane-
ous acquisition of 3 imaging planes (tri-plane imaging) or of a complete full-volume dataset, 
instead of the serially acquired 3 apical views; 2) no need to change the transducer position, 
avoiding a false-positive or negative stress echo due to imaging plane errors; 3) inclusion 
of the whole LV in one acquisition, with the potential of analyzing the standard long axis 
views but also multiple parallel short axis slices 23. Initial studies showed similar sensitivity 
and specificity for 2D and 3D stress echo, but with a dramatically shorter scanning time 24. 
Limitations of the clinical application may be related to the image quality, which is still lower 
than 2D echocardiography (but may be improved with the use of eco contrast) 25, and to the 
temporal resolution, which may be unsatisfactory especially during peak stress.
assessment of lv dyssynchrony
In the last years, several studies emphasized the importance of LV dyssynchrony assessment 
to improve the selection of candidates to cardiac resynchronization therapy (CRT) 25,26, beyond 
the application of the current guidelines. However, data from the recent PROSPECT study 
revealed that standard echocardiography and tissue Doppler imaging (TDI) had modest 
reproducibility for the assessment of LV dyssynchrony and yielded modest sensitivity/speci-
ficity for prediction of response to CRT 27. More recently, 3D echocardiographic approaches 
have been proposed for assessment of LV dyssynchrony. Color-coded TDI has been used in 
combination with tri-plane imaging, which allows for simultaneous visualization of the 3 
apical views and may be able to improve the reproducibility of TDI measures 28. Furthermore, 
RT3DE has been proposed as a promising technique for assessment of LV dyssynchrony based 
on analysis of LV regional volumetric changes. The LV 3D model is divided in 17 standard 
sub-volumes. For each volumetric segment, it is possible to derive time-volume data during 
the cardiac cycle and assess the time taken to reach the minimum systolic volume (Tmsv) 
(Figure 3). When all segments reach the minimum systolic volume at the same time, the LV 
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has synchronous contraction. Conversely, in a dyssynchronous ventricle a dispersion of the 
Tmsv is evident. The standard deviation of Tmsv for 16 segments (excluding the true apex) 
can be used as a marker of global LV dyssynchrony and can be expressed as a percentage of 
cardiac cycle rather than in ms to avoid the confounding effect of the heart rate. In this way, 
the ‘systolic dyssynchrony index’ (SDI) can be obtained. Therefore, in one acquisition RT3DE 
includes all myocardial segments and, measuring the regional volumetric changes, it evalu-
ates the composite effect of longitudinal, radial and circumferential contraction. Kapetanakis 
et al29 demonstrated the feasibility of SDI assessment in a large group of patients and normal 
subjects. The authors found an average SDI of 3.5% in normal individuals. In the patient 
population, the SDI showed an inverse correlation with LVEF and mean values ranged from 
4.5% to 15.6% according to the degree of LV systolic dysfunction. Recently, the value of the 
SDI index for the prediction of CRT response was studied, both acutely and late after device 
Figure 3. Example of the 3D LV model generated by post-processing of a RT3DE dataset and subdivided by the software in 17 sub-volumes (left 
panel). Right lower panel: for each volumetric segment, it is possible to derive time-volume curves over the cardiac cycle and assess the time 
needed to reach the minimum systolic volume (Tmsv, red dots). In this example, LV contraction is dyssynchronous and the standard deviation of 
16 segment Tmsv, expressed in percentage of the cardiac cycle (SDI) is 11.7%.
Right upper panel: example of parametric image, which employs color-coding (blue indicating early mechanical activation and orange-red is 
late activation) to represent Tmsv. In this heart failure patient, the infero-postero-lateral wall (segments 4, 5, 6, 10 and 11) is clearly the latest 
activated region.
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implantation. Marsan et al 30,31 demonstrated that a cut-off value of SDI of 6.4% has high 
sensitivity and specificity (88% and 85% respectively in a long-term follow-up study) and 
good reproducibility. The currently available software can also provide parametric images 
with a visual color-coded summary (in polar plot format) of LV regional contraction timings 
and a rapid identification of the latest activated LV wall (Figure 3).
In summary, RT3DE has several potential advantages over other echocardiographic tech-
niques for the assessment of LV dyssynchrony: 1) LV dyssynchrony analysis is combined with 
highly accurate quantification of LV size and function which enables simultaneous evaluation 
of therapy success, 2) RT3DE includes all LV segments in the dyssynchrony analysis, using an 
angle-independent measurement, 3) RT3DE uses a semi-automated procedure potentially 
resulting in more reproducible measurements, and it allows for a rapid assessment of the 
area of latest mechanical activation.
assessment of left atrIum sIze and functIon
Left atrium (LA) enlargement is associated with several cardiovascular diseases and is a 
well known predictor of adverse cardiovascular outcomes, including atrial fibrillation, heart 
failure, stroke and death 32,33. Accurate assessment of LA size is therefore crucial and, as 
recommended, should be based on LA volume measurement 5. For this purpose, 2D echo-
cardiography is the most commonly used imaging technique, although it relies on significant 
geometric assumptions and has poor test-retest reproducibility. Recently, RT3DE has been 
validated against MRI and showed to be more accurate and reproducible than 2D echocar-
diography for LA volume assessment 34,35, applying the same algorithm previously described 
for the LV (Figure 4). This technique can be used to quantify LA maximum volume (LAmax, 
just before mitral valve opening), but also minimum volume (LAmin, just before mitral valve 
closure) and the volume before atrial active contraction (LApreA, obtained from the last frame 
before mitral valve reopening). All LA volumes should be indexed to the body surface area 5.
By providing a detailed analysis of the phasic changes of LA volumes throughout the 
cardiac cycle, RT3DE enables the assessment of different LA functions 36–38. In fact, during 
LV systole and isovolumic relaxation, LA operates as a “reservoir” that receives blood from 
pulmonary veins and stores energy in form of pressure; during early diastole, it operates 
as a “conduit” for transfer blood into the LV; during late diastole, the LA “active” contraction 
contributes to LV stroke volume by 20–30% 39. Using RT3DE, several studies suggested to 
explore these different functions assessing the following indices36–38:
1) Atrial expansion index = [(LAmax – Lamin)/LAmin] x100, which is considered an index of 
LA reservoir function and is influenced by LA wall stiffness and systolic displacement of the 
mitral annulus.
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2) Passive atrial emptying fraction (LApassive) = [(LAmax – LApreA)/LAmax] x100, as an 
index of LA conduit function, which is mainly related to LV diastolic function.
3) Active atrial emptying fraction = [(LApreA – LAmin)/LApreA] x100, as an index of LA 
active function. The major determinants of this function are the heart rhythm, the intrinsic 
contractility of the atrial myocardium and LApreA (according to the Frank-Starling effect).
Recent studies have used RT3DE to assess LA volume and function in different cardiac 
diseases, such as mitral valve diseases, atrial fibrillation, heart failure. Furthermore, the effect 
of specific therapies, such as cardiac resychronization therapy, atrial fibrillation ablation and 
mitral valve repair 31,40 on LA volume and functions has been evaluated. Using RT3DE, reverse 
remodeling of the LA and improvement in LA function has been demonstrated.
Figure 4. Assessment of LA volumes using RT3DE. Automatic border detection (yellow line) is obtained marking 5 reference points in the apical 
2- and 4-chamber views (upper panel) and manual corrections can be made to exclude the LA appendage and the pulmonary vein ostia. The LA 
3D model is automatically provided by the software (right lower panel) and can be evaluated also using the short-axis view (left lower panel). 
The changes in LA volumes during the heart cycle are plotted as a curve.
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assessment of rIght ventrIcular sIze and functIon
Because of its complex geometry, the assessment of right ventricular (RV) volumes and 
function is extremely challenging. Conventional 2D echocardiography may be therefore 
inadequate, because it relies on significant geometrical assumptions. However, an accurate 
assessment of RV size and function is of great importance because of the diagnostic and 
prognostic implications in several cardiac diseases. Without the need for geometrical model-
ling, RT3DE showed to be able to improve the accuracy and reproducibility of RV volumes 
quantification, as compared to 2D echocardiography 41,42. Furthermore, a new software for 
the 3D dataset post-processing, specifically adapted for RV morphology, has recently been 
Figure 5. Example of a 3D right ventricular (RV) reconstruction in a normal subject, using a dedicated software (TomTec Imaging Systems, 
Munich, Germany). The RV 3D model (upper panel) is obtained applying a semiautomated border detection algorithm over a complete cardiac 
cycle and RV end-diastolic (EDV) and end-systolic (ESV) volumes are automatically displayed, together with RV stroke volume (SV) and RV 
ejection fraction (RVEF).
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introduced (Figure 5). Tamborini et al applied this software in a large population for the 
assessment of RV volume and ejection fraction and found this analysis feasible and not time-
consuming 43.
valvular heart dIseases
The study of valvular heart diseases is one of the most important application of RT3DE. This 
technique is in fact ideally suited for a comprehensive assessment of the geometry of valves 
and subvalvular apparatus, given the non-planar anatomy and the complex function of these 
structures. By cropping the 3D dataset, unique “en face” views from both sides of the valve 
can be generated in real-time. Furthermore, any other possible oblique cut-plane or so-called 
multiplanar reconstructions (MPRs) can be easily obtained. Consequently, this approach 
certainly provides a more complete picture of valve diseases and may also lead to a better 
communication of the echocardiographic findings to the surgeon and to a more appropriate 
choice of treatment.
mitral valve
RT3DE has provided important insights into mitral valve (MV) physiopathology and signifi-
cantly contributed to the understanding of its anatomy and function. This technique was able 
to demonstrate the saddle shape of the annulus and the important interrelationship between 
mitral leaflets, chordae, papillary muscles and the LV 44. Dedicated software, such as 4D MV-
Assessment (TomTec Imaging systems, Unterschleissheim, Germany) and MV-Quantification 
(Philips Medical System, Bothell, Washington, USA), are now available to derive 3D quantifica-
tion of the MV annulus dimension, leaflet surface, tenting volume, aorto-mitral angle and 
papillary muscles geometry (Figure 6).
In patients with mitral stenosis, RT3DE can provide accurate planimetry of the valve orifice 
area, identifying the correct plane of the valve opening and obtaining, by cropping the im-
age, the real smallest orifice area (Figure 7). Compared with 2D traditional planimetry and 
Doppler-derived methods (pressure half-time, proximal isovelocity surface area), RT3DE 
showed the best agreement (r = 0.9) with the invasive measurement (mitral orifice area 
obtained using the Gorlin formula) and lower intra- and inter-observer variability 45,46. Fur-
thermore, this approach is less influenced by cardiac rhythm and hemodynamic conditions. 
In addition, RT3DE provides an accurate visualization of the degree of leaflet thickness, com-
missural fusion and calcification and can be applied after percutaneous mitral valvuloplasty 
to assess the commissural splitting.
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P
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Figure 6. 3D reconstruction of mitral valve (MV) anatomy using MV-Quantification software (Philips Medical System, Bothell, Washington, 
USA) from transesophageal 3D images. In the first panel an example of normal MV anatomy. In the second panel an example of a prolapsed (P3) 
MV. From these models, several measurements of MV annulus, leaflets and subvalvular apparatus can be derived. Furthermore, the aorto-mitral 
relationship can be studied. A = anterior leaflet; AL = antero-lateral commisure; Ao = aortic valve; P = posterior leaflet; P = postero-medial 
commisure.
Figure 7. Mitral valve stenosis: 3D transversal section viewed from the apex of the left ventricle. The commissural fusion is clearly visible and 
the residual smallest mitral valve orifice can be measured directly (yellow line) identifying the correct plane.
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The presence of MV prolapse is often over- or under-estimated using conventional 2D 
echocardiography, due to its non-planar leaflet-annulus relationship. In turn, RT3DE permits 
detailed visualization of the scallops involved, the chordal anatomy and the annulus enlarge-
ment that is often coexisting (Figure 6). Recently in more than 100 patients undergoing MV 
repair, Pepi et al demonstrated the accuracy of transthoracic and transesophageal RT3DE, 
as compared to 2D echocardiography, for the localization of MV prolapse 47. Transthoracic 
RT3DE (90%) and 2D transesophageal (85%) approaches showed similar accuracy, slightly 
lower than transesophageal RT3DE (96%) but significantly higher than 2D transthoracic 
echocardiography. In particular, RT3DE was highly accurate also in patients with complex MV 
prolapse (commissural lesions, bileaflet lesions, P1 and P3 prolapse), helping the surgeon to 
plan an appropriate procedure and improving the likelihood of MV repair.
With the advent of a fully-sampled matrix array transducer, the application of Color Dop-
pler RT3DE has become feasible, although still with a low temporal resolution. This modality 
Figure 8. Direct assessment of size and shape of mitral valve effective regurgitant orifice area (EROA). The 3D dataset is manually cropped by 
an image plane perpendicularly oriented to the jet direction until the narrowest cross-sectional area of the jet. EROA is measured by manual 
planimetry (white line) of the color Doppler signal tilting the image in an ‘en face’ view.
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provides important information to grade the severity of mitral regurgitation, crucial for ap-
propriate patient management and timing of surgical intervention. In fact, Color Doppler 
RT3DE, allowing for an unlimited plan orientation and in particular for an “en face” view of 
the MV, provides a direct assessment of size and shape of the effective regurgitant orifice 
area (EROA), obviating the geometric assumptions applied by 2D echocardiography (Figure 
8). Initial studies showed the incremental value of RT3DE measurements of EROA over 2D 
proximal isovelocity surface area and vena contracta width methods. The studies by Iwakura 
et al 48 and Kahlert et al 49 emphasized the importance of a 3D approach in patients with 
functional MR, in whom 2D echocardiography significantly underestimated the size of the 
regurgitant orifice.
Figure 9. Example of percutaneous aortic valve replacement in a patient with severe aortic stenosis (aortic valve area = 0.72 cm2). In the upper 
panel, a 3D short-axis view of the aortic valve with extensive calcifications of the 3 cusps. The moment when the catheter goes through LV 
outflow tract and the aortic valve is depicted in the left lower panel. Of note, no echo-markers for the identification of the exact position of the 
balloon are available so far. In the lower right panel, a 3D image of the aortic valve prosthesis, with a clear visualization of the leaflets inside the 
stent.




Compared with MV, experience visualizing aortic valve with RT3DE is limited, because of the 
low accessibility (in the far field) and the thin cusps. Most of the studies on aortic valve dis-
eases have been performed using a real-time 3D transesophageal approach with a feasibility 
in over 80% of patients (more in native than in prosthetic valves) 50. In patients with aortic 
stenosis, preliminary studies showed that the direct planimetry of the valve orifice is more 
accurate using RT3DE as compared to conventional 2D echocardiography 51. In addition, the 
evaluation of the stenosis severity by the continuity equation was more accurate using a 3D 
approach for LV outflow tract measurement 52. Recently, 3D transesophageal echocardiogra-
phy has also been proposed as a new tool to guide and monitor percutaneous aortic valve 
replacement (Figure 9) 53.
The utility of RT3DE for the study of RV valves (tricuspid and pulmonary) has not been 
comprehensively explored. However, this technique has the unique capability of obtaining 
the short-axis plane of the tricuspid valve (TV) with a simultaneous visualization of the 
three leaflets that is not possible to achieve with conventional 2D echocardiography. This 
characteristic opens new opportunities for the evaluation of TV stenosis, regurgitation and 
congenital diseases. So far, initial observations, mostly in the pediatric population, showed 
promising results using RT3DE for the study of TV anatomy (annulus and leaflets) 54,55.
congenItal heart dIseases
Three-dimensional echocardiography, using both reconstructions methods and real-time 
analysis, has been applied to detect several forms of congenital heart diseases. This tech-
nique permits a complete visualization of the complex spatial relationships of the cardiac 
lesions without extending the examination time. Furthermore, it provides a realistic and 
almost specimen-like preview of the surgical anatomy that facilitates planning of the surgi-
cal treatment. In patients with atrial or ventricular septal defects for example, RT3DE allows 
accurate evaluation of type, size, location and motion of the defect as well as the spatial 
relationships with the adjacent structures (Figures 10 and 11). Furthermore, measurement of 
the magnitude of shunting and information about adequacy of rims for device closure can be 
also obtained 53,56,57. RT3DE also showed to reliably define anatomic details of bicuspid aortic 
valves, Tetralogy of Fallot, patent ductus arteriosus, sinus of Valsalva aneurysm, Ebstein’s 
anomaly, subvalvular membranes and several other complex congenital diseases 58.
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future applIcatIons
Considering the abovementioned advantages over conventional 2D echocardiography, it 
is likely that RT3DE will become a routine part of most echocardiographic examinations. 
Furthermore, future advances in transducer and computer technology will allow for min-
iaturized probes with larger scanning volume, higher spatial and temporal resolution and 
more sophisticated and completely automated quantification software (including 3D speckle 
tracking analysis for assessment of myocardial strain and torsion mechanics).
Particularly promising is the potential application of RT3DE to guide intracardiac proce-
dures, mainly using the transesophageal approach. In fact, this technique may be useful in 
various transcatheter interventions: 1) percutaneous MV annuloplasty, for the identification 
Figure 10. Left atrial view of an atrial septal defect using RT3DE. The size and the localization in relation with the aorta are clearly depicted. 
More important, the presence of a small rim surrounding the defect can be identified.
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of the coronary sinus and quantification of the angle between the aortic orifice and the MV 
plane; 2) percutaneous aortic valve replacement, for the selection of the correct size and 
position of the prosthesis and on-line monitoring of the procedure; 3) atrial septal defect and 
patent foramen ovale closures with occluder devices 53; 4) elecrophysiological procedures, 
guiding the transeptal puncture and the positioning of the ablation catheters in the LA, 
eventually in combination with electroanatomical mapping systems 59. In all these proce-
dures, transesophageal RT3DE may improve the imaging guidance and reduce the radiation 
exposure from fluoroscopy.
conclusIons
RT3DE has made an important transition from a research tool to a clinically applicable imag-
ing technique. Main advantages of this modality over conventional 2D echocardiography 
are the accurate quantification of cardiac chamber size and function and the possibility of 
unlimited image plane orientations for better understanding of valvular or congenital heart 
diseases.
Figure 11. Real-time 3D echocardiogram (sagittal view) of a patient with a double outlet right ventricle with a large ventricular septum defect 
(see arrow).
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IntroductIon
In patients with severe, symptomatic drug-refractory heart failure and wide QRS complex, 
cardiac resynchronization therapy (CRT) has been demonstrated to have significant favorable 
effects on left ventricular (LV) remodeling and function and on clinical outcomes 1. However, 
a consistent percentage of patients fail to benefit from CRT when the established clinical and 
electrocardiographic selection criteria are applied 2. In particular, 20 to 30% of patients do not 
experience any clinical improvement after CRT and 40 to 50% of patients do not show any 
significant LV reverse remodeling or improvement in LV function. Therefore, at present atten-
tion has shifted towards a more accurate selection of CRT candidates, beyond the standard 
use of NYHA functional class, LV ejection fraction and QRS complex. Several contributory 
factors to CRT non-response have been reported, such as inappropriate LV lead position-
ing and, in patients with ischemic cardiomyopathy, the extent and location of scar tissue 
and viable myocardium 3,4. Furthermore, the presence of significant baseline LV mechani-
cal dyssynchrony has been demonstrated to be predictive for a positive response to CRT 5. 
Echocardiography has been extensively used for a direct assessment of LV dyssynchrony with 
different approaches. In this review, the value of 2D and 3D echocardiographic modalities 
to predict response to CRT will be discussed, highlighting the advantages and drawbacks of 
each modality.
two-dImensIonal echocardIography
Two-dimensional (2D) echocardiography is widely applied in the selection and manage-
ment of CRT patients, due to the low cost, broad availability, non-invasive approach and the 
extensive information that this technique can provide: 1) 2D echocardiography confirms 
the presence of an impaired LV systolic function at baseline and can evaluate CRT success 
at follow-up in terms of LV reverse remodeling and/or improvement of LV function; 2) 2D 
echocardiography evaluates the presence of other significant cardiac structural abnormali-
ties that might affect therapy success, such as valvular pathologies and the extent of akinetic/
thin (probably scar) myocardium; 3) 2D echocardiography can assess the presence of LV dys-
synchrony with adequate temporal resolution.
Visual assessment of wall motion synchrony by 2D echocardiography is probably the first 
and most straightforward step to approach a possible CRT candidate. However, the human 
eye with its limited temporal resolution is not able to precisely quantify the extent and loca-
tion of myocardial dyssynchrony 6. Nevertheless, it is possible to identify typical phenom-
ena that are associated with myocardial dyssynchrony. In the presence of delayed electrical 
conduction, the interventricular septum typically shows a characteristic multiphasic motion 
pattern (abnormal relaxation pattern) and the LV often demonstrates a rotating motion (typi-
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cally oriented counter-clockwise in late systole, often also referred to as “rocking motion” or 
“apical shuffle”), as seen in the apical 4-chamber view. In a small study on 53 patients, Jansen 
et al. were able to demonstrate that the identification of these two phenomena predicted the 
presence of LV dyssynchrony (defined by tissue Doppler criteria) and LV reverse remodeling 
after CRT with a sensitivity of more than 90% and a positive predictive value above 85% 7. The 
septal multiphasic motion pattern can be also detected and quantified from the M-mode 
short axis view at the level of the papillary muscles. The ‘septal-to-posterior wall motion 
delay’ is calculated as the shortest interval between the maximal posterior displacement 
of the septum and the maximal inward displacement of the posterior wall 8. However, this 
parameter demonstrated a limited predictive value and, more importantly, a poor feasibility 
especially in ischemic patients 9.
Two-dimensional echocardiography also permits the quantification of myocardial dys-
synchrony based on the analysis of endocardial wall motion. Breithardt et al. evaluated a 
semi-automated contour detection algorithm, which had been originally developed for 
stress-echocadiography, in a small cohort of CRT patients 10. Semi-automatically contoured 
septal and lateral wall motion curves were constructed from digitized video recordings of the 
apical 4-chamber view and averaged over several cardiac cycles to calculate the phase angle 
difference between the opposing walls. Patients with significant dyssynchrony, defined by a 
phase angle difference below -25° or above +25°, were better hemodynamic CRT responders, 
defined by a >10% increase in LV peak positive dP/dt and/or pulse pressure. This quantitative 
approach is obviously limited by the restriction to two opposing walls, but similar algorithms 
have later been transferred to 3D technology.
Kawaguchi et al. quantified LV dyssynchrony before and during CRT with contrast en-
hanced 2D echocardiography 11. Temporal and spatial pixel intensity changes were analyzed 
in up to 50 sequential beats (contrast variability imaging) and demonstrated improved septal 
inward motion and reduced LV septal-lateral dyssynchrony by CRT. This novel approach is 
clearly limited by its time-consuming and costly image acquisition which necessitates the 
intravenous administration of contrast agents and the lack of a widely commercially available 
software tool.
Modern quantitative analyses, such as tissue Doppler imaging (TDI) and speckle tracking 
analysis, are also based on 2D echocardiography and are discussed in more detail elsewhere 
in this Supplement. Briefly, TDI is at present the most frequently used technique for LV dys-
synchrony assessment 12. In particular, this technique allows the measurement of myocardial 
regional velocities with a very high temporal-resolution and, in relation to the electrical activ-
ity (QRS complex), enables the assessment of the electro-mechanical delay of 2 or more LV 
segments. Both two- and multiple-segmental approaches demonstrated their value for the 
prediction of clinical and echocardiographic response to CRT with high sensitivity and speci-
ficity 13,14. Recently, tissue synchronization imaging (TSI) has become available to simplify this 
approach, providing an intuitive color-coded image of the myocardium according to the 
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automatically detected time-to-peak systolic velocity (Ts) of each LV segment, together with 
the possibility of an automated quantitative assessment 15. Furthermore, when myocardial 
velocities are known, several other parameters can be derived off-line. Integrating veloci-
ties over time results in myocardial displacement, i.e. the total amount of tissue movement 
during systole. Alternatively, the spatial derivative of velocity and displacement leads to 
strain rate and strain calculation, respectively, as myocardial deformation measurements 16 
(Figure 1). However, these parameters have proven not to be as robust as myocardial velocity 
parameters for predicting response to CRT 14,17, probably due to the relatively poor repro-
ducibility, independent of the operator experience. Furthermore, for all myocardial motion 
and deformation measurements, angle-dependency of TDI analysis has to be considered a 
major drawback, limiting the application of this technique to few LV segments and to one 
component of contraction (longitudinal, radial and circumferential) at a time.
Speckle tracking analysis is a novel echocardiographic technique that allows myocardial 









Figure 1. Color-coded apical 4-chamber TDI images with off-line post-processing velocity, displacement, strain rate and strain tracings. The 
arrows indicate the systolic peak of the septum and lateral wall in each curve. Myocardial displacement is obtained integrating velocity over 
time. Myocardial strain rate is the spatial derivative of velocity and can be integrated throughout systole to obtain strain
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ing frame-to-frame the movement of natural myocardial acoustic markers (‘speckles’). The 
advantage of this technique, compared to TDI, is the angle-independency, allowing for the 
assessment of the 3 components of myocardial contraction (longitudinal, radial and circum-
ferential direction) in all LV segments. Initial studies have demonstrated the value of radial dys-
synchrony, assessed with this technique, to predict response to CRT 18,19. Furthermore, Gorcsan 
and colleagues suggested that combining radial dyssynchrony, measured by speckle tracking, 
with longitudinal dyssynchrony, measured by TDI, predicted echocardiographic response to 
CRT (88% sensitivity and 80% specificity) significantly better than either technique alone 20.
three-dImensIonal echocardIography
Early approaches to 3D echocardiography were based on the principle that a 3D data set is re-
constructed from a series of 2D images obtained using either freehand scanning or a mechani-
cally driven rotating transducer that sequentially recorded images at predefined intervals. 
This approach was limited by several technical aspects during image acquisition and required 
significant time-consuming off-line data processing 21. Nowadays, 3D echocardiography is 
a real-time technique that permits a rapid (5–7 minutes) post-processing of the 3D dataset 
off-line or on the scanner itself. In addition, the post-processing of the 3D dataset provides, in 
one single analysis, highly accurate quantification of LV volumes and function as well as the 
assessment of LV dyssynchrony with different modalities. In particular, 3D echocardiography, 
applying a semi-automated contour-tracing algorithm in multiple planes, has been validated 
against MRI and found to be more accurate and reproducible than 2D echocardiography 
for the assessment of LV volumes and function 22,23. These are crucial measurements in the 
evaluation of CRT success and carry out important prognostic implications 24. Furthermore, 
a 3D assessment of LV dyssynchrony has the advantage of a simultaneous acquisition of all 
LV segments, allowing for more extensive intersegment comparison, as compared with other 
2D techniques, and avoiding the problem of heart rate variability during image acquisition.
tri-plane tissue doppler imaging
Recently, color-coded TDI has been used in combination with tri-plane imaging, which allows 
for analysis of the 3D dataset along 3 major planes with a simultaneous visualization of the 
apical 4-, 2- and 3-chamber views (Figure 2). Sample volumes can be placed simultaneously 
in 12 LV segments and Ts of any LV segment can be compared during the same heartbeat. Van 
de Veire et al. applied this technique in 60 patients undergoing CRT and demonstrated that 
the standard deviation of Ts of 12 (6 basal and 6 mid segments) LV segments (Ts-SD-12), with 
a cut-off value of ≥33 ms, was able to predict echocardiographic response with a sensitivity 
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of 90% and a specificity of 83% 25. These findings further support the previous results of Yu et 
al. using single-plane TDI 14.
Similarly, it has become possible to apply TSI to the tri-plane view and this approach was 
found useful to identify the area of latest activation within the LV (Figure 3). Further studies 
are needed to confirm the feasibility of this technique in the clinical practice and to explore 
the value to predict response to CRT 25.
analysis of volumetric changes by real-time three-dimensional 
echocardiography
Real-time three-dimensional echocardiography (RT3DE) has emerged as a novel echocardio-
graphic technique for the assessment of LV dyssynchrony based on the analysis of regional 
volumetric changes. Briefly, LV 3D model is subdivided by the software in 17 wedge shaped 
(apart from the apex) sub-volumes according to standard segmentation (Figure 4). For the 
whole LV and for each volumetric segment, it is possible to derive time-volume data for the 
entire cardiac cycle and assess the time taken to reach the minimum systolic volume (Tmsv) 
Figure 2. Tri-plane TDI: example of the myocardial velocity curves that can be derived by positioning the sample volume in any LV segment of 
the tri-plane dataset (in this figure only 6 segments are displayed). This patient has substantial LV dyssynchrony with a wide dispersion of Ts: 
Ts-SD-12 is 57.5 ms (calculated between the aortic valve opening, AVO, and the aortic valve closure, AVC).
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(Figure 4). Segments should achieve the minimum volume at the same point in the cardiac 
cycle. However, when significant LV dyssynchrony is present, a wide dispersion of the Tmsv of 
the various segments occurs. The standard deviation of the Tmsv for 16 segments has been 
proposed as a measure of LV dyssynchrony and expressed as a percentage of the cardiac 
cycle (the systolic dyssynchrony index, SDI). Furthermore, parametric images, derived from 
over 800 virtual waveforms, are also provided by the software with a visual summary of LV 
regional contraction timings as a polar plot. The global Tmsv is used as timing reference and 
segments with a Tmsv that is approximately the same as global Tmsv are coded in green. 
Early segments are color-coded in blue, whereas late segments are coded in red/yellow, 
providing a rapid and intuitive assessment of the area of latest LV activation (Figure 5). This 
may be of particularly importance to guide an optimal LV lead placement. Kapetanakis et al. 
demonstrated the feasibility of LV dyssynchrony assessment with RT3DE in a large group of 
patients and normal subjects using SDI 26. In 26 patients referred for CRT implantation, the au-
thors observed that clinical responders (reduction in NYHA functional class) had significantly 
higher SDI at baseline as compared to non-responders (16.6±1.1% vs. 7.1±2.0%, p <0.001). In 
addition, after a mean follow-up of 10 months, a reduction in SDI was noted in responders, 
Figure 3. Example of tissue synchronisation imaging (TSI) applied to the tri-plane dataset. The time-to-peak systolic velocity is automatically 
detected for each LV segment (displayed as numbers in the polar plot) and the software provides an intuitive color-coded image of the 
myocardium (in yellow/orange the delayed segment), that is useful for the identification of the latest activated segment.
Nina Book.indb   60 26-09-11   12:03
61
Predicting response to CRT. The value of two- and three-dimensional echocardiography
whereas an increase in SDI was observed in non-responders. In a more recent study, Marsan 
et al. addressed the predictive value of this parameter and found that a SDI ≥5.6% had a 
sensitivity of 88% and a specificity of 86% to predict acute volumetric response to CRT 27.
Currently, no data are available on the predictive value of long-term response to CRT and 
the technique needs further validation for this application. Furthermore, RT3DE has still some 
limitations. First, the temporal resolution is suboptimal, about 30 to 35 ms. Nonetheless, the 
feasibility of LV dyssynchrony assessment has been demonstrated in a large group of normal 
individuals and unselected patients with and without QRS prolongation 26. Furthermore, the 
image quality is somewhat lower than 2D echocardiography and the incomplete visualiza-
tion of large ventricles may affect the quantitative analysis. However, several studies have 
reported a good feasibility in heart failure patients 27.
Figure 4. Example of 3D LV volumes generated by post-processing of a RT3DE dataset, acquired in a heart failure patient scheduled for CRT. 
The LV 3D model is subdivided by the software in 17 wedge shaped (apart from the apex) sub-volumes and for each volumetric segment, it is 
possible to derive time-volume data (lower panel) and assess the time taken to reach the minimum systolic volume (red dots).
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clInIcal ImplIcatIons and future dIrectIons
limitations of current lv dyssynchrony evaluation
Different echocardiographic approaches, with relative strengths and limitations, are avail-
able for the assessment of LV dyssynchrony and prediction of response to CRT. However, 
LV dyssynchrony assessment is a challenging goal, since it can not be considered an all-or-
none phenomenon but a dynamic condition that may vary widely and can be dependent 
on loading conditions 28. Consequently, it is still not clear which parameters, among those 
of myocardial motion, myocardial deformation or volume changes, would best reflect the 
complex pathophysiologic substratum of LV dyssynchrony in heart failure and whether the 
two-segmental model should be preferred over the multiple-segmental model. Therefore, 
a consensus on the definition of LV dyssynchrony is still lacking. In addition, the predictive 
value of these echocardiographic indices have been generated from small, single-center, 
non-randomized studies that used non-uniform definitions of response to CRT and evaluated 
a relatively short-term follow-up 5. Consequently, the results need to be confirmed in larger 
prospective multi-center studies. Ideally, the optimal predictor of a favourable response to 
Pre CRT After CRT
Figure 5. Parametric image derived from 3D dataset of a patient scheduled for CRT. The LV is divided into the standard segments (from 1 to 17). 
Using color coding (blue indicating early activation and orange-red late activation) representing regional time-to-minimum systolic volumes, 
the posterior wall is identified as the latest activated before CRT (left panel). Six months after CRT (right panel) the overall green color indicates 
absence of regions with delayed activation.
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CRT must have high sensitivity and specificity. In addition, it should also be simple to per-
form, widely available, easily reproducible and obtainable before and after CRT implantation.
future directions
The PROSPECT trial is currently evaluating in 426 patients whether specific echocardiographic 
measurements of dyssynchrony, including M-mode, Doppler and TDI, could be used to better 
predict a favourable response to CRT 29. The first, preliminary results revealed that none of 
the echocardiographic parameters was associated with a relevant additional response rate 30. 
However, these findings may be explained by the fact that a marked inter-core lab variability 
was found for these parameters, highlighting the challenges that the interpretation of these 
exams offer even to experienced personnel 31. Importantly, it should be noted that the most 
recent, 3D and automated imaging techniques were not included in this trial. Furthermore, 
a combined approach using different and complementary parameters of LV dyssynchrony, 
rather than using single parameters, may provide better results 20. More large prospective 
studies are needed to fully appreciate the role of LV dyssynchrony assessed with echocar-
diography in the prediction of response to CRT. Consequently, at present LV dyssynchrony 
assessment is not yet recommended for patient selection for CRT 12. Furthermore, it should be 
kept in mind that other pathophysiological issues may also be important to consider before 
CRT, including extent and location of scar tissue, optimal LV lead position and availability of 
coronary veins.
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objectives: To evaluate the value of real-time 3-dimensional echocardiography 
(RT3DE) to predict acute response to cardiac resynchronization therapy (CRT).
methods: 60 consecutive heart failure patients scheduled for CRT were included. 
RT3DE was performed before and within 48 hours after pacemaker implantation to 
calculate both left ventricular (LV) volumes and LV dyssynchrony. LV dyssynchrony 
was defined as the standard deviation of the time taken to reach the minimum 
systolic volume for 16 LV segments (referred to as the systolic dyssynchrony index, 
SDI). Patients were subsequently divided into acute responders or non-responders, 
based on a reduction ≥15% in LV end-systolic volume immediately after CRT.
results: 4 patients (7%) were excluded from further analysis because either subop-
timal apical acquisitions or significant translation artefacts. Out of the remaining 56 
patients, 35 patients (63%) were classified as acute responders. Baseline characteris-
tics were similar between responders and non-responders, except for the SDI, which 
was larger in responders. Moreover, responders demonstrated a significant reduc-
tion of SDI immediately after CRT (from 9.7±4.1% to 3.6±1.8%, p <0.001), whereas 
SDI did not change in non-responders (3.4±1.8% versus 3.1±1.1%, NS). ROC curve 
analysis revealed that a cut-off value for SDI of 5.6% yielded a sensitivity of 88% with 
a specificity of 86% to predict acute echocardiographic response to CRT (AUC 0.96).
conclusions: RT3DE is highly predictive for acute response to CRT (sensitivity 88% 
and specificity 86%). In addition, RT3DE allows assessment of changes in LV volumes 
and LV ejection fraction before and after CRT implantation.
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IntroductIon
In recent years cardiac resynchronization therapy (CRT) has become an established therapy 
for patients with drug-refractory heart failure and a wide QRS complex 1. However, close 
analysis of the large CRT trials revealed that up to 30% of patients did not respond to CRT 
when the established selection criteria were applied 2. Several studies addressing this 
issue have indicated that the presence of baseline left ventricular (LV) dyssynchrony is an 
important predictor of response to CRT 3. In the established selection criteria, the presence 
of a wide QRS complex has been used as a marker of cardiac dyssynchrony; however, recent 
findings showed that QRS duration correlated poorly with LV dyssynchrony, thereby explain-
ing its poor predictive value for response to CRT 4,5. Conversely, direct echocardiographic 
assessment of LV dyssynchrony has been demonstrated highly predictive for response to 
CRT 3. Since this observation, various echocardiographic parameters have been proposed 
to appropriately select CRT candidates ranging from simple M-mode-echocardiography to 
more advanced techniques such as tissue Doppler imaging (TDI) 6–12.
Recently, real-time 3-dimensional echocardiography (RT3DE) has become available as a 
novel promising technique for assessment of LV dyssynchrony based on analysis of regional 
volumetric changes of the LV. A potential advantage of the use of RT3DE in patients un-
dergoing CRT is that it allows both LV dyssynchrony assessment as well as highly accurate 
three-dimensional quantification of LV volumes and LV function during follow-up which 
allows assessment of therapy success. An initial study by Kapetenakis et al.13 demonstrated 
promising results when RT3DE was applied in a small group of patients undergoing CRT. In 
the current study, the value of RT3DE for prediction of response to CRT and the assessment LV 
volumes following CRT implantation was evaluated in a larger group of patients undergoing 
CRT implantation.
methods
patient population and protocol
Sixty consecutive heart failure patients, scheduled for implantation of a CRT device, were 
included in this study. Patients were selected for CRT on the following basis:
- LV ejection fraction (EF) ≤35%,
- QRS duration >120 ms and
- NYHA functional class III or IV, despite optimal medical treatment.
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Etiology was considered ischemic in the presence of significant coronary artery disease 
(>50% stenosis in ≥1 major epicardial coronary artery) on coronary angiographic examina-
tion and/or a history of myocardial infarction and previous coronary artery revascularizations. 
Patients with a recent myocardial infarction (<3 months) or decompensated heart failure 
were excluded.
Before implantation of the CRT device, LV volumes, LVEF and LV dyssynchrony were mea-
sured using RT3DE. LV stroke volume (SV) was also calculated using the pulsed-wave Doppler 
signal in the LV outflow tract. All echocardiographic measurements were repeated immedi-
ately (within 48 hours) after CRT implantation and the analysis was performed blinded to the 
pre-implantation data.
In addition, 20 patients were randomly identified to evaluate the inter- and intra-observer 
agreement for the analysis of LV volumes, LVEF and dyssynchrony. Bland-Altman analysis 
was performed to evaluate agreement between observer 1 and observer 2 to assess inter-
observer agreement and between 2 measurements by observer 1 to assess intra-observer 
agreement.
real-time 3-dimensional echocardiography
Acquisition of 3-dimensional data set
RT3DE was performed before and within 48 hours after CRT implantation. Patients were im-
aged in the left lateral decubitus position with a commercially available system (iE33, Philips 
Medical Systems, N.A., Bothell, Washington, USA) equipped with X3, fully sampled matrix 
transducer. Apical full-volume data sets were obtained in all patients.
For the evaluation of LV volumes and LVEF, the lowest scan line density was used and gain 
and compression were adjusted to obtain a good image quality and a clear endocardial bor-
der. With a specific software (Large Volume size, Vision 2007, Philips Medical Systems) 4 small 
real-time sub-volumes were acquired from alternate cardiac cycles and combined to provide 
a larger pyramidal volume (up to 103 x 103 degrees) and to ensure a complete capture of 
the LV. The acquisition was performed during end-expiratory apnoea within 1 breath hold 
and with a relatively stable heart rate to minimize translation artefacts between the 4 sub-
volumes. A 3D data set was considered unsuitable for analysis if >2 segments could not be 
visualized or if it contained visible translation artefacts. For the evaluation of LV dyssynchrony 
the frame rate was optimized by reducing the depth and by the acquisition of a full-volume 
data set of 7 sub-volumes.
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LV volumes and LV ejection fraction
RT3DE data sets were stored digitally and quantitative analysis of the 3D dataset was 
performed off-line using a semi-automated contour tracing algorithm (Q-Lab, version 5.0, 
Philips Medical Systems) over a complete heart cycle. The software provides for each frame 
the apical 4 chamber and 2 chamber views and the parasternal short-axis view. After first 
identifying the apex and mitral annulus on the end-diastolic and end-systolic frames (using 
5 reference points), a preconfigured ellipse is fitted to the endocardial border for each frame 
(mean number of frames: 16±4) and manually adjusted as required. The three-dimensional 
model of the LV is generated and LV volumes and LVEF are obtained (Figure 1). Papillary 
muscles were included in the LV cavity. The post-processing of the images required between 
2 and 4 minutes, depending on the manual adjustments needed.
Patients with an acute reduction ≥15% of LV end-systolic volume (reflecting acute im-
provement in LV systolic function) were considered acute responders to CRT 14. Additionally, 
LV SV was calculated before and within 48 hours after pacemaker implantation, using the 
pulsed-wave Doppler signal in the LV outflow tract from the apical long-axis view.
Figure 1. Example of 3D left ventricular (LV) volumes generated by post-processing of a RT3DE dataset, acquired in a patient scheduled for CRT. 
Panel A: pre CRT. Panel B: immediately post CRT. LV end-systolic volume (LVESV) and LV ejection fraction (LVEF) improved significantly.
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Assessment of LV dyssynchrony
The LV 3D model was subdivided in 16 pyramidal sub-volumes (6 basal segments, 6 mid 
segments and 4 apical segments). For the whole LV and for each volumetric segment, it is 
possible to derive time-volume data for the entire cardiac cycle and assess the time taken to 
reach the minimum systolic volume (Tmsv). From this information, as previously described 
by Kapetanakis et al.13, the standard deviation of 16 segments Tmsv expressed in percentage 
of cardiac cycle (the systolic dyssynchrony index, SDI) was calculated as a marker of global 
dyssynchrony of the LV. Of interest, the time-volume data of an akinetic segment is displayed 
by the software as a flat curve (excursion = 0) and the minimum systolic volume is identified 
in the middle of this curve, substantially not affecting the deviation standard of the timings 
(SDI). A completely dyskinetic segment (positive excursion) is excluded from the SDI calcula-
tion. For the baseline SDI calculation 36 out of 896 segments (4%) were discarded because 
dyskinetic; 232 segments (26%) were defined akinetic. After CRT, the same number of dyski-
netic segments was found, whereas the number of akinetic segments decreased to 198 (22%).
Figure 2. Example of left ventricular (LV) dyssynchrony analysis from a RT3DE data set using parametric images. The global Tmsv is used as 
timing reference; early segments are coded in blue, whereas late segments are coded in red. Pre CRT: Before CRT, the inferior segments are 
activated last. Post CRT: the homogeneous color indicates absence of regions with delayed activation, indicating resynchronization after CRT 
implantation. After implantation the systolic dyssynchrony index (SDI) decreased from 13.6% to 1.9%.
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In addition to the time-volume data, parametric images, derived from over 800 virtual 
waveforms, are provided by the software (Q-Lab, version 5.0, Philips Medical Systems) with a 
visual summary, as a polar plot, of LV regional contraction timings. The global Tmsv is used as 
timing reference. Accordingly, segments with a Tmsv about global Tmsv are coded in green. 
Early segments are coded in blue, whereas late segments are coded in red/yellow (Figure 2). 
Using both analysis of the regional time-to-minimum systolic volume and the parametric 
images, the latest activated LV wall (either lateral, posterior, inferior, septal, anteroseptal or 
anterior) was identified as a marker of regional dyssynchrony.
Reproducibility of the RT3DE measurements
Twenty patients were randomly identified for inter- and intra-observer agreement. Bland-
Altman analysis was performed to evaluate agreement between observer 1 and observer 
2 to determine inter-observer agreement. Similarly, the 3D measurements derived by the 
first observer were compared (Bland-Altman analysis) with the results calculated by the same 
operator 1 month later to determine intra-observer agreement.
The inter-observer agreement was good. According to the Bland-Altman analysis, the 
mean differences for SDI, LV end-diastolic volume (EDV), end-systolic volume (ESV) and EF 
were 0.1±1%, 1.3±17 ml, 0.3±17 ml and 0.4±4%, respectively, all not significantly different 
from zero. The intra-observer agreement was also good. The agreement between the 2 
measurements according to the Bland-Altman analysis was excellent with mean differences 
of 0.03±0.5% for SDI, 0.6±10 ml for LVEDV, 0.7±6 ml for LVESV and 0.8±3% for LVEF, all not 
significantly different from zero.
pacemaker implantation
The LV pacing lead was inserted transvenously via the subclavian route. First, a coronary 
sinus venogram was obtained using a balloon catheter. Next, the LV pacing lead was inserted 
through the coronary sinus, using an 8Fr-guiding catheter, and positioned as far as possible 
in the venous system, preferably in the (postero-) lateral vein. The right atrial and ventricular 
leads were positioned conventionally. When an indication for an internal defibrillator existed, 
a combined device was implanted. In all patients the implantation of the CRT device was suc-
cessful without major complications (Contak Renewal, Guidant Corp.; Insync III-CD or Insync 
Sentry, Medtronic Inc.). Two types of LV leads were used (Easytrak, Guidant Corp., or Attain, 
Medtronic Inc.). For each patient, the atrio-ventricular interval was adjusted to maximize 
mitral inflow duration with pulsed-wave Doppler echocardiography 15. No adjustment of the 
inter-ventricular delay was made.




Continuous data are presented as mean ± standard deviation. Categorical data are presented 
as absolute numbers or percentages. Comparisons between responders and non-responders 
were performed using the independent-samples t-test; comparisons between pre- and post-
implantation characteristics were performed using the paired-samples t-test. Before perform-
ing a Student’s t-test, the normal distribution of the continuous variables was verified using the 
Kolmogorov–Smirnov test and using the Levene’s test to check for equality in variances for all 
comparisons. Correlation analysis was used to compare the relationship between the change 
of SDI and the change of LVESV, LVEF and LV SV after CRT by the Pearson correlation coef-
ficients. Optimal cut-off value of SDI to predict acute echocardiographic response to CRT was 
determined by receiver-operating characteristic (ROC) curve analysis. The optimal cut-off value 
was defined as that providing the maximal accuracy to distinguish between echocardiographic 
responders/non-responders. For all tests, a p-value <0.05 was considered significant. A statisti-
cal software program SPSS 12.0 (SPSS Inc, Chicago, II, USA) was used for statistical analysis.
results
patient population
The study population consisted of 60 consecutive heart failure patients. Four patients (7%) 
were excluded from further analysis because of suboptimal apical acquisitions or significant 
translation artefacts. The baseline characteristics of the remaining 56 patients (45 men, mean 
age 65±9 years) are summarized in Table 1. All patients were in sinus rhythm and most patients 
were in NYHA class III; 62% of patients had ischemic cardiomyopathy. RT3DE revealed severe LV 
dilation (mean LVEDV 201±48 ml), with depressed LV function (mean LVEF 28±6%). In addition, 
substantial LV dyssynchrony was present as indicated by a mean SDI of 7.3±4.6%. The latest 
activated LV wall was the lateral in 17 patients (30%), the posterior in 16 patients (29%), the 
inferior in 13 patients (23%), the anterior in 9 patients (16%) and the septum in 1 patient (2%).
acute echocardiographic response
Immediately after CRT implantation, 35 patients (63%) experienced an acute reduction in LVESV 
≥15%; as pre-defined, these patients were classified as acute responders. The acute responders 
also showed a significant increase in LVEF and LV SV (Table 2). In contrast, LVEDV showed no 
immediate decrease after CRT implantation (from 201±48 ml to 191±46 ml, NS) (Table 2).
Nina Book.indb   74 26-09-11   12:03
75
RT3DE predicts acute response to CRT
Table 1. Baseline characteristics of the patient population (n = 56).
age (years) 65±9
Gender (M/F) 45/11
NYHA class III/IV (n) 53/3
QRS duration (ms) 148±31
ECG pattern:



















LV SV (ml) 38±14
SDI (%) 7.3±4.6
IVCD: non-specific intraventricular conduction delay, LBBB: left bundle branch block, LVEDV: left ventricular end-diastolic volume, LVESV: left 
ventricular end-systolic volume, LVEF: left ventricular ejection fraction, LV SV: left ventricular stroke volume, NYHA: New York Heart Association, 
SDI: systolic dyssynchrony index. 



















































* p <0.001 baseline versus follow-up. Abbreviations see Table 1.
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All baseline characteristics were comparable between responders and non-responders, 
except for LV dyssynchrony as measured with the use of RT3DE (assessing SDI) (Table 2 and 
Table 3).The SDI was significantly higher in responders as compared to non-responders 
(9.7±4.1% versus 3.4±1.8%, p <0.001). Moreover, responders demonstrated a significant 
reduction in SDI immediately after CRT (from 9.7±4.1% to 3.6±1.8%, p <0.001), whereas in 
non-responders SDI remained unchanged (from 3.4±1.8% to 3.1±1.1%, NS) (Table 2). In addi-
tion, the postero-lateral region (where the LV pacing lead is positioned) was latest activated 
in 74% of responders as compared to 33% of non-responders (p = NS).
prediction of acute response after crt implantation by rt3de
A fair correlation was observed between baseline SDI and the change in LVESV after CRT (r 
= 0.60, p <0.001), while a good correlation between baseline SDI and the change in LVEF 
after CRT was demonstrated (r = 0.70, p <0.001) (Figure 3). A fair correlation was also noted 
between baseline SDI and the change in LV SV after CRT (r = 0.51, p <0.001).






Age (years) 66±8 65±10 NS
Gender (M/F) 16/5 29/6 NS
Ischemic/Idiopathic (n) 15/6 20/15 NS
NYHA class III/IV (n) 21/0 32/3 NS
QRS duration (ms) 157±29 147±35 NS
ECG pattern:
LBBB/IVCD (n) 9/12 10/25 NS
IVCD: non-specific intraventricular conduction delay, LBBB: left bundle branch block, NYHA: New York Heart Association.
Figure 3. The correlation between the change (delta) in LV ejection fraction (LVEF) after CRT and baseline systolic dyssynchrony index (SDI) is shown.
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To defi ne the optimal cut-off  value to predict echocardiographic response to CRT, ROC 
curve analysis was performed. At a cut-off  value of 5.6% for LV dyssynchrony (SDI), a sensitiv-
ity of 88% with a specifi city of 86% were obtained to predict an acute reduction ≥15% of 
LVESV (area under the curve = 0.96, 95% CI = 0.9 -1.0, p <0.001) (Figure 4). Accordingly, using 
Figure 4. ROC curve analysis demonstrated a sensitivity of 88% with a specifi city of 86% to predict an acute reduction of left ventricular end-
systolic volume ≥15% after CRT at a cut-off  of 5.6% for LV dyssynchrony (SDI). AUC = area under the ROC curve.
Figure 5. Comparison between patients with substantial versus non-substantial LV dyssynchrony (SDI) (cut-off  value of ≥5.6%). The decrease 
in LV end-systolic volume (Panel A) and the increase in LV ejection fraction (Panel B) and in LV stroke volume (Panel C) are signifi cantly higher in 
patients with substantial LV dyssynchrony.
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this cut-off value, 34 patients (61%) had SDI ≥5.6%; these patients showed a significantly 
better improvement in LV systolic function (defined as a reduction of LVESV and an increase 
in LVEF and SV) as compared to patients with SDI <5.6% (Figure 5).
dIscussIon
The findings in the current study can be summarized as follows: 1) acquisition and analysis 
of a RT3DE data set is feasible and reproducible in patients with severely dilated left ven-
tricles and provides quantitative information on both LV volumes and LV dyssynchrony; 2) all 
baseline characteristics were comparable between responders and non-responders to CRT, 
except for LV dyssynchrony as measured using the SDI, which was larger in responders; 3) a 
SDI ≥5.6% had a sensitivity of 88% and a specificity of 86% to predict an acute reduction in 
LVESV after CRT implantation.
benefit of crt
Recent large clinical trials have demonstrated the beneficial effects of CRT on symptoms, 
exercise capacity, LV reverse remodeling and, most important, on clinical outcome.1 However, 
despite these impressive results approximately one third of patients fails to improve after 
CRT when the established selection criteria are being applied (NYHA functional class III or 
IV, LVEF ≤35% and QRS duration >120 ms) 2. Several studies have recently emphasized the 
importance of the presence of significant baseline LV dyssynchrony for the prediction of 
response to CRT 3. Traditionally QRS duration has been used as a marker of LV dyssynchrony; 
however recent data has suggested that QRS duration is a poor marker of LV dyssynchrony, 
thereby explaining its poor predictive value for response to CRT 4,5. Since the observation 
that QRS duration is a poor marker of LV dyssynchrony several echocardiographic methods 
have been introduced to quantify LV dyssynchrony. Most experience has been obtained with 
tissue Doppler imaging. For example Bax and colleagues 7 analyzed the electromechanical 
activation delay in the longitudinal direction among 4 basal LV segments, whereas Yu et 
al. 8,9 have used the standard deviation of time-to-peak systolic velocity of 12 LV segments. 
Both studies have identified the TDI parameters of LV dyssynchrony as powerful predictors 
of clinical response and LV reverse remodeling after CRT. More recently, also radial LV dys-
synchrony assessed by speckle tracking strain was able to predict immediate and long-term 
response to CRT 16. At present, it is still unclear which technique is the gold standard for LV 
dyssynchrony since large comparative studies directly comparing the relative merits of the 
different techniques are lacking 17.
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RT3DE has been recently introduced as a promising technique for the assessment of LV dys-
synchrony. In theory RT3DE has several potential advantages over other echocardiographic 
techniques: 1) Next to LV dyssynchrony analysis RT3DE permits highly accurate quantitative 
measurement of LV size and function which allows for simultaneous evaluation of therapy 
success, 2) RT3DE measures a composite effect of longitudinal, radial and circumferential 
contraction which is angle-independent, potentially resulting in more reproducible results 
and, 3) RT3DE is able to measure all (16) myocardial segments in 1 single recording allowing 
for a rapid assessment of the area of latest LV activation to guide optimal LV lead placement.
assessment of lv volumes and lv function by rt3de
A recent study by Yu et al.18 demonstrated that a reduction in LV end-systolic volumes is the 
best predictor of improved survival after CRT, whereas improvement in clinical parameters 
was not predictive. Therefore improvement in LV volumes after CRT implantation probably 
provides the most clinical meaningful marker of therapy success. Quantification of LV end-
systolic volume before CRT and during follow-up is therefore crucial in order to assess therapy 
success. In most studies the measurement of LV volumes and LVEF has been performed with 
echocardiography from a 2D dataset using the Simpson’s biplane method. It has been dem-
onstrated however, that the 3D echocardiographic approach is superior compared to the 
2D approach and comparable with magnetic resonance imaging for LV volumes estimation 
19,20. RT3DE, which was used in the current study, permits a rapid and accurate quantification 
of LV size and function with a semi-automated contour-tracing algorithm 21. Initial studies 
in CRT patients have used RT3DE to assess both acute changes in LV volumes as well as the 
effects at mid-term follow-up 13. In the current study a reduction ≥15% of LVESV immediately 
after CRT (reflecting improved LV systolic function) was used to define acute response and 
non-response after CRT. An acute improvement in LV end-systolic volume was noted in 63% 
of patients; this finding is in agreement with other studies focusing on the acute response to 
CRT using different 2D echocardiographic parameters including dP/dT, stroke volume, LVESV 
and LVEF 14,22–26.
Of interest, RT3DE can also provide information on regional LV function (measured as ex-
cursion) and consequently information on regional wall motion abnormalities. For instance, 
an akinetic segment is displayed as a flat curve, a dyskinetic segment as a positive excursion, 
whereas hypo- and normokinetic segments are displayed as negative excursions. Not only 
may the presence of baseline wall motion abnormalities (per se or included in wall motion 
score index) have influence on response to CRT, but also the effect of CRT on regional LV 
function can be evaluated. However, no studies have validated RT3DE (versus MRI or 2D 
echocardiography) for this specific analysis. Of note, wall motion abnormalities, such as 
akinesia and dyskinesia, do not affect the SDI calculation.
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In a small group of patients Kapetanakis and coworkers 13 demonstrated that patients with a 
significant improvement in symptoms and LV reverse remodeling after CRT (responders) had 
a larger SDI before CRT implantation, as compared to non-responders to CRT. In the current 
study similar results were found in a group of 56 heart failure patients: a higher SDI value 
was noted in the responders as compared to non-responders (9.7±4.1% versus 3.4±1.8%, p 
<0.001). However, the absolute SDI values were somewhat lower in the current study. This 
difference may partially be explained by the different software packages used for the 3D 
dataset analysis. In contrast to the Tomtec-software (as used by Kapetanakis et al.13), the Q-
lab software (used in the current study) does not permit the operator to change the point of 
time-to-minimum systolic volume which is automatically detected, yielding a better repro-
ducibility of the measurements, which tends to result in lower SDI values. Another difference 
between both studies is the fact that Kapetanakis et al.13 used an arbitrary cut-off value for 
significant mechanical dyssynchrony, which was defined as an SDI >3 SD above the mean 
for a group of normal subjects (8.3%). In the current study on the other hand, ROC curve 
analysis was performed to define the optimal cut-off value for SDI to predict response to CRT 
in a group of heart failure patients undergoing CRT; based on this ROC curve analysis, an SDI 
≥5.6% was identified as the optimal cut-off value which yielded a sensitivity of 88% with a 
specificity of 86% to predict an acute response to CRT. In contrast, the earlier proposed value 
of 8.3% for SDI yielded an excellent specificity (100%) with a lower sensitivity of 46%. Burgess 
et al. 27 compared RT3DE and TDI for the assessment of LV dyssynchrony. Applying a cut-off 
value of 32 ms for the Ts-SD of 12 segments and of 8.3% (cut-off value of Kapetanakis et al.) 
for the SDI, these authors demonstrated that TDI identified a much greater proportion of 
patients with significant LV dyssynchrony than RT3DE (64% versus 42%), suggesting that the 
population derived cut-off value of Kapetenakis is somewhat high.
An important advantage of RT3DE is the simultaneous assessment of 16 LV segments in 1 
recording. Through the analysis of each regional time-to-minimum systolic volume and the 
display of parametric imaging in polar plots (Figure 2), RT3DE permits a rapid identification 
of the area of latest mechanical activation. Tailoring the LV lead position to the exact area of 
maximal mechanical delay has recently attracted attention, although the technical limita-
tions of transvenous coronary sinus pacing still exist. Several studies demonstrated that LV 
pacing at the site of latest activation is associated with the maximal clinical benefit and the 
greatest LV reverse remodeling 28,29 compared with LV pacing at the standard location (the 
postero-lateral wall). In line with these results, the current study showed a clear, although 
not statistically significant, trend of a higher percentage of patients with the postero-lateral 
wall as the site of latest activation in responders (74%) compared to non-responders (33%).
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study limitations
Echocardiographic or clinical data at mid- or long-term follow-up were not available and 
the present study focused on acute response to CRT. However, several studies, as discussed 
above, have already explored the acute beneficial effects of CRT and, recently, Suffoletto 
et al. demonstrated that acute improvement in systolic function translated in LV reverse 
remodeling at mid-term follow-up 30. In view of the relatively small study population and the 
novelty of this technique, the predictive value of RT3DE needs to be further investigated in 
a multicenter prospective study. Also, the predictive value of RT3DE (SDI) as evaluated in the 
current study was not compared to other echocardiographic techniques currently available 
for LV dyssynchrony assessment such as TDI and strain imaging. Further multicenter studies 
are needed to explore the relative merits of the different techniques for the prediction of 
response to CRT, in order to define a gold standard for LV dyssynchrony assessment in CRT 
patients.
Recent studies have indicated that regional scar tissue and global scar burden may also be 
related to non-response to CRT. Data on scar tissue and/or segmental wall motion abnormali-
ties, however, were not systematically available in the current study. Furthermore, no data 
were available on the exact position of the LV pacing lead and consequently data on the 
potential effect of LV lead position in relation to the site of latest activation were not available.
conclusIons
RT3DE allows quantitative analysis of LV dyssynchrony as well as assessment of LV volumes 
and ejection fraction in heart failure patients. An SDI ≥5.6% is highly predictive for acute 
volumetric response to CRT.
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objectives: Different imaging modalities have been explored for assessment of 
left ventricular (LV) dyssynchrony. Gated myocardial perfusion SPECT (GMPS) with 
phase analysis is a reliable technique to quantify LV dyssynchrony and predict 
response to cardiac resynchronization therapy. Real time three-dimensional echo-
cardiography (RT3DE) is a novel imaging technique that provides an index of LV 
systolic dyssynchrony (SDI), based on regional volumetric changes as a function of 
time and calculated as the standard deviation of time-to-minimum systolic volume 
of 16-standard myocardial segments expressed in percentage of cardiac cycle. The 
aim of this study was to compare LV dyssynchrony evaluated with GMPS with LV 
dyssynchrony assessed with RT3DE.
methods: The study population consisted of 40 heart failure patients who under-
went both GMPS and RT3DE.
results: Good correlations between LV dyssynchrony assessed with RT3DE and 
GMPS were demonstrated (r = 0.76 for histogram bandwidth, r = 0.80 for phase SD, 
p <0.001). Patients with substantial LV dyssynchrony on GMPS (defined as ≥135° 
for histogram bandwidth and ≥43° for phase SD), had significantly higher SDI than 
patients without substantial LV dyssynchrony.
conclusions: The good correlations between LV dyssynchrony assessed with GMPS 
and with RT3DE provide further support for the use of RT3DE for reliable assessment 
of LV dyssynchrony.
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IntroductIon
Patients with heart failure, depressed left ventricular (LV) function and wide QRS complex 
may benefit from cardiac resynchronization therapy. Previous studies have shown that the 
presence of LV dyssynchrony is important for the response to cardiac resynchronization 
therapy (CRT) 1. Different imaging modalities have been explored for assessment of LV dyssyn-
chrony, including echocardiography 2,3, magnetic resonance imaging 4 and gated myocardial 
perfusion single photon emission computed tomography (GMPS) with phase analysis 5,6. A 
three-dimensional (3D) technique may be preferred since these techniques provide informa-
tion on LV dyssynchrony in the entire left ventricle. In addition, reliable information on LV 
ejection fraction (LVEF) can simultaneously be obtained. Recently, a novel echocardiographic 
technique has emerged for the assessment of LV dyssynchrony: real time three-dimensional 
echocardiography (RT3DE) 7. This technique allows accurate quantification of LV volumes and 
LVEF 8–10 and functional assessment of 16 LV segments. In addition, an index of LV systolic 
dyssynchrony (SDI), based on analysis of regional volumetric changes, can be derived from 
RT3DE to quantify the severity of LV dyssynchrony 7.
Initial results with RT3DE for assessment of LV dyssynchrony are promising but further 
validation is needed. In the current study, assessment of LV dyssynchrony by RT3DE was com-
pared with GMPS using phase analysis. Phase analysis is a count-based method that extracts 
the phase from the regional LV count changes during the cardiac cycle. Phase information is 
related to the onset of mechanical contraction in the 3D myocardial wall and therefore pro-
vides information on the synchrony of the contraction of the LV 11–13. This approach provides 
important information on the presence of LV dyssynchrony in patients with heart failure 
and can predict response to CRT 5,6. The aim of the present study was to investigate how LV 
dyssynchrony as evaluated with phase analysis with GMPS relates with LV dyssynchrony as 
assessed with RT3DE. Assessment of LVEF with both techniques was also compared.
methods
patients and study protocol
The study population consisted of 40 consecutive patients with drug-refractory heart failure, 
who were referred to our heart failure out-patient clinic for evaluation of therapeutic options 
(e.g. medical therapy, surgery, CRT). In all patients, GMPS was performed to exclude inducible 
ischemia or viability, in order to refer patients to revascularization if indicated 14,15. In addition, 
phase analysis was used to evaluate the presence of LV dyssynchrony. All patients also un-
derwent RT3DE for assessment of LV volumes and function, and LV dyssynchrony. Thereafter, 
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LV dyssynchrony measured with RT3DE was compared with LV dyssynchrony measured with 
phase analysis.
Patients’ clinical status was evaluated by assessment of NYHA functional class, exercise 
capacity (using the 6-minute walk test) and quality-of-life score (using the Minnesota quality-
of-life questionnaire).
gated myocardial perfusion spect
Resting GMPS with technetium-99m tetrofosmin (500 MBq, injected at rest) was performed 
using a triple head SPECT camera system (GCA 9300/HG, Toshiba Corp.) equipped with low 
energy high resolution collimators. A 20% window around the 140-KeV energy peak of 
technetium-99m tetrofosmin was used. A total of 90 projections (step and shoot mode, 35 
seconds per projection, imaging time 23 minutes) was obtained over a 360-degree circular 
orbit. GMPS acquisition involved 16 frames per cardiac cycle with an average temporal 
resolution of 45 ms. Data were stored in a 64 x 64 matrix. Data were reconstructed by filtered 
backprojection and then reoriented to yield gated short-axis images. The reconstruction was 
performed over 360 degrees and took generally 3–5 minutes. LVEF was assessed from the 
gated short-axis images using previously validated and commercially available automated 
software (quantitative gated SPECT, QGS, Cedars-Sinai Medical Center, Los Angeles, Califor-
nia) 16.
All studies were then submitted to the Emory Cardiac Toolbox for phase analysis 11. A phase 
distribution was extracted from a GMPS study, representing the regional onset of mechanical 
contraction of the LV. It can be displayed in a polar map or in 3D and used to generate a 
phase histogram. Two quantitative indices have been recently validated to assess LV dyssyn-
chrony with phase analysis and to predict response to CRT 5,6: 1. histogram bandwidth, which 
includes 95% of the elements of the phase distribution; 2. phase SD, which is the SD of the 
phase distribution. In a normal heart LV contraction is homogeneous and phase distribution 
is nearly uniform with a highly peaked distribution. As the LV mechanical synchrony worsens, 
histogram bandwidth and phase SD are expected to increase. Based on previous work 6, we 
applied a cut-off value of 135º for histogram bandwidth and of 43º for phase SD to define 
substantial LV dyssynchrony.
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real time three-dimensional echocardiography
Acquisition of the 3-dimensional data set
Patients were imaged in left lateral decubitus position with a commercially available sys-
tem (iE33, Philips Medical Systems, N.A., Bothell, Washington, USA) equipped with X3, fully 
sampled matrix transducer. Apical full-volume data sets were obtained in all patients. The 
acquisition of all images could be completed in approximately 5 minutes in all patients. For 
the evaluation of LV volumes and LVEF, the lowest scan line density was used and gain and 
compression were adjusted to obtain a good image quality and a clear endocardial border. 
With dedicated software (Large Volume Size, Vision 2007, Philips Medical Systems) 4 small 
real-time sub-volumes were acquired from alternate cardiac cycles and combined to provide 
a larger pyramidal volume (up to 103 x 103 degrees) and to ensure a complete capture of the 
LV. The acquisition was performed during end-expiratory phase of 1 breath-hold and with 
a relatively stable heart rate to minimize translation artefacts between the 4 sub-volumes. 
For the evaluation of LV dyssynchrony the frame rate was optimized by reducing the depth 
and by the acquisition of a full-volume data set of 7 sub-volumes with an average temporal 
resolution of 30 ms.
Assessment of LV volumes and LV ejection fraction
RT3DE data sets were stored digitally and quantitative analysis of the 3D data was performed 
off-line using a semi-automated contour tracing algorithm (Q-Lab, version 5.0, Philips Medi-
cal Systems) over a complete heart cycle. The echocardiographic examination and the off-line 
analysis were performed by the same experienced echocardiographist, blinded to the GMPS 
and clinical data.
After first identifying the apex and mitral annulus on end-diastolic and end-systolic slices, 
a preconfigured ellipse was fitted to the endocardial border for each frame. The endocardial 
border definition was optimal in most of patients and, in case of a suboptimal automated 
contour tracing, manual adjustments have been performed (in 12 out of 40 patients). A 
3D model of the LV was then generated and LV volumes and LVEF fraction were provided 
(Figure 1). Papillary muscles were included in the LV cavity. The post-processing of the images 
required between 2 and 5 minutes.
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Assessment of LV dyssynchrony
The LV 3D model was subdivided in 16 pyramidal sub-volumes (6 basal segments, 6 mid 
segments and 4 apical segments). For the whole LV and for each volumetric segment, it is 
possible to derive time-volume data for the entire cardiac cycle and assess the time taken to 
reach the minimum systolic volume (Tmsv). As previously described by Kapetanakis et al 7, 
the standard deviation of 16 segments Tmsv expressed in percentage of cardiac cycle (SDI) 
was calculated. Parametric images, derived from over 800 virtual waveforms, are also pro-
vided by the software (Q-Lab, version 5.0, Philips Medical Systems) with a visual presentation 
(polar plot) of LV regional contraction timings. The global Tmsv is used as timing reference 
and coded in green. Early segments are coded in blue, whereas late segments are coded in 
red/yellow (Figure 2) allowing a rapid identification of the area of latest activation.
Figure 1. Example of 3D LV volumes and LVEF generated by post-processing of a RT3DE dataset, acquired in a heart failure patient.
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Reproducibility of the RT3DE measurements
Twenty patients were selected to evaluate the inter- and intra-observer agreement for the 
analysis of LVEF and LV dyssynchrony. Bland-Altman analysis was performed to evaluate 
agreement between observer 1 and observer 2 to determine inter-observer agreement. An 
excellent agreement was found with a mean difference for SDI and LVEF of 0.1±2 % (p = 
NS) and 0.4±3 % (p = NS), respectively. Similarly, the 3D measurements derived by the first 
observer were compared (Bland-Altman analysis) with the results calculated by the same 
operator 1 month later. The intra-observer agreement was excellent with average differences 
of 0.03±0.4 % (p = NS) for SDI and 0.8±2 % (p = NS) for LVEF.
statistical analysis
Continuous data are presented as mean ± SD. Categorical data are presented as absolute 
number or percentages. Unpaired and paired Student t test, Mann-Whitney test and χ2 test 
were used for appropriate comparisons. Pearson’s correlation analysis was performed to 
evaluate the relation between LV dyssynchrony (SDI) by RT3DE and histogram bandwidth and 
phase SD by the phase analysis of GMPS. A similar approach was used to compare assessment 
of LVEF by RT3DE and GMPS together with the Bland-Altman analysis that was performed to 
evaluate the mean difference between the two techniques. A p-value <0.05 was considered 
to be statistically significant. A statistical software program SPSS 12.0 (SPSS Inc, Chicago, II, 
USA) was used for statistical analysis.
Figure 2. Example of a patient with severe LV dyssynchrony on both RT3DE and phase analysis with GMPS. 
Panel A: Polar map generated by post processing of a RT3DE dataset. Early activated segments are coded in blue, whereas late activated 
segments are coded in red/yellow allowing a rapid identification of the area of latest activation. This patient had an SDI of 16.4%. 
Panel B: Histogram distribution generated by phase analysis displaying a non-uniform and wide-spread distribution (early activated segments 
in blue, late activated segments in yellow) (same patient as panel A). This patient had a histogram bandwidth of 257º and a phase SD of 77.7º





Baseline characteristics of the study population (32 men; mean age 62±10 years) are sum-
marized in Table 1. Most patients had ischemic etiology of cardiomyopathy (75%) and 68% 
of patients was in NYHA functional class III. Mean QRS duration was 135±33 ms. Patients 
had severe LV dysfunction and dilatation (mean LVEF 29±7%, mean LV end-diastolic volume 
223±70 ml).
The correlation between LVEF assessed with GMPS and RT3DE was good (r = 0.84 (r2 = 0.7, 
p <0.001). The Bland-Altman analysis revealed a small, but non-significant difference in the 
value of LVEF measured with RT3DE and GMPS: GMPS LVEF was 0.8±8 % lower than RT3DE 
LVEF (p = NS) (Figure 3).
lv mechanical dyssynchrony
The mean value of SDI in the study population was 7.8±4.8%, whereas from phase analysis 
the mean value of histogram bandwidth was 149±73º and the mean value of phase SD was 
46.0±21.7º. A good correlation was observed between SDI and LV dyssynchrony assessed with 
Table 1. Baseline characteristics of the study population (n = 40).
age (yrs) 62±10
Gender (M/F) 32/8



















Histogram bandwidth (º) 149±73
Phase SD (º) 46±22
LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; 6-MWT = 
6 minute walk test; QoL = quality of life score.
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phase analysis. Pearson’s correlation coefficient was 0.76 (r2 = 0.58) for histogram bandwidth 
(p <0.001) and 0.80 (r2 = 0.64) for phase SD (p <0.001) (Figures 4A and 4B). Based on previous 
work,6 we applied a cut-off value of 135º for histogram bandwidth and of 43º for phase SD 
to define substantial LV dyssynchrony. Considering the value of histogram bandwidth, 21 
patients (52%) had substantial LV dyssynchrony (defined as ≥135º). No significant differences 
in baseline echocardiographic characteristics were found between patients with and without 
substantial LV dyssynchrony (Table 2), except that SDI was higher in patients with histogram 
bandwidth ≥135º: 10.4±5.1% versus 4.8±1.8% (p <0.001) (Figure 5A). Considering phase SD, 
19 patients (48%) had substantial LV dyssynchrony (defined as ≥43º) and these patients had 
a significantly higher value of SDI as compared to patients without substantial LV dyssyn-
chrony: 11.2±4.8% versus 4.7±1.9% (p <0.001) (Figure 5B).
Figure 3. Bland-Altman scatter plot of differences in LVEF between RT3DE and GMPS and the average LVEF between the two techniques: GMPS 
LVEF is 0.8±8 % lower than RT3DE LVEF (p = NS).
observer were compared (Bland-Altman analysis) with the results
calculated by the same operator 1 month later. The intraobserver
agreement was excellent with average differences of 0.03  0.4%
(P  NS) for SDI and 0.8  2% (P  NS) for LVEF.
Statistical Analysis
Continuous data are presented as mean  SD. Categorical data are
presented as absolute number or percentages. Unpaired and paired
Student t test, Mann-Whitney test, and 2 test were used for appro-
priate comparisons. Pearson’s correlation analysis was performed to
evaluate the relation between LV dyssynchrony (SDI) by RT3DE and
histogram bandwidth and phase SD by the phase analysis of GMPS.
A similar approach was used to compare assessment of LVEF by
RT3DE and GMPS together with the Bland-Altman analysis that was
performed to evaluate the mean difference between the two tech-
niques. A P value less than .05 was considered to be statistically
significant. A statistical software program (SPSS 12.0, SPSS Inc,
Chicago, IL) was used for statistical analysis.
RESULTS
Patient Characteristics
Baseline characteristics of the study population (32 men; mean age
62  10 years) are summarized in Table 1. Most patients had
ischemic cause of cardiomyopathy (75%) and 68% of patients were
in NYHA functional class III. Mean QRS duration was 135  33
milliseconds. Patients had severe LV dysfunction and dilatation
(mean LVEF 29  7%, mean LV end-diastolic volume 223  70 mL).
The correlation between LVEF assessed with GMPS and RT3DE
was good (r  0.84 [r2  0.7, P  .0001]). The Bland-Altman analysis
revealed a small, but nonsignificant difference in the value of LVEF
measured with RT3DE and GMPS: GMPS LVEF was 0.8  8% lower
than RT3DE LVEF (P  NS) (Figure 3).
Figure 3 Bland-Altman scatter plot of differences in left ven-
tricular ejection fraction (LVEF) between real-time 3-dimen-
sional echocardiography (RT3DE) and gated myocardial perfu-
sion single photon emission computed tomography (GMPS)
and average LVEF between two techniques: GMPS LVEF is
0.8  8% lower than RT3DE LVEF (P  not significant).
Figure 4 (A), Correlation between histogram bandwidth as-
sessed with phase analysis of gated myocardial perfusion
single photon emission computed tomography (GMPS) and left
ventricular (LV) dyssynchrony assessed with real-time 3-dimen-
sional echocardiography (RT3DE) (systolic dyssynchrony index
[SDI]). (B), Correlation between phase SD by phase analysis of
GMPS and LV dyssynchrony assessed with RT3DE (SDI).
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observer were compared (Bland-Altman analysis) with the results
calculated by the same operator 1 month later. The intraobserver
agreement was excellent with average differences of 0.03  0.4%
(P  NS) for SDI and 0.8  2% (P  NS) for LVEF.
Statistical Analysis
Continuous data are presented as mean  SD. Categorical data are
presented as absolute number or percentages. Unpaired and paired
Student t test, Mann-Whitney test, and 2 test were used for appro-
priate comparisons. Pearson’s correlation analysis was performed to
evaluate the relation between LV dyssynchrony (SDI) by RT3DE and
histogram bandwidth and phase SD by the phase analysis of GMPS.
A similar approach was used to compare assessment of LVEF by
RT3DE and GMPS together with the Bland-Altman analysis that was
performed to evaluate the mean difference between the two tech-
niques. A P value less than .05 was considered to be statistically
significant. A statistical software program (SPSS 12.0, SPSS Inc,
Chicago, IL) was used for statistical analysis.
RESULTS
Patient Characteristics
Baseline characteristics of the study population (32 men; mean age
62  10 years) are summarized in Table 1. Most patients had
ischemic cause of cardiomyopathy (75%) and 68% of patients were
in NYHA functional class III. Mean QRS duration was 135  33
milliseconds. Patients had severe LV dysfunction and dilatation
(mean LVEF 29  7%, mean LV end-diastolic volume 223  70 mL).
The correlation between LVEF assessed with GMPS and RT3DE
was good (r  0.84 [r2  0.7, P  .0001]). The Bland-Altman analysis
revealed a small, but nonsignificant difference in the value of LVEF
measured with RT3DE and GMPS: GMPS LVEF was 0.8  8% lower
than RT3DE LVEF (P  NS) (Figure 3).
Figure 3 Bland-Altman scatter plot of differences in left ven-
tricular ejection fraction (LVEF) between real-time 3-dimen-
sional echocardiography (RT3DE) and gated myocardial perfu-
sion single photon emission computed tomography (GMPS)
and average LVEF between two techniques: GMPS LVEF is
0.8  8% lower than RT3DE LVEF (P  not significant).
Figure 4 (A), Correlation between histogram bandwidth as-
sessed with phase analysis of gated myocardial perfusion
single photon emission computed tomography (GMPS) and left
ventricular (LV) dyssynchrony assessed with real-time 3-dimen-
sional echocardiography (RT3DE) (systolic dyssynchrony index
[SDI]). (B), Correlation between phase SD by phase analysis of
GMPS and LV dyssynchrony assessed with RT3DE (SDI).
Table 1 Baseline characteristics of the study population
(n  40)
Age (y) 62  10
Male/female 32/8
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QoL score 29  15




LVEF (%) 29  7
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Phase SD (degrees) 46  22
LVEDV, Left ventricular end-diastolic volume; LVEF, left ventricular
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6-minute walk test; NYHA, New York Heart Association; QoL, quality of
life.
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Figure 4A. Correlation between histogram bandwidth assessed with phase analysis of GMPS and LV dyssynchrony assessed with RTDE (SDI).
Figure 4B. Correlation between phase SD by phase analysis of GMPS and LV dyssynchrony assessed with RT3DE (SDI).
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The relatively low percentage of patients with substantial LV dyssynchrony may be partially 
explained by the characteristics of the study population that consists of heart failure patients 
with varying degrees of LV dysfunction and both wide and narrow QRS complexes.
A B
Figure 5A. LV dyssynchrony assessed with RT3DE (SDI) is significantly higher in patients with substantial LV dyssynchrony on phase analysis, 
using a cut-off value for histogram bandwidth of 135º as previously described.6
Figure 5B. LV dyssynchrony assessed with RT3DE (SDI) is significantly higher in patients with substantial LV dyssynchrony on phase analysis, 
using a cut-off value for phase SD of 43º as previously described.6
Table 2. Baseline characteristics of patients with substantial and without substantial LV dyssynchrony assessed by histogram bandwidth and 








Ischemic etiology, n (%) 12 (63) 18 (86) NS
LVEF (%) 29±7 30±8 NS
LVEDV (ml) 229±69 219±74 NS
LVESV (ml) 164±59 155±63 NS






Ischemic etiology, n (%) 13 (62) 17 (89) NS
LVEF (%) 29±7 30±8 NS
LVEDV (ml) 224±68 223±76 NS
LVESV (ml) 161±59 157±64 NS
SDI (%) 4.7±1.9 11.2±4.8 <0.001
SDI = systolic dyssynchrony index assessed with RT3DE. For other abbreviations see Table 1.
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lv systolic function vs. lv mechanical dyssynchrony
Of the 40 patients included, 22 (55%) had LVEF ≤30%, assessed by RT3DE, whereas 18 (45%) 
patients had LVEF >30%. No significant difference in LV dyssynchrony, measured with both 
RT3DE and phase analysis, was noted between the two groups. Histogram bandwidth was 
148±67º in patients with LVEF ≤30% and 150±81º in patients with LVEF >30% (p = NS); phase 
SD was 45.1±18.3º in patients with LVEF ≤30% and 47.0±25.8º in patients with LVEF >30% (p 
= NS); accordingly SDI was 6.9±3.0% in patients with LVEF ≤30% and 8.8±6.3% in patients 
with LVEF >30% (p = NS).
Correlations between GMPS variables histogram bandwidth and phase SD, and SDI were 
slightly better for patients with LVEF >30% (histogram bandwidth: y = 0.0662x – 1.1875, r 
= 0.85 (r2 = 0.72); and phase SD: y = 0.2101x – 1.1238, r = 0.86 (r2 = 0.74)) as compared with 
patients with LVEF ≤30% (histogram bandwidth: y = 0.0305x + 2.4374, r = 0.69 (r2 = 0.48); 
phase SD: y = 0.1185x + 1.5864, r = 0.73 (r2 = 0.53)).
discussion
The findings in the current study support the use of RT3DE for assessment of LV dyssynchrony; 
assessment of LV dyssynchrony according to RT3DE using SDI, correlated well with previously 
validated nuclear imaging techniques for assessment of LV dyssynchrony. In particular, SDI 
by RT3DE correlated well with histogram bandwidth and phase SD by GMPS phase analysis.
In addition, both techniques can assess the LVEF with high accuracy, and the correlation 
between both modalities for assessing LVEF in the current study was good (r = 0.84, p <0.001) 
with a small, non-significant difference (mean difference 0.8±8 %).
LV dyssynchrony appears important in the response to CRT. Many techniques have been 
used to assess LV dyssynchrony and to predict response to CRT. For example, TDI has been 
used for assessing longitudinal myocardial velocities and strain, and speckle tracking focuses 
on the evaluation of radial strain 2,17. Other non-echocardiographic techniques for assess-
ment of LV dyssynchrony include GMPS with phase analysis 5,6, and velocity encoded mag-
netic resonance imaging (VE-MRI)4. However, all these techniques have their disadvantages: 
echocardiographic techniques only allow assessment of dyssynchrony in a 2D setting, GMPS 
with phase analysis involves radiation and VE-MRI cannot be applied after CRT implantation. 
The optimal modality would be a 3D approach that combined all the different components of 
myocardial contraction (longitudinal, radial circumferential), that is also suitable for repeated 
imaging without imposing a radiation burden. RT3DE is a novel echocardiographic tech-
nique that appreciates radial, longitudinal and circumferential timing of the myocardium. 
Moreover, it permits identification of the area of latest mechanical activation and accurate 
assessment of LV function and size without imposing a radiation burden. Recently, Kapeta-
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nakis et al 7 have studied the feasibility of LV dyssynchrony assessment with RT3DE in a large 
group of patients and normal subjects. The authors developed an index (SDI) to quantify 
LV dyssynchrony with RT3DE by calculating the time to reach minimum regional volume 
for each segment as a percentage of the cardiac cycle. The SDI was defined as the SD of 
the timings of all 16 segments. After classifying patients according to their LV systolic (dys)
function (normal with LVEF >50%, mild dysfunction with LVEF 40-49%, moderate dysfunction 
with LVEF 30-39%, and severe dysfunction with LVEF <30%), the authors were able to show 
significant differences in SDI between these 4 groups. In addition, 26 patients were referred 
for CRT implantation. It was observed that responders to CRT had significantly higher SDI at 
baseline than the non-responders (16.6±1.1% vs 7.1±2.0%, p <0.001). After a mean follow-up 
of 10±1 months, a reduction in SDI could be demonstrated in the responders to CRT, whereas 
an increase in SDI was observed in the non-responders. Although these results are promising, 
only a moderate correlation could be detected for SDI and the SD of the maximum sustained 
systolic velocity (Ts-SD) as assessed with TDI (r = 0.38). These observations are in line with 
data reported by Burgess and colleagues 18, who compared RT3DE and TDI for the assessment 
of LV dyssynchrony in 100 patients with ischemic cardiomyopathy. The authors hypothesized 
that the poor correlation between these 2 techniques could be in part explained by the 
respective assessment of longitudinal versus radial timing.
In the current study, the performance of RT3DE for assessment of LV dyssynchrony was 
compared with phase analysis with GMPS in heart failure patients with varying degrees of 
LV dysfunction and both wide a narrow QRS complexes. Table 3 provides and head-to-head 
comparison between the two techniques from a technical point of view. The temporal resolu-
tion of GMPS is perceived to be slightly lower as compared with echocardiography. Both 
techniques use the first harmonic Fourier approximation to improve the temporal resolution. 
The first harmonic Fourier approximation can enhance phase calculation if it is applied to 
data with lower temporal resolution by transforming discrete data points into a continuous 
curve. For GMPS phase analysis only the systolic portion of the data is used to determine the 
phase. By fitting the curve closely with the systolic data points, the artifactual phase differ-
ence resulting from a lower temporal resolution is importantly reduced 6.
Table 3. Head-to head comparison between GMPS and RT3DE from a technical point of view.
gmps rt3de
Mean imaging time 23 min 5 min
Mean post-processing time 3-5 min 2-5 min
Mean temporal resolution 45 ms 30 ms
Mean frame rate 16 frames per cycle 20-35 frames per sec
LV dyssynchrony assessment regional time-to-onset of mechanical contraction regional time-to-minimum systolic volume
LV dyssynchrony parameter Histogram bandwidth Phase SD SDI
SDI = systolic dyssynchrony index.
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LV dyssynchrony assessed by RT3DE and GMPS
Although phase analysis with GMPS measures the regional onset of mechanical contrac-
tion and RT3DE the regional time-to-minimum systolic volume, both techniques evaluate 
the regional changes with a 3D approach, combining all the different components of myo-
cardial contraction. A good correlation between RT3DE and phase analysis with GMPS was 
demonstrated for the assessment of LV dyssynchrony (r = 0.76 for histogram bandwidth, r = 
0.80 for phase SD). A good correlation between the two techniques was also found for LVEF 
assessment. However, the correlation coefficient (r = 0.84) was somewhat lower as compared 
to other validation studies between RT3DE and cardiac magnetic resonance imaging ( r = 0.9) 
19,20, although Jenkins et al 21 found a correlation coefficient of 0.81, which is fairly in line with 
our results.
Several limitations of the current study need attention. The patient cohort was relatively 
small, and larger populations need to be studied. Moreover, as we compared 2 different tech-
niques, the basis of regional myocardial dyssynchrony is fundamentally different: GMPS con-
siders the onset of mechanical contraction whereas RT3DE assesses the timing of minimum 
systolic volume. Nevertheless this difference, the present study shows that both techniques 
seem to correlate fairly well (r = 0.76 for histogram bandwidth and r = 0.80 for phase SD). In 
the present study, follow-up data after CRT implantation were not available.
A more general limitation is the radiation burden of GMPS, which renders the technique 
less suitable for repeated imaging.
conclusIons
The current findings demonstrate that LV dyssynchrony assessed by RT3DE correlated well 
with histogram bandwidth and phase SD derived from phase analysis and GMPS. The cor-
relation between LVEF derived from both techniques was also good. These findings provide 
further support for the use of RT3DE for reliable assessment of LV dyssynchrony.
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objectives: Detailed information about the absolute temporal occurrence of 
myocardial motion and deformation events during the cardiac cycle is still lacking. 
However, the normal time-range of these parameters may be of great importance 
as a reference for detecting and interpreting mechanical dyssynchrony and for iden-
tifying a delayed contraction in case of left ventricular (LV) dysfunction. The aim of 
this study was to determine in young healthy subjects and for different LV segments 
the value of: 1) time to peak systolic longitudinal velocity, displacement, strain rate 
and strain, using tissue Doppler imaging (TDI); 2) time to minimum systolic volume, 
using real-time three-dimensional echocardiography (RT3DE) and 3) time to maxi-
mum thickness, using cardiac magnetic resonance imaging (MRI).
methods: A total of 20 young healthy volunteers (13 men, mean age 32±4 years) 
underwent both cardiac MRI and echocardiografic examination, including TDI and 
RT3DE. To define LV ejection time and isovolumic relaxation time (IVRT), aortic valve 
closure and opening and mitral valve opening were identified.
results: For all LV segments, longitudinal peak systolic velocity and strain rate were 
early-systolic events. Peak systolic longitudinal displacement and strain, in turn, 
occurred in the late systole or, in 20-30% of LV segments, during IVRT, similarly to 
minimum systolic volume and maximum myocardial thickness.
conclusions: The current study provides a systematic report of the normal 
time-range of the measurements obtained by TDI, RT3DE and cardiac MRI. Peak 
systolic longitudinal velocity and strain rate significantly precede peak longitudinal 
displacement, strain, minimum systolic volume and maximum thickness.
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Temporal occurrence of LV systolic mechanical events
IntroductIon
Tissue Doppler imaging (TDI) has been extensively applied for the assessment of left ven-
tricular (LV) dyssynchrony 1 and systolic function 2–4. Measurements were mainly based on 
myocardial velocities 4–7 (expression of myocardial motion), but also on strain and strain rate 
imaging (which evaluate myocardial deformation) 3,8,9. A systematic description of the normal 
temporal occurrence of myocardial motion and deformation events has not been reported. 
However, this information would be of great interest to better interpret LV dyssynchrony and 
to define when a segment has a delayed contraction 10–12. Real-time 3-dimensional echocar-
diography (RT3DE) has also been proposed as a novel technique for the assessment of LV 
dyssynchrony and systolic function, based on the analysis of regional volumetric changes 13. 
Also for this technique, the normal values of the time taken to reach the minimum systolic 
volume are not known. This may be of clinical importance for comparison with other imaging 
techniques. Similarly, cardiac magnetic resonance imaging (MRI) provides accurate informa-
tion on myocardial deformation (as myocardial thickness) 14, but the normal time-values of 
this measure have not been extensively explored 15. Accordingly, the aim of this study was to 
determine the value of time to peak systolic velocity, strain rate, displacement, strain, mini-
mum systolic volume and maximum thickness for different LV segments, in young healthy 
subjects using the various techniques.
methods
A total of 20 young healthy volunteers (13 men, mean age 32±4 years) underwent, on the 
same day, both cardiac MRI and an echocardiografic examination, including TDI and RT3DE. 
All subjects gave informed consent and the protocol was approved by the institutional review 
board. No subject had a history of cardiac disease or cardiac symptoms and all of them were 




Body surface area (m2) 1.86±0.14
Heart rate (bpm) 63±10
Diastolic function
E/A 1.7±0.2
Deceleration time (ms) 163±20
Left ventricular ejection fraction (%) 63±2
Left ventricular end-diastolic volume (ml) 102±18
Left ventricular end-systolic volume (ml) 38±8
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normotensive and in sinus rhythm. The resting electrocardiogram (ECG) and the standard 
2-dimensional echocardiographic examination were normal (Table 1).
Studies were performed using a commercially available system (Vingmed Vivid Seven, 
General Electric Healthcare, Horten, Norway) and a 3.5-Mhz transducer. Left ventricular 
end-diastolic and end-systolic volumes and LV ejection fraction were calculated from the 
conventional apical 2- and 4-chamber views using the biplane Simpson’s technique. Peak 
velocity in early (E wave) and late (A wave) diastole of the transmitral flow was derived from 
conventional pulsed-wave Doppler imaging and the ratio was E/A calculated. To define LV 
ejection time and isovolumic relaxation time (IVRT), aortic valve closure (AVC) and opening 
(AVO) and mitral valve opening (MVO) were identified on pulsed-wave Doppler traces ob-
tained from LV inflow and outflow tract and expressed as a percentage of the cardiac cycle.
Color Doppler TDI was superimposed on the underlying 2-dimensional grey-scale images 
(2-, 4- and 3-chamber apical views) to assess longitudinal myocardial regional function. Gain 
settings, filters and pulse repetition frequency were adjusted to optimize color saturation 
and to avoid any aliasing within the image. Sector size and depth were optimized for the 









Figure 1. Examples of normal myocardial velocity, displacement, strain rate and strain curves obtained from the basal septum. The small arrows 
indicate the systolic peak of each curve. Myocardial displacement is obtained integrating velocity over time. Myocardial strain rate is the spatial 
derivative of velocity and can be integrated throughout systole to obtain strain 3.
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images were digitally stored for off-line analysis (EchoPac, GE Vingmed Ultrasound, Horten, 
Norway). During post-processing, sample areas (8 x 5 mm) were placed at the level of 12 LV 
segments (basal and mid segments of the septum, lateral, inferior, anterior, posterior and 
anteroseptal walls) and a semi-automated tissue tracking was used to maintain the sample 
area in the region of interest throughout the cardiac cycle. For each segment, assessment of 
regional myocardial velocity, displacement, strain and strain rate were performed. Time from 
R wave (from the ECG signal) to peak systolic longitudinal velocity (Ts), displacement (Td), 
strain rate (Tsr) and strain (Tє) were calculated (Figure 1) and expressed as a percentage of 
the cardiac cycle to take the possible difference in heart rate during the echocardiographic 
and MRI studies into account. In particular, whether peak systolic longitudinal velocity, dis-
placement, strain rate and strain occur after the AVC was noted, and the time from AVC was 
measured.
Apical full-volume data sets were obtained in all subjects using the iE33 system (Philips 
Medical Systems, N.A., Bothell, Washington, USA) equipped with X3, fully sampled matrix 
transducer. Gain and compression were optimized to obtain a good image quality and scan 
line density was adjusted to ensure a complete capture of the LV (sector width = 90 x 90 
degrees). Real-time sub-volumes were acquired from alternate cardiac cycles and combined 
to provide the larger pyramidal volume during 1 breath-hold. Frame rate was optimized (32 
frames/sec) reducing the depth and acquiring a full-volume data set of 7 sub-volumes. RT3DE 
data sets were stored digitally and quantitative analysis was performed off-line using a semi-
automated contour tracing algorithm (Q-Lab, version 5.0, Philips Medical Systems) over a 
complete heart cycle. After first identifying, with 5 reference points, the apex and mitral annu-
lus on end-diastolic and end-systolic slices, a preconfigured ellipse is fitted to the endocardial 
border for each frame and manually adjusted as required. Three-dimensional (3D) model of 
the LV is generated and subdivided in 17 wedge shaped (apart from the apex) sub-volumes. 
For 12 volumetric segments (6 basal and 6 mid) the time taken to reach the minimum systolic 
Figure 2. Three-dimensional model of a normal left ventricle (left panel) and time-volume curves derived from the 6 basal and 6 mid segments 
(right panel). The red dots identify the minimum systolic volume for each segment.
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volume (Tmsv) from the R wave of the ECG was calculated (Figure 2). Furthermore, the time 
from AVC to the minimum systolic volume was assessed. To be comparable with the other 
imaging techniques, these timings were expressed as a percentage of the cardiac cycle.
MRI data acquisition was performed on a 1.5 T scanner (ACS-NT15 Intera, software release 
11, Philips Medical Systems, Best, The Netherlands), using the body coil for transmission and 
a five element phased array cardiac-coil placed on the chest for signal reception. First, scout 
images and 2- and 4-chamber acquisitions were performed, needed for planning. A cine-set 
of 10-12 multi-slice images were acquired in short-axis orientation, covering the complete 
left ventricle from apex to base. Each slice was acquired in one single breath-hold. Steady-
state free-precession was used for optimal image contrast. The following imaging parameters 
were used: slice thickness of the imaging planes = 10 mm, with no gap; Field-of-View = 350 
mm (80% rectangular); scan matrix = 192 × 154, with reconstructed voxels of 1.37 × 1.37 × 8.0 
mm; flip angle α = 50°; TR/TE = 3.3/1.7. One signal average was used. Gated cardiac synchro-
nization was applied and 40 phases per cardiac cycle were reconstructed, yielding a temporal 
resolution of around 20 ms. From the complete short-axis dataset, 2 slices were selected 
representing the basal and mid-ventricular level and divided into 6 standard segments 16. In 
these slices, epicardial and endocardial contours were manually drawn for all phases, using 
the QMass software package (Medis, Leiden, The Netherlands). For each segment, a radial 
wall thickness curve was plotted and the time from the R wave (and, in case of post-systolic 
peak thickness, from the AVC) to maximum wall thickness (Tt) was determined and expressed 































Figure 3. Example of the assessment of myocardial thickness using magnetic resonance imaging in a normal subject. In the slice representing 
the basal left ventricular level (left panel), epicardial and endocardial contours are drawn for all phases and the radial wall thickness curves for 
the 6 segments are plotted (right panel) to derive the time to maximum thickness.
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Temporal occurrence of LV systolic mechanical events
Continuous data are presented as mean±SD; dichotomous data are presented as numbers 
and percentages. For multiple comparison between different LV segments and different tim-
ing parameters, parametric analysis of variance (ANOVA) was performed with Scheffe’s post 
hoc analysis, after testing for normal data distribution (Kolmogorov-Smirnov test). The repro-
ducibility of the TDI, RT3DE and MRI measurements was assessed by Bland-Altman analysis 
using the image dataset of 10 randomly selected subjects (120 segments): mean differences 
±2SD are reported. Statistical significance was set at two tailed p <0.05. A statistical software 
program SPSS 12.0 (SPSS Inc, Chicago, II, USA) was used for statistical analysis.
results
tissue doppler imaging
The mean Ts values for each LV segment are displayed in Table 2. The myocardial peak systolic 
velocity occurred for all the segments immediately after the AVO (= 7.5±6%, expressed as 
percentage of cardiac cycle) (Figure 4A) and no significant differences were found between 
the segments, although a trend toward an earlier Ts for the mid segments compared to the 
Table 2. Mean segmental (12-segment model) values of time to peak systolic velocity (Ts), peak displacement (Td), peak systolic strain rate 
(Tsr) and peak strain (Tє) as derived from TDI. Also summarized are the mean segmental (12-segment model) values of time to minimum 
systolic volume (Tmsv) as measured by RT3DE and time to maximum thickness (Tt) as measured by MRI. The timings are expressed as a 
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Figure 4. Distribution of time to peak systolic velocity and displacement (panel A) and time to peak systolic strain rate and strain (panel B), all 
measured with TDI, in relation to the aortic valve opening (AVO) or closing (AVC). Of note, MVO = mitral valve opening. In panel C, distribution 
of time to minimum systolic volume, measured with RT3DE, and time to maximum wall thickness, measured with MRI. Peak systolic velocity 
and strain rate are early systolic events, whereas peak displacement and strain occur late in systole. Likewise, minimum systolic volume and 
maximum myocardial thickness occur late in systole.
On the Y-axis, each of the 12 LV segments analyzed: BA = basal anterior; BAS = basal anteroseptal; BI = basal inferior; BL = basal lateral; BP = 
basal posterior; BS = basal septum; MA = mid anterior; MAS = mid anteroseptal; MI = mid inferior; ML = mid lateral; MP = mid posterior; MS 
= mid septum.
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basal segments was noted. The intra- and inter-observer agreement for the Ts measurement, 
calculated on 120 segments, were good: 3±16 ms and 7±28 ms (p = NS), respectively.
The mean Td values for each LV segment are shown in Table 2 and were significantly dif-
ferent from the Ts values (p <0.001, post hoc analysis of ANOVA). Of interest, peak displace-
ment occurred immediately before AVC (= 36.7±5.3%) or during the IVRT (before MVO = 
41.2±5.9%) (Figure 4A). Out of 240 segments, 31 (13%) showed a peak displacement 9±6 ms 
(= 0.9±0.6% of the cardiac cycle) after the AVC. No significant differences for Td values were 
found between the LV segments (Table 2). The intra- and inter-observer agreement for the Td 
measurement (120 segments) were good: 2±18 ms and 1±46 ms (p = NS), respectively.
Table 2 shows the mean values of Tsr for each LV segment. Peak systolic strain rate occurred 
immediately after the AVO (Figure 4B). Subsequently, Tsr was similar to Ts (p = NS) and signifi-
cantly different from Td (p <0.001, post hoc analysis of ANOVA). The intra- and inter-observer 
agreement for the Tsr measurement (120 segments) were good: 2±12 ms and 3±34 ms (p = 
NS), respectively.
Peak strain, in turn, occurred just before AVC or during the IVRT (Figure 4B). In particular, 43 
(18%) out of 240 segments showed a peak displacement 16±10 ms (= 16±11% of the cardiac 
cycle) after AVC. The post hoc analysis of ANOVA revealed that Tє was similar to Td (p = NS) 
and significantly different (p <0.001) from Ts and Tsr (Table 2). The intra- and inter-observer 
agreement for the Tє measurement (120 segments) were good: 2±29 ms and 4±56 ms (p = 
NS), respectively.
No significant differences both for Tsr and Tє were found between the LV segments. How-
ever, Tsr and Tє tended to occur earlier in the mid compared to the basal segments (Table 2).
real-time three-dimensional echocardiography
Table 2 shows the Tmsv values for each LV segment. The minimum systolic volume has been 
reached before the AVC or during the IVRT (Figure 4C) and therefore Tmsv was similar to Td 
and Tє (p = NS) and significantly different from Ts and Tsr (p <0.001). Of interest, 75 (31%) 
out of 240 segments showed a minimum systolic volume 33±27 ms (34±27% of the cardiac 
cycle) after AVC. No significant differences were found between the LV segments for Tmsv, 
although Tmsv tended to occur earlier in the mid compared to the basal segments (Table 
2). The intra- and inter-observer agreement for the Tmsv measurement (120 segments) were 
good: 1±11 ms and 1±42 ms (p = NS), respectively.




The maximum myocardial radial thickness was reached before the AVC or during the IVRT 
(Figure 4C) and therefore Tt was similar (p = NS) to Td, Tє and Tmsv and significantly different 
(p <0.001) form Ts and Tsr. A total of 49 (20%) segments showed a maximum thickness 23±18 
ms (24±18% of the cardiac cycle) after AVC. No significant differences were found between 
the LV segments, although a trend toward an earlier Ts for the mid segments compared to 
the basal segments was noted (Table 2). The intra- and inter-observer agreement for the Tt 
measurement (120 segments) were good: 1±10 ms and 2±33 ms (p = NS), respectively.
dIscussIon
The present study provides insight into the temporal occurrence of cardiac mechanical 
events in normal subjects using different imaging techniques. The main findings can be 
summarized as follows: 1) peak systolic velocity and strain rate are early systolic events; 2) 
peak displacement and strain occur in the late systole, similarly to minimum systolic volume, 
measured with RT3DE, and maximum myocardial thickness, measured with MRI.
Different imaging techniques, using either myocardial motion or myocardial deformation 
measurements, have been applied to evaluate LV function and more recently, to detect the 
time difference in mechanical events among different LV segments (in order to assess LV 
dyssynchrony for patients considered for cardiac resynchronization therapy) 4–9. However, 
beyond the relative comparison between segments, the absolute temporal occurrence of 
myocardial motion and deformation events during the cardiac cycle has been reported only 
occasionally 17 and detailed information on the normal range of these timings is still lacking. 
Nevertheless, these values may be of great importance and are needed as a reference for 
detecting and interpreting mechanical LV dyssynchrony. Furthermore, these values may be 
helpful for identifying a delayed contraction in case of (subclinical) cardiac dysfunction.
The current study provides normal reference values for timing of the different phenom-
ena occurring in cardiac systole. No significant differences in the time-occurrence of these 
phenomena were found among different LV segments, probably because of the limited tem-
poral-resolution of these imaging techniques. However, the results highlight the difference 
between these different phenomena, namely that peak velocity and strain rate occur early 
in systole whereas the resultant action (displacement, strain, minimal LV volume, maximum 
wall thickness) occur late in systole.
Tissue Doppler imaging, because of the high temporal resolution, is one of the most suit-
able techniques to detect small differences in myocardial timings 4 and is currently one of the 
frequently used techniques to assess LV dyssynchrony. In particular, TDI can measure myo-
cardial velocity and displacement (obtained by integration of velocity over time) that both 
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reflect myocardial motion, but also myocardial strain rate (as the spatial derivative of velocity) 
and strain (obtained by integration of strain rate over time), both reflecting myocardial defor-
mation 3. Other echocardiographic modalities, such as RT3DE 13, and non-echocardiographic 
imaging modalities, such as MRI 18;19, provide further possibilities to evaluate LV dyssynchrony 
in different manners. RT3DE measures LV regional volumetric changes during the cardiac 
cycle, reflecting myocardial motion. MRI provides accurate information on changes of re-
gional myocardial thickness, reflecting myocardial deformation. Based on temporal delays in 
any of these parameters between different regions in the LV, dyssynchrony can be derived. 
Since these imaging modalities do not assess the same mechanical phenomena, these dif-
ferent echocardiographic and MRI approaches may not be entirely comparable. Only few 
studies performed a direct comparison between these different techniques. Burgess et al. 20 
compared TDI and RT3DE for the assessment of LV dyssynchrony in heart failure patients and 
reported a poor agreement between the 2 techniques (r = 0.11). The different mechanical 
events and, more important, the different ventricular timings measured by these techniques 
may be potential explanations for these findings 20. In normal subjects, as demonstrated in 
the current study, peak velocity and peak strain rate are reached in early systole, while peak 
strain, displacement, minimum systolic volume and maximum thickness are end-systolic 
events. The early-systolic phase of the cardiac cycle corresponds to the peak systolic ven-
tricular pressure, while at the end of the systole and during IVRT, ventricular pressure rapidly 
declines. Furthermore, these phases of the cardiac cycle may be differently influenced by 
alterations of myocardial contractility and loading conditions 21. LV dyssynchrony may there-
fore affect the abovementioned systolic measurements in a different way and a systematic 
report of the normal range of these timings for each modality would be of great importance 
as a reference. For example, Breithardt et al. 10 described in heart failure patients a significant 
delay between myocardial motion and deformation using TDI. The authors found that peak 
myocardial velocities significantly preceded (~ 90 ms) peak myocardial strain and suggested 
that this dissociation might be dependent on the degree of asynchrony and on the underly-
ing disease (ischemic vs. non-ischemic cardiomyopathy). However, no references to normal 
values were reported to further interpret these findings. The present study provides these 
values and showed that, also in normal subjects, Ts consistently preceded Tє, although with 
greater difference (~ 200 ms). Furthermore, Tsr was also found to be significantly earlier than 
the measurements of total amount of deformation or motion (peak displacement, peak strain, 
miminum systolic volume and maximum thickness). Consequently, these measurements will 
not correlate well in direct comparisons, since they represent different parameters, occurring 
at different timings in systole; in contrast, these parameters may be combined to provide 
more solid information on LV dyssynchrony 22. However, further studies, including normal 
subjects with older age and heart failure patients, are needed to confirm these results.
Cardiac MRI and TDI have been applied to obtain quantitative information on global and 
regional LV systolic function 2,3,14, avoiding the disadvantages of observer-dependent inter-
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pretation. RT3DE has recently become available with the potential of similar application 23. 
Beyond the absolute measure of the maximum motion and/or deformation of a LV segment, 
the time-analysis of these events might be helpful to further interpret myocardial (subclinical) 
dysfunction. The presence of myocardial dysfunction and/or conduction disturbances may in 
fact lead to an absolute delay of LV contraction with or without any intra-ventricular relative 
delay or significant reduction of the global contraction. Several studies proposed the pres-
ence of post-systolic (after AVC) shortening as a marker of myocardial dysfunction, mainly 
during acute/chronic ischemia or in case of myocardial scar 11,12. In fact, this phenomenon 
may occur in dyskinetic segments as a passive mechanism, but can also occur in hypokinetic 
segments as a result of prolonged contraction (active process) or delayed relaxation, and 
therefore may be related to residual myocardial viability 11,12. However, post-systolic shorten-
ing has also been described as a normal finding in healthy subjects in approximately 20-30% 
of LV segments 12. In particular, Kowalski et al. 17 found in 40 normal subjects that both peak 
radial and longitudinal strain occur either during IVRT (20 to 60 ms after AVC) or shortly 
before AVC. Zwanenburg et al. 24 obtained similar results for peak circumferential strain. The 
present study further confirms these findings for peak longitudinal strain and broadened the 
analysis including measurements of other imaging modalities. Peak displacement, minimum 
systolic volume and maximum thickness were found to occur during IVRT in 20-30% of LV 
segments, as well. The precise physiologic basis of this phenomenon is not known but can be 
related to a reshaping of the LV cavity during IVRT that should facilitate LV filling phase 25. The 
presence of post-systolic shortening, besides the technique used to detect it, can therefore 
not be considered pathognomonic for disease. Further studies are needed to confirm these 
findings in subjects with older age, in which this phenomenon might be even accentuated, 
and to compare normal individuals with different type of patients.
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objectives: Several 2-dimensional TDI echocardiographic techniques have proven 
useful to identify CRT responders. Recently a 3-dimensional probe allowing simul-
taneous acquisition of TDI data in 3 imaging planes became available. The present 
study evaluated the value of tri-plane tissue Doppler imaging (TDI) to predict re-
verse left ventricular (LV) remodeling after cardiac resynchronization therapy (CRT).
methods: Sixty heart failure patients, scheduled for CRT, underwent tri-plane echo-
cardiography with simultaneous TDI acquisition before and 6 months after implan-
tation. From the tri-plane dataset a 3-dimensional left ventricular (LV) volume was 
generated and LV volumes and ejection fraction were calculated. Intraventricular 
dyssynchrony was quantitatively analyzed by evaluating time from onset QRS to 
peak myocardial systolic velocity in 12 LV segments from the tri-plane dataset and 
calculation of the standard deviation (Ts-SD-12). Clinical response was defined as an 
improvement of at least 1 New York Heart Association class. Reverse LV remodeling 
was defined as ≥15% decrease of LV end-systolic volume at 6 months follow-up.
results: Responders to CRT had significantly more LV dyssynchrony at baseline than 
non-responders; Ts-SD-12: 42±14 versus 22±12 (P<0.0001). A cut-off value of 33 for 
baseline Ts-SD-12, acquired from the tri-plane TDI dataset, yielded a sensitivity of 
89% with a specificity of 82% to predict clinical response to CRT; sensitivity and 
specificity to predict reverse LV remodeling were 90% and 83%.
conclusions: Tri-plane TDI echocardiography predicts clinical response and reverse 
LV remodeling 6 months after CRT implantation.
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IntroductIon
Cardiac resynchronization therapy (CRT) is now accepted as an alternative therapeutic option 
in heart failure patients who remain highly symptomatic despite optimized medical treat-
ment 1. However, using classic selection criteria for CRT including New York Heart Association 
(NYHA) Class III or IV, impaired left ventricular (LV) systolic function and conduction delay on 
the surface electrocardiogram (i.e. wide QRS complex >120 ms), up to 30% of CRT patients 
do not respond favourably 2. The presence of LV dyssynchrony is considered a key issue in the 
identification of potential responders to CRT 3,4. Numerous 2-dimensional (2-D) echocardio-
graphic methods, often using tissue Doppler imaging (TDI), have been proposed to quantify 
LV dyssynchrony and predict response to CRT 5–10. The TDI method originally described by 
Yu and co-workers is a standard deviation of electromechanical activation times (Ts-SD-12) 
based on a 12-segment model of the LV 7,11. To calculate this dyssynchrony parameter, 3 differ-
ent apical views need to be acquired separately, non-simultaneously, thus neglecting heart 
rate variability. Recently, a 3-dimensional (3D) TDI imaging modality, tri-plane TDI, became 
available which permits simultaneous acquisition of TDI from all LV segments during the 
same heartbeat. In addition, the tri-plane technique allows calculation of 3-D volumes and 
LV ejection fraction. There are no published data available on the potential role of tri-plane 
TDI to predict response to CRT.
In the present study, this novel 3-D echocardiographic technique, tri-plane TDI, was applied 
to 60 heart failure patients to quantify LV volumes, ejection fraction and LV dyssynchrony 
at baseline and at 6 months follow-up. Aim of the study was to assess the value of this tri-




The study population comprised of 60 consecutive heart failure patients scheduled for CRT. 
Inclusion criteria were severely symptomatic heart failure despite optimal medical treatment 
(NYHA class III or IV), depressed LV ejection fraction and wide QRS complex (>120 ms, with left 
bundle branch block or interventricular conduction delay) on the surface electrocardiogram. 
Patients with atrial fibrillation or a previously implanted pacemaker were excluded.




Within 24 hours before CRT implantation, all patients underwent the following examina-
tions: 12-lead electrocardiogram and extensive tri-plane transthoracic echocardiography as 
described below. NYHA functional class was assessed by a clinician blinded to all other data. 
Subjects completed the Minnesota living-with-heart-failure questionnaire, a 21-question 
self-administered instrument with scores ranging from 0 to 5 for each question; higher scores 
indicate poorer quality of life 12. Exercise capacity was assessed using the 6-minute hall walk 
test 13. Six months after implantation of the CRT device, all patients underwent the same 
examinations including tri-plane echocardiography.
tri-plane tdI echocardiography
Acquisition of the 3D dataset
Studies were performed with a commercially available echocardiographic platform (VIVID 
7, GE Vingmed Ultrasound, Horten, Norway), equipped with a 3V-probe for tri-plane acquisi-
tion. Patients were scanned in left lateral decubitus position, from the apical window. Care 
was taken to visualize the true LV apex allowing simultaneous acquisition of the apical 4-, 
2- and 3-chamber views. Color-coded TDI was applied to the tri-plane view to assess longitu-
dinal myocardial regional function. Gain settings, filters and pulse repetition frequency were 
adjusted to optimize color saturation. Sector size and depth were optimized for the highest 
possible frame rate. At least three consecutive beats were recorded and the images were 
digitally stored for offline analysis (EchoPac, GE Vingmed Ultrasound, Horten, Norway).
Quantification of LV volumes and ejection fraction
During post-processing, the tri-plane dataset was frozen in end-diastole and the endocardial 
border was manually traced in the apical 4-, 2- and 3-chamber views respectively. Then, using 
the same heartbeat, the tri-plane dataset was frozen in end-systole and again the endocardial 
border was manually traced in the apical 4-, 2- and 3-chamber views. A 3-D LV end-diastolic 
and end-systolic volume was generated automatically by the software and LV volumes and 
ejection fraction were reported accordingly (Figure 1).
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Quantitative analysis of LV dyssynchrony
During post-processing, the tri-plane color-coded TDI dataset was used to analyze myocar-
dial velocity curves from 12 LV segments derived from information acquired during the same 
heartbeat. Sample volumes were placed in the basal and mid segments of the septal, lateral, 
inferior, anterior, posterior and anteroseptal LV walls of the tri-plane dataset to calculate time 
from the beginning of QRS to peak myocardial systolic velocity (Ts). From these 12 measure-
ments a standard deviation was calculated (Ts-SD-12) as a measure of intraventricular dys-
synchrony. A patient example is provided in Figure 2. Additionally, peak myocardial systolic 
velocities were measured pre- and post-implantation at the basal septal, lateral, inferior and 
anterior LV walls.
Implantation of crt device
The LV pacing lead was inserted transvenously via the subclavian route. First, a coronary 
sinus venogram was obtained during occlusion of the coronary sinus with a balloon catheter. 
Next, the LV pacing lead was inserted into the coronary sinus with the help of an 8F guiding 
catheter and positioned as far as possible in the venous system, preferably in the (postero-) 
lateral vein. The right atrial and ventricular leads were positioned conventionally. When a 
conventional indication for an internal defibrillator existed, a CRT-D device was implanted. At 
implantation, both the sensing and pacing thresholds (at pulse duration of 0.5 ms) of the LV 
pacing lead were measured.
Figure 1. Example of 3-D LV volumes, generated from a tri-plane dataset, at baseline (Panel A) and at 6 months follow-up (Panel B) Note the 
significant decrease of LV volumes and the increase in LV ejection fraction.
Nina Book.indb   121 26-09-11   12:04
Chapter 6
122
definition of response to crt
Patients were subsequently divided into clinical responders and non-responders, based on 
an improvement in NYHA functional class by ≥1 score, 6 months post implantation. Echo-
cardiographic response was defined as a reduction of at least 15% in LV end-systolic volume 
(reverse LV remodeling) at 6 months follow-up 14.
statistical analysis
All analyses were performed with the statistical software program SPSS 12.0.1 (SPSS Inc, 
Chicago, Il, USA). Continuous data are presented as mean (standard deviation). Categorical 
data are presented as absolute numbers or percentages. Comparisons between responders 
and non-responders were performed using the independent-samples T test; comparisons 
between pre- en post-implantation characteristics were performed using the paired-samples 
Figure 2. Example of myocardial velocity curves at the basal septum and lateral wall of the left ventricle derived from a tri-plane dataset. At 
baseline there is a significant delay between the septum and lateral wall (Panel A). The standard deviation (Panel B) of all 12 LV segments 
is 92, indicating severe LV dyssynchrony. At 6 months follow-up, the septum and lateral wall are activated simultaneously (Panel C) and LV 
dyssynchrony has significantly improved (Panel D).
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T test. Correlations between changes in dyssynchrony or changes in myocardial velocities and 
LV end-systolic volume and ejection fraction were evaluated with Spearman correlations test. 
Receiver-operating characteristic (ROC) curves were also analyzed to determine the value of 
Ts-SD-12 to predict clinical response and reverse LV remodeling after CRT. From these ROC 
curves, the area under the curve was calculated and presented with 95% confidence intervals 
(95% CI). A p-value <0.05 was considered significant.
results
patient population
A total of 60 consecutive patients (47 men, 13 women) undergoing CRT implantation were 
included in the study. Mean age was 66 (11) years, 37 patients (62%) had ischemic cardio-
myopathy, 23 (38%) had non-ischemic cardiomyopathy. Moreover, 54 patients (90%) were in 
NYHA class III and 6 (10%) in NYHA class IV. All patients were on optimized medical treatment 
including beta-blockers (62%), angiotensin converting enzyme inhibitors (85%), diuretics 
(84%) and aldactone (39%). Mean QRS width was 146 (32) ms. Using tri-plane technology, 
mean LV end-diastolic volume was 207 (74) ml, mean LV end-systolic volume 160 (71) ml and 
mean LV ejection fraction 25 (10) %.
validation of the tri-plane technique
Consistent correlations were found between the Ts data measured using a conventional 
2-D method and Ts data measured using triplane technology; r ranging between 0.94 and 
0.98 (p <0.001). Bland–Altman analysis shows excellent limits of agreement between LV dys-
synchrony (Ts-SD-12) measured by 2-D analysis and LV dyssynchrony measured by triplane 
technology (Figure 3).
clinical response 6 months post crt implantation
At 6 months follow-up, 63% of the patients showed clinical improvement as defined by an 
increase of NYHA class by at least 1 score. The only pre-implantation characteristic differing 
significantly between responders and non-responders was the extent of LV dyssynchrony as 
assessed with tri-plane TDI (42 (14) vs 22 (12), p <0.001). Besides an improvement of NYHA 
class (3.1 (0.3) at baseline, 1.7 (0.5) at follow-up, p <0.0001), clinical responders also showed 
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improvement in 6-minute walking distance (335 (104) m at baseline, 388 (79) m at follow-up, 
p = 0.001), quality of life score (32 (19) at baseline, 22 (17) at follow-up, p = 0.001) LV end-
diastolic volume (197 (62) ml at baseline, 172 (56) ml at follow-up, p <0.001), LV end-systolic 
volume (150 (60) ml at baseline, 108 (41) ml at follow-up, p <0.001) and LV ejection fraction 
(26 (9) % at baseline, 37 (9) % at follow-up, p <0.001). Moreover LV dyssynchrony Ts-SD-12 
improved from 42 (14) to 23 (12) (p <0.001).
reverse lv remodeling at 6 months follow-up
A total of 58% of patients exhibited a reduction of LV end-systolic volume ≥15% within 6 
months after CRT implantation (Figure 4). Patients with reverse LV remodeling did not only 
show improvement of LV end-systolic volume (- 48.6 ml on average) but also a significant de-
crease of LV end-diastolic diameter (- 31.9 ml on average) and an increase of LV ejection frac-
tion (+ 13.4% on average). Baseline clinical and echocardiographic characteristics of patients 
without and with reverse LV remodeling are reported in Table 1. The only pre-implantation 
characteristic differing significantly between patients with and without reverse LV remodel-
ing was the extent of LV dyssynchrony as assessed with tri-plane TDI. Figure 5 shows a relation 
between the decrease in LV dyssynchrony and the decrease in LV end-systolic volume or the 
increase in LV ejection fraction.
class by >1 score, 6 months after implantation.
Echocardiographic response was defined as a reduction of at
least 15% in LV end-systolic volume (reverse LV remodelling) at
6 months’ follow-up.14
Statistical analysis
All analyses were performed with the statistical software
program SPSS 12.0.1 (SPSS Inc, Chicago, IL, USA).
Continuous data are presented as mean (SD). Categorical data
are presented as absolute numbers or percentages. In the
validation group, 2-D and triplane Ts data were compared
using the Pearson correlation analysis. The Bland–Altman graph
was used to compare Ts-SD-12 obtained with the conventional
and triplane method. Comparisons between responders and
non-responders were made using the independent-samples t-
test; comparisons between pre- and postimplantation charac-
teristics were performed using the paired-samples t-test.
Correlations between changes in dyssynchrony and LV end-
systolic volume and ejection fraction are graphically depicted
using simple regression analysis. Receiver operating character-
istic (ROC) curves were also analysed to determine the ability of
Ts-SD-12 to predict clinical response and reverse LV remodelling
Figure 2 Example of myocardial velocity curves at the basal septum and lateral wall of the left ventricle derived from a triplane dataset. At baseline
there is a significant delay between the septum and lateral wall (A). The standard deviation (B) of all 12 LV segments is 92, indicating severe LV
dyssynchrony. At 6 months’ follow-up, the septum and lateral wall are activated simultaneously (C) and LV dyssynchrony has significantly improved
(D).
Figure 3 Bland–Altman plot comparing left ventricular dyssynchrony
(Ts-SD-12) measured by a conventional two-dimensional method and
triplane technology. SD, standard deviation.
Cardiac imaging and non-invasive testing
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Figure 3. Bland–Altman plot comparing left ventricular dyssynchrony (Ts-SD-12) measured by a conventional two-dimensional method and 
triplane technology. SD, standard deviation.
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after CRT. From these ROC curves, the area under the curve
was calculated and presented with 95% confidence intervals
(95% CIs). A p value ,0.05 was considered significant.
RESULTS
Study group
A total of 60 consecutive patients (47 men, 13 women)
undergoing CRT implantation were included in the study.
Mean age was 66 (11) years, 37 patients (62%) had ischaemic
cardiomyopathy, 23 (38%) had non-ischaemic cardiomyopathy.
Moreover, 54 patients (90%) were in NYHA class III and 6
(10%) in NYHA class IV. All patients were receiving optimised
medical treatment including b-blockers (62%), angiotensin
converting enzyme inhibitors (85%), diuretics (84%) and
aldactone (39%). Mean QRS width was 146 (32) ms. Using
triplane technology, mean LV end-diastolic volume was 207
(74) ml, mean LV end-systolic volume 160 (71) ml and mean LV
ejection fraction 25 (10)%.
Validation of the triplane technique
Consistent correlations were found between the Ts data
measured using a conventional 2-D method and Ts data
measured using triplane technology; r ranging between 0.94
and 0.98 (p,0.001). Bland–Altman analysis shows excellent
limits of agreement between LV dyssynchrony (Ts-SD-12)
measured by 2-D analysis and LV dyssynchrony measured by
triplane technology (fig 3).
Pacemaker implantation
CRT device and lead implantation was successful in all patients
without major complications (Contak Renewal, Guidant, and
Insync Sentry, Medtronic Inc). Two types of LV lead were used:
Easytrack (Guidant, St Paul, Minnesota, USA) or Attain
(Medtronic Inc, Minneapolis, Minnesota, USA). In 83% of
cases a CRT-D device was implanted.
Clinical response 6 months after CRT implantation
At 6 months’ follow-up, 63% of the patients showed clinical
improvement as defined by an increase of NYHA class by at
least one score. The only pre-implantation characteristic
differing significantly between responders and non-responders
was the extent of LV dyssynchrony as assessed with triplane
TDI (42 (14) vs 22 (12), p,0.001). Besides an improvement of
NYHA class (3.1 (0.3) at baseline, 1.7 (0.5) at follow-up,
p,0.001), clinical responders also showed improvement in 6-
minute walking distance (335 (104) m at baseline vs 388 (79) m
at follow-up, p=0.001) and quality of life score (32 (19) at
Figure 4 Change in left ventricular (LV) volumes and LV ejection fraction at baseline and at 6 months’ follow-up in patients exhibiting reverse
remodelling (A, C) and those without reverse remodelling (B, D).
Table 1 Baseline characteristics of patients without and with reverse







(n= 35 ) p Value
Age (years) 65 (10) 67 (12) NS
Gender (M/F), % 83/17 77/25 NS
Ischaemic/idiopathic, % 52/48 31/69 NS
NYHA III/IV, % 88/12 94/6 NS
6-Min walking (m) 331 (119) 326 (101) NS
Quality of life 37 (19) 32 (20) NS
QRS width (ms) 142 (37) 149 (28) NS
LVEDV (ml) 210 (91) 206 (61) NS
LVESV (ml) 164 (89) 158 (59) NS
LVEF (%) 25 (11) 25 (9) NS
Ts-SD-12 20 (10) 44 (12) ,0.001
Results are shown as mean (SD) unless stated otherwise.
LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction;
LVESV, left ventricular end-systolic volume; NYHA, New York Heart Association; Ts-
SD-12, standard deviation of time to peak systolic myocardial velocity measured at 12
left ventricular segments derived from a triplane dataset.
Cardiac imaging and non-invasive testing
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Figure 4. Change in LV volumes and LV ejection fraction at baseline (grey) and at 6 months follow-up (white) in patients exhibiting reverse 
remodeling (Panels A and C) and those without reverse remodeling (Panels B and D).






n = 35 
p-value
Age (years) 65 (10) 67 (12) NS
Gender (M/F) 83% / 17% 77% / 25% NS
Ischemic/Idiopathic 50% / 50% 31% / 69% NS
NYHA III/IV 88% / 12% 94% / 6% NS
6-min walking (m) 331 (119) 326 (101) NS
Quality of life 37 (19) 32 (20) NS
QRS width (ms) 142 (37) 149 (28) NS
LVEDV (ml) 210 (91) 206 (61) NS
LVESV (ml) 164 (89) 158 (59) NS
LVEF (%) 25 (11) 25 (9) NS
Ts-SD-12 20 (10) 44 (12) < 0.001
Results are shown as mean (SD) unless stated otherwise.
LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume; NYHA: New York 
Heart Association; Ts-SD-12: standard deviation of time to peak systolic myocardial velocity measured at 12 left ventricular segments derived 
from a triplane dataset.
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prediction of clinical response after crt by tri-plane tdI
Overall, Ts-SD-12 measured with tri-plane technology, was significantly larger in clinical re-
sponders than in non-responders, indicating severe LV dyssynchrony in the clinical respond-
ers. Figure 6A shows the ROC curve illustrating the excellent ability of Ts-SD-12, measured 
with tri-plane TDI technology, to predict clinical response. An ideal cut-off value for Ts-SD-12 
to predict clinical response 6 months after CRT implantation, was defined at 33 ms based on 
the highest possible sensitivity (89%) and specificity (82%).
prediction of reverse lv remodeling after crt by tri-plane tdI
Overall, Ts-SD-12 measured with tri-plane technology, was significantly larger in patients 
with reverse LV remodeling as compared to patients without reverse LV remodeling, indicat-
ing severe LV dyssynchrony in patients with reverse remodeling. Figure 6B shows the ROC 
curve illustrating the excellent value of Ts-SD-12, measured with tri-plane TDI technology, 
to predict reverse LV remodeling. An ideal cut-off value for Ts-SD-12 to predict reverse LV 
remodeling at 6 months follow-up, was defined at 33 ms based on the highest possible 
sensitivity (90%) and specificity (83%).
baseline vs 22 (17) at follow-up, p=0.001). LV dyssynchrony
Ts-SD-12 improved from 42 (14) to 23 (12) (p,0.001).
Reverse LV remodelling at 6 months’ follow-up
A total of 35 (58%) patient exhibited reduction of LV end-
systolic volume >15% within 6 months after CRT implanta-
tion (fig 4). Patients with reverse LV remodelling showed not
only an improvement of LV end-systolic volume (248.6 ml on
average) but also a signific t decr ase f LV end-dias olic
diameter (231.9 ml on average) and an increase of LV ejection
fraction (+ 13.4% on average). Table 1 reports the baseline
clinical and echocardiographic characteristics of patients with-
out and with reverse LV remodelling.
The only pre-implantation characteristic differing signifi-
cantly between patients with and without reverse LV remodel-
ling was the extent of LV dyssynchrony as assessed with
triplane TDI. Patients with reverse LV remodelling at 6 months’
follow-up also exhibited a significant decrease of the degree of
LV dyssynchrony (a mean reduction of 22 ms as compared to a
mean increase of 1.7 ms in non-responders, p,0.001).
Figure 5 shows a relation between the decrease in LV
dyssynchrony and the decrease in LV end-systolic volume or
the increase in LV ejection fraction.
Prediction of cli ical response after CRT implantation by triplane
TDI
Overall, Ts-SD-12 measured with triplane technology was
significantly larger in clinical responders than in non-respon-
ders, indicating severe LV dyssynchrony in the clinical
responders. Figure 6A shows the ROC curve illustrating the
excellent ability of Ts-SD-12, measured with triplane TDI
technology, to predict clinical response. An ideal cut-off value
for Ts-SD-12 to predict clinical response 6 months after CRT
implantation, was defined at 33 ms based on the highest
possible sensitivity (89%) and specificity (82%).
Prediction of reverse LV remodelling after CRT implantation by
triplane TDI
Overall, Ts-SD-12, measured with triplane technology, was
significantly larger in patients with reverse LV remodelling than
Figure 5 Scatter plots showing the relation between the decrease in left ventricular dyssynchrony (quantified as Ts-SD-12) and (A) decrease in left
ventricular end-systolic volume (LVESV); (B) increase in left ventricular ejection fraction (LVEF), 6 months after cardiac resynchronisation therapy. A
line is fitted using simple regression analysis and the r2 values are reported, respectively.
Figure 6 (A) Receiver operating characteristic (ROC) curve for Ts-SD-12 predicting clinical response 6 months after cardiac resynchronisation therapy
(CRT) implantation; the area under the curve (AUC) is indicated with the 95% confidence interval. (B) ROC curve for Ts-SD-12 predicting reverse LV
remodelling (defined as at least 15% reduction in LV end-systolic volume) 6 months after CRT implantation; the AUC is indicated with the 95%
confidence interval.
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Figure 5. Scatter plots showing the relation between the decrease in left ventricular dyssynchrony (quantified as Ts-SD-12) and (A) decrease 
in left ventricular end-systolic volume (LVESV); (B) increase in left ventricular ejection fraction (LVEF), 6 months after cardiac resynchronisation 
therapy. A line is fitted using simple regression analysis and the r2 values are reported, respectively.
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dIscussIon
The findings in the current study can be summarized as follows: 1) the 3-D echo approach 
permits integrated assessment of LV volumes, LV ejection fraction and LV dyssynchrony; 2) 
in patients undergoing CRT, LV dyssynchrony was the only predictor of clinical response to 
CRT; 3) the standard deviation of time to peak myocardial systolic velocity in 12 LV segments 
(Ts-SD-12) ≥33, calculated from the tri-plane TDI dataset, had a sensitivity of 90% with a 
specificity of 83% to predict reverse LV remodeling, at 6 months post CRT implantation.
Several authors have emphasized the importance of quantifying the degree of LV dyssyn-
chrony in CRT candidates, to identify potential responders. Earlier studies proposed methods 
using M-mode 5 or pulsed-wave TDI 15,16, but recently, color-coded TDI 6,7,10 and techniques 
derived from color-coded TDI such as TSI 17 and strain rate imaging 8,9 have gained interest. 
The majority of color-coded TDI techniques are based on the measurement of time intervals 
between onset of the QRS complex and peak myocardial systolic velocity. Some authors have 
compared the activation times of the septal and lateral LV segments; for this approach TDI 
registration of the apical 4-chamber view, using 2-D technology, is sufficient 6.
Others used information derived from various LV segments. Yu and co-workers originally 
described the model (derived from 2D data) using electromechanical activation times of 12 
LV segments to quantify LV dyssynchrony 7,11. A potential problem with the 2D approach if 
baseline vs 22 (17) at follow-up, p=0.001). LV dyssynchrony
Ts-SD-12 improved from 42 (14) to 23 (12) (p,0.001).
Reverse LV remodelling at 6 months’ follow-up
A total of 35 (58%) patients exhibited a reduction of LV end-
systolic volume >15% within 6 months after CRT implanta-
tion (fig 4). Patients with reverse LV remodelling showed not
only an improvement of LV end-systolic volume (248.6 ml on
average) but also a significant decrease of LV end-diastolic
diameter (231.9 ml on average) and an increase of LV ejection
fraction (+ 13.4% on average). Table 1 reports the baseline
clinical and echocardiographic characteristics of patients with-
out and with reverse LV remodelling.
The only pre-implantation characteristic differing signifi-
cantly between patients with and without reverse LV remodel-
ling was the extent of LV dyssynchrony as assessed with
triplane TDI. Patients with reverse LV remodelling at 6 months’
follow-up also exhibited a significant decrease of the degree of
LV dyssynchrony (a mean reduction of 22 ms as compared to a
mean increase of 1.7 ms in non-responders, p,0.001).
Figure 5 shows a relation between the decrease in LV
dyssynchrony and the decrease in LV end-systolic volume or
the increase in LV ejection fraction.
Prediction of clinical response after CRT implantation by triplane
TDI
Overall, Ts-SD-12 measured with triplane technology was
significantly larger in clinical responders than in non-respon-
ders, indicating severe LV dyssynchrony in the clinical
responders. Figure 6A shows the ROC curve illustrating the
excellent ability of Ts-SD-12, measured with triplane TDI
technology, to predict clinical response. An ideal cut-off value
for Ts-SD-12 to predict clinical response 6 months after CRT
implantation, was defined at 33 ms based on the highest
possible sensitivity (89%) and specificity (82%).
Prediction of reverse LV remodelling after CRT implantation by
triplane TDI
Overall, Ts-SD-12, measured with triplane technology, was
significantly larger in patients with reverse LV remodelling than
Figure 5 Scatter plots showing the relation between the decrease in left ventricular dyssynchrony (quantified as Ts-SD-12) and (A) decrease in left
ventricular end-systolic volume (LVESV); (B) increase in left ventricular ejection fraction (LVEF), 6 months after cardiac resynchronisation therapy. A
line is fitted using simple regression analysis and the r2 values are reported, respectively.
Figure 6 (A) Receiver operating characteristic (ROC) curve for Ts-SD-12 predicting clinical response 6 months after cardiac resynchronisation therapy
(CRT) implantation; the area under the curve (AUC) is indicated with the 95% confidence interval. (B) ROC curve for Ts-SD-12 predicting reverse LV
remodelling (defined as at least 15% reduction in LV end-systolic volume) 6 months after CRT implantation; the AUC is indicated with the 95%
confidence interval.
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Figu  6. Panel A: ROC curve for Ts-SD-12 predicting clinical response 6 months after CRT implantation; the area under the curve is indicated 
with the 95% confidence interval. Panel B: ROC curve f r Ts-SD-12 pr dicting reverse LV remodeling (defined as at least 15% reduction i  LV 
end-systolic volume) 6 months post CRT implantation; the area under the curve is indicated with the 95% confidence interval.
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one uses the 12-segment model, is the cumbersome data acquisition. At least three separate 
color-coded 2D datasets are to be acquired, non-simultaneously. This implies that heart-rate 
variability is often neglected, resulting in non-simultaneous comparison of segmental coor-
dination. Moreover, in all CRT studies assessing LV remodeling, LV volumes and LV ejection 
fraction were estimated from 2-D datasets with Simpson’s biplane method.
Tri-plane imaging is a 3-D technique that integrates data from 3 conventional apical 
views. Validation studies have demonstrated that the tri-plane approach is superior to the 
bi-plane method and comparable to magnetic resonance imaging for LV volume estimation 
18,19. Recently a 3D probe became commercially available (GE Vingmed Ultrasound, Horten, 
Norway) allowing simultaneous acquisition of a tri-plane dataset and color-coded TDI. In 
the present study, we have demonstrated the multi-purpose of this tri-plane TDI dataset in 
60 heart failure patients scheduled for CRT implantation. A 3D LV volume was generated 
allowing evaluation of volumetric changes 6 months post-implantation, showing reverse LV 
remodeling in responders.
Furthermore an established 2-D TDI-based method 7,11 to quantify LV dyssynchrony using 
a 12-segment LV model was successfully applied to the tri-plane dataset. Sample volumes 
were placed in 12 LV segments and myocardial peak systolic velocities or time to peak systolic 
velocities of any LV segment could be compared during the same heartbeat. From these data, 
the Ts-SD-12 was calculated. Using 2D technology, Yu et al applied the Ts-SD-12 in 30 CRT 
patients and reported that a cut-off value >32.6 ms permitted separation of responders and 
non-responders to CRT 7,11 In a subsequent study the same authors used TSI in a 2-D dataset 
to quantify LV dyssynchrony 17. The Ts-SD-12 was most powerful to predict reverse LV remod-
eling; ROC curve analysis revealed an area of 0.90 with a sensitivity of 87% and a specificity of 
81% employing a cut-off value of 34.4 ms. In the present study, the Ts-SD-12 was calculated 
from the tri-plane dataset. A ROC curve area of 0.95 was shown with a sensitivity of 90% and 
a specificity of 87% for a cut-off value of 33 ms, well in line with the above-mentioned 2-D 
studies. The advantage of the tri-plane method is that acquisition of a single tri-plane dataset 
allows simultaneous comparison of 12 LV segments during the same heartbeat whereas the 
2-D method requires at least 3 acquisitions.
Experience with 3D echocardiographic evaluation of CRT patients is limited. Kapetanakis 
et al used real-time 3D echocardiography and calculated a systolic dyssynchrony index 
derived from dispersion of time to minimal regional volume in 26 patients undergoing CRT 
implantation 20. The authors noted that patients with a large systolic dyssynchrony index 
before implantation experienced the greatest reduction in mechanical dyssynchrony after 
CRT, whereas patients without symptomatic improvement had a statistically lower systolic 
dyssynchrony index before CRT implantation. The method described by Kapetanakis et al 20 is 
based on identification of the last LV region reaching minimum regional volume; the tri-plane 
method is based on the assessment of LV dyssynchrony from TDI velocity curves, currently 
the most frequently used echocardiographic method to predict benefit from CRT 4.
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study limitations
Patients with atrial fibrillation and previous pacemakers were excluded; further studies are 
needed in these specific patient populations to explore the value of 3-D TDI.
conclusIons
In the present study, a novel 3-D echocardiographic application, allowing simultaneous 
acquisition of a tri-plane TDI dataset, was successfully applied in 60 heart failure patients 
scheduled for CRT. From the tri-plane TDI dataset, quantitative analysis of LV dyssynchrony 
could be derived as well as LV volumes and ejection fraction. LV dyssynchrony, derived from 
the tri-plane TDI dataset, was highly predictive for clinical response and LV reverse remodel-
ing after 6 months of CRT.
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phase analysis of gated myocardial 
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objectives: To compare left ventricular (LV) dyssynchrony assessment by phase 
analysis from gated myocardial perfusion SPECT (GMPS) with LV dyssynchrony 
assessment by tri-plane tissue Doppler imaging (TDI). Baseline LV dyssynchrony 
assessed with standard deviation (SD) of time-to-peak systolic velocity of 12 LV seg-
ments (Ts-SD) with TDI has proven to be a powerful predictor of response to CRT. 
Information on LV dyssynchrony can also be provided by GMPS with phase analysis 
of regional LV maximal count changes throughout the cardiac cycle.
methods: Forty heart failure patients, referred for evaluation of potential eligibility 
for CRT, underwent both 3D echocardiography, with tri-plane TDI, and resting GMPS. 
From tri-plane TDI, Ts-SD was used as a validated parameter of LV dyssynchrony and 
compared with different indices (histogram bandwidth, phase SD, histogram skew-
ness and kurtosis) derived from phase analysis of GMPS.
results: Histogram bandwidth and phase SD showed good correlation with Ts-SD (r 
= 0.77 and r = 0.74, p <0.001 respectively). Patients with substantial LV dyssynchrony 
assessed with tri-plane TDI (Ts-SD ≥33 ms) had also significantly higher values of 
histogram bandwidth and phase SD.
conclusions: The results of this study support the use of phase analysis by GMPS 
to evaluate LV dyssynchrony. Histogram bandwidth and phase SD showed the best 
correlation with Ts-SD assessed with tri-plane TDI and appeared the most optimal 
variables for assessment of LV dyssynchrony with GMPS.
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LV dyssynchrony assessed by tri-plane TDI and GMPS
IntroductIon
Cardiac resynchronization therapy (CRT) has become an established therapy for patients with 
end-stage heart failure 1. However, up to 30% of the patients do not respond to CRT when 
selection is based on the traditional clinical and electrocardiographic criteria (New York Heart 
Association (NYHA) functional class III or IV, left ventricular ejection fraction (LVEF) <35%, and 
QRS duration >120 ms) 2. In the search for better selection criteria for CRT, it has been shown 
that patients with LV dyssynchrony have a higher likelihood of a positive response to CRT 3–8. 
Over the past few years, the assessment of LV dyssynchrony has been studied extensively 
with echocardiography.
The most frequently used technique is tissue Doppler imaging (TDI) which permits evalu-
ation of timing of regional myocardial velocity, and comparison of different regions yields 
information on LV dyssynchrony.
Bax et al. 3 have used a 4-segment model to assess LV dyssynchrony (4 basal LV segments: 
anterior, lateral, inferior and septal) and reported that a delay ≥65 ms among the 4 segments 
was a strong predictor of response to CRT. Other authors extended the analysis by evaluating 
the activation pattern of the entire LV. This method, originally described by Yu and co-workers 
6–8, uses the standard deviation (SD) of electromechanical activation times based on a 12-seg-
ment model of LV (Ts-SD). The authors investigated 56 patients with heart failure who un-
derwent CRT implantation and demonstrated that a cut-off value of 34.4 ms for Ts-SD could 
predict reverse LV remodeling after CRT with a sensitivity of 87% and a specificity of 81% 7. 
However, to calculate this parameter of LV dyssynchrony, 3 apical views need to be acquired 
separately. A 3-dimensional (3D) TDI imaging modality (tri-plane TDI) has become available 
to overcome this limitation. Tri-plane TDI allows simultaneous acquisition of all LV segments 
during the same heartbeat rendering the technique more precise than the 2-dimensional 
(2D) TDI equivalent. Another recent development is the use of gated myocardial perfusion 
single photon emission computed tomography (GMPS) for assessment of LV dyssynchrony 
9,10. A count-based method has been developed to extract phase information from the re-
gional LV count changes throughout the cardiac cycle, and this phase information is related 
to the time interval when a region, in the 3D LV wall, starts to contract (phase analysis). This 
technique has recently been implemented to the Emory Cardiac Toolbox as a diagnostic tool 
for assessment of LV mechanical dyssynchrony 9.
To further validate the use of GMPS with phase analysis for the assessment of LV dyssyn-
chrony, a direct comparison with tri-plane TDI was performed in a cohort of heart failure 
patients.




patients population and data collection
Forty consecutive patients with heart failure, referred for evaluation of potential eligibility for 
CRT, were included in this study. Traditional selection criteria for CRT were applied, includ-
ing moderate-to-severe drug refractory heart failure (NYHA class III or IV), depressed LVEF 
(<35%) and prolonged QRS duration (>120 ms). Patients with a recent myocardial infarction 
(<3 months) or decompensated heart failure were excluded. Evaluation of the clinical status 
included assessment of NYHA functional class, quality-of-life score (using the Minnesota 
quality-of-life questionnaire) and exercise capacity (using the 6-minute walk test). Extensive 
echocardiographic analysis, using 3D transthoracic echocardiography, was performed 
to assess LV dyssynchrony. Resting GMPS with technetium-99m tetrofosmin was clinically 
performed to exclude extensive ischemia and/or viability 11,12, in order to refer patients to 
revascularization if indicated. Thereafter, all scans were subjected to phase analysis to evalu-
ate LV dyssynchrony. The results of the phase analysis with GMPS to assess LV dyssynchrony 
were subsequently compared with LV dyssynchrony derived from tri-plane TDI.
echocardiography
3D data set acquisition
All patients underwent transthoracic echocardiography performed with a commercially 
available echocardiographic platform (VIVID 7, GE Vingmed Ultrasound, Horten, Norway), 
and equipped with a 3V-probe for 3D acquisition.
Patients were scanned in left lateral decubitus position, from the apical window in tri-plane 
modus, acquiring simultaneously the apical 4-, 2- and 3-chamber views. Care was taken to 
visualize the true LV apex. Color-coded TDI was applied to the tri-plane view to assess longitu-
dinal myocardial regional function. Gain settings, filters and pulse repetition frequency were 
adjusted to optimize color saturation. Sector size and depth were optimized for the highest 
possible frame rate. At least two consecutive beats were recorded from each view and the 
images were digitally stored for off-line analysis (EchoPac, GE Vingmed Ultrasound, Horten, 
Norway). The echocardiographic examination and the off-line analysis were performed by 
the same experienced echocardiographist, blinded to the GMPS and clinical data.
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3D analysis of LV dyssynchrony
During post-processing, the tri-plane TDI dataset was used to analyze myocardial veloc-
ity curves as previously described with 2D TDI echocardiography 6–8. Sample volumes were 
placed in the basal and mid segments of the septal, lateral, inferior, anterior, posterior and 
anteroseptal LV walls to calculate the time from the beginning of the QRS complex to peak 
systolic velocity (Ts), using the same heart beat (Figure 1). Subsequently, the standard de-
viation of Ts (Ts-SD) of the 12 myocardial segments was calculated and used as a parameter 
of LV dyssynchrony 6-8. A cut-off value of Ts-SD ≥33 ms was used to define the presence of 
substantial LV dyssynchrony.
gated myocardial perfusion spect
Resting GMPS with technetium-99m tetrofosmin (500 MBq, injected at rest) was performed 
using a triple head SPECT camera system (GCA 9300/HG, Toshiba Corp.) equipped with low 
Figure 1. Example of the myocardial velocity curves that can be derived by positioning the sample volume in any LV segment of the tri-plane 
dataset. This patient has substantial LV dyssynchrony: the postero-lateral and anterior walls (orange, light blue and red curves) are activated 
later than the septal and inferior walls (yellow and green curves); standard deviation of 12 LV segments Ts is 57.5 ms.
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energy high resolution collimators. Around the 140-KeV energy peak of technetium-99m 
tetrofosmin, a 20% window was used. A total of 90 projections (step and shoot mode, 35 
seconds per projection, imaging time 23 minutes) were obtained over a 360-degrees circular 
orbit. GMPS acquisition involved 16 frames per cardiac cycle. Data were reconstructed by 
filtered backprojection and then re-oriented to yield gated short-axis images. Data recon-
struction was performed over 360 degrees. These images were then submitted to the Emory 
Cardiac Toolbox for phase analysis 9. GMPS images were analyzed at the department of ra-
diology of Emory University School of Medicine by J.C. and E.V.G., who were blinded to the 
echocardiographic and clinical data. A phase distribution was extracted from a GMPS study, 
representing the regional onset of mechanical contraction of the LV. It can be displayed in a 
polar map or in 3D and used to generate a phase histogram. An example of a patient without 
LV dyssynchrony is shown in Figure 2a, whereas an example of a patient with substantial LV 
dyssynchrony as assessed with phase analysis by GMPS is shown in Figure 2b. The following 4 
quantitative indices were obtained from the phase analysis of all patients: 1. histogram band-
width, which includes 95% of the elements of the phase distribution; 2. phase SD, which is 
the SD of the phase distribution; 3. phase histogram skewness, which indicates the symmetry 
of the histogram; 4. histogram kurtosis, which indicates the degree to which the histogram 
is peaked 9. In a healthy individual the LV contracts in a coordinated manner and the phase 
distribution is nearly uniform with a highly peaked distribution of the histograms. As the LV 
contraction becomes dyssynchronous the phase SD and histogram bandwidth are expected 
to increase (Figure 2b).
statistical analysis
Continuous data are presented as mean±SD; dichotomous data are presented as numbers 
and percentages. Comparison of data was performed using the unpaired Student t test or χ2 
test when appropriate. Pearson’s correlation analysis was performed to evaluate the relation 
between histogram bandwidth, phase SD, histogram skewness and histogram kurtosis by the 
phase analysis of GMPS and LV dyssynchrony (Ts-SD) by tri-plane TDI. A p-value <0.05 was 
considered to be statistically significant. A statistical software program SPSS 12.0 (SPSS Inc, 
Chicago, II, USA) was used for statistical analysis.
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Figure 2A: Example of a patient without LV dyssynchrony on GMPS. The non-normalized (upper panel) and normalized (lower panel) phase 
distributions are nearly uniform and the corresponding phase histograms are highly-peaked, narrow distributions.
Figure 2B: Example of a patient (same as in Figure 1) with LV dyssynchrony on GMPS. The non-normalized (upper panel) and normalized 
(lower panel) phase distributions show significant non-uniformity and the corresponding phase histograms have widespread distributions.





A total of 40 consecutive patients with heart failure were included in this study (29 (72%) 
men; mean age 66±10 years). Baseline characteristics are summarized in Table 1. Patients 
had severe LV dysfunction (mean LVEF 26±7%), with extensive LV dilatation (mean LV end-
diastolic volume 210±48 ml). LV dyssynchrony assessment with tri-plane TDI demonstrated a 
mean value of Ts-SD of 34±15 ms.
histogram bandwidth
The mean histogram bandwidth was 130º±69º (range 41º to 260º); the normal value is 
38.7º±11.8º for men and 30.6º±9.6º for women 9. A good correlation between histogram 
bandwidth and LV dyssynchrony, assessed with tri-plane TDI, was observed (r = 0.77, p 
<0.001, Figure 3).




















LVEDV=left ventricular end-diastolic volume; LVEF=left ventricular ejection fraction; LVESV=left ventricular end-systolic volume; 6-MWT=6 
minute walk test; QoL=quality of life score; Ts-SD=standard deviation of time to peak systolic velocity of 12 LV segments.
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phase sd
The mean phase SD was 40.2º±18.8º (range 14.5º to 77.9º), whereas the normal value is 
14.2º±5.1º for men and 11.8º±5.2º for women 9. Pearson’s correlation showed a good correla-
tion between phase SD and Ts-SD (r = 0.74, p <0.001, Figure 4).
y = 3.6358x + 6.0178





























Figure 3. Correlation between histogram bandwidth assessed with GMPS and LV dyssynchrony assessed with tri-plane TDI (Ts-SD).
y = 0.9426x + 8.0115























Figure 4. Phase SD assessed with GMPS versus LV dyssynchrony assessed with tri-plane TDI (Ts-SD).




The mean histogram skewness was 2.50±0.81 (range 1.16 to 5.49), whereas the normal value 
is 4.19±0.68 for men and 4.60±0.72 for women 9. A poor correlation with LV dyssynchrony 
assessed with tri-plane TDI was demonstrated by Pearson’s correlation (r = -0.30, p = 0.06).
histogram kurtosis
The mean histogram kurtosis was 7.38±6.23 (range 1.08 to 37.42), whereas the normal value 
is 19.72±7.68 for men and 23.21±8.16 for women 9. No correlation between histogram kurto-
sis and Ts-SD was shown by Pearson’s correlation (r = -0.14, p = 0.38).
substantial versus no substantial lv dyssynchrony
Of the 40 patients included, 20 (50%) had a substantial LV dyssynchrony (defined as Ts-SD 
≥33 ms) 7,8. No significant differences in baseline characteristics were noted between the two 
patient groups (Table 2). Histogram bandwidth and phase SD were significantly higher in pa-
tients with Ts-SD ≥33 ms compared to patients with Ts-SD <33 ms: 186º±52º versus 74º±24º 
(p <0.001) and 55.3º±13.6º versus 25.1º±7.6º (p <0.001), respectively (Figure 5a and b). In 
addition, histogram skewness was significantly lower in patients with Ts-SD ≥33 ms than in 
Table 2. Baseline characteristics of patients with substantial (≥33 ms) and no substantial LV dyssynchrony (<33 ms) assessed by SD of time to 








Age (yrs) 67±10 66±9 NS
Gender (M/F) 14/6 15/5 NS
QRS duration (ms) 145±31 149±36 NS
NYHA class 3.0±0.4 3.0±0.4 NS
Etiology, n (%)
Ischemic 14 (70) 11 (55) NS
Idiopathic 6 (30) 9 (45) NS
LVEF (%) 25±7 26±7 NS
LVEDV (ml) 209±47 207±50 NS
LVESV (ml) 159±46 153±42 NS









Histogram kurtosis 6.36±7.94 8.40±3.79 NS
For abbreviations see Table 1.
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patients with Ts-SD <33 ms (2.23±0.93 versus 2.78±0.55, p = 0.03). No significant difference 
between the 2 groups was observed for histogram kurtosis (6.36±7.94 versus 8.4±3.79, p = 
NS) (Figure 5c and 5d). An example of a patient with substantial LV dyssynchrony on both 
tri-plane TDI as on phase analysis with GMPS is provided in Figure 1 and 2b.
Ischemic versus idiopathic dilated cardiomyopathy
In total, 25 patients (62%) had an ischemic cardiomyopathy and 15 patients (38%) had an id-
iopathic dilated cardiomyopathy. No differences in echocardiographic variables, including LV 
dyssynchrony assessed by tri-plane TDI, or GMPS phase analysis indices were found between 
ischemic and non-ischemic patients. No significant differences in correlation coefficients 
were observed between patients with ischemic cardiomyopathy and patients with idiopathic 
dilated cardiomyopathy for the 4 different GMPS variables (Table 3).
















































































Figure 5. Figure 5A: Patients with substantial versus no substantial LV dyssynchrony (Ts-SD), using a cut-off value ≥33 ms. Histogram 
bandwidth is significantly higher in patients with substantial LV dyssynchrony. Figure 5B: Patients with substantial versus no substantial LV 
dyssynchrony (Ts-SD), using a cut-off value ≥33 ms. Phase SD is significantly higher in patients with substantial LV dyssynchrony. Figure 5C: 
Patients with substantial versus no substantial LV dyssynchrony (Ts-SD), using a cut-off value ≥33 ms. Histogram skewness is significantly lower 
in patients with substantial LV dyssynchrony. Figure 5D: Patients with substantial versus no substantial LV dyssynchrony (Ts-SD), using a cut-off 
value ≥33 ms. No significant difference in histogram kurtosis was demonstrated between patients without and patients with substantial LV 
dyssynchrony as assessed with tri-plane echocardiography.




The main findings of the present study can be summarized as follows:
1) LV dyssynchrony assessment with phase analysis on GMPS is feasible in heart failure 
patients screened for eligibility for CRT implantation. The phase analysis variables histogram 
bandwidth and phase SD show good correlation with LV dyssynchrony as measured with 
tri-plane TDI (Ts-SD), suggesting that GMPS phase analysis can be used to quantify LV dys-
synchrony. 2) Patients with substantial LV dyssynchrony on tri-plane TDI have significantly 
higher values of histogram bandwidth and phase SD derived from phase analysis with GMPS 
(histogram bandwidth: 186º±52º versus 74º±24º, p <0.001), and phase SD: 55.3º±13.6º versus 
25.1º±7.6º (p <0.001).
CRT is now considered an important therapeutic option in the treatment of patients with 
end-stage heart failure 1. Although encouraging beneficial effects have been reported, 
including improvement in LVEF and reduction in heart failure symptoms, it has also been 
demonstrated that up to 30% of patients do not have a favorable response to CRT. The pres-
ence of LV dyssynchrony is considered a key issue in the identification of potential respond-
ers to CRT 3–6. Echocardiography and in particular TDI have been extensively used to assess 
LV dyssynchrony. Several parameters derived from myocardial velocity curves of different 
LV segments have been proposed to quantify LV dyssynchrony and predict response to CRT 
3–8. Yu and coworkers described a model (derived from 2D TDI data) to quantify global LV 
dyssynchrony using Ts-SD of 12 LV segments 6–8. The authors reported a cut-off value >32.6 
ms to distinguish between responders and non-responders 8 and a cut-off value >34.4 ms as 
the most powerful predictor of LV reverse remodeling 7. In this study LV dyssynchrony was 
evaluated by Ts-SD from tri-plane TDI and compared with LV dyssynchrony assessment with 
phase analysis by GMPS. The tri-plane TDI technique avoids the problem of heart rate vari-
ability since simultaneous acquisition of the 3 apical views is possible; in the present study a 
cut-off value ≥33 ms was used to define substantial LV dyssynchrony on tri-plane TDI.
Information on cardiac dyssynchrony can also be derived from nuclear imaging. Kerwin et 
al. 13 evaluated interventricular dyssynchrony in 13 heart failure patients using multi-gated 
equilibrium blood pool scintigraphy and phase analysis. Patients were imaged during biven-
Table 3. Correlation coefficients of LV dyssynchrony, assessed with tri-plane TDI, versus the different LV dyssynchrony parameters, derived from 
phase analysis of GMPS (idiopathic dilated cardiomyopathy versus ischemic cardiomyopathy).







Histogram Bandwidth r = 0.79 r = 0.78 NS
Phase SD r = 0.77 r = 0.75 NS
Histogram skewness r = -0.22 r = -0.48 NS
Histogram kurtosis r = -0.07 r = -0.35 NS
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tricular pacing and in sinus rhythm. During biventricular pacing, a significant improvement 
in interventricular synchrony was observed. Moreover, an improvement in LVEF was reported 
for all 13 patients during biventricular pacing (17.2±7.9% to 22.5±8.3%, p <0.001) and the 
increase in LVEF correlated significantly with the improvement in interventricular synchrony 
(r = 0.86; p <0.001). Fauchier et al. 14 used equilibrium radionuclide angiography and phase 
analysis to evaluate the prognostic value of interventricular and intraventricular dyssynchro-
ny in 103 patients with idiopathic dilated cardiomyopathy. Phase images were generated 
from the scintigraphic data, and mean phase angles and SDs were calculated for the right and 
left ventricle. During a follow-up period of 27±23 months, 18 major cardiac events occurred. 
Multivariate analysis revealed that LV intraventricular dyssynchrony and elevated pulmonary 
capillary wedge pressure were the only independent predictors of cardiac events.
GMPS is currently used in patients with heart failure to exclude ischemia and/or viability 
before referring for CRT implantation, and to assess total scar burden in patients with isch-
emic cardiomyopathy 11,12. Indeed, various studies have shown that the presence of severe 
resting perfusion defects, as assessed with GMPS, limit the response to CRT 15–17. Recently, 
Chen et al. 9 developed with GMPS a count-based method to extract phase information from 
the regional LV count changes throughout the cardiac cycle. The phase information is related 
to the regional onset of mechanical contraction of the LV (phase analysis) and provides 
information on the synchronicity of the LV contraction. The authors assessed in 90 normal 
individuals the normal range for 4 quantitative indices which can be used as markers of LV 
dyssynchrony (histogram bandwidth, phase SD, histogram skewness and histogram kurtosis) 
9. Recently, these 4 GMPS indices have been compared with LV dyssynchrony assessment 
by TDI in 75 patients with severe heart failure. It was shown that among the 4 quantitative 
indices of phase analysis, the variables histogram bandwidth and phase SD correlated best 
with LV dyssynchrony as assessed by TDI 10. The current study involved a different patient 
subset, and provides further support that phase analysis with GMPS can be useful in the 
evaluation of LV dyssynchrony.
The value of GMPS to assess LV dyssynchrony has been analyzed and the indices derived 
from phase analysis were compared with Ts-SD measured by tri-plane TDI. It was shown that 
histogram bandwidth and phase SD correlated well with Ts-SD as evaluated by tri-plane TDI 
(histogram bandwidth: r = 0.77 and phase SD: r = 0.74). In addition, significantly higher values 
for histogram bandwidth and phase SD were observed in patients with substantial LV dys-
synchrony on tri-plane TDI compared with patients without substantial LV dyssynchrony on 
tri-plane TDI.




In the present study, follow-up data after CRT implantation were not available. Therefore the 
value of phase analysis to predict response to CRT could not be determined. Furthermore, 
GMPS may be less suitable for repeated analysis during the follow-up after CRT implantation, 
due to radiation burden of the technique.
conclusIons
The results of this study confirm the feasibility to evaluate LV dyssynchrony with phase 
analysis by GMPS and its applicability in the clinical setting. In particular, histogram band-
width and phase SD showed a good correlation with LV dyssynchrony measured with Ts-SD 
as assessed with tri-plane TDI. Future prospective studies in larger patient populations with 
follow-up after CRT implantation are needed to elucidate the potential role of GMPS with 
phase analysis for prediction of response to CRT.
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Noninvasive imaging of cardiac venous 
anatomy with 64-slice computed 
tomography and noninvasive assessment 
of LV dyssynchrony by 3D tissue 
synchronization imaging in patients with 
heart failure scheduled for CRT
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Erven, E R Holman, J de Sutter, E E van der Wall, M J Schalij, and J J Bax
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objectives: Objectives of this study were to perform a prospective head-to-head 
comparison between multi-slice computed tomography (MSCT) venography and 
invasive venography in cardiac resynchronization therapy (CRT) candidates as well 
as to evaluate the relation between left ventricular (LV) lead position and effect on 
LV dyssynchrony and immediate response to CRT.
methods: Twenty-one consecutive heart failure patients scheduled for CRT implan-
tation were prospectively enrolled to undergo 64-slice MSCT to visualize the venous 
system, invasive venography during device implantation, and tri-plane tissue syn-
chronization imaging (TSI) before and after implantation.
results: Excellent agreement between MSCT and invasive venography was noted. 
No significant differences were observed between both techniques regarding vessel 
diameters. In 12 patients, a match was observed between the area of latest me-
chanical activation (on TSI) and LV lead position. These patients showed a significant 
decrease in LV dyssynchrony (43±7 ms to 11±9 ms, p <0.001) with acute reduction 
in LV end-systolic volume (188±54 ml to 162±48 ml, p <0.01) and improvement in LV 
ejection fraction (22%±9% to 34%±9%, p <0.01). Patients with a mismatch between 
area of latest activation and LV lead position remained dyssynchronous without 
improvement in LV function.
conclusions: Visualization of major tributaries of the coronary sinus was com-
parable between invasive venography and MSCT venography. Optimal LV lead 
positioning in a vein draining the area of latest mechanical activation (determined 
from tri-plane TSI) resulted in acute improvement of LV dyssynchrony and systolic 
function after CRT implantation.
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IntroductIon
Cardiac resynchronization therapy (CRT) is an attractive treatment for highly symptomatic 
heart failure patients with wide QRS complex and depressed left ventricular (LV) systolic 
function 1. In large randomized clinical trials, up to 30% of patients do not respond favourably 
to CRT 2,3. Two major issues need to be addressed during the selection process of potential 
candidates to improve the success rate 3. First, LV dyssynchrony appears an important predic-
tor of response to CRT 4. The amount of intraventricular dyssynchrony can be reliably assessed 
noninvasively with tissue Doppler echocardiography 5. Second, attention to venous anatomy 
ensures the area of latest activation can be reached through a suitable vein. Particularly in 
patients with ischemic cardiomyopathy, lack of a suitable branch of the coronary sinus may 
hamper successful endovascular LV lead implantation 6. In 2005, preliminary data suggested 
that the cardiac venous system could be depicted noninvasively using 16-slice multi-slice 
computed tomography (MSCT) 7. Recently, the feasibility of 64-slice MSCT to evaluate the car-
diac veins was confirmed in a retrospective analysis of 100 patients 8. However, prospective 
comparisons between MSCT and invasive venography for assessment of venous anatomy are 
lacking. Moreover, information on location of LV dyssynchrony and venous anatomy should 
be integrated to determine whether a transvenous or a surgical approach should be selected 
for LV lead positioning. In the present study, 21 consecutive patients with heart failure sched-
uled for CRT underwent 64-slice CT of the cardiac venous system, invasive venography during 
device implantation, and 3-dimensional tissue synchronization imaging (TSI) echocardiogra-
phy before CRT to assess location and extent of LV dyssynchrony. Study aims were (1) to 
perform a head-to-head comparison between MSCT venography and invasive venography in 
CRT candidates (to further validate the use of MSCT for assessing venous anatomy), and (2) 
to evaluate the effect of CRT when the LV lead is positioned inside or outside a vein draining 
the area of latest mechanical activation.
methods
A total of 21 consecutive patients with heart failure scheduled for CRT, underwent 64-slice 
MSCT before, and invasive venography during CRT implantation. Exclusion criteria were atrial 
fibrillation, documented contrast allergy, and reduced renal function (serum creatinine >140 
μmol/L).
Imaging was performed with a 64-detector row Toshiba Multislice Aquilion 64 system 
(Toshiba Medical Systems, Otawara, Japan) with a collimation of 64 x 0.5 mm and a rota-
tion time of 0.4 seconds. Between 95 and 140 ml (mean 108±11 ml) of contrast material 
(Iomeron 400, Bracco Altana Pharma GmbH, Konstanz, Germany) at an injection rate of 5 
ml/min was used with an automatic bolus triggering technique. To optimize the scan for 
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venous visualization, an additional 2-second delay was applied after the contrast bolus 
reached the descending aorta before triggering the scan. For optimal filling of the cardiac 
venous system, the use of saline chasing was omitted. Tube voltage was 120 kV at 300 mA. A 
segmental reconstruction algorithm allowed inclusion of patients with a range of heart rates. 
The majority of the patients were already taking low-dose β-blockers; additional β blockade 
was considered contra-indicated because of the presence of heart failure. During the MSCT 
examination, electro-cardiography was performed simultaneously for retrospective gating of 
the data. An initial data set was reconstructed at 75% of the RR interval, with a slice thickness 
of 0.5 mm and a reconstruction interval of 0.3 mm. Data reconstruction was performed on a 
Vitrea post-processing workstation (Vital Images, Plymouth, Minnesota).
Three-dimensional volume-rendered reconstructions were used to obtain general infor-
mation on the anatomy of the cardiac veins. Thereafter, the course of the veins was evaluated 
in three orthogonal planes using multi-planar reformatting. The tributaries of the coronary 
sinus evaluated 9 include posterior interventricular vein, posterior vein of the LV, and left 
marginal vein. First-degree side branches were also noted, if present. The diameter of the 
coronary sinus ostium was measured in 2 directions (anteroposterior and superoinferior), 
and the diameters of the tributaries were measured close to their origin.
Retrograde venography was performed after implantation of the right atrial and right ven-
tricular leads in all 21 patients. The coronary sinus was cannulated from a subclavian entry 
site by an 8F guiding catheter. A balloon occlusion catheter (Arrow model 6714; Arrow Inter-
national Inc., Reading, Pennsylvania, or Medtronic model 6215, Medtronic Inc., Minneapolis, 
Minnesota) was advanced to the proximal part of the coronary sinus. Three venograms (right 
anterior oblique 30°, anteroposterior and left anterior oblique 30° views) were then obtained 
with an acceptable occlusion balloon position. A non-ionic contrast agent with low osmolar-
ity (Iomeron 350; Bracco Altana Pharma GmbH) was used. Next, the balloon occlusion cath-
eter was withdrawn and the LV pacing lead was positioned, preferably in the (postero)lateral 
vein. The choice of LV lead position was made independently by the implanting cardiologist, 
who was blinded to the MSCT and dyssynchrony data. At implantation, both the sensing and 
pacing thresholds (at pulse duration of 0.5 ms) of the LV pacing lead were measured. The final 
position of the LV pacing lead was assessed by fluoroscopy.
The different image series were stored digitally and analyzed by an experienced observer 
without knowledge of the MSCT data, at a separate workstation using commercially available 
software (QCA-CMS version 6.0; Medis, Leiden, The Netherlands). Images were first analyzed 
to identify the tributaries of the coronary sinus and presence of 1st degree side branches. The 
proximal vein diameters of the coronary sinus, posterior interventricular vein, posterior vein of 
the left ventricle, and left marginal vein were measured after catheter-based image calibration.
All patients underwent a transthoracic echocardiogram before and within 72 hours after 
CRT implantation. Studies were performed with a commercially available echocardiographic 
platform (VIVID 7; GE Vingmed Ultrasound, Horten, Norway), equipped with a 3V-probe for 
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3-dimensional acquisition. Patients were scanned in left lateral decubitus position, from the 
apical window in tri-plane modus. Care was taken to visualize the true LV apex, allowing simul-
taneous acquisition of the apical 4-, 2-, and 3-chamber views. Color-coded TSI was applied to 
the tri-plane view to assess longitudinal myocardial regional function. Gain settings, filters, and 
pulse repetition frequency were adjusted to optimize color saturation. Sector size and depth 
were optimized for the highest possible frame rate. At least 2 consecutive beats were recorded 
from each view, and the images were digitally stored for offline analysis (EchoPac; GE Vingmed 
Ultrasound). During post-processing, the tri-plane data set was frozen in end-diastole, and the 
endocardial border was manually traced in the apical 4-, 2- and 3-chamber views, respectively. 
Then, using the same heartbeat, the tri-plane data set was frozen in end-systole, and again 
the endocardial border was manually traced in the apical 4-, 2-, and 3-chamber views. Three-
dimensional LV end-diastolic and end-systolic volumes were generated automatically by the 
software (Echopac), and LV ejection fraction was reported accordingly 10.
During post-processing, the tri-plane TSI data set was used to analyze myocardial velocity 
curves as previously described.5 TSI automatically calculates the time from the beginning 
of the QRS complex to peak systolic velocity in every position in the image with reference 
to the QRS interval. The TSI algorithm detects positive velocity peaks within a specified time 
interval, and the color coding ranges from green (earliest), over yellow-orange to red (latest) 
within this interval. By using surface mapping and manual tracing of the endocardial borders, 
a 3-dimensional rendered volume was automatically generated, allowing for a spatial repre-
sentation of electromechanical activation times. Sample volumes were placed in the basal 
and mid segments of the septal, lateral, inferior, anterior, posterior, and anteroseptal LV walls 
to measure the time between onset of QRS complex and peak systolic myocardial velocity. 
From these 12 measurements, the LV dyssynchrony parameters calculated include delay 
between septum and lateral wall 11,12 and standard deviation of all 12 LV segments 13,14. The 
severity of mitral regurgitation was graded semiquantitatively from color-flow Doppler in the 
conventional parasternal long-axis and apical 2- and 4-chamber images. Mitral regurgitation 
was characterized as mild, 1+ (jet area/left atrial area <10%); moderate, 2+ (jet area/left atrial 
area 10% to 20%); moderately severe, 3+ (jet area/left atrial area 20% to 45%); and severe, 4+ 
(jet area/left atrial area >45%) 15.
All analyses were performed with the statistical software program SPSS 12.0.1 (SPSS, Inc., 
Chicago, Illinois). Continuous data are presented as mean±SD. Categorical data are presented 
as absolute numbers or percentages. Comparisons between MSCT and invasive venography 
were performed using the independent samples t test and Pearson’s correlation analysis; 
comparisons between characteristics before and after implantation were performed using 
the paired samples t test. Comparisons between categorical variables were performed with 
Chi-Square testing. A p-value <0.05 was considered significant.




There were 13 (62%) men and 8 (38%) women with a mean age of 67±11 years; all were in New 
York Heart Association (NYHA) class III despite optimized medical therapy (86% used diuret-
ics, 95% angiotensin-converting enzyme inhibitors, 71% β-blockers, 48% spironolactone). 
Patients with ischemic (12, 57%) and those with nonischemic cardiomyopathy (9, 43%) were 
both included; 6 (29%) had a history of percutaneous coronary intervention, and 6 (29%) 
had a history of coronary artery bypass grafting (combined with mitral valve annuloplasty 
in 2 patients). MSCT was successfully performed in all included patients. Average heart rate 
during scanning was 65±14 beats/min, scan time 21±11 seconds, helical pitch 14.3±0.7. On 
average, 108±11 ml of contrast was used. CRT device and transvenous LV lead implantation 
were successful in all but 1 patient (absence of suitable veins on venography, and this patient 
was referred for surgical LV lead implantation), without major complications. All remaining 
20 patients received a combined CRT-implantable cardioverter defibrillator device (Contak 
Renewal 4 CRT-D, Guidant, and Insync Marquis or Sentry CRT-D, Medtronic Inc.). Two types 
of LV leads were used, Easytrack 4517-90 (Guidant) or Attain OTW bipolar 4194 (Medtronic 
Inc.). Five patients underwent upgrading of a previously implanted implantable cardioverter 
defibrillator to a CRT-debrillator device. During implantation, invasive balloon occlusion 
venography was performed in all 21 patients.
table 1. Prevalence of the major cardiac veins and number of side branches using multi-slice computed tomography (MSCT) and invasive venography.
n/total (%)
MSCT Invasive Venography
Coronary sinus 21/21 (100%) 21/21 (100%)
Posterior interventricular vein 21/21 (100%) 18/21 (86%)
0 side branches 14/21 (67%) 12/18 (66%)
1 side branch 2/21 (9%) 3/18 (17%)
2 side branches 4/21 (19%) 3/18 (17%)
3 side branches 0/21 (0%) 0/18 (0%)
4 side branches 1/21 (5%) 0/18 (0%)
Posterior vein of LV 20/21 (95%) 20/21 (95%)
0 side branches 15/20 (75%) 12/20 (60%)
1 side branch 2/20 (10%) 1/20 (5%)
2 side branches 3/20 (15%) 6/20 (30%)
3 side branches 0/20 (0%) 0/20 (0%)
4 side branches 0/20 (0%) 1/20 (5%)
Left marginal vein 12/21 (57%) 13/21 (62%)
0 side branches 6/12 (50%) 5/13 (38%)
1 side branch 2/12 (17%) 3/13 (23%)
2 side branches 3/12 (25%) 4/13 (31%)
3 side branches 0/12 (0%) 0/13 (0%)
4 side branches 1/12 (8%) 1/13 (8%
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Identification of the coronary sinus and its major tributaries on MSCT and invasive venog-
raphy in the entire study population is reported in Table 1. The posterior interventricular 
vein was not observed with invasive venography in 3 patients (14%), whereas on MSCT 
this vein was observed in all patients. The left marginal vein was observed in 12 patients 
(57%) on MSCT and in 13 patients (62%) with invasive venography. The number of visible 
side branches of the major tributaries is reported in Table 1. Figure 1 illustrates the excellent 
agreement between MSCT and invasive venography in a patient with heart failure with a 
history of coronary artery bypass grafting. The diameters of the coronary sinus and tributar-
ies, measured with MSCT and invasive venography are depicted in Figure 2. No significant 
differences in measured diameters were observed between MSCT and invasive venography, 
and excellent correlations were observed between noninvasively and invasively measured 
diameters (Figure 2).
At baseline, all patients had severe LV dilatation with depressed LV function, accompanied 
by functional mitral regurgitation (Table 2); also, a significant extent of LV dyssynchrony was 
observed 11–14. Immediately after implantation, LV end-diastolic volume remained unchanged, 
whereas LV endsystolic volume decreased significantly with an improvement in LV ejection 
fraction and mitral regurgitation. The extent of LV dyssynchrony was significantly reduced 
after CRT implantation.
Figure 1. Cardiac venous anatomy of an 80-year-old man with severe heart failure and history of coronary artery bypass grafting. The left panel 
is a 3-dimensional volume-rendered reconstruction from 64-slice MSCT data. The right panel is a fluoroscopic image from invasive venography. 
All major tributaries of the coronary sinus are visualized using both techniques, specifically, a small posterior interventricular vein (PIV), a 
posterior vein of the left ventricle (PVLV), and a large left marginal vein (LMV). Note the prominent side branch of the LMV (block arrow) and the 
connection between the LMV and PVLV (lightning flash). The left ventricular lead was successfully implanted in the LMV.
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Using a 12-segment LV model with 3-dimensional TSI imaging, the area of latest mechanical 
activation was lateral in 8 patients (38%), anterolateral in 9 (43%), posterolateral in 2 (9.5%), 
and inferolateral in 2 (9.5%). From the fluoroscopic images obtained during CRT implantation, 
the precise LV lead position was determined. If the LV lead was positioned in a cardiac vein 
draining the area of latest mechanical activation, this was considered a match between LV 
lead position and area of latest activation. In 12 patients (57%), a match was noted between 
the area of latest mechanical activation on tri-plane TSI and the final LV lead position. In 
these patients, a significant decrease in LV dyssynchrony was observed (Figure 3). Moreover, 
positioning the LV lead in a vein draining the area of latest mechanical activation (match) 
resulted in an acute decrease in LV end-systolic volume (average reduction of 26 ml or 13.3%) 
with an increase in LV ejection fraction (average increase of 12%) after CRT implantation. In 
contrast, LV dyssynchrony persisted in the 8 patients (38%) with a mismatch between the LV 
lead position and the area of latest mechanical activation, and improvement in LV ejection 
fraction and reduction in LV end-systolic volume were not observed in these patients (Figure 
3). Figure 4 shows pre-implantation venograms and MSCT images of an 85-year-old patient 
with heart failure. A large left marginal vein is identified and used for LV lead implantation. 
mized for the highest possible frame rate. At least 2 con-
secutive beats were recorded from each view, and the im-
ages were digitally stored for offline analysis (EchoPac; GE
Vingmed Ultrasound).
During postprocessing, the tri-plane data set was frozen
in end-diastole, and the endocardial border was manually
traced in the apical 4-, 2- and 3-chamber views, respec-
tively. Then, using the same heartbeat, the tri-plane data set
was frozen in end-systole, and again the endocardial border
was manually traced in the apical 4-, 2-, and 3-chamber
views. Three-dimensional LV end-diastolic and end-sys-
tolic volumes were generated automatically by the software
(Echopac), and LV ejectio f action was reported accord-
ingly.10
During postprocessing, the tri-plane TSI data set was
used to analyze myocardial velocity curves as previously
described.5 TSI automatically calculates the time from
the b ginning of he QRS compl x to peak sys olic ve-
locity in every position in the image with reference to the
QRS interval. The TSI algorithm detects positive velocity
peaks within a specified time interval, and the color
coding ranges from green (earliest), over yellow-orange
to red (latest) within this interval. By using surface map-
ping and manual tracing of the endocardial borders, a
3-dimensional rendered volume was automatically gen-
erated, allowing for a spatial representation of electro-
mechanical activation times. Sample volumes were
placed in the basal and mid segments of the septal,
lateral, inferior, anterior, posterior, and anteroseptal LV
walls to measure the time between onset of QRS complex
and peak systolic myocardial velocity. From these 12
measurements, the LV dyssynchrony parameters calcu-
lated include delay between septum and lateral wall11,12
and standard deviation of all 12 LV segments.13,14
The severity of mitral regurgitation was graded semi-
quantitatively from color-flow Doppler in the conven-
tional parasternal long-axis and apical 2- and 4-chamber
images. Mitral regurgitation was characterized as mild,









Figure 1. Cardiac venous anatomy of an 80-year-old man with severe heart failure and history of coronary artery bypass grafting. The left panel is a
3-dimensional volume-rendered reconstruction from 64-slice MSCT data. The right panel is a fluoroscopic image from invasive venography. All major
tributaries of the coronary sinus are visualized using both techniques, specifically, a small posterior interventricular vein (PIV), a posterior vein of the left
ventricle (PVLV), and a large left marginal vein (LMV). Note the prominent side branch of the LMV (block arrow) and the connection between the LMV
and PVLV (lightning flash). The left ventricular lead was successfully implanted in the LMV.
Figure 2. No significant differences are observed between invasive venog-
raphy or MSCT in quantitative assessment of the diameters of the CS in the
anteroposterior (AP) and superoinferior (SI) direction, the posterior inter-
ventricular vein (PIV), the posterior vein of the left ventricle (PVLV), and
the left marginal vein (LMV). Correlation coefficients between invasively
and noninvasively measured diameters are mentioned below the X-axis.
Table 2
Echocardiographic observations before and after cardiac
resynchronization therapy (CRT) implantation
Before CRT After CRT p Value
Mitral regurgitation grade 1.5  0.9 1.1  0.9 0.001
3-dimensional volumetric
parameters
LV end-diastolic volume (ml) 239  56 239  55 NS
LV end-systolic volume (ml) 183  50 168  50 0.05
LV ejection fraction (%) 24  9 31  10 0.05
LV dyssynchrony indexes
Septal-to-lateral delay (ms) 84  19 45  50 0.001
Standard deviation 12 LV
segments (ms)
43  8 26  21 0.001
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Figure 2. No significant differences are observed between invasive venography or MSCT in quantitative assessment of the diameters of the 
CS in the anteroposterior (AP) and superoinferior (SI) direction, the posterior interventricular vein (PIV), the posterior vein of the left ventricle 
(PVLV), and the left marginal vein (LMV). Correlation coefficients between invasively and noninvasively measured diameters are mentioned 
below the X-axis.
Table 2. Echocardiographic observations before and after cardiac resynchronization therapy (CRT) implantation.
before crt after crt p-value
Mitral regurgitation grade 1.5±0.9 1.1±0.9 <0.001
3-dimensional volumetric parameters:
LV end-diastolic volume (ml) 239±56 239±55 NS
LV end-systolic volume (ml) 183±50 168±50 <0.05
LV ejection fraction (%) 24±9 31±10 <0.05
LV dyssynchrony indexes: 
Septal-to-lateral delay (ms) 84±19 45±50 0.001
Standard deviation 12 LV segments (ms) 43±8 26±21 0.001
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This LV lead position matched the area of latest mechanical activation (identified with 3-di-
mensional TSI), and synchrony was restored acutely after CRT (septal-to lateral delay 90 ms at 
baseline, 10 ms after implantation, standard deviation of 12 LV segments 45 ms at baseline, 5 
ms after implantation). In addition, a reduction of LV end-systolic volume from 191 to 153 ml 
was observed with an increase in LV ejection fraction from 13% to 28%.
area/left atrial area 10% to 20%); moderately severe, 3
(jet area/left atrial area 20% to 45%); and severe, 4 (jet
area/left atrial area 45%).15
All analyses were performed with the statistical software
program SPSS 12.0.1 (SPSS, Inc., Chicago, Illinois). Con-
tinuous data are presented as mean  SD. Categorical data
are presented as absolut numbers or percentages. Compar-
isons between MSCT and invasive venography were per-
formed using the independent-samples t test and Pearson’s
correlation analysis; comparisons between characteristics
before and after implantation were performed using the
paired-samples t test. Comparisons between categorical
variables were performed with Chi-Square testing. A p
value 0.05 was considered significant.
Results
There were 13 (62%) men and 8 (38%) women with a mean
age of 67  11 years; all were in New York Heart Association
(NYHA) class III despite optimized medical therapy (86%
used diuretics, 95% angiotensin-converting enzyme inhibitors,
71%  blockers, 48% spironolactone). Patients with ischemic
(12, 57%) and those with nonischemic cardiomyopathy (9,
43%) were both included; 6 (29%) had a history of percuta-
n ous coronary intervention, and 6 (29%) had a history of
coronary artery bypass grafting (combined with mitral valve
annuloplasty in 2 patients). MSCT was successfully performed
in all included patients. Average heart rate during scanning
was 65  14 beats/ in, scan time 21  11 seconds, helical
pitch 14.3  0.7. On average, 108  11 ml of contrast was
used. CRT device and transvenous LV lead implantation were
successful in all but 1 patient (absence of suitable veins on
venography, and this patient was referred for surgical LV lead
implantation), without major complications. All remaining 20
patients received a combined CRT-implantable cardioverter-
defibrillator device (Contak Renewal 4 CRT-D, Guidant, and
Insync Marquis or Sentry CRT-D, Medtronic Inc.). Two types
of LV leads were used, Easytrack 4517-90 (Guidant) or Attain
OTW bipolar 4194 (Medtronic Inc.). Five patients underwent
upgrading of a previously implanted implantable cardioverter-
defibrillator to a CRT-debrillator device. During implantation,
invasive balloon occlusion venography was performed in all
21 patients.
Figure 3. (A) The favorable effects of positioning the left ventricular lead within the area of latest mechanical activation (match). (B) Absence of these
effects in patients showing a mismatch between lead position and area of latest mechanical activation. The upper graphs depict dyssynchrony
parameters calculated from tri-plane TSI data, specifically, septal-to-lateral delay (SL delay) and standard deviation of time to peak myocardial systolic
velocity in 12 LV segments (SD12). The lower graphs depict LV-end systolic volume (LVESV) and LV end-diastolic volume (LVEDV) before and
after CRT implantation.
Figure 4. Case example of an 85-year-old patient with idiopathic dilated cardiomyopathy, NYHA class III heart failure and wide QRS complex (157 ms,
LBBB-configuration). MSCT shows a large left marginal vein with prominent side branches (A, B, C). These findings are confirmed by invasive venography
(D, E, F). In the 3-dimensional LV dyssynchrony assessment with TSI (I), the late mechanical activation (yellow) is located in the lateral wall. The LV lead
is positioned in the left marginal vein (G, H), resulting in synchronous activation of the LV, represented (green) on TSI, obtained immediately after CRT
(J). In addition, a reduction of LV end-systolic volume from 191 to 153 ml was observed, with an increase in LV ejection fraction from 13% to 28%.
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Figure 3. (A) The favorable effects of positioning the left ventricular lead within the area of latest mechanical activation (match). (B) Absence 
of these effects in patients showing a mismatch between lead position and area of latest mechanical activation. The upper graphs depict 
dyssynchrony parameters calculated from tri plane TSI data, specifically, septal-to-lateral delay (SL delay) and standard deviation of time to 
peak myocardial systolic velocity in 12 LV segments (SD12). The lower graphs depict LV-end systolic volume (LVESV) and LV end-diastolic volume 
(LVEDV) before and after CRT implantation.




Until recently, invasive venography was the only technique enabling clinicians to evaluate 
the coronary sinus and its major tributaries. In several preliminary studies, 16-slice MSCT was 
proposed as a valid non-invasive alternative 7,16,17. These findings were recently confirmed in 
a retrospective analysis of 100 patients using 64 slice MSCT technology 8. All studies report a 
significant variability in the cardiac venous system, particularly in patients with a history of 
myocardial infarction 7,8,16,17. These results may have important implications for the decision 
of transvenous or surgical LV lead positioning 8,18. In contrast to previous reports on MSCT 
venography, the present study included exclusively patients with heart failure who were 
actually scheduled for CRT implantation, allowing for a direct comparison between MSCT ve-
nography and invasive venography during CRT implantation. In agreement with previously 
published series, the left marginal vein was not observed in a large percentage of patients 7,8,9. 
Moreover, all tributaries of the coronary sinus that were eventually used for LV lead insertion 
during CRT implantation were visualized on MSCT. Furthermore, no significant differences 
were observed between invasive venography and 64-slice MSCT venography regarding 
diameters of the different vessels, in line with a preliminary comparison between 16-slice 
MSCT and invasive venography 17.
In selected patients, CRT reduced symptoms, improved exercise capacity, and reduced 
morbidity and mortality 19,20,21. In these large randomized trials, CRT is successful in approxi-
mately 70% of patients. Positioning the LV lead in a vein draining the area of latest mechani-
cal activation may be a valuable strategy to further improve the success rate.3 Tissue Doppler 
techniques have proven their efficacy to identify the area of latest mechanical activation 
4,5,12,13,14,22. In the present study, tri-plane TSI was used to locate the area of latest mechanical 
activation. This approach may be particularly useful because it provides a true 3-dimensional 
representation of the left ventricle with a 3-dimensional dyssynchrony map obtained during 
a single heartbeat. Moreover, automated dyssynchrony calculations are possible that may 
potentially reduce observer variability. In 57% of patients, a match between area of latest 
mechanical activation and final LV lead position was noted, and CRT resulted in acute resyn-
chronization with acute reduction in LV end-systolic volume and improvement in LV ejection 
fraction. These favourable effects were not observed in patients with a mismatch between 
area of latest mechanical activation and LV lead position. These observations agree with 
recent studies highlighting the importance of matching the LV lead position with the site of 
latest activation 23,24,25. This relation between the response to CRT and the match between area 
of latest mechanical activation and LV lead position underscores the important role of non 
invasive imaging to determine LV lead implantation strategy. With tri-plane TSI, the precise 
area of latest mechanical activation can be derived, whereas MSCT depicts the cardiac venous 
system on a 3-dimensional LV volume set. Transvenous LV lead implantation is preferred if a 
suitable tributary of the coronary sinus matches the area of latest mechanical activation. In 
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Figure 4. Case example of an 85-year-old patient with idiopathic dilated cardiomyopathy, NYHA class III heart failure and wide QRS complex 
(157 ms, LBBB-configuration). MSCT shows a large left marginal vein with prominent side branches (A, B, C). These findings are confirmed by 
invasive venography (D, E, F). In the 3-dimensional LV dyssynchrony assessment with TSI (I), the late mechanical activation (yellow) is located 
in the lateral wall. The LV lead is positioned in the left marginal vein (G, H), resulting in synchronous activation of the LV, represented (green) on 
TSI, obtained immediately after CRT (J). In addition, a reduction of LV end-systolic volume from 191 to 153 ml was observed, with an increase in 
LV ejection fraction from 13% to 28%.
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the absence of a suitable coronary sinus tributary in the area of latest mechanical activation, 
a surgical approach may be preferred. In the present study, the LV lead was positioned with-
out taking the LV dyssynchrony information into account. Accordingly, only 57% of patients 
exhibited a match between LV lead position and area of latest mechanical activation. These 
patients had substantial benefit from CRT. The remaining 43% of patients, however, had a 
mismatch between LV lead position and area of latest activation and did not benefit from 
CRT. Potentially, superior results could have been obtained if the pre-implantation informa-
tion provided by tri-plane TSI and MSCT had influenced the implantation strategy in these 
patients. At present, CT venography is still associated with substantial radiation, but further 
technological development will most likely result in reduction of radiation burden.
Nina Book.indb   162 26-09-11   12:04
163
Venous anatomy and LV dyssynchrony assessment in CRT
references
 1. Abraham WT. Cardiac resynchronization therapy. Prog Cardiovasc Dis 2006;48:232–238.
 2. Mehra MR, Greenberg BH, Cardiac resynchronization therapy. Caveat medicus! J Am Coll Cardiol 
2004;43:1145–1148.
 3. Bax JJ, Abraham T, Barold SS, Breithardt OA et al. Cardiac resynchronization therapy: part 1 issues 
before device implantation. J Am Coll Cardiol 2005;46:2152–2167.
 4. Yu CM, Bax JJ, Monaghan M, Nihoyannopoulos P. Echocardiographic evaluation of cardiac 
dyssynchrony for predicting a favourable response to cardiac resynchronization therapy. Heart 
2004;90(suppl 6):vi17–vi22.
 5. Bank AJ, Kelly AS. Tissue Doppler imaging and left ventricular dyssynchrony in heart failure. J 
Cardiac Fail 2006;12:154 –162.
 6. Goitein O, Lacomis JM, Gorcsan J III, Schwartman D. Left ventricular pacing lead implantation: 
potential utility of multimodal image integration. Heart Rhythm 2006;3:91–94.
 7. Jongbloed MR, Lamb HJ, Bax JJ et al. Noninvasive visualization of the cardiac venous system us-
ing multislice computed tomography. J Am Coll Cardiol 2005;45:749 –753.
 8. Van de Veire N, Schuijf J, De Sutter J et al. Non-invasive visualization of the cardiac venous sys-
tem in coronary artery disease patients using 64-slice computed tomography. J Am Coll Cardiol 
2006;48:1832–1838.
 9. von Lüdinghausen M. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol 
2003;168(suppl I):1–105.
 10. Rodevand O, Bjornerheim R, Aakhus S, Kjekshus J. Left ventricular volumes assessed by differ-
ent new three-dimensional echocardiographic methods and ordinary biplane technique. Int J 
Cardiovasc Imaging 1998;14:55– 63.
 11. Bax JJ, Bleeker GB, Marwick TH et al. Left ventricular dyssynchrony predicts response and progno-
sis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834 –1840.
 12. Van de Veire N, Bleeker G, De Sutter J et al. Tissue synchronization imaging accurately measures 
left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy. Heart 
2007;93:1034 –1039.
 13. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse 
remodeling and improved synchronicity by simultaneously delaying regional contraction after 
biventricular pacing therapy in heart failure. Circulation 2002;105:438–445.
 14. Yu CM, Zhang Q, Wing-Hong Fung J et al. A novel tool to assess systolic asynchrony and identify 
responders of cardiac resynchonization therapy by tissue synchronization imaging. J Am Coll 
Cardiol 2005;45:677– 684.
 15. Thomas JD. How leaky is that mitral valve? Simplified Doppler methods to measure regurgitant 
orifice area. Circulation 1997;95:548–550.
 16. Abbara S, Cury RC, Nieman K et al. Noninvasive evaluation of cardiac veins with 16-MDCT angiog-
raphy. Am J Roentgenol 2005;185:1001–1006.
 17. Mühlenbruch G, Koos R, Wildberger JE, Günther R, Mahnken AH. Imaging of the cardiac venous 
system: comparison of MDCT and conventional angiography. Am J Roentgenol 2005;185:1252–
1257.
 18. Singh JP, Houser S, Heist EK, Ruskin JN. The coronary venous anatomy. A segmental approach to 
aid cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:68 –74.
Nina Book.indb   163 26-09-11   12:04
Chapter 8
164
 19. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JG. Cardiac resynchro-
nization for patients with heart failure due to left ventricular systolic dysfunction–a systematic 
review and meta-analysis. Eur Heart J 2006;8:433– 440.
 20. Cleland JGF, Daubert J-C, Erdmann E et al on behalf of the CARE-HF Study Investigators. Longer-
term effects of cardiac resynchronization therapy on mortality in heart failure (the CARE-HF trial 
extension phase). Eur Heart J 2006;27:1928 –1932.
 21. Rivero-Ayerza M, Theuns DAMJ, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens L. Effects of 
cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of 
randomized controlled trials. Eur Heart J 2006;27:2682–2688.
 22. Van de Veire N, De Sutter J, Van Camp G et al on behalf of the Belgian Multicenter Registry on 
Dyssynchrony. Global and regional parameters of dyssynchrony in ischemic and non-ischemic 
cardiomyopathy. Am J Cardiol 2005;95:1020 –1023.
 23. Murphy RT, Sigurdsson G, Mullamalla S et al. Tissue synchronization imaging and optimal left 
ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006;97:1615–1621.
 24. Becker M, Franke A, Breithardt O et al. Impact of left ventricular lead position on the efficacy 
of cardiac resynchronization therapy. A two-dimensional strain echocardiography study. Heart 
2007;93:1197–1203.
 25. Becker M, Kramann R, Franke A et al. Impact of left ventricular lead position in cardiac resynchro-
nization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D 
echocardiography. Eur Heart J 2007;28:1211–1220.
Nina Book.indb   164 26-09-11   12:04
Nina Book.indb   165 26-09-11   12:04
Nina Book.indb   166 26-09-11   12:04
part Ib
Real-time three-dimensional 
echocardiography for the assessment of 
left atrium volumes and function
Nina Book.indb   167 26-09-11   12:04
Nina Book.indb   168 26-09-11   12:04
chapter 9
Real-time three-dimensional 
echocardiography as a novel approach 
to assess left ventricular and left atrium 
reverse remodeling and to predict 
response to CRT
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objectives: Real-time 3-dimensional echocardiography (RT3DE) is a novel promis-
ing technique for the assessment of left ventricular (LV) dyssynchrony. Aim of this 
study was to explore the value of RT3DE to assess LV and left atrium (LA) reverse 
remodeling and to predict response to cardiac resynchronization therapy (CRT).
methods: A total of 57 consecutive heart failure patients scheduled for CRT were 
included and RT3DE was performed before and 6 months after implantation. LV dys-
synchrony was defined as the standard deviation of the time to reach the minimum 
systolic volume for 16 LV segments, expressed in percentage of cardiac cycle (systolic 
dyssynchrony index, SDI). Patients were divided in responders or non-responders, 
based on a reduction ≥15% in LV end-systolic volume after CRT.
results: Six patients (10%) were excluded from further analysis because of subopti-
mal images. Out of the remaining 51 patients, 34 (67%) were classified as respond-
ers. Baseline characteristics were similar between responders and non-responders, 
except for the SDI, which was larger in responders (9.7±3.6% vs. 5.1±1.8%, p <0.001). 
ROC curve analysis revealed that a cut-off value for SDI of 6.4% yielded a sensitivity 
of 88% with a specificity of 85% to predict response to CRT. In responders, RT3DE 
also demonstrated beneficial effects of CRT on LA: 1) significant LA reverse remodel-
ing; 2) significant improvement in LA total emptying fraction and in LA conduit and 
reservoir function.
conclusions: RT3DE allows assessment of changes in LV and LA volumes and func-
tion after CRT and it is highly predictive for response to CRT.
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IntroductIon
Cardiac resynchronization therapy (CRT) is considered an additional therapeutic option in 
heart failure patients who remain highly symptomatic despite optimized medical treatment 1. 
Large studies have demonstrated a significant improvement in clinical and echocardiographic 
endpoints 2. However, up to 30% of the patients do not respond to CRT when selection is 
based on the traditional clinical and electrocardiographic criteria 3. In the search for better 
selection criteria for CRT, it has been demonstrated that a direct echocardiographic assess-
ment of left ventricular (LV) dyssynchrony is highly predictive for response to CRT 4. A novel 
echocardiographic technique has emerged for the assessment of LV dyssynchrony based on 
the analysis of regional volumetric changes: real time three-dimensional echocardiography 
(RT3DE). Promising results for the assessment of LV dyssynchrony have been shown when 
RT3DE was applied in patients with varying degrees of LV dysfunction and in normal subjects 
5. Furthermore, we have recently shown the value of RT3DE to predict acute echocardio-
graphic response to CRT 6. Clinically more important however, is the response at long-term 
follow-up. In the current study, the value of RT3DE both to assess LV reverse remodeling and 
to predict echocardiographic response to CRT was evaluated at 6 months follow-up.
In addition, it has been recently demonstrated that RT3DE provides a highly accurate 
evaluation of left atrium (LA) size and function 7,8 that are established markers of adverse 
cardiovascular outcomes 9–11. Only few data are available about the effect of CRT on LA re-
modeling and function 12. In the current study, it was hypothesized that a favorable response 
to CRT would also lead to an improvement in LA size and function.
methods
patient population and protocol
The study population consisted of 57 consecutive patients with heart failure scheduled for 
CRT implantation. Traditional selection criteria for CRT were applied: New York Heart Associa-
tion (NYHA) functional class III-IV, LV ejection fraction (EF) ≤35%, and QRS duration >120ms. 
Patients with atrial fibrillation were excluded to allow a complete evaluation of LA function. Of 
note, acute results after CRT in 42 of these patients have been reported recently 6. Before CRT 
implantation and at 6 months follow-up, clinical status (including NYHA class, 6-minute walk-
ing distance and Minnesota quality-of-life score) was assessed and LV and LA size and func-
tion were measured using RT3DE. Assessment of mitral regurgitation and LV filling pattern 
was performed using 2D Color-Doppler echocardiography. The echocardiographic analysis 
was performed by an experienced observer blinded to pre- and post-implantation data.




Patients were imaged with a commercially available system (iE33, Philips Medical Systems, 
Bothell, Washington, USA) equipped with an X3, fully sampled matrix transducer. Apical 
full-volume data sets were obtained combining, within 1 breath-hold, 7 small real-time sub-
volumes to provide a larger pyramidal volume. Frame rate ranged from 20 to 35 frames/sec. A 
3D data set was considered unsuitable for analysis if >2 segments could not be visualized or if 
it contained visible translation artifacts. RT3DE data sets were stored digitally and quantitative 
analysis was performed off-line using a semi-automated contour tracing algorithm (Q-Lab, 
version 5.0, Philips Medical Systems); post-processing of the images required 5-7 minutes.
Assessment of LV volumes and ejection fraction
During post-processing of the 3D data set, the software automatically displays the apical 
4- and 2-chamber views and the parasternal short-axis view. After initial identification of the 
apex and the mitral annulus with 5 reference points on the end-diastolic and end-systolic 
frames, a preconfigured ellipse is fitted to the endocardial border for each frame. A manual 
adjustment of the endocardial border was performed if required. A LV 3D model is automati-
cally generated and LV volumes and LVEF are calculated.
Patients with a reduction ≥15% of LV end-systolic volume (ESV) at 6 months follow-up were 
considered responders to CRT 13.
Figure 1. Example of 3D LA volumes obtained by post-processing of a 3D dataset, acquired in a patient scheduled for CRT. Left panel: before CRT 
(LA maximum volume = 40 ml/m2; LA minimum volume = 18 ml/m2). Right panel: 6 months after CRT (LA maximum volume = 21 ml/m2, LA 
minimum volume = 12 ml/m2).
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Assessment of LA volumes and function
Analysis of 3D images was performed using the same semi-automated contour tracing 
algorithm as for the LV, marking 5 atrial reference points (Figure 1). Manual corrections of 
the automatic trace were made to exclude LA appendage and pulmonary veins entrance. 
LA volume was measured at 3 phases of the cardiac cycle: 1) maximum volume (LAmax) at 
end-systole, just before mitral valve opening; 2) minimum volume (LAmin) at end-diastole, 
just before mitral valve closure; 3) volume before atrial active contraction (LApreA), obtained 
from the last frame before mitral valve reopening or at the end of P wave on ECG. As recom-
mended 14, LA volumes were indexed to the body surface area (BSA). According to previous 
studies8,15,16, LA function was explored assessing the following indices:
1) Total atrial emptying fraction (LAEF) = [(LAmax - LAmin)/LAmax] x100
2) Active atrial emptying fraction (LAactive) = [(LApreA - LAmin)/LApreA] x100, as an index 
of LA booster pump function.
3) Passive atrial emptying fraction (LApassive) = [(LAmax - LApreA)/LAmax] x100, as an 
index of LA conduit function.
4) Atrial expansion index (LAreservoir) = [(LAmax - Lamin)/LAmin] x100, which is considered 
an index of LA reservoir function.
Assessment of LV dyssynchrony
The LV 3D model was subdivided by the software in 17 standard wedge shaped (apart from 
the apex) sub-volumes. For each volumetric segment the time taken to reach the minimum 
systolic volume (Tmsv) was calculated (Figure 2). As previously described by Kapetanakis 
et al 5, the standard deviation of the Tmsv for 16 segments (excluding the true apex) was 
expressed as a percentage of cardiac cycle (obtaining the systolic dyssynchrony index, SDI) 
and used as a marker of global LV dyssynchrony. Parametric images are also provided by the 
software with a visual summary, as a polar plot, of LV regional contraction timings and a rapid 
identification of the latest activated LV wall (Figure 2).
Reproducibility of the RT3DE measurements
Twenty patients were randomly identified for inter- and intra-observer agreement. According 
to the Bland-Altman analysis, inter-observer agreement was good. The mean differences for 
SDI, LVESV and LVEF were 0.1±1%, 0.3±17 ml and 0.4±4%, respectively (p = NS). The mean 
differences for LAmax, LAmin and LApreA were 4.2±6.4 ml, 0.52±3.4 ml and 2.8±4.4 ml, 
respectively (p = NS).
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The intra-observer agreement was also excellent with mean differences of 0.7±6 ml for 
LVESV, 0.8±3% for LVEF, 1.8±3.9 ml for LAmax, 0.16±2.1 ml for LAmin and 0.9±1.7 ml for 
LApreA (p = NS).
color-doppler echocardiography
The severity of mitral regurgitation was graded semi-quantitatively from color-Doppler in the 
parasternal long-axis and apical 4-chamber view and characterized as follows: absent, mild 
(ratio jet area/LA area<20%), moderate (jet area/LA area 20% to 40%) and severe (jet area/
LA area>40%) 17.
Doppler measurements of LV diastolic function were performed according to the Canadian 
Consensus recommendations 18 and the patients were divided in 2 groups, namely those with 
and those without restrictive filling pattern defined as follows: ratio of early (E) to late (A) 
diastolic filling velocities (E/A) >2 and deceleration time (DT) of E <150 ms.
Figure 2. Example of the 3D LV model generated by post-processing of a RT3DE dataset and subdivided by the software in 17 sub-volumes (left 
panel). Panel A: for each volumetric segment, it is possible to derive time-volume curves and assess the time needed to reach the minimum 
systolic volume (Tmsv, red dots). In this example, the dispersion of Tmsv is high (SDI 12.4%) at baseline (graph on the left), while after CRT 
(graph on the right) the segmental time-volume curves are more synchronous (SDI 2.2%). Panel B: parametric image, using color-coding (blue 
indicating early activation and orange-red late activation) representing Tmsv, showing that the inferior and posterior LV regions are the latest 
activated before CRT (polar plot on the left). Six months after CRT (polar plot on the right) the overall green color indicates absence of regions 
with delayed activation.
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pacemaker implantation
The LV pacing lead was inserted transvenously via the subclavian route and positioned as 
far as possible in a lateral or postero-lateral vein. The right atrial and ventricular leads were 
positioned in the right atrial appendage (or on the right atrium lateral wall) and in the 
right ventricular apex, respectively. All patients received a combined device (CRT-D; Contak 
Renewal, Guidant Corp.; Insync III-CD or Insync Sentry, Medtronic Inc.) without major com-
plications. Two types of LV leads were used (Easytrak, Guidant Corp.; Attain, Medtronic Inc.). 
For each patient, the device was programmed in DDD mode (lower rate 40 bpm) and the 
atrio-ventricular interval was adjusted to maximize mitral inflow duration with pulsed-wave 
Doppler echocardiography. No adjustment to the inter-ventricular delay was made.
statistical analysis
Continuous data are presented as mean±standard deviation. Categorical data are presented 
as absolute numbers or percentages. T-test and χ2-test were used for appropriate comparisons. 
Changes in NYHA class, LV filling pattern and mitral regurgitation before and after CRT have 
been evaluated with Wilcoxon ranks test. To determine the relationship between baseline 
variables and echocardiographic response to CRT, logistic regression analysis was applied. 
First, univariate analysis was performed, followed by a multivariate analysis including those 
variables who had a p-value ≤0.25 at univariate analysis. Linear regression analysis was per-
formed to study the relationship between the changes in LVESV and in LA volumes after CRT. 
Optimal cut-off value of SDI to predict echocardiographic response to CRT was determined 
by receiver operating characteristic (ROC) curve analysis. For all tests, a p-value<0.05 was 
considered significant. A statistical software program SPSS 12.0 (SPSS Inc, Chicago, USA) was 
used for statistical analysis.
results
patient population
Six patients (10.5%) were excluded from further analysis because of suboptimal images; 
baseline characteristics of the remaining 51 patients are summarized in Table 1. RT3DE re-
vealed severe LV dilatation (mean LVEDV 200±47 ml), with depressed LV function (mean LVEF 
28±6%). Furthermore, a moderate-severe LA dilatation (LAmax 40±18 ml/m2) and dysfunc-
tion (LAEF 36±14%) was observed 19,20.
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Mean LV dyssynchrony (SDI) was 8.4±3.9% and the latest activated LV wall was the lateral 
in 17 patients (33%), the posterior in 15 patients (29%), the inferior in 12 patients (24%) and 
the anterior in 7 patients (14%).
clinical response to crt
At 6 months follow-up evaluation, significant improvement in NYHA functional class (from 
3±0.5 to 1.9±0.8, p <0.001), 6-minute walk distance (from 335±119m to 385±117m, p <0.001) 
and Minnesota quality-of-life questionnaire (from 30±19 to 23±18, p <0.05) was observed.
echocardiographic response to crt
LV volumes and function
Reverse LV remodeling was observed on RT3DE at 6 months follow-up: LVEDV decreased from 
200±47 ml to 179±47 ml (p <0.001) and LVESV from 145±40 ml to 117±40 ml (p <0.001). Fur-
thermore, a significant improvement in LVEF was observed, from 28±6% to 35±8% (p <0.001).





Quality of life score 30±19
















MR, n (absent/mild/moderate/severe) 11/21/14/5
Restrictive LV filling pattern, n (%) 12 (24%)
SDI (%) 8.4±3.9
EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic volume, LV: left ventricular, MR: mitral regurgitation, NYHA: New York Heart 
Association, SDI: systolic dyssynchrony index, 6-MWT: 6 minutes walk test.
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LA volumes and function
After 6 months follow-up, a significant reduction of LA volumes was observed on RT3DE: LA-
max decreased from 40±18 ml/m2 to 35±16 ml/m2 (p <0.001); LAmin decreased from 26±18 
ml/m2 to 22±15 ml/m2 (p <0.001) and LApreA from 31±18 ml/m2 to 26±15 ml/m2 (p <0.001). 
In addition, a significant improvement in LA function was observed: LAEF increased from 
36±14% to 40±14% (p <0.01), LApassive from 24±9% to 26±10% (p = 0.01) and LAreservoir 
from 66±39% to 76±43% (p = 0.02). No significant improvement was observed in LAactive 
(from 17±11% to 19±11%, p = NS).









Age (years) 65±8 67±10 NS
Gender (M/F) 28/6 13/4 NS
Ischemic/idiopathic (n) 18/16 13/4 NS
















  337±154*  
NS
NS































































* = p <0.001 baseline versus follow-up. Abbreviations see Table 1.




Six months after CRT implantation, 34 patients (67%) experienced a reduction in LVESV ≥15% 
and were classified as responders. Compared to non-responders, these patients also showed 
a significantly larger reduction in LVEDV and a larger increase in LVEF (Table 2).
Similarly, at 6 months follow-up, a significant improvement in LA size (LAmax decreased 
from 38±21 to 32±16 ml/m2, p <0.001) and LA function (except for LAactive) was detected in 
responders, whereas non-responders showed stable or slightly worse LA volumes and func-
tion (Table 3). Linear regression analysis demonstrated a significant relationship between the 
changes in LVESV and in LA volumes at 6 months after CRT. Of interest, when patients showed 
a reduction in LVESV ≥15% (responders), most of them also demonstrated a significant reduc-
tion (≥10%) in LAmax and LAmin (Figure 3).
Table 3. Left atrium size and function, before and 6 months after CRT implantation, in the total study population and in responders (≥15% 







































































* = p <0.01 baseline versus follow-up. LA: left atrium; LAactive: active atrial emptying fraction; LAEF: total atrial emptying fraction; LAmax: 
maximum volume; LAmin: minimum volume; LApassive: passive atrial emptying fraction; LApreA: volume before atrial contraction; LAreservoir: 
atrial expansion index.
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prediction of echocardiographic response to crt
All baseline clinical and echocardiographic characteristics were comparable between 
responders and non-responders, except for LV dyssynchrony assessed with SDI (Table 2), 
which was significantly higher in responders compared to non-responders (9.7±3.6% versus 
5.1±1.8%, p <0.001). Moreover, responders demonstrated a significant reduction in SDI after 
CRT (from 9.7±3.6% to 3.0±1.6%, p <0.001), whereas in non-responders the SDI remained 
unchanged (5.1±1.8 versus 4.8±2.7%, p = NS).
At the univariate analysis baseline SDI was significantly associated with echocardiographic 
response to CRT (Table 4). After correction for other baseline characteristics in the multivari-
ate analysis, SDI remained the only variable significantly correlated with response to CRT (p = 
0.006, OR = 1.58, 95% CI = 1.14-2.20). To define the optimal cut-off value for SDI for prediction 
of echocardiographic response to CRT, ROC curve analysis was performed. The area under the 
curve was 0.92, which indicates a good predictive value, and a cut-off value of 6.4% yielded 
a sensitivity of 88% and a specificity of 85% to predict LV reverse remodeling at 6 months 
follow-up.
Figure 3. Relationship between reverse remodeling of LV end-systolic volume (LVESV) and reverse remodeling of LA maximum volume (LAmax; 
Panel A; y = 0.46x+2.66, r = 0.6, p <0.001) and of LA minimum volume (LAmin; Panel B; y = 0.56x+4.72, r = 0.6, p <0.001) at 6 months 
follow-up.
Of interest, when patients showed a reduction in LVESV ≥15% (responders, see dotted vertical line in Figures), a significant reduction (≥10%, 
see dotted horizontal line) in LAmax and LAmin was also observed in 88% and 82% of responders, respectively.




In the current study, RT3DE demonstrated a significant improvement in LV remodeling and 
function at 6 months after CRT associated with a significant improvement in LA volumes 
and function. In addition, LV dyssynchrony (as measured with SDI) was the only predictor of 
echocardiographic response to CRT with high sensitivity and specificity.
use of rt3de to assess therapy success after crt
Left ventricle
In the current study, RT3DE has been used to measure LV volumes and function before and 
after CRT. Response to CRT has been differently defined, using both clinical and echocar-
diographic parameters. Since Yu et al demonstrated that a reduction in LVESV is the best 
predictor of improved survival after CRT 21, quantification of LVESV before implantation and 
during follow-up became crucial in order to assess therapy success. Overcoming the draw-
backs of geometric assumptions and cut-plane reproducibility in sequential studies, RT3DE 
has been validated against MRI and found to be far more accurate and reproducible than 
2-dimensional echocardiography for LV volumes assessment 22,23. Furthermore, RT3DE, in the 
same acquisition and analysis, integrates this information with a quantitative assessment of 
LV dyssynchrony.
Table 4. Univariate analysis: estimates of correlation between clinical and echocardiographic variables and response to CRT, defined as a 
reduction ≥15% of LV end-systolic volume. In bold the p-value of the baseline variables included in the multivariate analysis.
odds ratio (95% cI) p–value
Age 0.98 (0.91-1.05) 0.51
Etiology 0.35 (0.09-1.28) 0.10
QRS duration 0.98 (0.96-1.00) 0.19
LVEDV 0.99 (0.98-1.01) 0.37
LVEF 1.09 (1.00-1.23) 0.06
SDI 1.65 (1.18-2.32) 0.004
LAmax 1.01 (0.97-1.02) 0.47
LAEF 1.02 (0.97-1.07) 0.34
For abbreviations see Tables 1 and 3.
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Left atrium
RT3DE provides an accurate and geometric assumption-free quantification of LA volume, 
which has been suggested the most reliable index of LA size 14, and allows for an extensive 
assessment of LA function through the analysis of phasic LA volume changes during the 
cardiac cycle 7,8. Only one study thus far examined how LA size and function change after CRT. 
Yu et al evaluated with 2D echocardiography, tissue Doppler and strain imaging, LA size and 
function before and shortly after CRT 12. The authors noted a reduction only in LA minimum 
volume due to an improvement in LA active function and an increase in systolic atrial strain 
(suggesting an improvement of atrial compliance).
In the current study, with longer follow-up, clear LA reverse remodeling was observed only 
in responders, with a significant reduction of all LA volumes. This result probably reflects LA 
structural changes that require a long-lasting reduction in LA volume- and pressure-overload 
to be highlighted 24.
Moreover, significant improvement in LA conduit and reservoir functions was observed in 
responders. LA conduit function is mainly related to LV diastolic function that has been dem-
onstrated to improve after CRT 8,16. Although a significant improvement in LV filling pattern 
was not observed (Table 2), the analysis was limited to the presence/absence of an advanced 
diastolic dysfunction and by the use only of Doppler measurements.
LA reservoir function reflects the ability of the LA to fill during ventricular systole and it 
is mainly influenced by LA wall stiffness and mitral annulus systolic displacement 16,25. The 
improvement of LA reservoir function after CRT can be subsequently explained by the 
improvement in LV systolic function and the increase in LA compliance. Of note, the major 
determinants of LA active function are heart rhythm and LApreA (Frank-Starling effect) 8. All 
the patients of the study were in sinus rhythm with a fairly normal baseline LA active func-
tion 16 and did not show significant changes in LApreA after CRT; accordingly, no significant 
improvement in LAactive was observed.
The improvement in LA size and function after CRT demonstrated in the present study may 
also have important clinical implications, since there is strong evidence that in heart failure 
patients LA enlargement is a robust predictor of adverse cardiovascular outcomes such as 
atrial fibrillation occurrence, worsening heart failure and thromboembolic events 9,10.
assessment of lv dyssynchrony by rt3de and prediction of echocardiographic 
response to crt
Several studies demonstrated the importance of the presence of significant baseline LV dys-
synchrony to predict response to CRT 4. Echocardiography and in particular tissue Doppler 
and strain imaging have been extensively used to assess LV dyssynchrony and to predict 
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response to CRT4,26. Nevertheless, the results of PROSPECT trial recently suggested that TDI 
and conventional echocardiographic measures have limited value for prediction of response 
to CRT, when these techniques are applied in the community rather than in expert centers, 
indicating the need for sufficient training in data acquisition and analysis 13. In addition, 
novel techniques, such as 2D strain imaging and RT3DE, were not included in the PROSPECT 
trial and may provide complete and accurate information on LV dyssynchrony. In particular, 
RT3DE measures LV regional volumetric changes during the cardiac cycle, as a composite 
effect of longitudinal, radial and circumferential contraction. Kapetanakis et al demonstrated 
the feasibility of LV dyssynchrony assessment (SDI) with RT3DE in a large group of patients 
and normal subjects 5; 26 patients underwent CRT implantation and responders to CRT had 
significantly higher SDI at baseline than non-responders (16.6±1.1% vs. 7.1±2.0%, p <0.001). 
We obtained similar results: a higher baseline SDI was found in responders as compared to 
non-responders (9.7±3.6% vs. 5.1±1.8%, p <0.001), although the absolute SDI values were 
somewhat lower in the current study. This difference may be explained by the different 
software packages used for the 3D dataset analysis. In contrast to the TomTec software (used 
by Kapetanakis et al), the Q-Lab software uses a different contour tracing algorithm and does 
not permit the operator to change the point of Tmsv which is automatically detected, yield-
ing a better reproducibility of the measurements but with a trend towards a lower SDI values. 
Direct comparisons are needed to elucidate these findings.
Furthermore, the cut-off value used by Kapetanakis et al for significant mechanical dys-
synchrony was arbitrarily derived as an SDI >3SD above the mean value obtained in normal 
subjects (8.3%). We recently reported a cut-off value for SDI of 5.6% to optimally predict acute 
echocardiographic response after CRT implantation 6, and a similar cut-off value (6.4%) was 
obtained in the current study to predict response at 6 months follow-up.
study limitations
The patient cohort was relatively small and the predictive value of RT3DE needs to be as-
sessed for clinical endpoints and confirmed in larger prospective studies.
Data on scar tissue and the exact LV lead position were not systematically available, which 
have been shown to affect response to CRT 27,28. Also, the contribution of reduction in mitral 
regurgitation on LA size and function after CRT should be explored in a larger group of 
patients.
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conclusIons
RT3DE allows assessment of the effects of CRT on LV and LA volumes and function. Baseline 
LV dyssynchrony (as measured with SDI) is predictive for echocardiographic response to CRT.
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objectives: Real-time 3-dimensional echocardiography (RT3DE) can provide a 
unique combination of accurate left atrium (LA) volume quantification and rapid, 
automatic assessment of LA function. The aim of the study was to evaluate the 
changes in LA volumes and function in patients with atrial fibrillation (AF) undergo-
ing radiofrequency catheter ablation (RFCA), using RT3DE.
methods: Fifty-seven consecutive patients referred for RFCA were studied. Paroxys-
mal AF was present in 43 patients (75%), and persistent AF in 14 (25%). After a mean 
follow-up of 7.9±2.7 months, patients were divided into 2 groups: successful RFCA 
(SR group) and recurrence of AF (AF group). RT3DE was performed before, within 3 
days and 3 months after RFCA to assess LA volumes (maximum, minimum and preA) 
and LA functions (passive, active and reservoir). 
results: A total of 38 patients (67%) had successful RFCA (SR group). Immediately 
after RFCA, no significant changes in LA volumes and function were observed. After 
3 months, a significant reduction in LA volumes (maximum: from 26±8 to 23±7 mL/
m2, p <0.01) was noted only in the SR group, together with a significant improve-
ment in LA active (from 22±8 to 33±9%, <0.01) and reservoir functions (from 116±45 
to 152±54%, p <0.01). Conversely, the AF group showed a trend towards a deteriora-
tion of LA volumes and function.
conclusions: In patients who maintain sinus rhythm after RFCA, a significant re-
verse remodeling and functional improvement of the LA is observed using RT3DE.
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IntroductIon
Recently, real-time 3-dimensional echocardiography (RT3DE) has been validated against 
magnetic resonance imaging and it has been shown to be more accurate and reproducible 
than 2-dimensional (2D) echocardiography for the quantification of left atrial (LA) volumes 
1,2. Furthermore, RT3DE may be a novel, reliable technique for the assessment of LA function, 
providing unique information about phasic changes of LA volumes during the cardiac cycle 
3,4. In the present study, RT3DE was used to evaluate the changes in LA volumes and function 
in atrial fibrillation (AF) patients treated with radiofrequency catheter ablation (RFCA).
methods
Over a 10 months period, 57 consecutive patients (44 men; age 56±9 years) with symptom-
atic drug-refractory AF, referred to our institution for RFCA in accordance to the current 
guidelines criteria, were included in this study. According to the ACC/AHA/ESC Guidelines 
definition 5, paroxysmal AF was present in 43 patients (75%), while persistent AF was present 
in the remaining 14 patients (25%); none of the patients had permanent AF. Mean AF dura-
tion (calculated from the time of the first episode) was 4.6±4.1 years and the patients had 
an unsuccessful treatment with 3±1 anti-arrhythmic drugs (mainly flecainide, propafenone, 
sotalol and amiodarone).
After RFCA, the patients were evaluated at the out-patient clinic on a regular basis. During 
follow-up, all medication, including anti-arrhythmic drugs, were continued in all patients for 
3 months after the RFCA procedure. Afterwards, anti-arrhythmic drugs were discontinued 
at discretion of the physician. At the latest follow-up, successful RFCA was defined as the 
absence of symptomatic recurrences lasting more than 3 minutes 6 and/or the absence of AF 
episodes lasting more than 30 seconds (detected with 24-hours Holter ECG recording and 
surface ECG) during follow-up, after a blanking period of 1 month 5,7. Accordingly, the study 
population was divided into 2 groups: patients with successful RFCA (SR group) and patients 
who had recurrence of AF (AF group).
Before, and within 3 days after the ablation procedure, RT3DE was performed to assess 
LA and left ventricular (LV) size and function. In addition, conventional 2D color-Doppler 
echocardiography was performed to assess mitral regurgitation (MR) and LV filling pattern. 
After 3 months follow-up, the echocardiograms were repeated to assess the effect of the 
RFCA on LA volumes and function.
Patients were imaged with a commercially available system (iE33, Philips Medical Systems, 
Bothell, Washington) equipped with X3, fully sampled matrix transducer. Apical full-volume 
data sets were obtained in all patients, combining 7 small real-time sub-volumes to provide a 
larger pyramidal volume. The acquisition was performed during end-expiratory apnea within 
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1 breath hold. Frame rate ranged from 20 to 35 frames/sec. The RT3DE data sets were stored 
digitally and quantitative analyses were performed off-line using a semi-automated contour 
tracing algorithm (Q-Lab, version 5.0, Philips Medical Systems) based on 5 reference points. In 
all patients the image quality was sufficient for quantitative analysis and the post-processing 
of the images was performed within 10 minutes. Left ventricular volumes and function were 
assessed as previously described in detail 8.
Quantification of LA volumes was performed using the semi-automated contour tracing 
algorithm developed for the LV, but marking 5 atrial reference points: 4 at the anterior, infe-
rior, lateral and septal part of atrial dome and 1 at the level of the mitral annulus (Figure 1). 
The position of the reference points was chosen to avoid changes in the view orientation that 
the software automatically generates, since the position of the dome of the LA is opposite of 
the apex of the LV. Manual corrections of the automatic trace were made to exclude the LA 
appendage and the pulmonary vein ostia. Left atrial volumes were measured at 3 time points 
during the cardiac cycle:
Figure 1. Assessment of LA volumes using RT3DE. An automatic border detection is obtained marking 5 reference points in the apical 2- and 
4-chamber views (upper panel) and the LA 3D model is provided by the software. The changes of LA volumes during the heart cycle are plotted 
as a curve (lower panel).
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1) maximum volume (LAmax) at end-systole, just before mitral valve opening;
2) minimum volume (LAmin) at end-diastole, just before mitral valve closure;
3) volume before atrial active contraction (LApreA) obtained from the last frame before mitral 
valve reopening or at time of the P wave on the surface ECG. All LA volumes were indexed 
to the body surface area, as recommended 9.
Twenty patients were randomly identified for inter- and intra-observer agreement. Ac-
cording to the Bland-Altman analysis, intra-observer variability was excellent with a mean 
differences of 1.2±2.9 mL for LAmax, 0.1±1.1 mL for LAmin and 0.8±2.3 mL for LApreA (p = NS). 
Inter-observer variability was also good with a mean difference for LAmax, LAmin and LApreA of 
3.6±5.6 mL, 0.7±5.4 mL and 1.9±3.4 mL, respectively (p = NS).
The LA function was derived from the LA volumes and expressed with the following pa-
rameters 10,11:
1) Total atrial emptying fraction: LAEF = [(LAmax – LAmin)/LAmax] x100
2) Active atrial emptying fraction: LAactive = [(LApreA – LAmin)/LApreA] x100, which is considered 
an index of LA active contraction.
3) Passive atrial emptying fraction: LApassive = [(LAmax – LApreA)/LAmax] x100, which is considered 
an index of LA conduit function.
4) Atrial expansion index: LAreservoir = [(LAmax – LAmin)/LAmin] x100, which is considered an index 
of LA reservoir function.
The severity of MR was graded semi-quantitatively from color-Doppler images in the 
conventional parasternal long-axis and apical 4-chamber view and characterized as follows: 
absent, mild (ratio jet area/LA area <20%), moderate (jet area/LA area 20% to 40%) and se-
vere (jet area/LA area >40%) 12. Left ventricular diastolic function was evaluated according to 
the Canadian Consensus recommendations 13 through the following Doppler measurements: 
ratio of early (E) to late (A) diastolic filling velocities (E/A) and deceleration time (DT) of the 
E wave.
The RFCA procedure was aimed at electrical isolation of all pulmonary veins from the LA. 
Endocardial mapping was performed with a 4-mm quadripolar mapping/ablation catheter 
(7Fr Thermocool, Biosense Webster, Diamond Bar, California, USA), using a 3D electroana-
tomic mapping system (CARTO, BiosenseWebster). A 6Fr diagnostic catheter placed in the 
right atrium served as a temporal reference. Radiofrequency current was applied outside the 
ostia of all pulmonary veins, using the ablation catheter with a 4-mm open loop irrigated 
tip. The following power and temperature settings were used: irrigation rate 20 ml/min, 
maximum temperature 50º C, and maximum radiofrequency energy 30W. At each point, the 
radiofrequency current was applied until a voltage of <0.1 mV was achieved, with a maximum 
of 60 s/point. The procedure was considered successful when pulmonary vein isolation was 
confirmed by the recording of entrance block during SR or pacing in the coronary sinus. All 
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patients received heparin intravenously (activated clotting time >300 sec) to avoid thrombo-
embolic complications during the catheter ablation procedure. After RFCA, the rhythm was 
continuously monitored until discharge.
Continuous data are presented as mean±standard deviation. Categorical data are present-
ed as absolute numbers or percentages. Independent-samples T test and Wilcoxon rank-test 
were used to compare continuous variables, as appropriate, and χ2 test was used to compare 
categorical variables. Sequential data measurements were analyzed by the general linear 
model (GLM) procedure for repeated measures. For all tests, a p-value <0.05 was considered 
significant. A statistical software program SPSS 15.0 (SPSS Inc, Chicago, II, USA) was used for 
statistical analysis.
results
Baseline clinical characteristics of the study population are summarized in Table 1. At base-
line, RT3DE revealed a mild enlargement of LA volume and a moderate reduction in LAEF, 
LAactive and LAreservoir (Table 2), as compared to the reference values for a normal LA 
9,14. Left 
ventricular systolic and diastolic functions were normal and in 27 patients MR was present 
(mild n = 24; moderate n = 3) (Table 3). Six patients were in AF at the baseline evaluation and 
all had a recurrence of AF during follow-up. In these patients, LApreA, LAactive, LApassive and LV 
diastolic function could therefore not be assessed.
After a mean follow-up of 7.9±2.7 months, 38 patients (67%) had successful RFCA (SR 
group), whereas 19 patients (33%) had recurrence of AF (AF group). Of note, these patients 
Table 1. Baseline clinical characteristics of the total study population and of patients with and without recurrence of atrial fibrillation after 
radiofrequency catheter ablation.
variable total study population
n = 57




Age (years) 56±9 57±9 53±9
Male/Female 44/13 28/10 16/3
Body surface area (m2) 2.1±0.2 2.1±0.3 2.1±0.1
Atrial fibrillation
   Paroxysmal/Persistent 45 (79%)/12 (21%) 34 (89%)/4 (11%) 11 (58%)/8 (42%)*
Duration atrial fibrillation (years) 4.6±4.1 4.5±4.1 4.6±4.1
Number of anti-arrhythmic drugs per patient 3±1 3±1 3±1
Angiotensin converting enzyme-inhibitor and/or 
Angiotensin receptor blocker, 26 (46%) 17 (45%) 9 (47%)
Heart rate (beats/minute) 62±20 60±13 66±36
Hypertension 25 (44%) 13 (34%) 11 (58%)
Diabetes mellitus 6 (11%) 6 (15%) 0 (0%)
Coronary artery disease 3 (5%) 2 (5%) 1 (5%)
*: p <0.05 sinus rhythm  group versus atrial fibrillation group. 
Nina Book.indb   192 26-09-11   12:04
193
RT3DE for assessment of LA size and function after CRT
were classified in the same group also at 3 months follow-up evaluation. No significant dif-
ferences were found in the baseline clinical characteristics between the AF and SR groups, 
except for the percentage of patients with persistent AF (Table 1). At baseline, RT3DE showed 
larger LAmax in the AF group than in the SR group (31±8 vs. 26±8 mL/m
2, p <0.05), but no 
significant differences in LA and LV function (Table 2 and 3). Conventional 2D color-Doppler 
echocardiography revealed a comparable LV diastolic function and prevalence of MR (mild/ 
moderate) between the 2 groups (Table 3). Immediately after the RFCA procedure, no signifi-
cant changes in LA volumes were observed (Table 2). However, after 3 months of follow-up, a 
significant decrease in LA volumes was noted in the SR group, involving LAmax, LAmin and LApreA 
volumes. Conversely, the AF group showed a trend towards an increase in LA volumes during 
Table 2. Left atrium (LA) volumes and function at baseline, immediately after and 3 months after the ablation procedure in the total study 
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*: p <0.01 (GLM for repeated measures within subjects). 
§: p value derived from GLM for repeated measures between subjects (sinus rhythm vs. atrial fibrillation)
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follow-up (Table 2). An example of a patient in the SR group with a significant reduction of 
LAmax and LAmin is shown in Figure 2. In both groups, no significant changes in LA function 
were noted immediately after the RFCA procedure. However, after 3 months of follow-up, 
a significant improvement of LAactive and LAreservoir was noted in the SR group, whereas in the 
AF group these parameters showed a significant deterioration (Figure 3). In contrast, LApassive 
function did not change significantly in both groups. In concordance with the changes in 
LAactive, a significant improvement in LAEF was observed in the SR group, while a significant 
deterioration in LAEF was observed in the AF group (Table 2).
Mean LV ejection fraction was 58±9% in the SR group and 57±11% in the AF group (p = NS) 
and no significant changes were observed during follow-up. Similarly, LV diastolic function 
was normal in both groups before the RFCA procedure and did not change during follow-up 
(Table 3). However, 12 patients in the SR group and 3 patients in the AF group had an abnor-
mal LV relaxation based on E/A <1. For these patients an improvement in LV filling pattern 
was noted in the SR group only (E/A ratio from 0.7±0.2 to 1.6±0.5, p <0.01). Only 3 patients 
had clinically relevant MR (moderate or severe) and a significant improvement in the degree 
of MR after RFCA was only observed in the SR group (Table 3).
Figure 2. Example of a patient with significant reduction of LAmax and LAmin, 3 months after the RFCA (panel B vs. panel A). LAmax decreased from 
83 to 66 mL/m2 and LAmin decreased from 44 to 33mL/m
2.
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dIscussIon
The main findings of the current study can be summarized as follows: 1) three months after 
RFCA, a significant reduction in LA volumes and a clear improvement of LA active contrac-
tion and LA reservoir function was observed in patients with a successful RFCA procedure; 2) 
patients with recurrence of AF after RFCA showed a trend towards a worsening of LA volumes 
and function.
In the present study, RT3DE was used to assess LA volumes and function in patients treated 
with RFCA for AF. The assessment of LA size is fundamental in the management of patients 
with AF, since it has important prognostic value and is used as a surrogate marker of therapy 
success 15–18. The most recent recommendations for cardiac chamber quantification indicate 
LA volume as the preferred measurement of LA size 9. However, the majority of the previous 
Table 3. Left ventricular function at baseline and 3 months after the ablation procedure in the total study population and in patients with or 








































*: p <0.01 baseline versus follow-up.
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B
Figure 3. Left atrium active emptying fraction (LAactive; panel A) and expansion index (LAreservoir; panel B) at baseline, immediately after catheter 
ablation and at 3 months follow-up (FU) in SR and AF groups.
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studies only evaluated LA diameter and LA area, using conventional 2D echocardiography 
16,18,19. Although most frequently used, 2D echocardiography is limited for the assessment of 
LA volume by significant geometric assumptions and low reproducibility due to diverging 
position and orientation of imaging planes. RT3DE has been demonstrated to be more ac-
curate for LA volumes quantification, with the most favorable test-retest variation 1,2,4. In addi-
tion to LA volumes, assessment of LA function is of particular significance in patients treated 
with RFCA for AF. However, accurate non-invasive measurements for LA function are still 
lacking. Recently, initial studies have proposed tissue Doppler imaging (TDI) and 2D strain as 
new modalities to assess LA myocardial function 20,21. However, these techniques need to be 
further validated for this purpose and have some limitations related to the angle dependency 
of TDI 21 and the difficult analysis of LA systole with 2D strain 20. In contrast, RT3DE is well 
validated 3,4,22 and provides a unique combination of an accurate measurement of LA volumes 
together with a rapid and automatic detection of phasic changes of LA volumes that provides 
detailed information of the different LA functions.
The relationship between LA enlargement and AF is complex: structural changes of the LA 
may be related several factors including 1) pressure or volume overload due to underlying 
structural heart disease; 2) the increased LV filling pressure induced by the tachyarrhythmia; 
3) AF itself 23,24. Supporting the latter hypothesis, abnormal atrial histology (fibrosis, necrosis 
and inflammation) has been found uniformly in patients with lone AF 25. Furthermore, LA 
dilatation has been directly correlated with the duration of AF, as a result of LA electrical 
and structural remodeling 18. In the present study, mild dilatation of the LA was noted at 
baseline using RT3DE. This may be explained by the relatively low prevalence of patients 
with persistent AF and with structural heart disease (Table 1). Of note, the AF group, com-
pared to the SR group, demonstrated larger baseline LA volumes, probably related to the 
higher percentage of persistent AF. Furthermore, after 3 months a significant decrease in LA 
volumes was noted in patients with successful RFCA. These results are in agreement with 
previous studies that showed a significant reduction in LA volumes after conversion of AF to 
SR, either by electrical cardioversion or RFCA 6,14,26. The reduction in LAmin as observed in the 
present study is most probably the direct result of the improvement of LA active contraction; 
whereas the reduction in LAmax is reflecting a true reverse remodeling that is related with the 
long-lasting restoration of SR. Although LA reverse remodeling may also be ascribed to atrial 
scarring caused by RFCA, this is very unlikely since LA volumes tended to worsen in patients 
with recurrence of AF during follow-up.
In addition, an improvement in LA function was observed in patients who maintained SR 
after RFCA. The LA serves multiple functions. During LV systole and isovolumic relaxation, 
it operates as a “reservoir” that receives blood from pulmonary veins and stores energy in 
the form of pressure; during the early diastole, it operates as a “conduit” for transfer blood 
into the LV after mitral valve opening; during the late diastole the “active” contraction of LA 
contributes to LV stroke volume by 20-30% 22,23. To interpret the baseline and follow-up find-
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ings of the present study, it is important to consider that the major determinants of LAactive are 
the heart rhythm, the atrial contractility and the LApreA (Frank-Starling effect) 
3,11. The LAreservoir 
is rather influenced by LV systolic function (mitral annulus displacement) and by LA wall stiff-
ness 11,27. On the contrary, LApassive is mainly related to LV diastolic function 
11,28.
In the present study, a moderate reduction of LAactive and LAreservoir was noted at baseline 
evaluation. Conversely, no significant impairment of LApassive was observed. Since LV systolic 
and diastolic functions were normal on average and LApreA was even decreased compared to 
the normal values, the reduction in LAactive and LAreservoir is most probably related to the effect 
of AF itself on the contractility and the stiffness of atrial walls.
Immediately after RFCA, no significant changes in LA functions were found, but LAactive 
tended to worsen. This finding occurred in both the SR and AF groups and can be related 
to the phenomenon of atrial “stunning” 29. After 3 months of follow-up, a significant im-
provement in LAactive and LAreservoir was noted in the SR group, whereas in the AF group these 
parameters showed a significant deterioration. Since LV systolic and diastolic functions did 
not change after RFCA and LApreA was even decreased, the functional improvement in the 
SR group is most probably related to a favorable effect of the long-lasting restoration of SR 
on the intrinsic characteristics of the atrial myocardium 24. These findings are in line with 
previous studies 6,14 and carry important clinical implications, since they may translate into a 
reduced risk of AF recurrences and thrombo-embolic complications at long-term follow-up 
24. However, the exact impact of LA reverse remodeling and improvement of LA function on 
cardiovascular outcomes remains to be determined.
The results of the present study need to be confirmed in a larger population with longer 
clinical and echocardiographic follow-up. In addition, in patients with paroxysmal AF, asymp-
tomatic recurrences cannot be excluded and may have influenced the success rate in the 
present study.
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objectives: Contrast-enhanced echocardiography is widely used to enhance left 
ventricular (LV) endocardial border delineation in stable patients with known or 
suspected coronary artery disease. In patients with acute myocardial infarction, 
accurate assessment of LV function and size is important, but data on the safety 
of contrast-enhanced echocardiography in the early stage of myocardial infarction 
(within 24 hours) are lacking. In the current study, the experience on the safety of 
contrast-enhanced echocardiography within 24 hours of acute myocardial infarc-
tion is reported.
methods: A total of 115 consecutive patients (58±11 years; 77% male) admitted 
to the coronary care unit for ST-elevation acute myocardial infarction underwent 
clinically indicated contrast-enhanced echocardiography within 24 hours of hospital 
admission to assess LV size and function. Perflutren (Luminity®, Bristol-Myers Squibb 
Pharma, Bruxelles, Belgium) was used as contrast agent. Safety was determined 
evaluating vital signs, physical examination, ECG and adverse events.
results: On contrast-enhanced echocardiography, mean LV ejection fraction was 
44±11% and 56% of patients had a LV ejection fraction ≤45%. Administration of echo 
contrast did not induce any significant change in vital signs, physical examination 
and ECG. Major adverse events were not observed whereas minor events occurred 
in 4% of patients (hypersensitivity at the injection site in 3 and transient back pain 
in 2).
conclusions: These data provide evidence on the safety of contrast-enhanced 
echocardiography in the first 24 hours of myocardial infarction; larger patient co-
horts are needed to confirm these findings.
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IntroductIon
Contrast-enhanced echocardiography is widely used to provide cardiac chamber opacifica-
tion and to improve left ventricular (LV) endocardial border delineation in patients with 
known or suspected coronary artery disease 1, but data on the safety of contrast-enhanced 
echocardiography in patients in the first 24 hours after acute myocardial infarction are lack-
ing. It is however particularly important in this subset of patients to have accurate informa-
tion on LV function and LV dimensions, both for therapeutic and prognostic reasons. In this 
article, we report the experience on the safety of contrast-enhanced echocardiography with 
Perflutren (Luminity®, Bristol-Myers Squibb Pharma, Bruxelles, Belgium) performed the first 
day after acute myocardial infarction.
methods
patient population
Over a 6 months period, a total of 115 consecutive patients admitted to the coronary care 
unit for ST-elevation acute myocardial infarction underwent urgent coronary angiography 
and primary percutaneous coronary intervention. Contrast-enhanced echocardiography was 
clinically performed in the coronary care unit within 24 hours from patients’ admission to op-
timally evaluate LV dimensions, LV regional and global function and to exclude LV thrombus 
formation and mechanical complications of infarction.
contrast-enhanced echocardiography
Patients were imaged in the left lateral decubitus position with a commercially available 
system (Vivid 7 Dimension, GE Healthcare, Horten, Norway) equipped with a M3S phased 
array transducer (3.5 MHz). Luminity® was used as contrast agent. Each patient received an 
infusion of 1.3 mL of echo contrast diluted in 50 mL of 0.9% NaCl solution through a 20 gauge 
intravenous catheter in a proximal forearm vein. Infusion rate was initially set at 4.0 mL/min 
and then titrated to achieve optimal LV cavity enhancement without attenuation artifacts 
2. Contrast-enhanced echocardiography was performed using harmonic imaging at low 
mechanical index (0.26). Images were obtained in the standard 4-, 2- and 3-chamber apical 
views and care was taken to record the images at a phase when the contrast agent flow 
was relatively stable with absent or minimal swirling in the apex. LV end-diastolic (EDV) and 
end-systolic (ESV) volumes were measured according to the Simpson’s biplane method 3 and 
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LV ejection fraction was calculated as [(EDV-ESV)/EDV] x100. Qualitative assessment of the 
regional wall motion was performed according to the 16-segment model of the American 
Society of Echocardiography and the global wall motion score index was calculated for each 
patient 3. The three LV apical views were also systematically checked for the presence of LV 
thrombi and mechanical complications of infarction.
safety monitoring
The safety of contrast-enhanced echocardiography was assessed by evaluating the vital signs 
(blood pressure and heart rate), physical examination, ECG and occurrence of adverse events. 
Vital signs were assessed within 10 minutes before the administration of echo contrast and 
repeated after 2, 15, 30 and 60 minutes. Physical examination was performed before and 
after contrast-enhanced echocardiography and daily until discharge. Furthermore, during 
hospitalization, all patients had continuous 12-lead ECG monitoring for the occurrence of 
arrhythmias and ischemia and an additional standard single-lead ECG was monitored during 
the examination. All patients were evaluated for the occurrence of adverse events during 
echo contrast administration and the following days of hospitalization. The investigators 
characterized the intensity of potential adverse events.
statistical analysis
Continuous variables are expressed as mean and standard deviation. Categorical data are 
presented as absolute numbers and percentages.
results
patient population
Clinical characteristics of the patients are summarized in Table 1. Mean age of the patients 
was 58±11 years; 88 (77%) were male. The infarct-related artery was the left anterior descend-
ing coronary artery in 48 (42%) patients and obstructive multi-vessel disease (i.e. more than 1 
vessel with a luminal narrowing ≥70%) was present in 39 (34%) patients.
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contrast-enhanced echocardiography
The mean infusion rate of echo contrast during echocardiography was 3.0±0.6 mL/min and 
the total infusion dose was on average 16 µL/kg. As shown in Table 1, the mean LV ejection 
fraction was 44±11%, with 64 (56%) patients having HAD a LV ejection fraction ≤45%. In all 
the patients, contrast-enhanced echocardiography excluded the presence of LV thrombi and 
mechanical complications of infarction, including 7 patients in whom an apical thrombus 
was suspected based on non-enhanced 2D echocardiography.
safety monitoring
Administration of echo contrast did not induce any significant change in vital signs, physical 
examination and ECG. No death, acute myocardial infarction or other cardiovascular events 
occurred during the echocardiographic examination or the remaining hospitalization period. 
The only adverse events observed were transient hypersensitivity at the injection site (in 3 
patients) and transient back pain (in 2 patients); all these adverse events were rated as mild 
in intensity and required no treatment.
table 1. Clinical and echocardiographic characteristics of  the patient population (n = 115).
age (years) 58±11
Gender (male/female) 88/27
Diabetes, n (%) 10 (9)
Family history of coronary artery disease, n (%) 48 (42)
Hypercholesterolemia, n (%) 18 (16)
Hypertension, n (%) 40 (35)
Current or previous smoking, n (%) 73 (63)
Previous myocardial infarction, n (%) 11 (10)
Previous myocardial revascularization, n (%) 7 (6)
Body mass index (kg/m²) 27±4
Anterior myocardial infarction, n (%) 47 (41)
Infarct-related artery, n (%)
- left anterior descending coronary artery
- left circumflex coronary artery




Multi-vessel disease, n (%) 39 (34)
Left ventricular end-diastolic volume (mL) 97±25
Left ventricular end-systolic volume (mL) 54±19
Left ventricular ejection fraction (%)
- <35%, n (%)
- 35-45%, n (%)





Wall motion score index 1.9±0.4




Echocardiography is readily available, can be quickly performed at bedside and is frequently 
the primary test to evaluate LV size and function in patients with known or suspected coro-
nary artery disease 3. In patients with suboptimal acoustic windows, intravenous echo con-
trast is administered to improve endocardial border delineation and to increase accuracy and 
reproducibility of regional and global LV function assessment 4–6. Contrast-enhanced echo-
cardiography may be particularly important in patients presenting with acute myocardial 
infarction. Urgent and repeated echocardiographic examinations are indeed crucial in these 
patients, in order to evaluate regional and global LV function and to exclude LV thrombi and 
mechanical complications of infarction 7–9. Contrast-enhanced echocardiography, providing 
more accurate and reproducible data, as compared to non-enhanced echocardiography, is 
therefore more reliable for the following therapeutic decision-making 10. Moreover, potential 
alternative diagnostic imaging techniques (i.e. transesophageal echocardiography, radionu-
clide ventriculography and cardiac magnetic resonance) are more invasive or expensive 10.
Luminity® is a second-generation contrast agent that comprises a perfluoropropane 
microbubble coated with a particularly flexible bilipid shell 11. This contrast agent has a mi-
crovascular rheology similar to that of the red blood cells, with a transient and hemodynami-
cally insignificant microbubble entrapment in the pulmonary microcirculation 12. Moreover, it 
does not require cellular uptake, and the fluorocarbon gas is filtered out by the lungs within 
minutes 12. Preclinical and clinical studies demonstrated a high safety index of this echo con-
trast agent in animal models, healthy humans and patients with suspected cardiac disease 
4,13. Post-marketing surveillance data confirmed these results, with a very low reported 
risk of major events (1:10,000 risk of serious cardiopulmonary events and 1:500,000 risk of 
death) 14,15. Although a clear relationship of these events with contrast injection has not been 
proven, non-immunoglobulin E-mediated or anaphylactoid reactions from local complement 
activation, as well as sudden increase of pulmonary artery pressure in patients with impaired 
pulmonary function, have been proposed as potential explanatory mechanisms 14.
Overall, the safety profile of Luminity® seems to be quite similar to that reported for another 
commercially available hexafluoride-based agent (SonoVue®, Bracco, Milan, Italy), but with a 
lower incidence of allergic reactions 11,16. Hypersensitivity to the shell component polyethyl-
ene glycol, not present in Luminity®, could in part account for this difference 16.
Therefore, substantial safety data already exist for the use of Luminity® in stable patients 
with known or suspected cardiac disease 4,17, but safety data on its use in patients within 24 
hours of acute myocardial infarction are lacking. In the current clinical report, administration 
of Luminity® shortly after acute myocardial infarction (within 24 hours) was safe and well 
tolerated, even in the presence of LV dysfunction. No significant changes in vital signs, physi-
cal examination and ECG were observed, while possible transient increase of serum cardiac 
biomarkers indicating micro-damage to cardiomyocytes could not be detected due to the 
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confounding effect of the recent acute myocardial infarction. No major adverse events were 
observed and minor adverse events occurred in 4% of patients and were mild in intensity and 
required no treatment. These findings were quite similar to that reported by previous clinical 
studies (minor events in 6.8% of 1558 patients) 17. In particular, in the present case series no 
patient referred headache (the most common side effect of Luminity®), while 3 and 2 patients, 
respectively, complained hypersensitivity at the injection site and transient back pain.
conclusIons
Current data provide evidence on the safety of using Luminity® in the acute phase of myocar-
dial infarction, even if these findings need further confirmation in larger cohorts of patients. 
In this specific clinical setting, the risk/benefit ratio associated to the use of this echo contrast 
agent seems to be particularly favorable, considering the provided advantages for the diag-
nostic process and the therapeutic management.
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objectives: Accurate and reproducible assessment of left ventricular (LV) systolic 
function is important in patients with acute myocardial infarction (AMI). Real time 
three-dimensional echocardiography (RT3DE) is an accurate technique, but it relies 
heavily on good image quality. Aim of the present study was to evaluate the incre-
mental value of contrast-enhanced RT3DE.
methods: A total of 140 consecutive patients (58±11 years; 78% men) with ST-eleva-
tion AMI clinically underwent non-enhanced and contrast-enhanced RT3DE within 
24 hours from AMI to evaluate global and regional LV systolic function. Endocardial 
border definition was graded for each of the 16 LV segments as: 0 = border invisible; 
1 = border visualized only partially and 2 = complete visualization of the border. 
Three image quality groups (good, fair and uninterpretable) were identified. LV 
volumes and ejection fraction were measured off-line. Wall motion was graded for 
each visible segment as: 1 = normal; 2 = hypokinetic; 3 = akinetic and 4 = dyskinetic.
results: During contrast-enhanced RT3DE, as compared to non-enhanced RT3DE, 
the number of segments with complete visualization of the endocardial border in-
creased from 66% to 84% (p <0.001) and the number of patients with a good quality 
echocardiogram increased from 59% to 94% (p <0.001). Intra- and inter-observer 
agreement for assessment of global and regional LV systolic function improved dur-
ing contrast-enhanced RT3DE, as compared to non-enhanced RT3DE.
conclusions: Assessment of LV systolic function in AMI patients with RT3DE is 
frequently hampered by suboptimal echocardiographic quality. Contrast-enhanced 
RT3DE is of incremental value, improving the endocardial border visualization and 
the reproducibility of LV function assessment.
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IntroductIon
The assessment of global and regional left ventricular (LV) systolic function is extremely 
important among patients with acute myocardial infarction (AMI), since it carries significant 
therapeutic and prognostic implications 1–6. Recently, real time three-dimensional echocar-
diography (RT3DE) has been introduced for assessment of LV function and volumes. RT3DE 
has been validated against magnetic resonance imaging and found to be more accurate and 
reproducible as compared to two-dimensional echocardiography (2DE) 7–13. However, even 
more than 2DE, RT3DE relies heavily on the presence of good image quality 14;15.
The use of intravenous contrast agents during 2DE has been shown to be of incremental 
value, improving LV endocardial border visualization among patients with suboptimal image 
quality and increasing the accuracy and reproducibility of LV systolic function measurements 
16–22. In contrast, data regarding the use of echo contrast during RT3DE are scarce 14;23–25. In par-
ticular, no specific data exist about the efficacy of contrast-enhanced RT3DE performed early 
after AMI; the safety of contrast-enhanced echocardiography early after AMI was reported 
recently with 2DE 26. Aim of the present study was therefore to investigate, in a large cohort of 
consecutive patients with AMI, the potential incremental value of contrast-enhanced RT3DE 
over non-enhanced RT3DE for assessment of LV function and volumes.
methods
patient population
The patient population consisted of 140 patients admitted to the coronary care unit because 
of ST-elevation AMI.The diagnosis of ST-elevation AMI was made on the basis of typical ECG 
changes and/or ischemic chest pain associated with elevation of cardiac biomarkers 27.
All patients underwent immediate coronary angiography and primary percutaneous coro-
nary intervention. As part of the clinical work-up, RT3DE (with echo contrast) was performed 
in the coronary care unit within 24 hours from patients’ admission to accurately evaluate 
global and regional LV systolic function.
echocardiography
Patients were imaged in left lateral decubitus position with a commercially available sys-
tem (Vivid 7, GE Healthcare, Horten, Norway) equipped with a 3V phased array transducer 
(2.5 MHz). First, apical full volume 3D data sets were acquired in harmonic mode, integrating, 
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during a brief breath-hold, 8 R-wave-triggered sub-volumes into a larger pyramidal volume 
(90° by 90°) with a complete capture of the LV. Thereafter, the same acquisition was repeated 
during echo contrast administration (Luminity®, Bristol-Myers Squibb Pharma, Bruxelles, Bel-
gium) to optimize LV border delineation. Each patient received an intravenous infusion of 1.3 
ml of echo contrast diluted in 50 ml of 0.9% NaCl solution; the rate of infusion was initially set 
at 4.0 ml/min and then titrated to achieve optimal LV chamber opacification and endocardial 
border delineation 28. Contrast-enhanced RT3DE was performed in harmonic mode at low 
mechanical index (0.26), and care was taken to record the images at a phase when echo 
contrast flow was relatively stable with absent or minimal swirling in the apex. The 3D data 
sets were digitally stored for the off-line analysis.
echocardiographic analysis
The 3D data sets were analyzed on-line for the analysis of LV chamber opacification and 
off-line for the analysis of LV endocardial border definition and LV volumes and function. 
The off-line analysis was performed using a dedicated software (4D LV-Analysis©; TomTec, 
Munich, Germany) by an observer who had no knowledge of the patient’s identity, medical 
history and symptom status. As described elsewhere 29, the software automatically displays 
in a quad-screen the 4-chamber view, as a reference view, the 2- and 3- chamber views with 
default interplane angles at 60 degrees and a short-axis view (Figure 1). The interplane angles 
can be manually modified in order to obtain adequate orientation of the 3 apical views 
and their meeting point can be adjusted in the middle of the LV cavity in order to avoid LV 
foreshortening. This procedure can also be used to evaluate regions between the 3 adjacent 
conventional apical views.
Figure 1.  Left panel. Example of fair quality echocardiogram during non-enhanced RT3DE. Right panel. Optimal left ventricular chamber 
opacification and improved endocardial border definition during contrast-enhanced RT3DE in the same patient. The 3 apical views are shown 
with the 4-chamber as a reference view in the top right and the 2- and 3-chamber views in the bottom left and bottom right, respectively. Top 
left: short-axis view.
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LV chamber opacification
The degree of LV chamber opacification during echo contrast administration was graded ac-
cording to 5 points rating scale 17;28: 0 = no contrast enhancement; 1 = weak or little contrast 
enhancement; 2 = adequate contrast enhancement that facilitates image interpretation; 3 = 
full contrast enhancement that definitely aids image interpretation; 4 = excessive contrast 
enhancement that hampers interpretation. The percentage of patients with adequate-to-full 
contrast enhancement was calculated. The mean time needed to achieve adequate-to-full 
contrast enhancement was measured.
LV endocardial border definition
Qualitative assessment of the endocardial border was performed both in non-enhanced 
and contrast-enhanced images. A standard 16-segment model was used 30. Adequacy of LV 
endocardial border definition was graded for each of the 16 cardiac segments as follows 22: 0 
= border invisible; 1 = border visualized only partially throughout the cardiac cycle and/or in-
complete segment length, and 2 = complete visualization of the border. A global endocardial 
visualization score was calculated as the sum of each LV segment’s score.
On basis of the global score, 3 image quality groups were defined: good (score 25-32), fair 
(score 17-24) and uninterpretable (score ≤16) 15;22. Uninterpretable echocardiograms were 
deemed non-diagnostic and further analyses of LV volumes and global and regional LV func-
tions were considered not feasible.
LV volumes and global systolic function
The algorithm used by the software to calculate LV end-diastolic volume (EDV), LV end-
systolic volume (ESV) and LVEF is described in detail elsewhere 29. Briefly, the endocardial 
border is manually traced in the 3 apical views (including LV trabeculations and papillary 
muscles within the cavity) in both the end-diastolic and end-systolic frames. Subsequently, 
the software automatically identifies the endocardial border in the entire 3D dataset; further 
manual adjustments are possible in approximately 30 coronal and sagittal planes. Finally, a 
reconstruction of the LV model is generated and LV volumes and LVEF are obtained.




Qualitative assessment of the regional wall motion was performed both in non-enhanced 
and contrast-enhanced images, according to the same 16-segment model used for the evalu-
ation of LV endocardial border definition 30. Segments with invisible endocardial border were 
excluded from this analysis. Wall motion was graded for each of the visualized segments as 
follows: 1 = normal; 2 = hypokinetic; 3 = akinetic and 4 = dyskinetic. A global wall motion 
score index (WMSI) was calculated as the sum of each LV segment’s score divided by the 
number of visualized segments.
Reproducibility of RT3DE measurements
The datasets of 20 patients with a good quality echocardiogram and 20 patients with a fair 
quality echocardiogram during non-enhanced RT3DE were randomly selected and analyzed 
again 1 month later by the original observer and by a second observer who was blinded to 
the results of the previous analysis. Intra- and inter-observer agreement was assessed for the 
measurements of LV volumes and LVEF and the grading of regional wall motion.
statistical analysis
Continues variables are expressed as mean and standard deviation. Categorical data are 
presented as absolute numbers and percentages.
The global endocardial visualization score and the measurements of LV volumes, LVEF and 
WMSI were compared between the 2 imaging techniques with the paired t-test. To determine 
whether there was a statistically significant difference in the comparison between categorical 
variables, the McNemar test was performed for binary data and the marginal homogeneity 
test for multinomial response data. Intra- and inter-observer agreement in the measurements 
of LV volumes and LVEF were assessed using Bland-Altman analysis and expressed as the 
mean difference between the 2 measurements ±2 standard deviations. To evaluate intra- and 
inter-observer agreement in the grading of regional wall motion, weighted Kappa test was 
used and the level of agreement was interpreted as follows: 0 to 0.2 = poor to slight; 0.21 to 
0.4 = fair; 0.41 to 0.6 = moderate; 0.61 to 0.8 = substantial; and 0.81 to 1.0 = nearly perfect. 
A p-value <0.05 was considered statistically significant. Statistical analysis was performed 
using the SPSS software package (SPSS 15.0, Chicago, Illinois).
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results
patient population
Baseline characteristics of the patient population are summarized in Table 1. Mean age of 
the patients was 58±11 years; 109 (78%) were male. Fifteen (11%) patients had a history of 
myocardial infarction and 12 (9%) had previous surgical or percutaneous myocardial revas-
cularization. The infarct-related artery was the left anterior descending coronary artery in 60 
(43%) patients, the left circumflex coronary artery in 19 (13%) and the right coronary artery in 
61 (44%). Obstructive multi-vessel disease (i.e. more than 1 vessel with a luminal narrowing 
≥70%) was present in 51 (36%) patients.
echocardiography
The mean infusion rate of echo contrast was 3.0±0.6 ml/min and the total infusion dose was 
on average 16 µl/kg.
LV chamber opacification
Adequate-to-full enhancement during echo contrast infusion was noted in 130 (93%) pa-
tients. Weak or little contrast enhancement was observed in 9 (6%) patients and excessive 




Family history of coronary artery disease 54 (39%)
Hypercholesterolemia 26 (19%)
Hypertension 50 (36%)
Current or previous smoking 85 (61%)
Previous myocardial infarction 15 (11%)
Previous myocardial revascularization 12 (9%)
Body mass index (kg/m²) 27±4
Current anterior myocardial infarction 60 (43%)
Current infarct-related artery
- left anterior descending coronary artery
- left circumflex coronary artery




Multi-vessel coronary artery disease 51 (36%)
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contrast enhancement in 1 (1%) patient. The mean time needed to achieve adequate-to-full 
LV contrast enhancement was 65±20 sec.
LV endocardial border definition
During non-enhanced RT3DE, from the total number of 2240 LV segments, the endocardial 
border was invisible in 243 (11%) and visualized only partially in 509 (23%). A complete vi-
sualization of the border was possible in 1488 (66%) segments (Table 2). The mean global 
endocardial visualization score was 25±6. A total of 82 (59%) patients had a good quality 
echocardiogram, while 44 (31%) and 14 (10%) had a fair quality and uninterpretable echocar-
diogram, respectively (Figure 2).
During contrast-enhanced RT3DE, a complete visualization of the border was possible in 
1890 (84%) segments (p <0.001 as compared to non enhanced RT3DE) (Table 2). The LV en-
docardial border definition significantly improved in the segments of each LV wall (Table 2). 
As compared to non-enhanced RT3DE, the mean global endocardial visualization score im-
proved to 29±3 (p <0.001). A total of 131 (94%) patients had a good quality echocardiogram, 
while 7 (5%) and 2 (1%) had a fair quality and uninterpretable echocardiogram, respectively 
(p <0.001 in comparison to non-enhanced RT3DE) (Figure 2).
An example of LV chamber opacification and improved endocardial border definition dur-
ing contrast-enhanced RT3DE, as compared to non-enhanced RT3DE is displayed in Figure 1.
Figure 2. Image quality during non-enhanced and contrast-enhanced RT3DE.
p <0.001 for comparison between the 2 imaging techniques.
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LV volumes and global systolic function
Non-enhanced RT3DE provided significantly lower values of LVEDV as compared to contrast-
enhanced RT3DE (107±28 ml vs.113±27 ml, p <0.001). The values of LVESV were not statisti-
cally different between the 2 techniques (59±21 ml vs. 61±20 ml, p = ns). Accordingly, non-
enhanced RT3DE provided slightly, but significantly lower values of LVEF (45±9% vs. 47±9%, 
p = 0.003).
LV regional systolic function
WMSI assessed on non-enhanced and contrast-enhanced images were 1.8±0.4 and 1.7±0.4, 
respectively (p = 0.04).
Table 2. Left ventricular endocardial border definition with non-enhanced and contrast-enhanced RT3DE.
non-enhanced rt3de contrast-enhanced rt3de p-value
Overall segments (n = 2240)
- border invisible
- border visualized only partially








Anterior wall segments (n = 420)
- border invisible
- border visualized only partially








Antero-lateral wall segments (n = 420)
- border invisible
- border visualized only partially








Anterior septum segments (n = 280)
- border invisible
- border visualized only partially








Inferior wall segments (n = 420)
- border invisible
- border visualized only partially








Infero-lateral wall segments (n = 280)
- border invisible
- border visualized only partially








Inferior septum segments (n = 420)
- border invisible
- border visualized only partially








RT3DE: real-time three-dimensional echocardiography.
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Reproducibility of RT3DE measurements
Intra- and inter-observer agreement for the measurements of LV volumes, LVEF and the 
grading of regional wall motion obtained with the 2 techniques are shown in Tables 3 and 4. 
The weakest agreements were observed among patients with a fair quality echocardiogram. 
Contrast-enhanced RT3DE improved intra- and inter-observer agreement both in good and 
fair echocardiograms.
Table 3.  Intra- and inter-observer agreements for the measurements of left ventricular volumes and left ventricular global function, in relation 
to image quality during non-enhanced RT3DE.
good quality echocardiogram 
during non-enhanced rt3de
fair quality echocardiogram 
during non-enhanced rt3de
Intra-observer agreement

































Intra- and inter-observer agreements for the measurements of LV volumes and LVEF were assessed using the method proposed by Bland and 
Altman and expressed as the mean difference between the 2 measurements±2 standard deviations. EDV: end-diastolic volume; EF: ejection 
fraction; ESV: end-systolic volume; LV: left ventricle; RT3DE: real-time three-dimensional echocardiography.
Table 4. Intra- and inter-observer agreements for the grading of left ventricular regional wall motion, in relation to image quality during 
non-enhanced RT3DE.
good quality echocardiogram 
during non-enhanced rt3de
fair quality echocardiogram 
during non-enhanced rt3de
Intra-observer agreement
Non-enhanced Contrast-enhanced Non-enhanced Contrast-enhanced
LV RWM 0.77 0.95 0.69 0.92
Inter-observer agreement
Non-enhanced Contrast-enhanced Non-enhanced Contrast-enhanced
LV RWM 0.65 0.87 0.54 0.85
Intra- and inter-observer agreements for the grading of LV RWM were assessed using the weighted Kappa test and expressed as weighted 
Kappa value. LV: left ventricle; RT3DE: real-time three-dimensional echocardiography: RWM: regional wall motion.
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dIscussIon
The current results show that, among unselected patients in the early stage of AMI, contrast-
enhanced RT3DE has a high feasibility (93%), and is of incremental value for the assessment 
of LV systolic function. Specifically, as compared to non-enhanced RT3DE, 1) it significantly 
increased the number of LV segments with a complete visualization of the endocardial border 
(from 66% to 84%); 2) it increased the number of good quality echocardiograms (from 59% 
to 94%); and 3) it reduced the number of fair quality and uninterpretable echocardiograms 
(from 41% to 6%). Moreover, intra- and inter-observer agreement for the measurements of 
global and regional LV systolic function improved during contrast-enhanced RT3DE, particu-
larly among patients with fair quality echocardiogram during non-enhanced RT3DE.
advantages and limitations of rt3de
The most commonly used imaging modality for the evaluation of global and regional LV 
systolic function is 2DE. However, 2DE relies on significant geometric assumptions, resulting 
in modest agreement with reference methods and fair reproducibility 17;31.
More recently, RT3DE has been proposed to overcome the above mentioned limitations of 
2DE; RT3DE correlated well with magnetic resonance imaging for assessment of LV volumes 
and LV ejection fraction 8–11. In addition, it has been suggested that RT3DE has potential 
advantages for the evaluation of regional LV function in regions/planes that could not be 
adequately visualized with 2DE 7;13.
Because of its higher accuracy and reproducibility, RT3DE could be extremely useful for 
serial assessment of systolic function 32. RT3DE would be particularly useful in AMI patients, in 
whom accurate assessment of LV function and volumes is important for prediction of future 
adverse events 2;3.
However, RT3DE has still several limitations; particularly, RT3DE image quality is highly 
dependent on the acoustic window, due to a lower spatial and temporal resolution as com-
pared to 2DE 11;24. Accordingly, adequate endocardial border delineation may be difficult on 
RT3DE still frames, even in the presence of relatively good quality 2DE 33. Due to this limita-
tion, most of the previous RT3DE studies included only patients with an optimal acoustic 
window 8–10. Few studies explored the feasibility of RT3DE, in relation to the image quality, for 
the assessment of LV systolic function in unselected population and reported a prevalence of 
uninterpretable or poor quality RT3DE images in the range of 35% 15;24. This issue may be even 
more prominent in patients with AMI, in whom adequate assessment of LV function and vol-
umes is important for prognosis, but in whom RT3DE data acquisition may be hampered by 
reduced patient mobility 12;34. In the present study, 41% of 140 consecutive patients referred 
to RT3DE within 24 hours from AMI had a fair quality or uninterpretable echocardiogram. This 
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percentage is in line with previous studies 15;24 and may also be related to technical limitations 
associated to the performance of RT3DE in the coronary care unit, as well as the high body 
mass index of our study population.
Incremental value of contrast-enhanced rt3de
In the subset of patients with inadequate RT3DE images, contrast agents could improve LV 
endocardial border visualization, increasing the feasibility, accuracy and reproducibility of LV 
function assessment as previously reported with 2DE 16–22.
Thus far, few small studies 14;23–25 (16, 20, 39 and 50 patients, respectively) previously as-
sessed the accuracy of contrast-enhanced RT3DE, reporting a good agreement between 
contrast-enhanced RT3DE and magnetic resonance imaging for assessment of LV function 
and volumes. However, data regarding the feasibility of contrast-enhanced RT3DE and its 
incremental value over non-enhanced RT3DE (in terms of improved image quality) have not 
been shown. In the present study, we reported our experience on the feasibility and efficacy 
of contrast-enhanced RT3DE in a large, unselected cohort of patients in the early stage of AMI. 
Echo contrast infusion ensured optimal LV opacification in 93% of the patients. Moreover, the 
definition of the endocardial border significantly increased with the use of echo contrast, 
allowing more reliable and reproducible assessment of regional wall motion abnormalities. 
Of note, visualization of the anterior and anterolateral walls particularly improved with the 
use of echo contrast.
Overall, the prevalence of good quality echocardiograms increased from 59% to 94% with 
the intravenous contrast. The prevalence of fair image quality and uninterpretable echocar-
diograms decreased from 31% to 5% and from 10% to 1%, respectively.
study limitations
The present study has some limitations that should be acknowledged. First, the semi-
automated algorithm used for LV volume analysis requires manual tracing of the endocardial 
border in the 3 apical planes, which is a subjective procedure that could alter the reproduc-
ibility of the technique. Second, an independent gold standard (e.g. magnetic resonance 
imaging) was not performed and therefore data about accuracy of contrast-enhanced RT3DE 
could not be provided.
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conclusIons
In patients with recent AMI, the use of echo contrast significantly improved the endocardial 
border visualization and the reproducibility of measurements of global and regional LV sys-
tolic function.




 1. Nishimura RA, Reeder GS, Miller FA, Jr. et al. Prognostic value of predischarge 2-dimensional 
echocardiogram after acute myocardial infarction. Am J Cardiol 1984;53:429-432.
 2. Serruys PW, Simoons ML, Suryapranata H et al. Preservation of global and regional left ventricular 
function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986;7:729-742.
 3. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic 
volume as the major determinant of survival after recovery from myocardial infarction. Circula-
tion 1987;76:44-51.
 4. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination 
of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 
1990;65:567-576.
 5. Volpi A, De Vita C, Franzosi MG et al. Determinants of 6-month mortality in survivors of myocardial 
infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the 
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-2 Data Base. 
Circulation 1993;88:416-429.
 6. Oh JK, Gibbons RJ, Christian TF et al. Correlation of regional wall motion abnormalities detected 
by two-dimensional echocardiography with perfusion defect determined by technetium 99m 
sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarc-
tion. Am Heart J 1996;131:32-37.
 7. Collins M, Hsieh A, Ohazama CJ et al. Assessment of regional wall motion abnormalities with 
real-time 3-dimensional echocardiography. J Am Soc Echocardiogr 1999;12:7-14.
 8. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic 
measurements of left ventricular parameters using real-time three-dimensional echocardiogra-
phy. J Am Coll Cardiol 2004;44:878-886.
 9. Sugeng L, Mor-Avi V, Weinert L et al. Quantitative assessment of left ventricular size and func-
tion: side-by-side comparison of real-time three-dimensional echocardiography and computed 
tomography with magnetic resonance reference. Circulation 2006;114:654-661.
 10. Jenkins C, Bricknell K, Chan J, Hanekom L, Marwick TH. Comparison of two- and three-dimensional 
echocardiography with sequential magnetic resonance imaging for evaluating left ventricular 
volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol 
2007;99:300-306.
 11. Badano LP, Dall’Armellina E, Monaghan MJ et al. Real-time three-dimensional echocardiography: 
technological gadget or clinical tool? J Cardiovasc Med (Hagerstown ) 2007;8:144-162.
 12. Arruda-Olson AM, Bursi F, Gerber Y, May RH, Roger VL, Pellikka PA. Three-Dimensional Echo-
cardiography for Evaluating Left Ventricular Function in Patients With ST Elevation Myocardial 
Infarction: A Pilot Study. Mayo Clin Proc 2008;83:372-373.
 13. Jaochim Nesser H, Sugeng L, Corsi C et al. Volumetric analysis of regional left ventricular function 
with real-time three-dimensional echocardiography: validation by magnetic resonance and clini-
cal utility testing. Heart 2007;93:572-578.
 14. Corsi C, Coon P, Goonewardena S et al. Quantification of regional left ventricular wall motion 
from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects 
of contrast enhancement tested against cardiac magnetic resonance. J Am Soc Echocardiogr 
2006;19:886-893.
Nina Book.indb   226 26-09-11   12:04
227
Contrast-enhanced RT3DE after AMI
 15. Tighe DA, Rosetti M, Vinch CS et al. Influence of image quality on the accuracy of real time three-
dimensional echocardiography to measure left ventricular volumes in unselected patients: a 
comparison with gated-SPECT imaging. Echocardiography 2007;24:1073-1080.
 16. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an 
intravenous perfluorocarbon contrast agent improves echocardiographic determination of left 
ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J 
Am Coll Cardiol 1998;32:1426-1432.
 17. Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS. Efficacy and safety 
of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline 
left ventricular echocardiographic images. Am J Cardiol 2000;86:669-674.
 18. Thomson HL, Basmadjian AJ, Rainbird AJ et al. Contrast echocardiography improves the accuracy 
and reproducibility of left ventricular remodeling measurements: a prospective, randomly as-
signed, blinded study. J Am Coll Cardiol 2001;38:867-875.
 19. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of 
left ventricular volume and ejection fraction by contrast echocardiography: a comparison with 
magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-1035.
 20. Hoffmann R, von Bardeleben S, ten Cate F et al. Assessment of systolic left ventricular function: 
a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unen-
hanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-616.
 21. Hoffmann R, von Bardeleben S, Kasprzak JD et al. Analysis of regional left ventricular function by 
cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-en-
hanced echocardiography: a multicenter comparison of methods. J Am Coll Cardiol 2006;47:121-
128.
 22. Galema TW, Geleijnse ML, Yap SC et al. Assessment of left ventricular ejection fraction after 
myocardial infarction using contrast echocardiography. Eur J Echocardiogr 2008;9:250-254.
 23. Caiani EG, Coon P, Corsi C et al. Dual triggering improves the accuracy of left ventricular volume 
measurements by contrast-enhanced real-time 3-dimensional echocardiography. J Am Soc Echo-
cardiogr 2005;18:1292-1298.
 24. Krenning BJ, Kirschbaum SW, Soliman OI et al. Comparison of contrast agent-enhanced versus 
non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left 
ventricular systolic function. Am J Cardiol 2007;100:1485-1489.
 25. Jenkins C, Moir S, Chan J, Rakhit D, Haluska B, Marwick TH. Left ventricular volume measurement 
with echocardiography: a comparison of left ventricular opacification, three-dimensional echo-
cardiography, or both with magnetic resonance imaging. Eur Heart J 2008.
 26. Nucifora G, Marsan NA, Siebelink HM et al. Safety of contrast-enhanced echocardiography within 
24 h after acute myocardial infarction. Eur J Echocardiogr 2008;9:816-818.
 27. Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. Circulation 
2007;116:2634-2653.
 28. Weissman NJ, Cohen MC, Hack TC, Gillam LD, Cohen JL, Kitzman DW. Infusion versus bolus con-
trast echocardiography: a multicenter, open-label, crossover trial. Am Heart J 2000;139:399-404.
 29. Soliman OI, Krenning BJ, Geleijnse ML et al. A comparison between QLAB and TomTec full volume 
reconstruction for real time three-dimensional echocardiographic quantification of left ventricu-
lar volumes. Echocardiography 2007;24:967-974.
 30. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report 
from the American Society of Echocardiography’s Guidelines and Standards Committee and the 
Chamber Quantification Writing Group, developed in conjunction with the European Association 
Nina Book.indb   227 26-09-11   12:04
Chapter 12
228
of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 
2005;18:1440-1463.
 31. McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiog-
raphy: a systematic review of 3 methods. Am Heart J 2003;146:388-397.
 32. Chan J, Jenkins C, Khafagi F, Du L, Marwick TH. What is the optimal clinical technique for measure-
ment of left ventricular volume after myocardial infarction? A comparative study of 3-dimen-
sional echocardiography, single photon emission computed tomography, and cardiac magnetic 
resonance imaging. J Am Soc Echocardiogr 2006;19:192-201.
 33. Nemes A, Geleijnse ML, Krenning BJ et al. Usefulness of ultrasound contrast agent to improve 
image quality during real-time three-dimensional stress echocardiography. Am J Cardiol 
2007;99:275-278.
 34. Olszewski R, Timperley J, Szmigielski C et al. The clinical applications of contrast echocardiogra-
phy. Eur J Echocardiogr 2007;8:S13-S23.
Nina Book.indb   228 26-09-11   12:04
Nina Book.indb   229 26-09-11   12:04
Nina Book.indb   230 26-09-11   12:04
chapter 13
Impact of left ventricular dyssynchrony 
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objectives: The impact of left ventricular (LV) dyssynchrony after acute myocardial 
infarction (AMI) on LV ejection fraction (EF) is unknown.
methods: One hundred twenty-nine patients with a first ST-elevation AMI (58±11 
years, 78% men) and QRS duration <120 ms were included. All patients underwent 
primary percutaneous coronary intervention. Real-time 3-dimensional echocar-
diography and myocardial contrast echocardiography were performed to assess 
LV function, LV dyssynchrony, and infarct size. LV dyssynchrony was defined as the 
standard deviation of the time to reach the minimum systolic volume for 16 LV 
segments, expressed in percent cardiac cycle (systolic dyssynchrony index [SDI]). 
Myocardial perfusion at myocardial contrast echocardiography was scored (1 = 
normal/homogenous; 2 = decreased/patchy; 3 = minimal/absent) using a 16-seg-
ment model; a myocardial perfusion index, expressing infarct size, was derived by 
summing segmental contrast scores and dividing by the number of segments.
results: SDI in patients with AMI was 5.24±2.23% compared to 2.02±0.70% of 
controls (p <0.001). Patients with AMI and LVEF <45% had significantly higher SDI 
compared to patients with LVEF >45% (4.29±1.44 vs 6.95±2.40, p <0.001). At multi-
variate analysis, SDI was independently related to LVEF; in addition, the impact of 
SDI on LV systolic function was incremental to infarct size and anterior location of 
AMI (F change 16.9, p <0.001).
conclusions: LV synchronicity is significantly impaired soon after AMI. LV dyssyn-
chrony is related to LVEF and has an additional detrimental effect on LV function, 
beyond infarct size and the anterior location of AMI.
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IntroductIon
Advances in echocardiographic techniques, i.e., tissue Doppler echocardiography, speckle-
tracking echocardiography, and real-time 3-dimensional echocardiography (RT3DE) have 
recently demonstrated an impaired left ventricular (LV) synchronicity in patients with acute 
myocardial infarction (AMI) 1–3. In the setting of chronic heart failure, LV dyssynchrony is a 
phenomenon extensively described and related to impaired LV systolic function and poor 
prognosis 4–8. In the setting of AMI, however, it is unclear whether LV dyssynchrony is inde-
pendently associated with LV ejection fraction (EF). Moreover, the detrimental effect of LV 
dyssynchrony on LV systolic function in addition to other variables remains unknown. Accord-
ingly, the aim of the present study was twofold: (1) to assess the decrease in LV synchronicity 
after AMI (compared to normal values) and (2) to explore the relation between this decrease 
in LV synchronicity and LV systolic function. In particular, the effect of LV dyssynchrony on 
LVEF in addition to other variables was assessed.
methods
The population consisted of 159 consecutive patients admitted to the coronary care unit 
because of a first ST-segment elevation AMI. Patients with a QRS complex duration >120 ms 
were excluded from the study.
The diagnosis of AMI was made on the basis of typical ECG changes and/or ischemic chest 
pain associated with elevation of cardiac biomarkers 9. All patients underwent immediate 
coronary angiography and primary percutaneous coronary intervention (PCI). The infarct-
related artery was identified by the site of coronary occlusion during coronary angiography 
and ECG criteria. During PCI, the final TIMI (Thrombolysis In Myocardial Infarction) flow was 
assessed. In addition, the time from onset of symptoms to first balloon dilatation (symptoms-
to-balloon time) was determined.
Using the ECGs acquired on admission and 1 h after PCI, the ST-segment resolution was 
assessed, as previously described 10. The sum of ST-segment elevation was measured 60 ms 
after the J point in leads I, aVL, and V1 to V6 for anterior AMI and leads II, III, aVF, V5, and V6 for 
non-anterior AMI. The percentage of resolution of ST-segment elevation from before to after 
PCI was then calculated.
RT3DE was performed 48 hours after PCI to assess global LV systolic function and LV dys-
synchrony; immediately after RT3DE, myocardial contrast echocardiography was performed 
to assess infarct size. These echocardiographic examinations are part of the routine, compre-
hensive assessment of patients presenting with AMI in our clinics.
In addition, 30 subjects without evidence of structural heart disease and without known 
risk factors for coronary artery disease, matched for age, gender and body surface area, who 
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underwent RT3DE, were included as a normal control group. These individuals were derived 
from the echo database and were clinically referred for echocardiographic evaluation be-
cause of atypical chest pain, palpitations or syncope without murmur.
To determine the impairment of LV synchronicity after AMI, the patient data were compared 
with the data from the normal controls. In addition, the relation between LV systolic function 
and other clinical and echocardiographic variables (including LV dyssynchrony, infarct size, 
and infarct location) was evaluated.
Patients were imaged in left lateral decubitus position with a commercially available sys-
tem (Vivid 7, GE Healthcare, Horten, Norway) equipped with a 3V phased array transducer 
(2.5  MHz). Apical full volume 3D data sets were acquired in harmonic mode, integrating, 
during a brief breath-hold, 8 R-wave-triggered sub-volumes into a larger pyramidal volume 
(90° by 90°) with a complete capture of the LV. The 3D data sets were digitally stored for the 
off-line analysis.
Off-line analysis was performed by an observer who had no knowledge of the patient’s 
identity and standard 2DE and MCE results. A dedicated software (4D LV-Analysis©; TomTec, 
Munich, Germany) was used. The algorithm used by the software to calculate LV end-diastolic 
volume, LV end-systolic volume and LVEF is described in detail elsewhere 11. Briefly, a semi-
automated method for the detection of the apical 4-chamber view and the 60° and 120° 
incremental views and for the tracing of the endocardial border in the entire 3D dataset (in-
cluding LV trabeculations and papillary muscles within the LV volume) is used. Subsequently, 
a final reconstruction of the LV model is generated and LV volumes and LVEF are obtained. In 
addition, the same LV model was used for the assessment of LV dyssynchrony, as previously 
described 12. Briefly, the
LV model was automatically divided in 16 pyramidal subvolumes (6 basal segments, 6 mid 
segments, and 4 apical segments) based around a nonfixed central point. For each volumetric 
segment, the time–volume curve for the entire cardiac cycle was derived and the time taken 
to reach the minimum systolic volume was calculated. The standard deviation of the time 
taken to reach the minimum systolic volume expressed as percent cardiac cycle (systolic dys-
synchrony index [SDI]) was then calculated as a marker of global LV dyssynchrony 12.
Immediately after RT3DE, myocardial contrast echocardiography was performed to 
evaluate myocardial perfusion, to assess infarct size after AMI. The same ultrasound system 
equipped with a 3.5-MHz transducer was used. The 3 standard apical views were acquired 
using a low-power technique (mechanical index 0.10 to 0.26). Background gains were set 
so that minimal tissue signal was seen, and the focus was set at the level of the mitral valve. 
Luminity® (Bristol-Myers Squibb Pharma, Brussels, Belgium) was used as contrast agent. 
Each patient received an infusion of 1.3 mL of echo contrast diluted in 50 mL of 0.9% NaCl 
solution through a 20 gauge intravenous catheter in a proximal forearm vein. Infusion rate 
was initially set at 4.0 mL/min and then titrated to achieve optimal myocardial enhancement 
without attenuation artifacts 13. Machine settings were optimized to obtain the best pos-
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sible myocardial opacification with minimal attenuation. At least 15 cardiac cycles after high 
mechanical index (1.7) microbubble destruction 14 were stored in cine-loop format.
Analysis of myocardial contrast echocardiograms was performed off-line using EchoPAC 
version 7.0.0 (GE Healthcare, Horten, Norway). To evaluate myocardial perfusion, the LV was 
divided according to the same 16-segment model of the American Society of Echocardiog-
raphy 15. A semiquantitative scoring system was used to assess contrast intensity after micro-
bubble destruction: 1) normal/homogenous opacification; 2) reduced/patchy opacification; 
3) minimal or absent contrast opacification 14,16. A myocardial perfusion index, expressing 
infarct size, was derived by adding contrast scores of all segments and dividing by the total 
number of segments 14,16.
Continues variables are expressed as mean±standard deviation, when normally distrib-
uted, and as median and interquartile range, when not normally distributed. Categorical data 
are presented as absolute numbers and percentages. Differences in continuous variables 
between control subjects and AMI patients were assessed using the Student t test or the 
Mann-Whitney U test, if appropriate. Chi-square test or Fisher exact test, if appropriate, were 
computed to assess differences in categorical variables. Univariate and multivariate linear re-
gression analysis were performed to evaluate the relationship between LVEF in patients with 
AMI and the characteristics of age, gender, coronary risk factors, infarct location, multi-vessel 
disease, symptoms-to-balloon time, TIMI flow grade 3 after PCI, QRS duration, ST-segment 
resolution, peak troponin T, LV dyssynchrony (expressed as SDI) and infarct size (expressed 
as myocardial perfusion index) Only variables with p-value <0.1 at univariate analysis were 
entered as covariates in the multivariate model. To determine the potential incremental value 
of SDI over the other variables, the R2 of the multivariate model was compared to the R2 of the 
same model without SDI. A p-value <0.05 was considered statistically significant. Statistical 
analysis was performed using the SPSS software package (SPSS 15.0, Chicago, Illinois).
results
Reliable RT3DE and myocardial contrast echocardiographic data were obtained in 129 pa-
tients; consequently, 30 patients were excluded from further analysis. All control subjects 
had reliable RT3DE data.
Clinical and echocardiographic characteristics of AMI patients are listed in Table 1. A total 
of 60 (46%) patients had an anterior AMI; obstructive multi-vessel disease (i.e. > 1 vessel with 
a luminal narrowing ≥70%) was present in 46 (36%) patients.
As compared to control subjects, AMI patients had significantly lower LVEF (64±6% vs. 
46±9%, p <0.001) and significantly higher SDI (2.02±0.70% vs. 5.24±2.23%, p <0.001). The 
observed impairment of LV synchronicity in AMI patients is shown in Figure 1.
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Age (years) 57±11 58±11 0.53
Male gender 23 (77%) 100 (78%) 0.92
Body surface area (m2) 1.96±0.58 1.98±0.22 0.76
Diabetes - 14 (11%) -
Family history of coronary artery disease* - 49 (38%) -
Hypercholesterolemia† - 19 (15%) -
Hypertension‡ - 47 (36%) -
Current or previous smoking - 76 (59%) -
Anterior myocardial infarction - 60 (46%) -
Infarct-related artery
- left anterior descending coronary artery
- left circumflex coronary artery










Multi-vessel disease - 46 (36%) -
TIMI flow 3 109 (85%) -
Symptoms-to-balloon time (min) - 177 (134-219) -
QRS duration - 96±13 -
ST-segment resolution (%) - 62±31 -
Peak troponin T (µg/l) - 3.10 (1.52-6.89) -
LVEDV (ml) 90±23 110±30 0.01
LVESV (ml) 35±14 60±23 <0.001
LVEF (%) 64±6 46±9 <0.001
SDI (%) 2.02±0.70 5.24±2.23 <0.001
MPI - 1.25 (1.09-1.50) -
EF: ejection fraction; EDV: end-diastolic volume; ESV: end-systolic volume; LV: left ventricular; MPI: myocardial perfusion index; SDI: systolic 
dyssynchrony index; TIMI: Thrombolysis In Myocardial Infarction. Data are expressed as mean±SD, median (interquartile range), or number of 
subjects (percentage).
* Defined when close relatives had premature coronary artery disease
(men <55 years old and women <65 years old).
† Defined as total cholesterol level ≥240 mg/dl.
‡ Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg. Table 2. Clinical and echocardiographic 
characteristics of patients with acute myocardial infarction in relation to left ventricular systolic function.
dium chloride solution 50 ml through a 20-gauge intrave-
nous catheter in a proximal forearm vein. Infusion rate was
initially set at 4.0 ml/min and then titrated to achieve optimal
myocardial enhancement without attenuation artifacts.13 Machine
settings were optimized to obtain the best possible myocar-
dial opacification with minimal attenuation. At least 15
cardiac cycles after high mechanical index (1.7) micro-
bubble destruction14 were stored in cine-loop format.
Analysis of myocardial contrast echocardiograms was
performed off-line using EchoPAC 7.0.0 (GE Healthcare).
To evaluate myocardial perfusion, the left ventricle was
divided according to the 16-segment model of the American
Society of Echocardiography.15 A semiquantitative scoring
system was used to assess contrast intensity after micro-
Figure 1. SDI in control subjects (white bar) and patients with AMI (black
bar) (p 0.001).
Figure 2. SDI in patients with AMI in relation to LV systolic function, namely
LVEF 45% (white bar) and LVEF 45% (black bar) (p 0.001).
Table 2
Clinical and echocardiographic characteristics of patients with acute
myocardial infarction in relation to left ventricular systolic function
Variable LVEF 45% LVEF 45% p Value
(n  83) (n  46)
Age (years) 57  11 60  11 0.090
Men 60 (72%) 40 (87%) 0.056
Diabetes mellitus 9 (11%) 5 (11%) 1.00
Family history of
coronary artery disease
31 (37%) 18 (39%) 0.84
Hypercholesterolemia 12 (15%) 7 (15%) 0.91
Hypertension 35 (42%) 12 (26%) 0.069
Current or previous
smoker
47 (57%) 29 (63%) 0.48
Anterior wall acute
myocardial infarction
34 (41%) 26 (57%) 0.090
Multivessel coronary
disease




74 (89%) 35 (76%) 0.049
Symptoms-to-balloon
time (minutes)
170 (127–215) 184 (150–231) 0.16
QRS duration (ms) 94  13 99  13 0.027
ST-segment resolution (%) 65  31 56  30 0.13
Peak troponin T (g/l) 2.69 (1.23–5.39) 4.82 (1.85–11.02) 0.006
Left ventricular end-
diastolic volume (ml)
105  25 118  38 0.042
Left ventricular end-
systolic volume (ml)
51  14 75  28 0.001
Left ventricular ejection
fraction (%)
51  5 37  6 0.001
Systolic dyssynchrony
index (%)
4.29  1.44 6.95  2.40 0.001
Myocardial perfusion
index
1.19 (1.00–1.38) 1.56 (1.23–1.81) 0.001
Data are expressed as mean  SD, median (interquartile range), or
number of subjects (percentage).
Table 3
Univariate and multivariate regression analyses to determine independent
correlates of left ventricular systolic function in patients with acute
myocardial infarction
Univariate Multivariate




Age 0.17 0.058 0.025 0.72
Male gender 0.14 0.10 — —
Diabetes mellitus 0.017 0.85 — —
Family history of coronary
artery disease
0.092 0.30 — —
Hypercholesterolemia 0.031 0.73 — —
Hypertension 0.051 0.57 — —
Current or previous smoker 0.005 0.96 — —
Anterior wall acute
myocardial infarction
0.19 0.036 0.16 0.037
Multivessel coronary disease 0.19 0.032 0.94 0.35
Thrombolysis In Myocardial
Infarction flow grade 3
0.15 0.092 0.001 0.99
Symptoms-to-balloon time 0.077 0.38 — —
QRS duration 0.17 0.061 0.079 0.24
ST-segment resolution 0.21 0.015 0.028 0.69
Peak troponin T 0.28 0.001 0.037 0.62
Systolic dyssynchrony index 0.69 0.001 0.52 0.001
Myocardial perfusion index 0.65 0.001 0.28 0.034
The R2 of the model selected at multivariate analysis was 0.52.
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Figure 1. Systolic dyssynchrony index in control subjects (white bars) and acute myocardial infarction (AMI) patients (black bars) (p <0.001).
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Patients with AMI were subdivided into 2 groups according to LV systolic function (LVEF 
≥45%, n = 83; LVEF <45%, n = 46). Clinical and echocardiographic characteristics of these 2 
groups are presented in Table 2. Patients with LVEF <45% had more frequently multivessel 
disease (p = 0.032), less frequently TIMI flow grade 3 after primary PCI (p = 0.049) and higher 
peak troponin T (p = 0.006) compared to patients with LVEF ≥45% (Table 2). 
Regarding LV synchronicity, patients with LVEF <45% had significantly higher SDI (p 
<0.001) compared to patients with LVEF ≥45% (Table 2). Figure 2 shows the impairment of 
Table 2. Clinical and echocardiographic characteristics of patients with acute myocardial infarction in relation to left ventricular systolic function
variable lvef  ≥45% lvef  <45% p-value
(n = 83) (n = 46) 
Age (years) 57±11 60±11 0.090
Male gender 60 (72%) 40 (87%) 0.056
Diabetes 9 (11%) 5 (11%) 1.00
Family history of coronary artery disease 31 (37%) 18 (39%) 0.84
Hypercholesterolemia 12 (15%) 7 (15%) 0.91
Hypertension 35 (42%) 12 (26%) 0.069
Current or previous smoker 47 (57%) 29 (63%) 0.48
Anterior myocardial infarction 34 (41%) 26 (57%) 0.090
Multivessel-disease 24 (29%) 22 (48%) 0.032
TIMI flow 3 74 (89%) 35 (76%) 0.049
Symptoms-to-balloon time (min) 170 (127–215) 184 (150–231) 0.16
QRS duration (ms) 94±13 99±13 0.027
ST-segment resolution (%) 65±31 56±30 0.13
Peak troponin T ( μg/l) 2.69 (1.23–5.39) 4.82 (1.85–1.02) 0.006
LVEDV (ml) 105±25 118±38 0.042
LVESV (ml) 51±14 75±28 <0.001
LVEF (%) 51±5 37±6 <0.001
SDI (%) 4.29±1.44 6.95±2.40 <0.001
MPI 1.19 (1.00–1.38) 1.56 (1.23–1.81) <0.001
Abbreviations as in Table 1. Data are expressed as mean±SD, median (interquartile range), or number of subjects (percentage).
dium chloride solution 50 ml through a 20-gauge intrave-
nous catheter in a proximal forearm vein. Infusion rate was
initially set at 4.0 ml/min and then titrated to achieve optimal
myocardial enhancement without attenuation artifacts.13 Machine
settings were optimized to obtain the best possible myocar-
dial opacification with minimal attenuation. At least 15
cardiac cycles after high mechanical index (1.7) micro-
bubble destruction14 were stored in cine-loop format.
Analysis of myocardial contrast echocardiograms was
performed off-line using EchoPAC 7.0.0 (GE Healthcare).
To evaluate myocardial perfusion, the left ventricle was
divided according to the 16-segment model of the American
Society of Echocardiography.15 A semiquantitative scoring
system was used to assess contrast intensity after micro-
Figure 1. SDI in control subjects (white bar) and patients with AMI (black
bar) (p 0.001).
Figure 2. SDI in patients with AMI in relation to LV systolic function, namely
LVEF 45% (white bar) and LVEF 45% (black bar) (p 0.001).
Table 2
Clinical and echocardiographic characteristics of patients with acute
myocardial infarction in relation to left ventricular systolic function
Variable LVEF 45% LVEF 45% p Value
(n  83) (n  46)
Age (years) 57  11 60  11 0.090
Men 60 (72%) 40 (87%) 0.056
Diabetes mellitus 9 (11%) 5 (11%) 1.00
Family history of
coronary artery disease
31 (37%) 18 (39%) 0.84
Hypercholesterolemia 12 (15%) 7 (15%) 0.91
Hypertension 35 (42%) 12 (26%) 0.069
Current or previous
smoker
47 (57%) 29 (63%) 0.48
Anterior wall acute
myocardial infarction
34 (41%) 26 (57%) 0.090
Multivessel coronary
disease




74 (89%) 35 (76%) 0.049
Symptoms-to-balloon
time (minutes)
170 (127–215) 184 (150–231) 0.16
QRS duration (ms) 94  13 99  13 0.027
ST-segment resolution (%) 65  31 56  30 0.13
Peak troponin T (g/l) 2.69 (1.23–5.39) 4.82 (1.85–11.02) 0.006
Left ventricular end-
diastolic volume (ml)
105  25 118  38 0.042
Left ventricular end-
systolic volume (ml)
51  14 75  28 0.001
Left ventricular ejection
fraction (%)
51  5 37  6 0.001
Systolic dyssynchrony
index (%)
4.29  1.44 6.95  2.40 0.001
Myocardial perfusion
index
1.19 (1.00–1.38) 1.56 (1.23–1.81) 0.001
Data are expressed as mean  SD, median (interquartile range), or
number of subjects (percentage).
Table 3
Univariate and multivariate regression analyses to determine independent
correlates of left ventricular systolic function in patients with acute
myocardial infarction
Univariate Multivariate




Age 0.17 0.058 0.025 0.72
Male gender 0.14 0.10 — —
Diabetes mellitus 0.017 0.85 — —
Family history of coronary
artery disease
0.092 0.30 — —
Hypercholesterolemia 0.031 0.73 — —
Hypertension 0.051 0.57 — —
Current or previous smoker 0.005 0.96 — —
Anterior wall acute
myocardial infarction
0.19 0.036 0.16 0.037
Multivessel coronary disease 0.19 0.032 0.94 0.35
Thrombolysis In Myocardial
Infarction flow grade 3
0.15 0.092 0.001 0.99
Symptoms-to-balloon time 0.077 0.38 — —
QRS duration 0.17 0.061 0.079 0.24
ST-segment resolution 0.21 0.015 0.028 0.69
Peak troponin T 0.28 0.001 0.037 0.62
Systolic dyssynchrony index 0.69 0.001 0.52 0.001
Myocardial perfusion index 0.65 0.001 0.28 0.034
The R2 of the model selected at multivariate analysis was 0.52.
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Figure 2. Systolic dyssynchrony index in patients with AMI in relation to LV systolic function, namely LVEF ≥45% (white bars) and LVEF <45% 
(black bars) (p <0.001).
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LV synchronicity in patients with AMI and LVEF <45% compared to those with LVEF ≥45%. 
Indeed, a significant relation (r = 0.69, p <0.001) was noted between LVEF and SDI.
Table 3 shows the results of the univariate and multivariate linear regression analysis per-
formed to determine the factors related to LV systolic function. At univariate analysis, several 
variables were significantly related to LVEF. However, at multivariate analysis, only anterior 
location of AMI (beta -0.16, p = 0.037), SDI (beta -0.52, p <0.001), and myocardial perfusion 
index (beta -0.28, p = 0.034) were independent factors associated with LVEF. Adding SDI to 
the multivariate model significantly increased R2 from 0.45 to 0.52 (F change 16.9, p <0.001).
Figure 3 shows an example of a patient with severe impairment of LV systolic function and 
synchronicity after AMI.
dIscussIon
The results of the present study show that LV synchronicity (assessed by RT3DE) is significantly 
impaired soon after AMI. The severity of this impairment is related to LV systolic function. In 
addition, the impact of SDI on LV systolic function was incremental to infarct size and anterior 
location of AMI.
The presence and clinical relevance of LV dyssynchrony in the setting of chronic heart failure 
has been extensively investigated in the previous decade; in this group of patients, loss of LV 
Table 3. Univariate and multivariate linear regression analyses to determine the independent correlates of left ventricular systolic function in 
patients with acute myocardial infarction.
univariate multivariate
β p-value β p-value
Age -0.17 0.058 0.025 0.72
Male gender -0.14 0.10 - -
Diabetes 0.017 0.85 - -
Family history of coronary artery disease 0.092 0.30 - -
Hypercholesterolemia -0.031 0.73 - -
Hypertension 0.051 0.57 - -
Current or previous smoker -0.005 0.96 - -
Anterior myocardial infarction -019 0.036 -0.16 0.037
Multi-vessel disease -0.19 0.032 -0.94 0.35
TIMI flow 0.15 0.092 0.001 0.99
Symptoms-to-balloon time -0.077 0.38 - -
QRS duration -0.17 0.061 -0.0079 0.24
ST-segment resolution 0.21 0.015 0.028 0.69
Peak troponin T -0.28 0.001 0.037 0.62
SDI -0.69 <0.001 -0.52 <0.001
MPI -0.65 <0.001 -0.28 0.034
The R2 of the model selected at multivariate analysis was 0.52.
Abbreviations as in Table 1.
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synchronous contraction is related to impaired LV systolic function and poor hemodynamic 
status and is a predictor of worse outcome 4–8. In addition, restoration of LV synchronicity, by 
cardiac resynchronization therapy, has been shown to reverse LV remodeling and to improve 
LV function and prognosis 17–19.
More recently, LV dyssynchrony has been described to occur also in patients with AMI 
1–3,20. However, the clinical meaning of this phenomenon has not been yet fully elucidated. 
In particular, it is unclear whether the presence of LV dyssynchrony after AMI independently 
influences LV function in these patients. Moreover, the detrimental effect of LV dyssynchrony 
in addition to other variables (e.g., infarct size and anterior location of AMI) on LV systolic 
function remains unknown.
In the present study, RT3DE was used to assess LV systolic function and LV synchronicity 
after AMI. This approach has been documented to provide highly accurate measurements 
of LVEF21; in addition, it is more robust than tissue Doppler echocardiography for the evalu-
ation of LV dyssynchrony, being more reproducible and more consistent in differentiating 
healthy subjects from those affected by LV dyssynchrony 22. Moreover, myocardial contrast 
Figure 3. Example of a patient showing severe impairment of LV systolic function (LVEF 22%) and synchronicity (SDI 11.3%) after AMI.
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echocardiography was used to obtain information about myocardial perfusion abnormalities 
after AMI and, hence, infarct size 23.
In line with previous observations 1, impairment of LV synchronicity (expressed as SDI) was 
observed in patients with AMI compared to control subjects. In addition, LV dyssynchrony 
was significantly associated to LV systolic function. Importantly, this relation remained af-
ter adjustment for infarct size and anterior location of AMI, being incremental over these 
variables in determining LVEF. LV dyssynchrony results in a non-homogenous distribution of 
myocardial load and deformation and thus increases myocardial energy demand 24; this may 
negatively influence the contractility of residual viable myocardium, thus further impairing 
LV function. The results of the present study suggest that LV dyssynchrony soon after AMI has 
an additional detrimental impact on LV performance, beyond the infarct size itself; moreover, 
it may potentially contribute to the vicious circle of progression of LV dysfunction 2. In this 
perspective, therapeutic approaches aiming to recover a more synchronous LV contraction 
(e.g., with cardiac resynchronization therapy) may be beneficial and improve LV systolic func-
tion, thus preventing LV remodeling. However, further studies are needed to support this 
hypothesis.
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Reduced left ventricular torsion early 
after myocardial infarction is related to 
left ventricular remodeling
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objectives: Left ventricular (LV) torsion is emerging as a sensitive parameter of LV 
systolic myocardial performance. The aim of the present study was to explore the 
effects of acute myocardial infarction (AMI) on LV torsion, and to determine the 
value of LV torsion early after AMI in predicting LV remodeling at 6-month follow-up.
methods: A total of 120 patients with a first ST-elevation AMI (59±10 years, 73% 
male) were included. All patients underwent primary percutaneous coronary inter-
vention. After 48 hours, speckle tracking echocardiography was performed to assess 
LV torsion; infarct size was assessed by myocardial contrast echocardiography. At 
6-month follow-up, LV volumes and LV ejection fraction were reassessed, in order 
to identity patients who developed LV remodeling (defined as ≥15% increase in LV 
end-systolic volume).
results: As compared to control subjects, peak LV torsion in AMI patients was 
significantly impaired (1.54±0.64°/cm vs 2.07±0.27°/cm; p <0.001). At multivariate 
linear regression analysis, only LV ejection fraction (β = 0.36, p <0.001) and infarct 
size (β = -0.47, p <0.001), were independently associated with peak LV torsion. At 
6-month follow-up, 19 patients showed LV remodeling. At multivariate logistic 
regression analysis, only peak LV torsion (OR = 0.77; 95% CI 0.65-0.92; p = 0.003) and 
infarct size (OR = 1.04; 95% CI, 1.01–1.07; p = 0.021) were independently related to LV 
remodeling. Peak LV torsion provided modest but significant incremental value over 
clinical, echocardiographic, and myocardial contrast echocardiography variables in 
predicting LV remodeling. By receiver-operating characteristic curve analysis, peak 
LV torsion ≤1.44º/cm provided the highest sensitivity (95%) and specificity (77%) to 
predict LV remodeling.
conclusions: LV torsion is significantly impaired early after AMI. The amount of 
impairment of LV torsion predicts LV remodeling at 6-month follow-up.
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IntroductIon
Remodeling of the left ventricle (LV) after acute myocardial infarction (AMI) is associated to 
the development of heart failure and to poor survival rate 1,2. Accordingly, identification of 
patients prone to develop post-infarction LV remodeling represents an important issue in 
clinical cardiology. These considerations have stimulated the research of new parameters 
able to provide a quantitative and objective estimation of the myocardial damage post-AMI 
and to identify the patients at risk of LV remodeling 3.
The systolic twisting motion of the LV along its longitudinal axis, resulting from the op-
posite rotation of the LV apex compared to the base, is emerging as an important, sensitive 
parameter of LV systolic function 4. Recently, echocardiographic assessment of LV rotational 
mechanics based on speckle-tracking analysis has been introduced and validated against so-
nomicrometry and magnetic resonance imaging 5,6. In the clinical setting however, not much 
data on changes in LV torsion after AMI are available 7,8, and no specific data exist concerning 
the role of LV torsion in predicting post-infarction LV remodeling.
Accordingly, the aim of the present evaluation was twofold. First, we sought to determine 
the correlates of LV torsion after AMI, and second, we aimed to explore the relation between 
LV torsion and the development of LV remodeling at 6-month follow-up.
methods
patient population and data collection
The population consisted of 146 consecutive patients admitted to the coronary care unit 
because of a first ST-segment elevation AMI. The diagnosis of AMI was made on the basis of 
typical ECG changes and/or ischemic chest pain associated with elevation of cardiac biomark-
ers 9. All patients underwent immediate coronary angiography and primary percutaneous 
coronary intervention (PCI). The infarct-related artery was identified by the site of coronary 
occlusion during coronary angiography and ECG criteria. During PCI, final TIMI (Thrombolysis 
In Myocardial Infarction) flow was assessed.
Clinical evaluation included 2-dimensional echocardiography with speckle-tracking analy-
sis to assess LV global longitudinal strain and torsion, and myocardial contrast echocardiog-
raphy (MCE) was performed 48 hours after PCI to assess the extent of perfusion abnormalities 
and infarct size. At 6-month follow-up, 2-dimensional echocardiography was performed to 
re-assess LV volumes and LV ejection fraction (EF). These echocardiographic examinations are 
part of the routine, comprehensive assessment of AMI patients in our clinics.
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In addition, 20 subjects without evidence of structural heart disease and without known 
risk factors for coronary artery disease, matched for age, gender and body surface area, who 
underwent 2-dimensional echocardiography, were included as a normal control group. These 
individuals were derived from the echo database and were clinically referred for echocardio-
graphic evaluation because of atypical chest pain, palpitations or syncope without murmur.
To determine the reduction in LV torsion after AMI, the patient data were compared with 
the data from the normal controls. In addition, the independent correlates of LV torsion after 
AMI were investigated and the role of LV torsion in predicting LV remodeling (defined as 
≥15% increase in LV end-systolic volume [ESV]) at 6-month follow-up was assessed 1,10.
two-dimensional echocardiography
All AMI patients and control subjects were imaged in left lateral decubitus position with a 
commercially available system (Vivid 7 Dimension, GE Healthcare, Horten, Norway) equipped 
with a 3.5-MHz transducer. Standard 2-dimensional images and Doppler and color-Doppler 
data were acquired from the parasternal and apical views (4-, 2- and 3-chamber) and digitally 
stored in cine-loop format; analyses were subsequently performed offline using EchoPAC 
version 7.0.0 (GE Healthcare, Horten, Norway). LV end-diastolic volume (EDV) and LVESV were 
measured according to the Simpson’s biplane method and LVEF was calculated as [(EDV-
ESV)/EDV] x100 11.
Qualitative assessment of regional wall motion was performed according to the 16-seg-
ment model of the American Society of Echocardiography and the global wall motion score 
index (WMSI) was calculated for each patient 11. As previously described 12, transmitral and 
pulmonary vein pulsed-wave Doppler tracings were used to classify diastolic function as 1) 
normal; 2) diastolic dysfunction grade 1 (mild); 3) diastolic dysfunction grade 2 (moderate); 4) 
diastolic dysfunction grade 3 (severe); 5) diastolic dysfunction grade 4 (severe).
speckle-tracking analysis
Longitudinal strain analysis
Longitudinal strain analysis of the LV was performed by speckle-tracking imaging (EchoPAC 
version 7.0.0). Gray-scale 2D apical images of the LV (4-, 2-, and 3-chamber views) were used 
with a frame rate ranging from 60 to 100 frames per second. From an end-systolic frame, 
the endocardial border was manually traced, and the software automatically traces 2 more 
concentric regions of interest (ROIs) to include the entire myocardial wall. Speckle-tracking 
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analysis detects and tracks the unique myocardial ultrasound patterns frame by frame. The 
in-plane frame-to-frame displacement of each pattern over time is used to derive strain. The 
software automatically validates the segmental tracking throughout the cardiac cycle and 
allows the operator further adjustment of the ROI to improve tracking quality. As previously 
described 13, GLS was calculated, as an index of global LV systolic function, by averaging the 
GLSs obtained automatically from each apical view.
Torsional mechanics analysis
Speckle tracking analysis was applied to evaluate LV basal and apical rotations, LV twist and 
LV torsion. Parasternal short-axis images of the LV were acquired at 2 different levels: 1) basal 
level, identified by the mitral valve and 2) apical level, as the smallest cavity achievable distally 
to the papillary muscles (moving the probe down and slightly laterally, if needed). Frame rate 
was 60-100 frames/s and 3 cardiac cycles for each short-axis level were stored in cine-loop 
format for the offline analysis (EchoPAC version 7.0.0). The endocardial border was traced at an 
end-systolic frame and the ROI was chosen to fit the whole myocardium. The software allows 
the operator to check and validate the tracking quality and to adjust the endocardial border 
or modify the width of the ROI, if needed. Each short-axis image was automatically divided 
into 6 standard segments: septal, anteroseptal, anterior, lateral, posterior, and inferior. The 
software calculated LV rotation from the apical and basal short-axis images as the average 
angular displacement of the 6 standard segments referring to the ventricular centroid, frame 
by frame. Counterclockwise rotation was marked as positive value and clockwise rotation as 
negative value when viewed from the LV apex. LV twist was defined as the net difference (in 
degrees) of apical and basal rotation at isochronal time points. LV torsion as then calculated 
as the ratio between LV twist (in degrees) and the LV diastolic longitudinal length (in cm) 
between the LV apex and the mitral plane 14.
Twenty patients were randomly selected for the assessment of reproducibility of peak LV 
twist. Bland-Altman analysis was performed to evaluate the intra- and inter-observer agree-
ment repeating the analysis 1 month later by the same observer and by a second indepen-
dent observer. The intra-observer agreement was excellent. According to the Bland-Altman 
analysis, the mean difference±2 standard deviations (SD) for peak LV twist was 0.05±0.35º. 
The inter-observer agreement was also good. According to the Bland-Altman analysis, the 
mean difference±2 SD for peak LV twist was 0.16±1.50º.




Immediately following 2-dimensional echocardiography, MCE was performed to evaluate 
myocardial perfusion, in order to assess infarct size after AMI. The same ultrasound system 
was used and the 3 standard apical views were acquired using a low-power technique (0.1-
0.26 mechanical index). Background gains were set so that minimal tissue signal was seen, 
and the focus was set at the level of the mitral valve. Luminity® (Bristol-Myers Squibb Pharma, 
Brussels, Belgium) was used as contrast agent. Each patient received an infusion of 1.3 mL of 
echo contrast diluted in 50 mL of 0.9% NaCl solution through a 20 gauge intravenous catheter 
in a proximal forearm vein. Infusion rate was initially set at 4.0 mL/min and then titrated to 
achieve optimal myocardial enhancement without attenuation artifacts 15. Machine settings 
were optimized to obtain the best possible myocardial opacification with minimal attenua-
tion. At least 15 cardiac cycles after high mechanical index (1.7) microbubble destruction 16 
were stored in cine-loop format for the offline analysis (EchoPAC version 7.0.0). The LV was 
divided according to a standard 16-segment model and a semiquantitative scoring system 
was used to assess contrast intensity after microbubble destruction: 1) normal/homogenous 
opacification; 2) reduced/patchy opacification; 3) minimal or absent contrast opacification 
11,16. A myocardial perfusion index (MPI), indicating the extent of infarct size, was derived by 
adding contrast scores of all segments and dividing by the total number of segment 16.
Twenty patients were randomly selected for the assessment of reproducibility of perfu-
sion scoring. Weighted Kappa test was performed to evaluate the intra- and inter-observer 
agreement repeating the analysis 1 month later by the same observer and by a second inde-
pendent observer. Both intra- and inter-observer agreements were good (weighted Kappa = 
0.86 and = 0.84, respectively).
statistical analysis
Continues variables are expressed as mean±SD, when normally distributed, and as median 
and interquartile range, when not normally distributed. Categorical data are presented as 
absolute numbers and percentages. Differences in continuous variables between 2 groups 
were assessed using the Student t test or the Mann-Whitney U test, if appropriate. Chi-square 
test or Fisher exact test, where appropriate, were computed to assess differences in categori-
cal variables.
Differences in continuous variables between >2 groups were assessed by 1-way ANOVA or 
Kruskal-Wallis test, where appropriate; when the result of the analysis was significant, a post 
hoc test with Bonferroni’s correction was applied.
Univariate and multivariate linear regression analysis (with an automatic stepwise selec-
tion procedure with backward elimination) were performed to evaluate the relationship be-
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tween peak LV torsion among AMI patients and the following clinical and echocardiographic 
variables: age, gender, infarct location (anterior vs. non-anterior), multi-vessel disease, TIMI 
flow grade 3 after PCI, peak troponin T, LVEDV, LVESV, LVEF, WMSI, presence of diastolic 
dysfunction, peak LV GLS and MPI. Age and sex were entered into the multivariate model 
independently of their probability value by univariate analysis and were kept fixed through-
out the stepwise selection procedure. Regarding the remaining variables, only those with a 
probability value <0.20 by univariate analysis were entered as covariates in the multivariate 
model. Linear-regression analyses were performed to evaluate the relation between peak 
LV torsion at baseline and LVESV at 6-month follow-up, as well as the change in LVESV after 
6-month follow-up compared with the baseline value.
Univariate and multivariate logistic regression analysis (with an automatic stepwise selec-
tion procedure with backward elimination) were performed to evaluate the relationship 
between the occurrence of LV remodeling at 6-month follow-up and the following baseline 
clinical and echocardiographic variables: age, gender, infarct location (anterior vs. non-
anterior), multi-vessel disease, TIMI flow grade 3 after PCI, peak troponin T, LVEDV, LVESV, 
LVEF, WMSI, presence of diastolic dysfunction, peak LV GLS, MPI and peak LV torsion. Age, 
gender, and LVESV were entered into the multivariate model independently of their prob-
ability value by univariate analysis and were kept fixed throughout the stepwise selection 
procedure. Regarding the remaining variables, only those with a probability value <0.20 by 
univariate analysis were entered as covariates in the multivariate model. The incremental 
predictive value of peak LV torsion over clinical, echocardiographic, and MCE variables was 
assessed by calculating the global chi-square values.
Receiver operator characteristic curve analysis was performed to determine the accuracy 
of baseline peak LV torsion to predict LV remodeling at 6-month follow-up in the overall 
patient population and among anterior and non-anterior AMI patients. A p-value <0.05 was 
considered statistically significant. Statistical analysis was performed using the SPSS software 
package (SPSS 15.0, Chicago, Illinois).
results
Reliable speckle-tracking curves for rotation analysis and diagnostic MCE data were obtained 
in 120 patients; consequently, 26 patients were excluded from further analysis. Of note, no 
significant difference was observed between included and excluded patients with regard 
to age (59±10 versus 57±10 years, p = 0.31), male sex (87 [73%] versus 17 [65%], p = 0.47), 
anterior location of AMI (55 [46%] vsus 13 [50%], p = ), and peak value of troponin T 3.04 
μg/L [1.65 to 7.03] versus 3.18 μg/L [1.74 to 12.62], p = 0.58). All control subjects had reliable 
speckle-tracking curves.
Nina Book.indb   251 26-09-11   12:04
Chapter 14
252
clinical and echocardiographic characteristics
Clinical and echocardiographic characteristics of control subjects and AMI patients are listed 
in Table 1. By definition, control subjects and AMI patients did not differ in age or gender. 
Among AMI patients, the infarct-related artery was the left anterior descending coronary 
artery in 55 (46%) patients and obstructive multi-vessel disease (i.e. more than 1 vessel with a 
luminal narrowing ≥70%) was present in 41 (34%) patients. The peak value of troponin T was 
3.04 (1.65-7.03 µg/l). The mean LVEF was 48±9%.






Age (years) 56±10 59±10 0.37
Male gender 15 (75%) 87 (73%) 0.82
Diabetes - 13 (11%)
Family history of coronary artery disease - 45 (37%)
Hypercholesterolemia - 16 (13%)
Hypertension - 43 (36%)
Current or previous smoking - 67 (56%)
Anterior myocardial infarction - 55 (46%)
Infarct-related artery
- left anterior descending coronary artery
- left circumflex coronary artery







Multi-vessel disease - 41 (34%)
TIMI flow grade 3 - 101 (84%)
Peak troponin T (µg/l) - 3.04 (1.65-7.03)
LVEDV (ml) 103±22 104±27 0.91
LVESV (ml) 40±10 55±21 <0.001
LVEF (%) 61±7 48±9 <0.001
















Peak LV GLS (%)
Peak LV basal rotation (˚)
Peak LV apical rotation (˚)
Peak LV twist (˚)
















MPI - 1.28 (1.08-1.50)
EF: ejection fraction; EDV: end-diastolic volume; ESV: end-systolic volume; GLS: global longitudinal strain; LV: left ventricular; MPI: myocardial 
perfusion index; WMSI: wall motion score index
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Figure 1. Left ventricular (LV) rotational mechanics curves of a control subject (panel A) and of a patient with anterior acute myocardial 
infarction (panel B). Panel A. Speckle-tracking analysis shows normal peak LV basal and apical rotations and consequently normal peak LV twist 
(18.4˚; white line). Panel B. Speckle-tracking analysis shows impaired peak LV basal and apical rotations and consequently reduced peak LV 
twist (6.8˚; white line).
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Compared to control subjects, AMI patients had significantly reduced peak LV basal rota-
tion (-5.1±2.7˚ vs. -6.8±2.7˚, p = 0.013), reduced peak LV apical rotation (8.4±4.6˚ vs. 11.6±2.8˚, 
p <0.001), and consequently decreased peak LV twist (12.7±5.2˚ vs. 17.7±2.1˚, p <0.001) and 
peak LV torsion (1.54±0.64°/cm versus 2.07±0.27°/cm,p <0.001). Among AMI patients, those 
with an anterior AMI had significantly lower peak LV apical rotation, LV twist, and LV torsion 
compared with the remaining AMI patients (6.5±4.3° versus 10.1±4.2°, p <0.001; 11.1±5.4° 
versus 14.0±4.7°, p = 0.002; and 1.35±0.65°/cm versus 1.70±0.58°/cm, p = 0.003, respectively), 
whereas peak LV basal rotation was not different (-5.4±2.6° versus -4.9±2.8°, p = 0.31). Of note, 
no significant difference was observed in peak LV basal rotation, apical rotation, LV twist, 
and LV torsion between patients (n = 37) with anterior AMI due to proximal LAD occlusion 
versus patients (n = 18) with anterior AMI due to mid or distal LAD occlusion (-5.2±2.5° versus 
-5.8±2.7°, p = 0.38; 6.9±4.3° versus 5.6±4.2°, p = 0.30; 11.4±5.2° versus 10.7±5.8°, p = 0.67; 
and 1.36±0.63°/cm versus 1.35±0.72°/cm, p = 0.95, respectively). Examples of LV rotational 
mechanics curves obtained by speckle-tracking analysis in a control subject and in a patient 
with AMI are shown in Figure 1.
determinants of lv twist among amI patients
Table 2 shows the results of the univariate and multivariate linear regression analyses per-
formed to determine the factors related to peak LV torsion among AMI patients. By univariate 
analysis, several variables were significantly related to peak LV torsion: anterior AMI, TIMI flow 
grade 3 after PCI, peak troponin T, LVEDV, LVESV, LVEF, WMSI, presence of diastolic dysfunc-
table 2. Univariate and multivariate linear regression analyses to determine the independent correlates of peak LV torsion in AMI patients.
univariate multivariate
β p-value β p-value
Age -0.080 0.38 0.057 0.37
Male gender  -0.048 0.61 -0.046 0.46
Anterior myocardial infarction -0.27 0.003 - -
Multi-vessel disease -0.13 0.17 - -
TIMI flow grade 3 0.25 0.005 - -
Peak troponin T -0.40 <0.001 - -
LVEDV -0.25 0.007 - -
LVESV -0.51 <0.001 - -
LVEF 0.65 <0.001 0.36 <0.001
WMSI -0.66 <0.001 - -
Presence of diastolic dysfunction -0.23 0.011 - -
Peak LV GLS -0.56 <0.001 - -
MPI -0.69 <0.001 -0.47 <0.001
Abbreviations as in Table 1.
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tion, peak LV GLS and MPI. However, by multivariate analysis, only LVEF (β = 0.36, p <0.001) 
and MPI (β = -0.47, p <0.001) were independently associated with peak LV torsion.
The relationships between peak LV torsion and MPI is shown in Figure 2. Patients without 
myocardial segments with minimal or absent contrast opacification had higher peak LV tor-
sion compared with patients with ≥1 myocardial segment with minimal or absent contrast 
opacification (1.84±0.49°/cm versus 1.27±0.63°/cm; p <0.001). In addition, a progressive 
reduction of peak LV torsion with increasing number of myocardial segments with minimal 
or absent contrast opacification was observed (Figure 3).
the LV diastolic longitudinal length (in cm) between the LV apex
and the mitral plane.14
Twenty patients were randomly selected to assess the reproduc-
ibility of peak LV twist. Bland-Altman analysis was performed to
evaluate intraobserver and interobserver agreement by repeating the
analysis 1 month later by the same observer and by a second
independent observer. Intraobserver agreement was excellent. Ac-
cording to Bland-Altman analysis, the mean difference 2 SD for
peak LV twist was 0.050.35°. Interobserver agreement was also
good. According to Bland-Altman analysis, the mean difference 2
SD for peak LV twist was 0.161.50°.
Myocardial Contrast Echocardiography
Immediately after 2D echocardiography, MCE was performed to
evaluate myocardial perfusion to assess infarct size after AMI. The
same ultrasound system was used, and the 3 standard apical views
were acquired with a low-power technique (mechanical index of 0.1
to 0.26). Background gains were set so that minimal tissue signal was
seen, and the focus was set at the level of the mitral valve. Luminity
(Perflutren, Bristol-Myers Squibb Pharma, Brussels, Belgium) was
used as the contrast agent. Each patient received an infusion of 1.3
mL of echo contrast diluted in 50 mL of 0.9% NaCl solution through
a 20-gauge intravenous catheter in a proximal forearm vein. Infusion
rate was initially set at 4.0 mL/min and then titrated to achieve
optimal myocardial enhancement without attenuation artifacts.15
Machine settings were optimized to obtain the best possible myo-
cardial opacification with minimal attenuation. At least 15 cardiac
cycles after high-mechanical-index (1.7) microbubble destruction
were stored in cine-loop format for offline analysis (EchoPAC
version 7.0.0).16 The LV was divided according to a standard
16-segment model, and a semiquantitative scoring system was used
to assess contrast intensity after microbubble destruction: (1) normal/
homogenous opacification, (2) reduced/patchy opacification, or (3)
minimal or absent contrast opacification.11,16 Minimal or absent
contrast opacification identifies myocardial segments with a 50%
transmural extent of infarction with high accuracy, as previously
demonstrated by Janardhanan et al.17 A myocardial perfusion index
(MPI), indicating the extent of infarct size, was derived by adding
contrast scores of all segments and dividing by the total number of
segments.16
Twenty patients were randomly selected to assess the reproduc-
ibility of perfusion scoring. A weighted  test was performed to
evaluate intraobserver and interobserver agreement by repeating the
analysis 1 month later by the same observer and by a second
independent observer. Both intraobserver and interobserver agree-
ments were good (weighted 0.86 and0.84, respectively). To
avoid measurements bias, all analyses were performed in blinded
fashion.
Statistical Analysis
Continuous variables are expressed as meanSD, when normally
distributed, and as median and interquartile range, when not nor-
mally distributed. Categorical data are presented as absolute numbers
and percentages.
Differences in continuous variables between 2 groups were
assessed with the Student t test or Mann-Whitney U test, where
appropriate. 2 or Fisher’s exact test, where appropriate, was
computed to assess differences in categorical variables. Differences
in continuous variables between 2 groups were assessed by 1-way
ANOVA or Kruskal-Wallis test, where appropriate; when the result
of the analysis was significant, a post hoc test with Bonferroni’s
correction was applied.
Univariate and multivariate linear-regression analyses (with an
automatic stepwise selection procedure with backward elimination)
were performed to evaluate the relation between peak LV torsion
among AMI patients and the following variables: age, sex, infarct
location (anterior versus nonanterior), multivessel disease, TIMI
flow grade 3 after PCI, peak troponin T value, LVEDV, LVESV,
LVEF, WMSI, presence of diastolic dysfunction, peak LV GLS, and
MPI. Age and sex were entered into the multivariate model inde-
Figure 2. Linear regression analysis illustrating the relation
between peak LV torsion and MPI.
Figure 3. Relation between peak LV torsion and number of
myocardial segments with minimal or absent contrast
opacification.
Table 2. Univariate and Multivariate Linear Regression
Analyses to Determine the Independent Correlates of Peak LV
Torsion in AMI Patients
Univariate Multivariate
 P Value  P Value
Age 0.080 0.38 0.057 0.37
Male 0.048 0.61 0.046 0.46
AMI 0.27 0.003 . . . . . .
Multivessel disease 0.13 0.17 . . . . . .
TIMI flow grade 3 0.25 0.005 . . . . . .
Peak troponin T 0.40 0.001 . . . . . .
LVEDV 0.25 0.007 . . . . . .
LVESV 0.51 0.001 . . . . . .
LVEF 0.65 0.001 0.36 0.001
WMSI 0.66 0.001 . . . . . .
Presence of diastolic dysfunction 0.23 0.011 . . . . . .
Peak LV GLS 0.56 0.001 . . . . . .
MPI 0.69 0.001 0.47 0.001
Abbreviations are as defined in text.
436 Circ Cardiovasc Imaging July 2010
 at Rijksuniversiteit Leiden on March 31, 2011circimaging.ahajournals.orgDownloaded from 
Figure 2. Linear regression analysis illustrating the relation between peak LV torsion and MPI.
the LV diastolic longitudinal length (in cm) between the LV apex
nd the mitral pl ne.14
Tw nty patients w re randomly selected to assess the reproduc-
ibility of peak LV twist. Bland-Altman analysis was performed to
evaluate intraobserver and interobserver agreement by repeating the
analysis 1 month later by the same observer and by a second
independent observer. Intraobserver agreement was excellent. Ac-
cording to Bland-Altman analysis, the mean difference 2 SD for
p ak LV twist was 0.050.35°. Interobserver agreement was also
good. According to Bland-Altman analysis, the mean difference 2
SD for peak LV twist was 0.161.50°.
yocardi l Contrast Echocardiography
Immediately after 2D echocardiography, MCE was performed to
evaluate myocardial perfusion to assess infarct size after AMI. The
same ultrasound system was used, and the 3 standard apical views
were acquired with a low-power technique (mechanical index of 0.1
to 0.26). Background gains were set so that minimal tissue signal was
seen, and the focus was set at the level of the mitral valve. Luminity
(Perflutren, Bristol-Myers Squibb Pharma, Brussels, Belgium) was
used as the contrast agent. Each patient received an infusion of 1.3
mL of echo contrast diluted in 50 mL of 0.9% NaCl solution through
a 20-gauge intravenous catheter in a proximal forearm vein. Infusion
rate was initially set at 4.0 mL/min and then titrated to achieve
optimal myocardial enhancement without attenuation artifacts.15
Machine settings were optimized to obtain the best possible myo-
cardial opacification with minimal attenuation. At least 15 cardiac
cycles after high-mechanical-index (1.7) microbubble destruction
were stored in cine-loop format for offline analysis (EchoPAC
version 7.0.0).16 The LV was divided according to a standard
16-segment model, and a semiquantitative scoring system was used
to assess contrast intensity after microbubble destruction: (1) normal/
homogenous opacification, (2) reduced/patchy opacification, or (3)
minimal or absent contrast opacification.11,16 Minimal or absent
contrast opacification identifies myocardial segments with a 50%
transmural extent of infarction with high accuracy, as previously
demonstrated by Janardhanan et al.17 A myocardial perfusion index
(MPI), indicating the extent of infarct size, was derived by adding
contrast scores of all segments and dividing by the total number of
segments.16
Twenty p tients were randomly selected to assess the reproduc-
ibility of perfusion scoring. A weighted  test was performed to
evaluate intraobserver and interob erver agreement by repeating the
analysis 1 month later by the same observer and by a second
independent observer. Both intraobserver and interobserver agree-
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fashion.
Statistical Analysis
Continuous variables are expressed as meanSD, when normally
distributed, and as median and interquartile range, when not nor-
mally distributed. Categorical data are presented as absolute numbers
and percentages.
Differences in continuous variables between 2 groups were
assessed with the Student t test or Mann-Whitney U test, where
appropriate. 2 or Fisher’s exact test, where appropriate, was
computed to assess differences in categorical variables. Differences
in continuous variables between 2 groups were assessed by 1-way
ANOVA or Kruskal-Wallis test, where appropriate; when the result
of the analysis was significant, a post hoc test with Bonferroni’s
correction was applied.
Univariate and multivariate linear-regression analyses (with an
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Table 2. Univariate and Multivariate Linear Regression
Analyses to Determine the Independent Correlates of Peak LV
Torsion in AMI Patients
Univariate Multivariate
 P Value  P Value
Age 0.080 0.38 0.057 0.37
Male 0.048 0.61 0.046 0.46
AMI 0.27 0.003 . . . . . .
Multivessel disease 0.13 0.17 . . . . . .
TIMI flow grade 3 0.25 0.005 . . . . . .
Peak troponin T 0.40 0.001 . . . . . .
LVEDV 0.25 0.007 . . . . . .
LVESV 0.51 0.001 . . . . . .
LVEF 0.65 0.001 0.36 0.001
WMSI 0.66 0.001 . . . . . .
Presence of diastolic dysfunction 0.23 0.011 . . . . . .
Peak LV GLS 0.56 0.001 . . . . . .
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Figure 3. Relation between peak LV torsion and number of myocardial segments with minimal or absent contrast opacification.
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lv remodeling at 6-month follow-up
A total of 8 out of 120 AMI patients included in the initial population did not complete the 
6-month follow-up; consequently, data at baseline and at 6-month follow-up were available 
for 112 patients. At 6-month follow-up, mean LVEDV was 114±37 ml whereas mean LVESV 
was 54±29 ml with a mean LVEF of 55±10%. A total of 19 patients developed LV remodeling.
Baseline clinical and echocardiographic characteristics of AMI patients with versus without 
LV remodeling are summarized in Table 3. At baseline, patients who developed LV remodel-
ing had larger LVESV (p = 0.036), lower LVEF (p <0.001), and higher MPI (p <0.001), indicating 
larger infarct size. Regarding LV rotational mechanics parameters, at baseline patients with 
LV remodeling had significantly lower peak LV apical rotation (p <0.001) and peak LV twist (p 
<0.001), and peak LV torsion (p <0.001) as compared to patients without LV remodeling; con-






Age (years) 58±10 61±9 0.20
Male gender 66 (71%) 15 (79%) 0.48
Diabetes 9 (10%) 2 (11%) 0.91
Family history of coronary artery disease 36 (39%) 7 (37%) 0.88
Hypercholesterolemia 13 (14%) 2 (11%) 0.74
Hypertension 34 (37%) 6 (32%) 0.68
Current or previous smoking 54 (58%) 9 (47%) 0.39
Anterior myocardial infarction 35 (38%) 13 (68%) 0.013
Multi-vessel disease 29 (31%) 9 (47%) 0.18
TIMI flow grade 3 81 (87%) 14 (74%) 0.16
Peak troponin T (µg/l) 2.54 (1.29-5.25) 9.63 (4.96-12.51) <0.001
LVEDV (ml) 101±23 106±34 0.59
LVESV (ml) 51±15 63±24 0.036
LVEF (%) 50±8 40±8 <0.001
LV diastolic longitudinal length (cm) 8.2±0.7 8.3±0.6 0.76
WMSI 1.63±0.30 2.05±0.21 <0.001
Presence of diastolic dysfunction 52 (56%) 16 (84%) 0.021
MPI 1.19 (1.00-1.41) 1.75 (1.38-1.81) <0.001
Peak LV GLS (%)
Peak LV basal rotation (˚)
Peak LV apical rotation (˚)
Peak LV twist (˚)
















Medical therapy at discharge
Antiplatelet agents
Angiotensin-convertin enzyme inhibitors   















Abbreviations as in Table 1.
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versely, no difference in peak LV basal rotation was observed between the 2 groups. Patients 
with more impaired peak LV torsion at baseline had larger LVESV at 6-month follow-up and a 
higher change in LVESV in the 6-month follow-up period (Figure 4).
Table 4 shows the results of the univariate and multivariate logistic regression analysis per-
formed to determine the relationship between clinical and echocardiographic characteristics 
at baseline and LV remodeling at 6-month follow-up. By univariate analysis, several variables 
were significantly related to LV remodeling: anterior AMI, peak troponin T, LVESV, LVEF, WMSI, 
presence of diastolic dysfunction, peak LV GLS, MPI and peak LV torsion. However, by mul-
tivariate analysis, only peak LV torsion (OR = 0.77; 95% CI 0.65-0.92; p = 0.003) and MPI (OR 
= 1.04, 95% CI, 1.01-1.07; p = 0.021) were independently related to the development of LV 
remodeling. Furthermore, peak LV torsion provided modest but significant incremental value 
over clinical, echocardiographic, and MCE variables in predicting LV remodeling (Figure 5).
By recever-operator-characteristics curve analysis (Figure 6), peak LV torsion ≤1.44°/cm 
provided the highest sensitivity (95%) and specificity (77%) to predict LV remodeling; diag-
nostic accuracy was high in both anterior and non-anterior AMI patients (Figure 6).
P0.58). All control subjects had reliable speckle-tracking
curves.
Clinical and Echocardiographic Characteristics
Clinical and echocardiographic characteristics of control
subjects and AMI patients are listed in Table 1. By definition,
control subjects and AMI patients did not differ in age or sex.
Among AMI patients, the infarct-related artery was the left
anterior descending coronary artery in 55 (46%) patients;
obstructive multivessel disease (ie, 1 vessel with a luminal
narrowing 70%) was present in 41 (34%) patients. Peak
value of troponin T was 3.04 g/L (1.65 to 7.03 g/L). Mean
LVEF was 489%.
Compared with control subjects, AMI patients had signif-
icantly reduced peak LV basal rotation (5.12.7° versus
6.82.7°, P0.013), reduced peak LV apical rotation
(8.44.6° versus 11.62.8°, P0.001), and consequently
decreased peak LV twist (12.75.2° versus 17.72.1°,
P0.001) and peak LV torsion (1.540.64°/cm versus
2.070.27°/cm, P0.001). Among AMI patients, those with
an anterior AMI had significantly lower peak LV apical
rotation, LV twist, and LV torsion compared with the
remaining AMI patients (6.54.3° versus 10.14.2°,
P0.001; 11.15.4° versus 14.04.7°, P0.002; and
1.350.65°/cm versus 1.700.58°/cm, P0.003, respec-
tively), whereas peak LV basal rotation was not different
(5.42.6° versus 4.92.8°, P0.31). Of note, no
significant difference was observed in peak LV basal
rotation, apical rotation, LV twist, and LV torsion between
patients (n37) with anterior AMI due to proximal LAD
occlusion versus patients (n18) with anterior AMI due to
mid or distal LAD occlusion (5.22.5° versus
5.82.7°, P0.38; 6.94.3° versus 5.64.2°, P0.30;
11.45.2° versus 10.75.8°, P0.67; and 1.360.63°/cm
versus 1.350.72°/cm, P0.95, respectively). Examples
of LV rotational mechanics curves obtained by speckle-
tracking analysis in a control subject and in a patient with
AMI are shown in Figure 1.
Determinants of LV Torsion Among AMI Patients
Table 2 shows the results of univariate and multivariate linear
regression analyses performed to determine the factors re-
lated to peak LV torsion among AMI patients. By univariate
analysis, several variables were significantly related to peak
LV torsion: anterior AMI, TIMI flow grade 3 after PCI, peak
troponin T value, LVEDV, LVESV, LVEF, WMSI, presence
of diastolic dysfunction, peak LV GLS, and MPI. However,
by multivariate analysis, only LVEF (0.36, P0.001) and
MPI (-0.47, P0.001) were independently associated
with peak LV torsion. The relation between peak LV torsion
and MPI is shown in Figure 2.
Patients without myocardial segments with minimal or
absent contrast opacification had higher peak LV torsion
compared with patients with 1 myocardial segment with
minimal or absent contrast opacification (1.840.49°/cm
versus 1.270.63°/cm; P0.001). In addition, a progressive
reduction of peak LV torsion with increasing number of
Figure 4. Relation between peak LV torsion at baseline and
LVESV at 6-month follow-up (A) and the change in LVESV after
6-month follow-up compared with baseline value (B).
Table 4. Univariate and Multivariate Logistic-Regression
Analyses to Determine the Independent Predictors of LV










Age 1.03 (0.98–1.09) 0.20 1.00 (0.93–1.08) 0.94
Male 1.53 (0.47–5.04) 0.48 3.62 (0.66–19.8) 0.14
AMI 3.59 (1.25–10.3) 0.017 . . . . . .
Multivessel disease 1.99 (0.73–5.40) 0.18 . . . . . .
TIMI flow grade 3 0.42 (0.13–1.36) 0.15 . . . . . .
Peak troponin T 1.23 (1.11–1.36) 0.001 . . . . . .
LVEDV 1.01 (0.99–1.03) 0.47
LVESV 1.04 (1.01–1.07) 0.006 0.99 (0.94–1.04) 0.77
LVEF 0.85 (0.78–0.92) 0.001 . . . . . .
WMSI* 1.73 (1.34–2.24) 0.001 . . . . . .
Presence of
diastolic dysfunction
4.21 (1.15–15.4) 0.030 . . . . . .
Peak LV GLS 1.43 (1.19–1.71) 0.001 . . . . . .
Peak LV torsion* 0.72 (0.62–0.82) 0.001 0.77 (0.65–0.92) 0.003
MPI* 1.79 (1.39–2.31) 0.001 1.04 (1.01–1.07) 0.021
Abbreviations are as defined in text. OR indicates odds ratio.
C-statistic0.93
*OR and 95% CI are intended for a 0.1-unit increase.
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Figure 4. Relation between peak LV torsion at baseline and LVESV at 6-month follow-up (A) and the change in LVESV after 6-month follow-up 
compared with baseline value (B).
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myocardial segments with minimal or absent contrast opaci-
fication was observed (Figure 3).
LV Remodeling at 6-Month Follow-Up
Eight of 120 AMI patients included in the initial population
did not complete the 6-month follow-up; consequently, data
at baseline and at 6-month follow-up were available for 112
patients. At 6-month follow-up, mean LVEDV was 11437
mL, whereas mean LVESV was 5429 mL and mean LVEF
was 5510%. A total of 19 patients developed LV
remodeling.
Baseline clinical and echocardiographic characteristics of
AMI patients with versus without LV remodeling are sum-
marized in Table 3. At baseline, patients who developed LV
remodeling had larger LVESVs (P0.036), lower LVEFs
(P0.001), and higher MPIs (P0.001), indicating larger
infarct size. Regarding LV rotational mechanics parame-
ters, at baseline patients with LV remodeling had signifi-
cantly lower peak LV apical rotation (P0.001), peak LV
twist (P0.001), and peak LV torsion (P0.001) com-
pared with patients without LV remodeling; conversely, no
difference in peak LV basal rotation was observed between
the 2 groups. Patients with more impaired peak LV torsion
at baseline had larger LVESVs at 6-month follow-up and a
higher change in LVESV in the 6-month follow-up period
(Figure 4).
Table 4 shows the results of univariate and multivariate
logistic regression analyses performed to determine the rela-
tion between clinical and echocardiographic characteristics at
baseline and LV remodeling at 6-month follow-up. By
univariate analysis, several variables were significantly re-
lated to LV remodeling: anterior AMI, peak troponin T value,
LVESV, LVEF, WMSI, presence of diastolic dysfunction,
peak LV GLS, peak LV torsion, and MPI. However, by
multivariate analysis, only peak LV torsion (odds ratio0.77;
95% CI, 0.65 to 0.92; P0.003) and MPI (odds ratio1.04;
95% CI, 1.01 to 1.07; P0.021) were independently related
to the development of LV remodeling. Furthermore, peak LV
torsion provided modest but significant incremental value
over clinical, echocardiographic, and MCE variables in pre-
dicting LV remodeling (Figure 5). By receiver-operator-
characteristics curve analysis (Figure 6), peak LV torsion
1.44°/cm provided the highest sensitivity (95%) and spec-
ificity (77%) to predict LV remodeling; diagnostic accuracy
was high in both anterior and nonanterior AMI patients
(Figure 6).
Discussion
The results of the present evaluation show that LV torsion is
significantly impaired early after AMI, owing to a reduction
of both basal and apical rotations. Infarct size (assessed by
MCE) was independently related to LV torsion. In addition,
LV torsion early after AMI was significantly and indepen-
dently related to the occurrence of LV remodeling at 6-month
follow-up.
Impact of AMI on LV Rotational Mechanics
Previous experimental and clinical studies have consistently
shown an impairment of LV torsional deformation in the
setting of acute and chronic MI.7,8,18–21 In addition, LV
torsion was related to global LV systolic function and the
extent of wall-motion abnormalities.7,8,21 The present evalu-
ation confirms and extends these previous observations. LV
systolic function was indeed significantly related to LV
torsion. More important, an independent correlation between
infarct size (assessed by MCE and expressed as MPI) and LV
torsion was noted on multivariate analysis. The larger damage
of the LV subepicardial myofibers and the greater disarrange-
ment of the typical architecture of LV myofibers secondary to
Figure 5. Incremental value of peak LV
torsion over clinical, echocardiographic,
and MCE variables in predicting LV
remodeling at 6-month follow-up.
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Figure 5. Incremental value of peak LV torsion over clinical, echocardiographic, and MCE variables in predicting LV remodeling at 6-month 
follow-up.






or (95% cI) p-value or (95% cI) p-value
age 1.03 (0.98-1.09) 0.20 1.00 (0.93-1.08) 0.94
male gender 1.53 (0.47-5.04) 0.48 3.62 (0.66-19.8) 0.14
anterior myocardial infarction 3.59 (1.25-10.3) 0.017 - -
multi-vessel disease 1.99 (0.73-5.40) 0.18 - -
tImI flow grade 3 0.42 (0.13-1.36) ,0.001 - -
peak troponin t 1.23 (1.11-1.36) <0.001 - -
lvedv 1.01 (0.99-1.03) 0.47 - -
lvesv 1.04 (1.01-1.07) 0.006 0.99 (0.94-1.04) 0.77
lvef 0.85 (0.78-0.92) <0.001 - -
wmsI 1.73 (1.34-2.24) <0.001 - -
presence of diastolic dysfunction 4.21 (1.15-15.4) 0.030 - -
peak lv gls 1.43 (1.19-1.71) <0.001 - -
peak lv torsion* 0.72 (0.62-0.82) <0.001 0.77 (0.65-0.92) 0.003
mpI* 1.79 (1.39-2.31) <0.001 1.29 (0.84-1.97) 0.24
Abbreviations as in Table 1. OR indicates odds ratio. C-statistic = 0.93
*OR and 95% CI are intended for a 0.1-unit increase.
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dIscussIon
The results of the present evaluation show that LV torsion is significantly impaired early after 
AMI, due to a reduction of both basal and apical rotation. Infarct size (assessed by MCE) was 
independently related to LV torsion. In addition, LV torsion early after AMI was significantly 
and independently related to the occurrence of LV remodeling at 6-month follow-up.
Impact of amI on lv rotational mechanics
Previous experimental and clinical studies have consistently shown an impairment of LV 
torsional deformation in the setting of acute and chronic myocardial infarction 7,8,18–21. In 
addition, LV torsion was related to global LV systolic function and the extent of wall motion 
abnormalities 7,8,21. The present evaluation confirms and extends these previous observations. 
LV systolic function was indeed significantly related to the LV torsion. More important, an 
independent correlation between infarct size (assessed by MCE and expressed as MPI) and LV 
larger infarcts may explain the observed relation between
infarct size and LV torsion.
Epicardial myofibers are indeed extremely important to
maintain LV torsional deformation.4 Epicardial myofibers
(compared with endocardial fibers) produce larger torque
(related to the larger radius) and determine the overall
directio of rotation.4 Damage to epicardial f bers therefore
appears mandatory for an impairment of LV torsional me-
chanics. Indeed, the present evaluation underscores that
larger infarcts (as indicated by higher MPI values), leading to
more extensive, transmural damage (spreading to epicardial
myofibers),17 result in a larger impairment of LV torsion.
Previous experimental studies in an occlusion-reperfusion
model provide evidence for this hypothesis by showing that
LV torsion was impaired in the presence of transmural
ischemia, whereas LV torsion was preserved in the presence
of subendocardial ischemia only.22,23 In addition, LV myofi-
bers have a typical spiral architecture that is also extremely
important in determining the LV systolic wringing motion.
Large infarcts may be associated with extensive distortion of
the typical architecture of LV myofibers, altering their obliq-
uity and eventually impairing LV torsion.24
Role of LV Torsion in Predicting LV Remodeling
Besides being strictly related to the myocardial damage after
AMI, LV torsion at baseline was found to be a strong
predictor of LV remodeling at 6-month follow-up; interest-
ingly, this relation remained even after adjustment for other
univariate predictors of LV remodeling, including infarct size
(expressed as MPI). Peculiar properties of the LV systolic
twisting motion may explain this finding.
LV torsion indeed is not simply an index of global LV
systolic function; previous mathematical models revealed the
essential role of LV torsion in optimizing LV oxygen demand
and the efficiency of LV systolic thickening by uniformly
distributing myofiber stress across the myocardial wall.25 A
significant impairment of LV torsion after AMI will therefore
result in increased myofiber stress and oxygen demand of the
remaining noninfarcted myocardium. This low-efficiency
state would further impair myocardial contractility, possibly
representing the initial step of a vicious circle of progressive
LV dilatation and decline in LV systolic function.18,24
Clinical Implications
The present evaluation underscores the value of LV torsion as
a sensitive global parameter of LV systolic myocardial
performance. Its impairment early after AMI is strictly related
to the extent of myocardial damage and possibly plays an
important role in the development of LV remodeling. Indeed,
peak LV torsion provided modest but significant incremental
value over clinical, echocardiographic, and MCE variables in
predicting LV remodeling. Accordingly, this parameter may
be used in clinical practice as an early marker for risk
stratification. Early assessment of LV torsion after AMI by
speckle tracking echocardiography could identify patients
(with reduced LV torsion) who may benefit from aggressive
medical therapy to prevent LV remodeling, heart failure, and
poor outcome.
Limitations
Some limitations should be acknowledged. First, only pa-
tients with ST-segment elevation AMI were included; conse-
quently, the results cannot be extrapolated to patients with
non–ST-segment elevation AMI. Another important limita-
tion concerns the acquisition of short-axis images. The
acquisiti n of true LV apic short-axis images is indeed
Figure 6. Receiver-operator-characteristics curve, testing the
accuracy of peak LV torsion to predict LV remodeling at
6-month follow-up. A, In the overall patient population, peak LV
torsion 1.44°/cm provided the highest sensitivity (95%) and
specificity (77%) to predict LV remodeling. B, Among patients
with anterior AMI, peak LV torsion 1.29°/cm provided the
highest sensitivity (92%) and specificity (74%) to predict LV
remodeling. C, Among patients with nonanterior AMI, peak LV
torsion 1.44°/cm provided the highest sensitivity (100%) and
specificity (81%) to predict LV remodeling. AUC indicates area
under the curve.
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larger infarcts may explain the observed relation between
infarct size and LV torsion.
Epicardial myofibers are indeed extremely important to
maintain LV torsional deformation.4 Epicardial myofibers
(compared with endocardial fibers) produce larger torque
(related to the larger radius) and determine the overall
direction of rotation.4 Damage to picardial fibers therefore
appears mandatory for an impairment of LV torsional me-
chanics. Indeed, the present evaluation underscores that
larger infarcts (as indicated by higher MPI values), leading to
more extensive, transmural damage (spreading to epicardial
myofibers),17 result in a larger impairment of LV torsion.
Previous experimental studies in an occlusion-reperfusion
model provide evidence for this hypothesis by showing that
LV torsion was impaired in the presence of transmural
ischemia, whereas LV torsion was preserved in the presence
of subendocardial ischemia only.22,23 In addition, LV myofi-
bers have a typical spiral architecture that is also extremely
important in determining the LV systolic wringing motion.
Large infarcts may be associated with extensive distortion of
the typical architecture of LV myofibers, altering their obliq-
uity nd eventuall imp iring LV torsion.24
Rol of LV Torsion in Predicting LV R model g
Besid s being strictly related to the myoc rdial damage after
AMI, LV torsion at b selin was found t be a strong
pr dictor of LV r modeling at 6-month follow-up; interest-
ingly, this relation remained even after adjustment for ot er
univariate predictors of LV remod ling, including infarct size
(expressed as MPI). Peculiar properties of the LV sy tolic
twi ting motion may expl in this findi g.
LV torsion indeed is not simply an index of global LV
syst lic function; previous mathematical models revealed the
essential role of LV torsion in optimizing LV oxygen demand
and the efficiency of LV systolic thickening by unif rmly
distributing myofiber stress across the myocardial wall.25 A
significant impairment of LV torsion after AMI will therefore
result in increased myof ber stress and oxygen demand of the
remaining oninfarcted myocardiu . This ow-efficiency
state would further impair myocardial co tractility, possibly
representing the initial step of a vici us circ e of progressive
LV dilatation and d cline in LV systolic functio .18,24
Clinical Implications
The present evaluation underscores the value of LV torsion as
a sensitive global parameter of LV systolic myocardial
perf rmance. Its impairment early after AMI is strictly r lated
to the extent of my cardial damage and possibly plays an
important role i the development of LV remodeling. Indeed,
peak LV torsion provided modest but significant incremental
value over clinical, ch cardiographic, and CE variables in
predicting LV r modeling. Accordi gly, this parameter may
be used in clinical practice s an early marker for risk
tratification. Early assessment of LV t rsion after AMI b
speckl tracking echocardi graphy could identify patients
(with reduced LV torsion) who may benefit from aggressive
medical therapy to prevent LV remodeling, heart failure, and
poor outco e.
Limita ions
Some limitations should be cknowledged. First, only pa-
tients with ST-segment elevation AMI were included; conse-
quently, the results cannot be extrapolated to patients with
non–ST-segme t elevation AMI. Another important limit -
tion concerns the acquisition of short-axis im ges. The
acquisition of true LV apical short-axis images is indeed
Figure 6. Receiver-operator-characteristics curve, testing the
accuracy of peak LV torsion to predict LV remodeling at
6-month follow-up. A, In the overall patient population, peak LV
torsion 1.44°/cm provided the highest sensitivity (95%) and
specificity (77%) to predict LV remodeling. B, Among patients
with anterior AMI, peak LV torsion 1.29°/cm provided the
highest sensitivity (92%) and specificity (74%) to predict LV
remodeling. C, Among patients with nonanterior AMI, peak LV
torsion 1.44°/cm provided the highest sensitivity (100%) and
specificity (81%) to predict LV remodeling. AUC indicates area
under the curve.
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larger infarcts may explain the observed relation between
infarct size and LV torsion.
Epicardial myofibers are indeed extremely important to
maintain LV torsional deformation.4 E icardial myofibers
(compared with endocardial fibers) produc larger torque
(rela ed to th larger r di s) and determine the overall
direction of rotation.4 Damage to epica di l fibers therefore
appears mandatory for an impairment of LV torsional me-
chanics. Indeed, the present evaluation underscores that
larger infarcts (as indicated by higher MPI values), leading to
more extensive, transmural damage (spreading to epicardial
myofibers),17 result in a larger impairment of LV torsion.
Previous experimental studies in an occlusion-reperfusion
model provide evidence for this hypothesis by showing that
LV torsion was impaired in the presence of transmural
ischemia, whereas LV torsion was preserved in the presence
of subendocardial ischemia only.22,23 In addition, LV myofi-
bers have a typical spiral architecture that is also extremely
important in determining the LV systolic wringing motion.
Large infarcts may be associated with extensive distortion of
the typical architecture of LV myofibers, altering their obliq-
uity and eventually impairing LV torsion.24
Role of LV Torsion in Predicting LV Remodeling
Besides being strictly related to the myocardial damage after
AMI, LV torsion at baseline was found to be a strong
predictor of LV remodeling at 6-month follow-up; interest-
ingly, this relation remained even after adjustment for other
univariate predictors of LV remodeling, including infarct size
(expressed as MPI). Peculiar properties of the LV systolic
twisting motion may explain this finding.
LV torsion indeed is not simply an index of global LV
systolic function; previous mathematical models revealed the
essential role of LV torsion in optimizing LV oxygen demand
and the efficiency of LV systolic thickening by uniformly
distributing myofiber stress across the myocardial wall.25 A
significant impairment of LV torsion after AMI will therefore
result in increased myofiber stress and oxygen demand of the
remaining noninfarcted myocardium. This low-efficiency
state would further impair myocardial contractility, possibly
representing the initial step of a vicious circle of progressive
LV dilatation and decline in LV systolic function.18,24
Clinical Implications
The present evaluation underscores the value of LV torsion as
a sensitive global parameter of LV systolic myocardial
performance. Its impairment early after AMI is strictly related
to the extent of myocardial damage and possibly plays an
important role in the development of LV remodeling. Indeed,
peak LV torsion provided modest but significant incremental
value over clinical, echocardiographic, and MCE variables in
predicting LV remodeling. Accordingly, this parameter may
be used in clinical practice as an early marker for risk
stratification. Early assessment of LV torsion after AMI by
speckle tracking echocardiography could identify patients
(with reduced LV torsion) who may benefit from aggressive
medical therapy to prevent LV remodeling, heart failure, and
poor outcome.
Limitations
Some limitations should be acknowledged. First, only pa-
tients with ST-segment elevation AMI were included; conse-
quently, the results cannot be extrapolated to patients with
non–ST-segment elevation AMI. Another important limita-
tion concerns the acquisition of short-axis images. The
acquisition of true LV apical short-axis images is indeed
Figure 6. Receiver-operator-characteristics curve, testing the
accuracy of peak LV torsion to predict LV remodeling at
6-month follow-up. A, In the overall patient population, peak LV
torsion 1.44°/cm provide the highest se sitivit (95%) nd
specificity (77%) to predict LV remodeling. B, Among patients
with anterior AMI, peak LV torsion 1.29°/cm provided the
highest sensitivity (92%) and specificity (74%) to predict LV
remodeling. C, Amo patients with nonanteri r AMI, peak LV
torsion 1.44°/cm provided the hig est sensitivity (100%) nd
specificity (81%) to predict LV remodeling. AUC indicates area
under the curve.
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Figure 6. Receiver-operator characteristic (ROC) curve, testing the accuracy of peak LV torsion to predict LV remod ling at 6-m nth follow-up. 
A, In the overall patient population, peak LV torsion ≤1.44°/cm provided the highest sensitivity (95%) and specificity (77%) to predict LV 
remodeling. B, Among patients with anterior AMI, peak LV torsion ≤1.29°/cm provided the highest sensitivity (92%) and spec ficity (74%) 
to predict LV remodeling. C, Among patients with nonanterior AMI, peak LV torsion ≤1.44°/cm provided the highest sensitivity (100%) and 
specificity (81%) to predict LV remodeling. AUC indicates area under the curve.
Nina Book.indb   259 26-09-11   12:04
Chapter 14
260
torsion was noted on multivariate analysis. The larger damage of the LV subepicardial myofi-
bers and the greater disarrangement of the typical architecture of LV myofibers secondary to 
larger infarcts may explain the observed relation between infarct size and LV torsion.
Epicardial myofibers are indeed extremely important to maintain LV torsional deforma-
tion 4. Epicardial myofibers (as compared to the endocardial fibers) produce larger torque 
(related to the larger radius), and determine the overall direction of rotation 4. Damage of the 
epicardial fibers appears therefore mandatory for an impairment of LV rotational mechanics. 
Accordingly, the present evaluation underscores that larger infarcts (as indicated by higher 
MPI values), leading to more extensive, transmural damage (spreading to the epicardial 
myofibers) 17, result in a larger impairment of LV torsion. Previous experimental studies using 
an occlusion-reperfusion model provided evidence for this hypothesis, by showing that LV 
torsion was impaired in the presence of transmural ischemia, while LV torsion was preserved 
in the presence of subendocardial ischemia only 22,23. In addition, LV myofibers have a typical 
spiral architecture that is also extremely important in determining the LV systolic wringing 
motion. Large infarcts may be associated with extensive distortion of the typical architecture 
of the LV myofibers, altering their obliquity and eventually impairing LV torsion 24.
role of lv twist in predicting lv remodeling
Besides being strictly related to the myocardial damage after AMI, LV torsion at baseline was 
found to be a strong predictor of LV remodeling at 6-month follow-up; interestingly, this 
relation remained even after adjustment for other univariate predictors of LV remodeling, 
including infarct size (expressed as MPI). Peculiar properties of the LV systolic twisting motion 
may explain this finding.
LV torsion indeed is not simply an index of global LV systolic function; previous mathemati-
cal models revealed the essential role of LV torsion in optimizing LV oxygen demand and 
the efficiency of LV systolic thickening by uniformly distributing myofiber stress across the 
myocardial wall 25. A significant impairment of LV torsion after AMI will therefore result in an 
increased myofiber stress and oxygen demand of the remaining non-infarcted myocardium. 
This low-efficiency state would further impair myocardial contractility, possibly representing 
the initial step of a vicious circle of progressive LV dilatation and decline in LV systolic func-
tion 18,24.
clinical implications
The present evaluation underscores the value of LV torsion as a sensitive global parameter 
of LV systolic myocardial performance. Its impairment early after AMI is strictly related to the 
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extent myocardial damage and possibly plays an important role in the development of LV 
remodeling. Accordingly, this parameter may be used in clinical practice as an early marker 
for risk stratification. Early assessment of LV torsion after AMI using speckle-tracking echocar-
diography could identify patients (with reduced LV torsion) who may benefit from aggressive 
medical therapy to prevent LV remodeling, heart failure and poor outcome.
study limitations
Some limitations should be acknowledged. First, only patients with ST-segment elevation 
AMI were included; consequently, the results cannot be extrapolated to patients with non–
ST-segment elevation AMI. Another important limitation concerns the acquisition of the 
short-axis images. The acquisition of true LV apical short-axis images is indeed dependent 
on the acoustic window (more than the basal short-axis view) and may be technically dif-
ficult to acquire in some patients. In addition, transducer position has a strong impact on the 
assessment of apical rotation by speckle-tracking echocardiography. It should, however, be 
emphasized that the most caudal transducer position was used to acquire the parasternal 
short-axis apical view; moreover, all patients without true LV apical short-axis images were 
not included in the present evaluation. Furthermore, motion throughout the planes at the 
basal level may reduce the accuracy of measurement of LV basal rotation. Finally, the im-
pairment of LV torsion observed early after AMI may be partially related to the presence of 
myocardial stunning; further studies are needed to assess the evolution of LV torsion after 
the acute phase of AMI.
conclusIons
LV torsion is significantly impaired early after AMI. The amount of impairment of LV torsion 
is related to infarct size. In addition, LV torsion at baseline predicts the occurrence of LV re-
modeling at 6-month follow-up, with modest but significant incremental value over clinical, 
echocardiographic and MCE variables.
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objectives: Velocity-encoded magnetic resonance imaging (VE-MRI), commonly 
used to perform flow measurements, can be applied for myocardial velocity analy-
sis, similar to tissue Doppler imaging (TDI). In this study, a comparison between 
VE-MRI and TDI was performed for the assessment of LV dyssynchrony and LV filling 
pressures.
methods: Ten healthy volunteers and 22 patients with heart failure secondary to 
ischemic cardiomyopathy underwent both VE-MRI and TDI. Longitudinal myocardial 
peak systolic (PSV) and diastolic (PDV) velocities and time to PSV (Ts) were measured 
with both techniques at the level of LV septum and lateral wall. To quantify LV dys-
synchrony, the delay in Ts between basal septum and lateral wall was calculated 
(SLD) and patients were categorized in 3 groups: minimal (SLD <30 ms), interme-
diate (30-60 ms) and extensive (>60 ms) LV dyssynchrony. The E/E’ ratio was also 
assessed and patients were divided in 3 groups: normal (E/E’ <8), probably abnormal 
(E/E’ = 8-15) and elevated (E/E’ >15) LV filling pressures.
results: Excellent correlations were observed for PSV and PDV (r = 0.95, p <0.001) 
measured with TDI and VE-MRI. A small bias (p <0.001) of -1.1±1.1 cm/s for PSV and 
of -0.45±1.03 cm/s for PDV was noted between the 2 techniques. A strong correla-
tion was also noted between Ts measured with TDI and VE-MRI (r = 0.97, p <0.001) 
without a significant difference. TDI and VE-MRI showed an excellent agreement for 
LV dyssynchrony and LV filling pressures classification with a weighted κ of 0.96 and 
0.91, respectively. 
conclusion: TDI and VE-MRI are highly concordant and can be used interchange-
ably for the assessment of LV dyssynchrony and filling pressures.
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IntroductIon
Velocity-encoded magnetic resonance imaging (VE-MRI), commonly used to perform flow 
measurements, can be applied for myocardial velocity analysis, similar to tissue Doppler im-
aging (TDI). Preliminary studies have compared TDI and VE-MRI in patients with hypertensive 
heart disease 1 and in patients scheduled for cardiac resynchronization therapy (CRT) 2;3. Good 
correlations between the 2 techniques were reported for the assessment of left ventricular 
(LV) myocardial velocities and timings. The aim of this study was to compare TDI and VE-MRI 
in patients with heart failure secondary to ischemic cardiomyopathy, including the measure-
ment of systolic and diastolic velocities and time to peak systolic velocity for different LV 
segments. Furthermore, the applicability of VE-MRI was evaluated for assessment of LV dys-
synchrony and estimation of LV filling pressures, using validated indices derived from TDI.
methods
A total of 10 healthy volunteers (5 men, 31±5 years) and 22 consecutive patients with heart 
failure secondary to ischemic cardiomyopathy (16 men, 58±11 years) underwent both 
cardiac MRI and echocardiographic evaluation including TDI, on the same day. The patients 
were clinically referred for echocardiography and cardiac MRI. All healthy volunteers gave 
informed consent and the protocol was approved by the institutional review board.
Echocardiography was performed using a commercially available system (Vingmed Vivid 
Seven, General Electric Healthcare, Horten, Norway) equipped with a 3.5-Mhz transducer. 
Left ventricular end-diastolic (EDV) and end-systolic (ESV) volumes and LV ejection fraction 
(EF) were calculated using the biplane Simpson’s technique 4. Peak velocity in early diastole (E 
wave) of the transmitral flow was derived from conventional pulsed-wave Doppler imaging.
For TDI images, the sector width was narrowed to visualize one myocardial wall at a time, 
to obtain a good alignment between the wall and the ultrasound beam and to reach a frame 
rate of at least 130 frames/second. At least 3 consecutive beats were recorded and the images 
were digitally stored for off-line analysis (EchoPac 6.1, GE Vingmed Ultrasound, Horten, Nor-
way). During post-processing, the color-coded TDI dataset was used to analyze longitudinal 
myocardial velocities: regions of interest (5 x 5 mm) were placed at the basal and mid level 
5 of LV septum and lateral wall. Semi-automated tissue tracking was used to maintain the 
sample area in the region of interest throughout the cardiac cycle. Subsequently, the follow-
ing variables were measured:
1) peak systolic velocity (PSV)
2) peak diastolic E’ velocity (E’PDV)
3) peak diastolic A’ velocity (A’PDV)
4) time from R wave (from the ECG signal) to PSV (Ts)
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The Ts is expressed as a percentage of the cardiac cycle, to take the possible difference in 
heart rate during the echocardiographic and MRI studies into account. To quantify LV dys-
synchrony, the delay in Ts between the basal septum and lateral wall was calculated (referred 
to as septal-to-lateral delay, SLD, Figure 1) 6 and the patients were categorized into 3 groups 
according to the extent of LV dyssynchrony: minimal (SLD <30 ms), intermediate (SLD 30 to 
60 ms) and extensive (SLD >60 ms) 6. Inter- and intra-observer agreement for the assessment 
of the SLD were 90% and 96% respectively, as previously reported 7.
In addition, the ratio of transmitral E wave velocity and mitral annulus septal early velocity 
(E/E’) was calculated. This ratio correlates closely with LV filling pressures8, and is therefore 
used in the evaluation of LV diastolic function 9. The patient population was divided into 
3 groups: normal LV filling pressures/LV diastolic function (E/E’ <8), probably abnormal LV 
filling pressures/LV diastolic function (E/E’ = 8-15) and elevated LV filling pressure/ LV diastolic 
dysfunction (E/E’ >15) 9;10.
MRI data acquisition was performed on a 1.5 T scanner (ACS-NT15 Intera, software release 
11, Philips Medical Systems, Best, The Netherlands). Scout images preceded the 2- and 
4-chamber acquisitions, conform standard cardiac MR protocols 11, using steady-state free 
precession 12. To obtain the transmitral blood flow, a spoiled gradient-echo phase-contrast 
acquisition was performed  13 with one-directional through-plane velocity-encoding. The 
acquisition plane was positioned at the mitral annulus in end-systole perpendicular to the 
expected transmitral flow 14. The maximum velocity sensitivity was set to 150 cm/s. Slice thick-
ness of the imaging plane was 8 mm, Field-of-View = 370 mm, scan matrix = 128´102, with 
voxels of 2.89´3.21´8.0 mm; flip angle a = 20°, TR/TE = 5.0/3.1; 4 signal averages (NSA) were 
used to increase the signal-to-noise ratio. Retrospective cardiac synchronization was used 
and 40 cardiac phases were reconstructed for one cardiac cycle. From the velocity curves, the 
maximum velocity of transmitral E wave was derived. A VE acquisition for the longitudinal 
velocity parallel to the long-axis of the LV, in a 4-chamber orientation, was performed with 
the following imaging parameters: slice thickness = 8 mm, Field-of-View = 370 mm, scan 
matrix = 128×76, with reconstructed voxels of 1.45×1.45×8.0 mm, flip angle α = 50°, TR/TE 
= 6.9/4.9; four NSA; velocity sensitivity was 20 cm/s. Retrospective cardiac triggering was 
used. Acquisition was performed with free breathing. The maximal number of phases was 
reconstructed, yielding a temporal resolution of 6-12 ms. Image analysis was performed off-
line, as previously described 3, using the extended version of QMass software (Medis, Leiden, 
The Netherlands). Regions of interest (5 x 5 mm) were positioned at the basal and mid level of 
the septum and lateral wall in all phase images as for echocardiography 5. Since the basal and 
mid levels move constantly, manual correction for the placement of the regions of interest is 
needed throughout the cardiac cycle. The mean velocity over the sample area was measured 
resulting in myocardial wall motion velocity graphs over one average cycle (Figure 1). Longi-
tudinal velocity toward the apex was defined as positive. The post-processing of the images 
required 3-5 minutes. Similar to echocardiography, peak systolic and diastolic velocities and 
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Ts (corrected for heart rate) were measured. To quantify LV dyssynchrony, the SLD was de-
rived from the basal segments of the septum and lateral wall. The patients were subsequently 
classified using the same cut-off values as applied to TDI. The coefficient of variation for SLD 
assessment with VE-MRI (defined as the standard deviation of the differences between the 2 
series of measurements divided by the mean of both measurements) was less than 10% for 
both intra- and inter-observer variation as previously reported  3. LV diastolic function was 
evaluated by estimation of LV filling pressures, using the septal E/E’ ratio 8. Patients were 
categorized in 3 groups according to the cut-off values validated for TDI echocardiography 10.
Continuous data are presented as mean±SD; dichotomous data are presented as numbers 
and percentages. Comparison of data was performed using the paired or unpaired Student t 
test. Pearson’s correlation analysis was performed to evaluate the relation between TDI and 
VE-MRI measurements. Bland-Altman analysis was performed to evaluate the differences in 
PSV, PDV and in time-to-peak velocities assessed with VE-MRI and TDI. The mean differences, 
trends and limits of agreement are reported. Agreement for LV dyssynchrony and diastolic 
function classification with TDI versus VE-MRI was assessed from a 3×3 table using weighted 
Figure 1. Left ventricular (LV) dyssynchrony assessment from myocardial velocity curves (of the septum and lateral wall) with tissue Doppler 
imaging (left panels) and velocity-encoded magnetic resonance imaging (right panels). White arrows indicate peak systolic myocardial 
velocities of the basal segments of septum and lateral wall. In the upper panels an example of a heart failure patient without significant 
LV dyssynchrony (no septal-to-lateral delay) is shown. The lower panels demonstrate examples of a heart failure patient with extensive LV 
dyssynchrony (septal-to-lateral delay = 90 ms).
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κ statistics (Fleiss-Cohen weighting). A p-value <0.05 was considered to be statistically sig-
nificant. A statistical software program SPSS 12.0 (SPSS Inc, Chicago, II, USA) was used for 
statistical analysis.
results
Baseline individual characteristics of the study population are summarized in Table 1. In 
the heart failure patients, the echocardiographic examination revealed severe LV dilatation 
(LVEDV 222±58 ml) and depressed LV ejection fraction (30±6 %). The majority of the patients 
were in NYHA functional class III (n = 16, 73%).
For the overall study population, the PSV measured with VE-MRI showed a very good cor-
relation with PSV measured with TDI (r = 0.95, p <0.001) (Figure 2). Bland-Altman analysis 
revealed a mean difference between TDI and VE-MRI of -1.1±1.1 cm/s, with a significant trend 
(p <0.01); limits of agreement ranged from -3.4 cm/s to 1.1 cm/s (Figure 3). The PSV (at basal 
and mid segments of LV septum and lateral wall) were higher in normal subjects than in heart 
failure patients, both measured with TDI (7.6±3.1 vs. 2.5±1.4 cm/s, p <0.001) and with VE-MRI 
(8.6±3.2 vs. 3.7±2.1 cm/s, p <0.001). Of interest, the correlation coefficient between TDI and 
VE-MRI was higher for normal individuals (r = 0.97, p <0.001) than for heart failure patients (r 
= 0.82, p <0.001).
The values of time to peak systolic velocities for each LV segment are shown in Table 2. 
An excellent correlation was observed in the overall study population between Ts measured 
with TDI and Ts measured with VE-MRI (r = 0.97, p <0.001) (Figure 4). Bland-Altman analysis 
showed a non-significant difference between both techniques of -0.26±1.71% (limits of 
agreement from -3.6% to 3.1%). The Ts, measured with both methods at the level of LV sep-
tum and lateral wall, were longer in heart failure patients than in normal individuals (Table 2). 
Of note, Pearson’s correlation analysis revealed comparable correlation coefficients for time 
to peak systolic velocities in heart failure patients (r = 0.96, p <0.001) and controls (r = 0.90, p 
<0.001). A strong correlation between TDI and VE-MRI was also observed for the assessment 
of LV dyssynchrony (r = 0.95, p <0.001). On TDI, according to the above mentioned classifica-
tion, 10 patients had minimal LV dyssynchrony (SLD <30 ms), 4 had intermediate (SLD 30 to 
60 ms) and 8 had extensive (SLD >60 ms) LV dyssynchrony. Similarly on VE-MRI, 9 patients 
had minimal, 5 had intermediate and 8 had extensive LV dyssynchrony (weighted κ for TDI vs. 
VE-MRI was 0.96). Of note, none of the controls showed LV dyssynchrony on both techniques.
In the total study population, the PDV (E’PDV and A’PDV) measured with VE-MRI showed 
an excellent correlation with PDV measured with TDI (r = 0.95, p <0.001) (Figure 2). The PDV 
measured with VE-MRI consistently exceeded the PDV measured with TDI. Bland-Altman 
analysis (using absolute values) revealed a mean difference of -0.45±1.03 cm/s between the 2 
techniques (p <0.001, limits of agreement from -2.5 to 1.5 cm/sec) (Figure 3). Both E’ PDV and 
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Figure 2. Correlation between peak systolic and diastolic velocities (at basal and mid segments of LV septum and lateral wall) measured with 
tissue Doppler imaging (TDI) and velocity-encoded magnetic resonance imaging (VE-MRI) in normal individuals (gray dots) and in heart failure 
patients (black triangles).
Figure 3. Bland-Altman scatter plot of differences in peak systolic velocity (Panel A) and peak diastolic velocity (using absolute values, Panel B) 
between TDI and VE-MRI and the average peak systolic velocity and peak diastolic velocity (using absolute values) between the 2 techniques.
Table 2. Time to peak systolic velocity (Ts) of 4 LV segments, expressed as a percentage of cardiac cycle, measured with velocity-encoded 
magnetic resonance imaging (VE-MRI) and tissue Doppler imaging (TDI) in normal subjects (controls) and in heart failure (HF) patients.
ve-mrI tdI




























*: p <0.001: normal subjects versus HF patients
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A’ PDV, measured at the level of LV septum and lateral wall, were higher in normal individuals 
than in heart failure patients. Mean E’ PDV in the controls vs. heart failure patients: -9.1±3.0 vs. 
-3.2±1.8 cm/s with TDI (p <0.001) and -9.6±3.3 vs. -3.7±2.3 cm/s with VE-MRI (p <0.001). Mean 
A’ PDV in the controls vs. heart failure patients: -3.7±1.6 vs. -2.1±1.4 cm/s with TDI (p <0.01) 
and -4.3±2.1 vs. -2.6±1.5 cm/s with VE-MRI (p <0.01). Interestingly, the correlation coefficient 
was higher for controls than for heart failure patients both for E’PDV (r = 0.96 vs. r = 0.87) and 
for A’PDV (r = 0.96 vs. r = 0.89).
For the evaluation of the maximum velocity of transmitral E wave, Doppler echocardiog-
raphy and MRI showed a strong correlation (r = 0.94, p <0.001). With Bland-Altman analysis 
a mean difference of -0.32±6.8 cm/sec (limits of agreement from -13.6 to 12.9 cm/sec) was 
observed, with a non-significant trend (p = NS). A strong correlation between MRI and echo-
cardiography was observed for the assessment of E/E’ ratio (r = 0.95, p <0.001). Interestingly 
on TDI, 9 patients had an E/E’ between 8 and 15, and 13 had E/E’ >15. On VE-MRI, 8 patients 
had E/E’ between 8 and 15, and 14 had E/E’ >15 (weighted κ for TDI vs. VE-MRI was 0.91).
dIscussIon
The main findings of the current study can be summarized as follows: 1) a strong correla-
tion was found between TDI and VE-MRI for the assessment of myocardial peak systolic and 
diastolic velocities, with a small difference between the 2 techniques; 2) a strong correlation 
was also found between TDI and VE-MRI for the assessment of Ts and the agreement between 
the 2 techniques was excellent when patients were categorized according to the severity 
of LV dyssynchrony; 3) excellent correlation and agreement was also found between the 2 













y = 0.91x + 0.01
r = 0.97, p <0.001
Tot segments = 128
Figure 4. Correlation between time to peak systolic velocities (Ts, at basal and mid segments of LV septum and lateral wall), corrected for the 
R-R interval, measured with tissue Doppler imaging (TDI) and velocity-encoded magnetic resonance imaging (VE-MRI) in normal individuals 
(grey dots) and in heart failure patients (black triangles).
Nina Book.indb   277 26-09-11   12:04
Chapter 15
278
Tissue Doppler imaging has been used in several studies  15–18 to measure longitudinal 
myocardial peak systolic velocities, providing quantitative information on regional LV systolic 
function and avoiding the disadvantages of observer-dependent interpretation. In addition, 
this technique plays a fundamental role in the diagnostic algorithm for LV diastolic dysfunc-
tion 9. In particular, the E/E’ ratio has been demonstrated to correlate closely with LV filling 
pressures 8;10 and to be a powerful predictor of survival 19. Cardiac MRI is widely accepted as 
the gold standard for the assessment of LV volumes and function. However, beyond the 
analysis of transmitral flow pattern 20, an accurate and clinically applicable method to assess 
LV diastolic function with MRI is still lacking. When applied for myocardial wall motion mea-
surement, VE-MRI may obtain similar data to that provided by TDI, without the limitations 
of the acoustical window, and can be used for the assessment of myocardial velocities and 
the E/E’ ratio. An initial study by Delfino et al 2 compared TDI and VE-MRI for the assessment 
of longitudinal myocardial velocities (PSV and E’PDV) in 10 normal volunteers and in 10 
patients scheduled for CRT. The authors reported a good correlation (r = 0.86) between the 
2 techniques, but a large bias in the value of peak velocities was found (-4.4±3.7 cm/sec). In 
the present study an excellent correlation between both methods was confirmed (r = 0.95 
for PSV and PDV), including a larger sample size, both basal and mid LV segments and using 
optimized image acquisition and analysis. A much smaller difference was noted between the 
2 techniques: -1.1±1.1 cm/s for PSV and -0.45±1.03 cm/s for PDV, probably due to technical 
differences between the 2 studies. First, Delfino and co-workers positioned the sample area 
in the VE-MRI acquisition on a short-axis view at 70% of the distance from apex, while in 
the TDI acquisition velocities were acquired at the basal level of the apical 4-chamber view. 
This may lead to potential errors due to the shifting of the myocardial wall, especially during 
systole. In the present study the sample area was placed in a 4-chamber orientation in both 
TDI and VE-MRI and the position of the samples was manually corrected in each phase in 
the VE-MRI. Second, in the current study the temporal resolution of VE-MRI was optimized 
and was comparable to that of TDI, whereas in the previous study the temporal resolution 
of VE-MRI was lower (30-40 ms). The residual small bias between the 2 techniques can be 
explained by acoustical window limits and non-optimal alignment between the wall and 
the ultrasound beam for TDI and potential phase errors and partial volume effects for MRI. 
These results need to be confirmed in larger studies that should test the applicability of MRI 
for these measurements in different centers. Unfortunately, at present a non-invasive gold 
standard is not available for the assessment of myocardial velocities. However, both VE-MRI 
and TDI have been previously validated in phantom models 21;22 and the strong correlation 
between the 2 techniques observed in the present study allows a reciprocal validation. More 
important, the excellent agreement found in the present study for the assessment of LV 
diastolic function (using the E/E’ ratio), supports the interchangeable use of both techniques 
in this clinical setting. However, the lack of a direct comparison with invasive measurements 
of LV filling pressures is a study limitation.
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Several single-center studies suggested that LV dyssynchrony may play an important 
role in the prediction of a favourable response to CRT 23, thereby improving the selection 
of candidates to CRT. The most frequently used technique to assess LV dyssynchrony is TDI 
and various parameters derived from myocardial velocity curves have been proposed for this 
purpose 6;24–26. However, recently published results of the first multi-center trial suggested 
that TDI and conventional echocardiographic measures have limited value for prediction of 
response to CRT, mainly due to a marked inter-laboratory variability for the assessment of 
these parameters 27. Cardiac MRI provides important information for the selection of poten-
tial candidates for CRT 28. In addition to an accurate quantification of LV size and function, 
MRI allows a precise assessment of the location and extent of scar tissue, which has been 
demonstrated to be important for prediction of response to CRT 28. Reliable and reproducible 
quantification of LV dyssynchrony would strengthen the role of cardiac MRI in the evaluation 
of potential candidates for CRT especially in patients with ischemic cardiomyopathy. Prelimi-
nary studies compared TDI and VE-MRI for the assessment of LV dyssynchrony. Delfino et al 2 
evaluated 10 patients scheduled for CRT and reported an excellent correlation between both 
techniques without any significant bias in the measurement of Ts. However, only 2 patients of 
the study population exhibited significant LV dyssynchrony. Westenberg et al 3 confirmed the 
good correlation and agreement between TDI and VE-MRI in LV dyssynchrony classification of 
20 non-ischemic patients. The present study extended previous findings 2;3 to a larger group 
of patients with heart failure secondary to ischemic cardiomyopathy and noted similar good 
results. These results confirm that MRI may be a valuable tool for patient selection prior to 
CRT, providing a comprehensive evaluation of LV size and function, extent of scar tissue and 
LV dyssynchrony.
However, several limitations for the applicability of cardiac MRI should be addressed. First, 
claustrophobia, cardiac arrhythmias, and cardiac devices limit the use of this technique. Sec-
ond, MRI can not provide follow-up information after CRT implantation and is not as readily 
available as TDI echocardiography.
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objectives: To assess the relative value of a novel measure of left ventricular (LV) 
dyssynchrony derived from magnetic resonance imaging (MRI) and the extent of 
scar tissue for prediction of response to cardiac resynchronization therapy (CRT).
methods: A total of 35 heart failure patients scheduled for CRT were included. 
LV dyssynchrony was defined as the standard deviation of 16 segment time-to-
maximum radial wall thickness (SDt-16) obtained from a cine-set of short-axis slices. 
Delayed-enhanced MRI was performed for scar analysis. Echocardiography was 
used to determine response to CRT (reduction ≥15% in LV end-systolic volume 6 
months after implantation).
results: At follow-up, 21 patients (60%) were classified as responders. On MRI, SDt-
16 was significantly higher in responders compared to non-responders (median 97 
ms vs. 60 ms, p <0.001) while the total extent of scar was larger in non-responders 
(median 35% vs. 3% in responders, p <0.001). At the logistic regression analysis, SDt-
16 was directly associated (OR = 6.3, 95%CI 3.1-9.9, p <0.001) and the total extent of 
scar was inversely associated (OR = 0.52, 95%CI 0.43-0.87, p <0.001) with response 
to CRT.
conclusions: MRI offers the unique opportunity to assess LV dyssynchrony and 
scar extent in a single session. Both these parameters are important predictors of 
echocardiographic response to CRT.
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IntroductIon
Magnetic resonance imaging (MRI) can provide a comprehensive assessment of cardiac 
morphology and function. Accordingly, MRI has been applied extensively for the evaluation 
of heart failure patients. In addition, MRI may be important for selection of candidates for 
cardiac resynchronization therapy (CRT). It has been demonstrated that a favorable response 
to CRT may depend on different factors, including the severity of left ventricular (LV) dyssyn-
chrony, and the extent and location of scar tissue in the LV 1. Various methods for assessment 
of LV dyssynchrony by MRI have recently been reported 2–5 and MRI is particularly suited for 
assessment of scar tissue. 6 Which of these parameters (dyssynchrony, scar tissue) is more 
important for response to CRT is still unclear.
In the present study, a novel approach to detect LV dyssynchrony with MRI is evaluated in 
patients undergoing CRT. In addition, the extent and location of scar tissue is assessed using 
contrast-enhanced MRI. Subsequently, the relative merits of LV dyssynchrony and scar tissue 
for prediction of response to CRT are evaluated.
methods
patient population and protocol
The study population consisted of 50 consecutive heart failure patients scheduled for CRT 
according to the current guidelines: New York Heart Association (NYHA) functional class III-IV 
despite optimal medical therapy, LV ejection fraction (EF) ≤35% and QRS duration ≥120 ms. 
Patients with recent myocardial infarction (<3 months), decompensated heart failure, previ-
ous cardiac pacemaker/ICD or intracranial clips were excluded. Six patients did not undergo 
MRI because of atrial fibrillation and 5 patients could not complete the image acquisition 
because of claustrophobia. The image quality was not considered good enough for further 
analysis in 4 patients, due to the poor compliance of the patient during the breath-holding 
procedure or frequent ectopic beats. The remaining 35 patients constituted the current 
study population and were enrolled within 6 months. Etiology was considered ischemic in 
the presence of significant coronary artery disease (>50% stenosis in ≥1 major epicardial 
coronary artery) on coronary angiography and/or history of myocardial infarction or previous 
revascularization.
Magnetic resonance imaging was performed before CRT to assess LV dyssynchrony using 
a novel approach (details see below). Normal values for this novel MRI technique to assess 
LV dyssynchrony were derived from 20 subjects without echocardiographic evidence of 
structural heart disease and matched for age and gender. For comparison, LV dyssynchrony 
was also evaluated at baseline by radial strain speckle tracking analysis.
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In the patients, the extent and location of scar tissue was derived from contrast-enhanced 
MRI. In addition, as part of the routine clinical work-up, echocardiography and assessment of 
clinical status (including NYHA class, 6-minute walking distance and Minnesota quality-of-
life score) were performed at baseline and 6 months (±2 weeks) after CRT implantation, to 
evaluate response to CRT.
For MRI dyssynchrony analysis, all subjects gave informed consent and the protocol was 
approved by the institutional review board.
magnetic resonance imaging
Data acquisition
Data acquisition was performed on a 1.5 T scanner equipped with powertrack 6000 gradients 
(Gyroscan ACS-NT/Intera, Philips Medical Systems, Best, The Netherlands), using the body 
coil for transmission and a 5 element phased array cardiac-coil placed on the chest for signal 
reception. Scout images and 2- and 4-chamber acquisitions were performed (conform stan-
dard cardiac MR protocols 7) needed for planning. A cine-set of 10-12 multi-slice images were 
acquired in short-axis orientation, covering the complete LV from apex to base. Each slice 
was acquired in a single breath-hold. Segmented gradient-echo (turbo field echo) was used, 
with parallel imaging (Sensitivity Encoding, acceleration factor 2) 8 and steady-state free-
precession 9 for fast imaging and optimal image contrast. The following imaging parameters 
were used: slice thickness of the imaging planes = 10 mm, with no gap; Field-of-View = 440 
mm; 80% scan percentage, scan matrix = 256 × 256, with reconstructed voxels of 1.56 × 1.56 
× 10.0 mm; flip angle α = 35°; TR/TE = 3.6/1.7. One signal average was used. Gated cardiac 
synchronization was applied and 40 phases per cardiac cycle were reconstructed, yielding a 
temporal resolution of around 20 ms.
In the patients, contrast-enhanced images were acquired 15 minutes after bolus injection 
of gadolinium diethylenetriamine pentaacetetic acid (Magnevist, Schering/Berlex, Berlin, 
Germany; 0.15 mmol/Kg) with an inversion recovery gradient echo sequence (400 x 400 mm2 
Field-of-View; 256 x 256 matrix size, 5-mm slice thickness with gap of -5mm, 15° flip angle, 
echo time 1.36 ms and 4.53-ms repetition time) 10. The inversion time was determined with 
a Look-Locker sequence 11 and was typically in the range of 250-300 ms. Depending on the 
patient’s heart rate and heart size, 20 to 24 slices in the short-axis orientation were obtained 
in 2 breath-hold acquisitions of approximately 15 seconds (Figure 1).
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LV dyssynchrony analysis
From the complete short-axis dataset, 3 slices were selected representing the basal, mid-
ventricular and apical level. In these slices, epicardial and endocardial contours (excluding 
trabeculations and papillary muscles) were drawn for all phases, using QMass analytical soft-
ware package (Medis, Leiden, the Netherlands). According to the standard 16-segment model 
12, the basal and mid-ventricular short-axis slices were divided into 6 segments, while the 
apical short-axis slice was divided into 4 segments. For each segment, a radial wall thickness 
curve was automatically plotted and the time from the R wave on the ECG to maximum wall 
thickness on MRI (Tt) was determined (Figure 2). The analysis of LV dyssynchrony included 
also a maximum wall thickness eventually occurring after the systolic phase. The standard 
deviation of 16 segments Tt (SDt-16) was calculated as a marker of global LV dyssynchrony. 
The post-processing of the images required between 6 and 10 minutes.
Figure 1. Short-axis slices obtained with contrast-enhanced magnetic resonance imaging showing a large transmural area of scarred 
myocardium (bright/white) at the level of the left ventricular septum, anterior wall and apex.




The endocardial and the epicardial borders were traced on short-axis slices (from the con-
trast-enhanced MRI dataset) and each slice was divided according to the standard myocardial 
segmentation 12. Hyperenhanced regions were defined by selecting a region-of-interest in-
side the normal myocardium and thresholding the window setting at 5 SD above the mean 
signal intensity, as previously reported 13. Normal myocardium was defined by the absence 
of any regional contrast enhancement on visual inspection. The total LV myocardial mass 
and the amount of scar tissue (expressed in grams) were quantified using QMass (Medis). 
The following parameters were derived: 1) total extent of scar, expressed as percentage of 
LV mass; 2) scar transmurality, defined as scar exceeding >50% of the myocardial wall, in any 
of the 16 segments 14; 3) scar location, considering both transmural and non-transmural scar. 
In particular, scar location was classified in 3 groups according to the typical coronary artery 
territories 15: antero-septum/anterior/apex (LAD), infero-septum/inferior (RCA) and postero-
lateral (LCX). The typical non-ischemic mid-wall pattern was also considered as a fourth group.
Figure 2. Assessment of left ventricular (LV) dyssynchrony using magnetic resonance imaging. From the complete LV short-axis dataset, 3 
slices are selected representing the basal, mid-ventricular and apical level and divided into 16 standard segments. In these slices, epicardial and 
endocardial contours are drawn for all phases (upper panel). For each segment a radial wall thickness curve is plotted and the time from the R 
wave on the ECG to maximum wall thickness (Tt) is measured. The standard deviation of 16 segments Tt (SDt-16) was calculated as a marker of 
global LV dyssynchrony. Panel A shows an example of a patient with a significant LV dyssynchrony (SDt-16 = 98 ms), while Panel B shows an 
example of a patient with synchronous LV contraction (SDt-16 = 40 ms).
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echocardiography
All patients were imaged in left lateral decubitus position using a commercially available sys-
tem (Vingmed Vivid 7, General Electric Healthcare, Horten, Norway). Images were obtained us-
ing a 3.5-MHz transducer and digitally stored in cine-loop format. The analysis was performed 
offline using EchoPAC version 6.0.1 (General Electric-Vingmed). From the conventional apical 
2- and 4-chamber views, LV end-diastolic (EDV), LV end-systolic volume (ESV) and LVEF were 
calculated using the biplane method of discs (modified Simpson’s rule) 15. In addition, from 
the short axis image of the LV at the level of the papillary muscles, LV dyssynchrony was 
evaluated by radial strain speckle tracking analysis, measuring the anteroseptal-to-posterior 
wall delay and the standard deviation of time to peak radial strain of 6 segments (SD-6s), as 
previously described 16;17.
At 6 months follow-up, patients were divided into responders or non-responders, based on 
a reduction ≥15% in LVESV 18.
Reproducibility of LVESV measurement was assessed on 20 randomly selected patients, 
using Bland-Altman analysis and repeating the measurement few days later by the same 
observer and by a second independent observer. According to the Bland-Altman analysis, 
the results were expressed as mean difference±2 standard deviation. The intra-observer 
agreement was 0.6±8.3 ml (p = 0.12), whereas the inter-observer agreement was 1.1±10.1 
ml (p = 0.078).
The severity of mitral regurgitation was graded semi-quantitatively from color-Doppler 
images obtained in the parasternal long-axis and apical 4-chamber views and characterized 
as follows: absent, mild (ratio jet area/LA area <20%), moderate (jet area/LA area 20% to 40%) 
and severe (jet area/LA area >40%) 19.
crt implantation
The LV pacing lead was inserted transvenously via the subclavian route. First, a coronary sinus 
venogram was obtained during occlusion of the coronary sinus with a balloon catheter. Next, 
the LV pacing lead (Easytrak, Boston Scientific, St. Paul, Minnesota, or Attain-SD, Medtronic, 
Minneapolis, Minnesota) was inserted into the coronary sinus with the help of an 8F guiding 
catheter and positioned as far as possible in the venous system, preferably in the (postero-) 
lateral vein. The final position of the LV pacing lead was assessed with cine fluoroscopy as 
previously described 20 and the relation between LV lead position and location of transmural 
scar was assessed. The right atrial and right ventricular leads were positioned convention-
ally. All patients received a biventricular pacemaker with cardioverter-defibrillator back-up 
(Contak Renewal 4RF, Boston Scientific; or InSync Sentry, Medtronic Inc.).




Clinical and echocardiographic (including speckle tracking analysis) continuous variables 
are presented as mean±standard deviation. The MRI continuous variables were not normally 
distributed (as evaluated by Kolmogorov-Smirnov tests) and therefore presented as medians 
and corresponding 25th and 75th percentiles. Categorical data are summarized as frequencies 
and percentages, and Wilcoxon-Mann-Whitney tests, chi-square tests with Yates’ correction or 
Fisher exact tests were used for appropriate comparisons. Pearson’s correlation analysis was 
performed to evaluate the relation between LV dyssynchrony measured by MRI and speckle 
tracking strain analysis. To determine the relationship between patients’ characteristics at 
baseline and echocardiographic response to CRT, univariable logistic regression analysis was 
applied (odds ratios with their corresponding 95% confidence intervals [CI] are reported).
The reproducibility of SDt-16 measurement was assessed by Bland-Altman analysis for 
repeated measures (mean differences and 95% limits of agreement are reported) using a 
randomly selected dataset of 10 patients and 5 normal subjects (total of 240 segments). 
The measurements derived by a first observer were compared with the results calculated 1 
month later by the same operator (intra-observer agreement) and by a second independent 
observer (inter-observer agreement). For all tests, a p-value <0.05 was considered significant. 
A statistical software program SPSS 12.0 (SPSS Inc, Chicago, Illinois) was used for statistical 
analysis.
table 1. Baseline characteristics of the study population: patients versus control subjects.
control subjects  
(n = 20)
patients
 (n = 35)
p-value
Age, years 62±8 63±11 0.61
Gender, male/female 15/5 26/9 0.47
NYHA class - 3.0±0.5 -
QRS duration, ms 91±9  145±33 <0.001
Etiology, n (%)














LVEDV, ml 87±30 230±70 <0.001
LVESV, ml 35±13 177±70 <0.001
LVEF, % 62±7 24±8 <0.001
MR moderate/severe, n (%) - 11 (31) -
EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic volume, LV: left ventricle, MR: mitral regurgitation, NYHA: New York Heart 
Association. 
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results
Baseline characteristics of the 35 patients are summarized in Table 1. The etiology of cardio-
myopathy was ischemic in 20 (57%) patients. Mean QRS duration was 145±33 ms. Standard 
echocardiography revealed severe LV dilatation (mean LVEDV 230±70 ml) with depressed LV 
systolic function (mean LVEF 24±8%).
magnetic resonance imaging
LV dyssynchrony
Reliable radial wall thickness curves were obtained in 793 (91%) of 880 segments. Intra- and 
inter-observer agreements for SDt-16 measurement were good: 1.75 ms (95% limits of agree-
ment 18.6/-15.15 ms; p = 0.62) and 2.23 ms (95% limits of agreement 27.8/-23.3 ms; p = 0.56), 
respectively (Figure 3).
Left ventricular dyssynchrony, as measured by SDt-16, was significantly larger in patients 
(median 88 ms [25th and 75th percentiles 67 and 99 ms]) as compared to control subjects 
(median 26 ms [25th and 75th percentiles 22 and 31 ms], p <0.001).
Similarly, echocardiographic radial strain speckle tracking analysis showed a significant LV 
dyssynchrony in the patients: the anteroseptal-to-posterior wall delay was 175±90 ms and 
SD-6s 90±52 ms.
Of note, according to the previously reported definition of significant LV dyssynchrony 16;17, 
24 patients (68.5%) showed an anteroseptal-to-posterior wall delay ≥130 ms and 19 patients 
(54%) a SD-6s ≥76 ms. Furthermore, a good correlation was found between LV dyssynchrony 
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Figure 3. Intra- (Panel A) and inter-observer (Panel B) agreements for SDt-16 measurement calculated with Bland-Altman analysis for 
repeated measures. The mean bias, the 95% limits of agreement and their associated 95% confidence intervals are reported.
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measured by MRI (SDt-16) and LV dyssynchrony derived from speckle tracking strain analysis 
(r = 0.60, p <0.001 for anteroseptal-to-posterior wall delay, and r = 0.77, p <0.001 for SD-6s).
Myocardial scar
Of the 35 patients, 24 (69%) had scar tissue on contrast-enhanced MRI. In these patients, the 
median total extent of scar was 12% (25th and 75th percentiles 4 and 36%) and transmural 
scar was present in 14 (40%) patients. In particular, scar involved most frequently the sep-
tum/anterior/apex region (8 patients, 40%) and the inferior wall (7 patients, 35%), while a 
postero-lateral scar was detected in 5 (25%) patients. Of interest, in 4 (27%) patients with 
non-ischemic cardiomyopathy, a mid-wall scar pattern was detected.
prediction of response to crt
Six months after CRT implantation, a reduction in LVESV ≥15% was noted in 21 patients (60%) 
who were classified as responders to CRT. Responders showed a significant improvement 
in clinical parameters (NYHA class, 6-minute walking distance, quality-of-life score) after 6 
months of CRT, whereas non-responders did not improve, except for a modest improvement 
in NYHA class (Table 2). Responders also exhibited an improvement in echocardiographic 
parameters (LVESV by definition, but also an improvement in LVEDV and LVEF), whereas non-
responders did not improve (Table 2).
No significant differences in baseline clinical and echocardiographic characteristics were 
noted between responders and non-responders (Table 2), except for a higher prevalence of 
ischemic etiology of heart failure in non-responders (86% vs. 38%, p = 0.007).
On MRI, the SDt-16 was significantly larger in responders compared to non-responders 
(median 97 ms [25th and 75th percentiles 90 and 106 ms] vs. 60 ms [25th and 75th percentiles 47 
and 71 ms], p <0.001) (Table 3). Similarly, on echocardiography the anteroseptal-to-posterior 
wall delay (212.4±76.5 ms vs. 97.6±64.6 ms, p <0.001) and SD-6s (110.7±46.9 ms vs. 47.7±31.9 
ms, p <0.001) were larger in responders as compared to non-responders.
Furthermore, the total extent of scar tissue was significantly larger in non-responders as 
compared to responders to CRT, with a median of 35% (25th and 75th percentiles 12 and 48%) 
for non-responders and a median of 3% (25th and 75th percentiles 0 and 8%) for responders 
(p <0.001). Similarly, a transmural scar was present in 71% of non-responders and in 19% of 
responders (p = 0.003) (Table 3).
No significant difference was found between responders and non-responders for scar loca-
tion (Table 3). However, a match between LV lead position and a transmural scar was found in 
8 (57%) non-responders and in 3 (14%) responders (p = 0.002, Table 3).
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Age, years 64±9 62±12 0.47
Gender, male/female 16/5 10/4 0.32
Ischemic/Non-ischemic, n (%) 8(38)/13(62) 12(86)/2(14) 0.007
































































*= p <0.001 baseline versus follow-up. 6-MWT: 6 minutes walk test. For the rest of abbreviations see Table 1.







Total scar extent, % (25th,75th percentiles) 3 (0-8) 35 (12-48) <0.001
Patients with scar, n (%) 11 (52) 13 (93) <0.001
Transmural scar, n (%) 4 (19) 10 (71) 0.003
Non transmural scar, n (%) 7 (33) 3 (21) 0.079














Match LV lead/transmural scar, n (%)  3 (14) 8 (57) 0.002
SDt-16, ms (25th, 75th percentiles) 97 (90-106) 60 (47-71) <0.001
SDt-16: standard deviation of 16 segment time-to-peak radial thickness.
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Importantly at the univariable logistic regression analysis, SDt-16 was strongly associated 
with response to CRT (OR = 6.3, 95% CI 3.1-9.9, p <0.001), while the total extent of scar was 
significantly associated with non-response to CRT (OR = 0.52, 95% CI 0.43-0.87, p <0.001). 
The presence of a match between the LV lead position and a transmural scar was also 
a significantly associated with non-response to CRT (OR = 0.125, 95% CI 0.031-0.630, p = 
0.012). Among the other clinical and echocardiographic variables, only the QRS duration was 
significantly associated with response to CRT (OR = 1.03, 95% CI 1.01-1.05, p = 0.048).
dIscussIon
The main findings of the current study can be summarized as follows: 1) LV dyssynchrony, 
measured by SDt-16, was significantly larger in heart failure patients as compared to normal 
individuals and showed a good correlation with LV dyssynchrony measured by speckle track-
ing strain analysis; 2) SDt-16, total extent of scar and the presence of a match between LV lead 
position and a transmural scar were strongly associated with response to CRT.
mrI for the assessment of lv dyssynchrony
Several single-center studies have suggested that the presence of significant baseline LV 
dyssynchrony may predict favorable response to CRT and thereby improve selection of 
potential candidates 1. Echocardiography, and in particular tissue Doppler imaging (TDI), has 
been used extensively to directly assess LV mechanical dyssynchrony 1. However, the recently 
published results of the PROSPECT trial suggested that standard echocardiography and TDI 
have limited value for prediction of response to CRT, mainly due to high inter-corelab vari-
ability 18. However, measurements of LV dyssynchrony derived from novel echocardiographic 
techniques and non-echocardiographic imaging modalities were not included in this trial. In 
particular, several techniques to assess LV dyssynchrony using MRI are emerging. Myocardial 
tissue tagging provides highly reproducible data on myocardial strain not only in the longi-
tudinal, but also in the radial and circumferential direction 2;3. However, the clinical applicabil-
ity of this method is limited by the time-consuming post-processing of the dataset. Also, 
velocity-encoded MRI has demonstrated good reproducibility and excellent agreement with 
TDI for assessment of the electromechanical delay between the LV septum and lateral wall 4. 
However, this method is mainly limited by the fact that it can include in the analysis only the 
basal and mid LV segments and it evaluates myocardial velocities and not measurements of 
active deformation. More recently, MRI tissue synchronization imaging has been proposed 
by Chalil et al. as a novel technique for the assessment of LV dyssynchrony and the predic-
tion of mortality and morbidity after CRT 5. This is a relatively simple and clinically applicable 
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approach that tracks only the endocardium using standard short-axis views and includes the 
whole LV in the analysis. However, it quantifies radial wall motion and therefore is still limited 
by the incapability to distinguish between active deformation, passive motion and noise.
In the present study, a novel MRI method that involves both endocardial and epicardial 
border detection, was used. By analyzing myocardial wall thickness instead of myocardial 
motion, it provides accurate information on LV regional active deformation (even when it 
occurs after the systolic phase) and therefore may reflect true LV dyssynchrony. Furthermore, 
this method does not require specific acquisitions, but only involves the standard cine-set of 
LV short-axis slices, from which radial wall thickness is derived.
Recent studies, using speckle tracking echocardiography, suggested that LV dyssynchrony 
measured by radial strain analysis is a good predictor of response to CRT and appeared su-
perior over longitudinal and circumferential strain 16;17. Similarly, in the current study, SDt-16 
demonstrated to be strongly associated with significant LV reverse remodeling at mid-term 
follow-up after CRT implantation. Future studies need to compare this approach with other 
MRI approaches for the assessment of LV dyssynchrony.
In addition, this measurement demonstrated an excellent reproducibility, although as-
sessed in a single-center study and on the same dataset (instead of repeating the MRI scan 
in the same patient).
mrI for the assessment of myocardial scar
In addition to LV dyssynchrony, other factors may play a significant role in the prediction 
of response to CRT 1. Initial single-center studies suggested that the amount and spatial 
distribution of myocardial scar may be important determinants of response to CRT 14;21–23. 
In particular, the presence of extensive scar tissue seems to be associated with limited LV 
remodeling and improvement in function after CRT 14;23. However, whether the scar extent 
has a predictive value for response to CRT in addition to the degree of LV dyssynchrony is 
still unknown, since the previous studies only focused on myocardial scar analysis without 
considering the potential interaction with LV dyssynchrony 14;23. In the present study, the total 
extent of scar was found to be strongly associated with echocardiographic response to CRT 
as well as LV dyssynchrony (measured with MRI). These findings confirm and support the 
evaluation of both parameters (myocardial scar and LV dyssynchrony) for the selection of 
the candidates to CRT. However, the results of the present study are not sufficient to solve 
more complicate clinical cases, in which the analysis of LV dyssynchrony and scar extent may 
provide discordant indication for CRT implantation (substantial LV dyssynchrony but exten-
sive scar or small scar with no substantial LV dyssynchrony). Consequently, an individual 
and comprehensive evaluation of each patient that undergoes to CRT, including clinical, 
echocardiographic and MRI variables, is fundamental.
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In addition, the location of a transmural scar in the postero-lateral region, where the LV 
pacing lead is usually positioned, seems to play an important role in the efficacy of CRT 21. 
However, White et al. have also demonstrated that a septal scar larger than 40% of the total 
mass was associated with unfavorable response to CRT 23. In the current study, the scar loca-
tion per se did not show a significant effect on CRT efficacy. However, a significant inverse 
relation was noted between the response to CRT and the presence of a match between the 
LV lead position and a transmural scar location.
clinical implications
The MRI approach proposed in the present study offers the potential advantage to obtain 
accurate measurements of both LV dyssynchrony and myocardial scar in a single session, 
without requiring multiple imaging investigations and specific MRI acquisitions, beyond 
the standard protocol. Furthermore, MRI provides detailed information about cardiac mor-
phology and function as well as quantification of trans-valvular flows. This comprehensive 
approach is particularly useful in heart failure patients and, according to the current results, 
seems to be capable to improve the selection of candidates to CRT. However, larger patient 
cohorts and multicenter studies are needed to confirm these findings and a longer follow-up 
is necessary to perform a survival analysis.
conclusIons
MRI offers the unique opportunity to assess LV dyssynchrony and the total extent of scar in 
a single session. Both these parameters showed to be strongly associated with echocardio-
graphic response to CRT.
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Agreement and disagreement between 
contrast-enhanced magnetic resonance 
imaging and nuclear imaging for 
assessment of myocardial viability
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objectives: The purpose of this study was to compare contrastenhanced MRI and 
nuclear imaging with 99mTc-tetrofosmin and 18F-fluorodeoxyglucose (18F-FDG) 
single photon emission computed tomography (SPECT) for assessment of myocar-
dial viability.
methods: Included in the study were 60 patients with severe ischaemic left ventric-
ular (LV) dysfunction, who underwent contrast-enhanced MRI, 99mTc-tetrofosmin 
and 18F-FDG SPECT. Myocardial segments were assigned a wall motion score from 
0 (normokinesia) to 4 (dyskinesia) and a scar score from 0 (no scar) to 4 (76–100% 
transmural extent). Furthermore, 99mTc-tetrofosmin and 18F-FDG segmental tracer 
uptake was categorized from 0 (tracer activity >75%) to 3 (tracer activity <25%). 
Dysfunctional segments were classified into viability patterns on SPECT: normal 
perfusion/18F-FDG uptake, perfusion/18F-FDG mismatch, and mild or severe 
perfusion/18F-FDG match.
results: Minimal scar tissue was observed on contrast-enhanced MRI (scar score 
0.4±0.8) in segments with normal perfusion/18F-FDG uptake, whereas extensive 
scar tissue (scar score 3.1±1.0) was noted in segments with severe perfusion/18F-
FDG match (p <0.001). High agreement (91%) for viability assessment between 
contrast-enhanced MRI and nuclear imaging was observed in segments without 
scar tissue on contrast-enhanced MRI as well as in segments with transmural scar 
tissue (83%). Of interest, disagreement was observed in segments with subendocar-
dial scar tissue on contrast-enhanced MRI.
conclusions: Agreement between contrast-enhanced MRI and nuclear imaging for 
assessment of viability was high in segments without scar tissue and in segments 
with transmural scar tissue on contrast-enhanced MRI. However, evident disagree-
ment was observed in segments with subendocardial scar tissue on contrast-
enhanced MRI, illustrating that the non-enhanced epicardial rim can contain either 
normal or ischaemically jeopardized myocardium.
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IntroductIon
Assessment of viability is essential for optimization of treatment in patients with ischaemic left 
ventricular (LV) dysfunction, since dysfunctional but viable myocardium is likely to improve 
after revascularization, whereas dysfunctional but nonviable myocardium will not benefit 1. 
Furthermore, patients with viable myocardium have better survival after revascularization 
than after medical treatment 2. At the present time, several noninvasive imaging modalities 
are available for the assessment of viability, including dobutamine echocardiography, single 
photon emission computed tomography (SPECT) and positron emission tomography (PET) 
3–5. Nuclear imaging using tracers such as 99mTc-tetrofosmin and 18F- fluorodeoxyglucose 
(18F-FDG) allows evaluation of viability by assessment of myocardial perfusion and glucose 
utilization 4. Contrast-enhanced magnetic resonance imaging (MRI) has been more recently 
introduced for assessment of viability 6–8. This technique offers visualization of scar tissue 
with high spatial resolution, enabling distinction between subendocardial and transmural 
scar 9. Kim et al. reported that in segments without contrast-enhancement on MRI, recovery 
of function is highly likely to occur after revascularization, whereas improvement of func-
tion is unlikely in segments with extensive, transmural contrast-enhancement 6. However, 
difficulties arise in dysfunctional segments with subendocardial scar tissue, which show an 
intermediate extent of recovery, since contrast-enhanced MRI provides only information on 
scar tissue, whereas the non-enhanced (viable) tissue can contain either normal or ischaemi-
cally jeopardized myocardium 10. Hence, the two imaging modalities discussed above provide 
different information on viability.
To our knowledge, only a few, relatively small studies have evaluated patients using both 
contrast-enhanced MRI and nuclear imaging to determine viability 11–14. Consequently, the 
exact relationship between viability assessed with contrast-enhanced MRI and nuclear im-
aging is still largely unknown. Therefore, the purpose of the present study was to compare 
contrast-enhanced MRI and nuclear imaging with 99mTc-tetrofosmin and 18F-FDG SPECT for 
the assessment of viability in patients with severe ischaemic LV dysfunction.
methods
patient population
The study population consisted of 60 patients with severe ischaemic LV dysfunction who 
underwent MRI, 99mTctetrofosmin SPECT and 18F-FDG SPECT. Patients with myocardial 
infarction (MI) <3 months before MRI or SPECT were excluded. Other exclusion criteria were 
(supra-)ventricular arrhythmias, pacemakers, intracranial clips and claustrophobia. Patient 
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characteristics are presented in Table 1. The local ethics committee approved the study and 
all patients gave informed consent.
mrI: data acquisition
A 1.5-T Gyroscan ACS-NT/Intera MRI scanner (Philips Medical Systems, Best, The Netherlands) 
equipped with a five-element cardiac synergy coil was used. Images were acquired during 
breath-holds of approximately 15 s using vector electrocardiographic gating. The heart was 
imaged from apex to base 15 with 10–12 imaging levels (dependent on the heart size) in 
the short-axis view using a balanced turbofield echo sequence with parallel imaging (SENSE, 
acceleration factor 2). Typical parameters were a field of view of 400×320 mm2, matrix of 
256×206 pixels, slice thickness of 10.00 mm, no slice gap, flip angle of 35°, time to echo of 
1.67 ms, and time to repeat of 3.3 ms. Temporal resolution was 25 to 39 ms. The geometric 
settings of the baseline scans were stored and repeated for the contrast-enhanced images 
to ensure matching of the same slices (and hence, myocardial segments). Contrast-enhanced 
images were acquired approximately 15 min after bolus injection of gadolinium diethyl-
enetriamine pentaacetic acid (Magnevist, Schering, Berlin, Germany; 0.15 mmol/kg) with an 
inversion-recovery 3-D turbofield echo sequence; the inversion time was determined with 
a real-time plan scan. Typical parameters were a field of view of 400×300 mm2, matrix of 
256×192 pixels, slice thickness of 5.00 mm, flip angle of 15°, time to echo of 1.1 ms, and time 
to repeat of 3.00 ms.
mrI: data analysis
To determine global function, endocardial borders were outlined manually on short-axis 
cine images with previously validated software (MASS; Medis, Leiden, The Netherlands) 16. 
Papillary muscles were regarded as part of the ventricular cavity, and epicardial fat was 
excluded. LV end-systolic volume (ESV) and LV end-diastolic volume (EDV) were calculated. 
Subsequently, ESV was subtracted from EDV and LV ejection fraction (LVEF) was calculated. 
To determine regional wall motion, cine MR images were visually interpreted by two expe-
rienced observers using a 17-segment model 17. Each segment was assigned a wall motion/
thickening score using the following five-point scale: 0 normal wall motion, 1 mild hypokine-
sia, 2 severe hypokinesia, 3 akinesia, and 4 dyskinesia. Wall thickening was taken into account 
for this classification, preempting the problem of postoperative paradoxical septal motion 
in patients with previous coronary artery bypass grafting. Contrast-enhanced images were 
scored visually by two experienced observers using the 17-segment model described above 
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17. Segmental scarring was graded on each segment using the following five-point scale: 0 
absence of hyperenhancement, 1 hyperenhancement of 1% to 25% of
LV wall thickness, 2 hyperenhancement extending from 26% to 50%, 3 hyperenhancement 
extending from 51% to 75%, and 4 hyperenhancement extending from 76% to 100% 18.
99mtc-tetrofosmin spect: data acquisition
Imaging was performed at rest, with 99mTc-tetrofosmin (500 MBq) using a triple-head SPECT 
camera (GCA 9300/HG, Toshiba Corporation) equipped with low-energy, general-purpose 
collimators. A 20% window was used around the 140-keV energy peak of 99mTc-tetrofosmin. 
A total of 90 projections (step-and-shoot mode of 35 s/projection, total imaging time 23 min) 
were obtained over a 360° circular orbit. Data were stored in a 64×64, 16-bit matrix. The raw 
scintigraphic data were reconstructed with filtered back projection using a Butterworth filter 
(cut-off frequency 0.26 cycles per pixel, order 9). No attenuation correction was used.
99mtc-tetrofosmin spect: data analysis
Additional reconstruction yielded standard long- and shortaxis projections perpendicular to 
the heart axis. Reconstructed slices were 6 mm in all directions. The short-axis slices were dis-
played in polar map format, adjusted for peak myocardial activity (100%). The myocardium 
was divided into 17 segments 17. Segmental tracer activity was categorized visually by two 
experienced observers on a four-point scale (0 normal tracer activity >75%, 1 mildly reduced 
tracer activity 50–75%, 2 moderately reduced tracer activity 25–50%, and 3 severely reduced 
tracer activity <25%).
18f-fdg spect: data acquisition
18F-FDG imaging, to evaluate myocardial glucose utilization, was performed on a separate 
day, after administration of acipimox (a nicotinic acid derivative, 500 mg, oral dose; Byk, 
Zwanenberg, The Netherlands) 19. Acipimox enhances myocardial 18F-FDG uptake by reduc-
ing the plasma level of free fatty acids 20. After acipimox administration, the patients received 
a low-fat, carbohydrate-rich meal. This small meal further enhances myocardial 18F-FDG 
uptake by stimulating endogenous insulin release 21. A blood sample was taken 60 min after 
acipimox administration to assess plasma glucose levels, and insulin was administered if 
needed. Then, 185 MBq 18F-FDG was injected at rest. Data were acquired 45 min later at 
rest using the same SPECT system as described for perfusion imaging, with commercially 
Nina Book.indb   305 26-09-11   12:04
Chapter 17
306
available 511-KeV collimators. Data were acquired over 360° and stored in a 64×64, 16-bit 
matrix. From the raw scintigraphic data, transaxial slices were reconstructed by filtered back 
projection using a Butterworth filter (cut-off frequency 0.17 cycles per pixel, order 8). Attenu-
ation correction was not applied.
18f-fdg spect: data analysis
Further reconstruction yielded standard short- and long-axis projections perpendicular to 
the heart axis. 18F-FDG shortaxis slides were displayed in polar map format, normalized to 
the maximum activity (set at 100%); the polar maps were divided into 17 segments 17. Seg-
mental tracer activity was categorized visually by two experienced observers on a four-point 
scale (0 normal tracer activity >75%, 1 mildly reduced tracer activity 50–75%, 2 moderately 
reduced tracer activity 25–50%, and 3 severely reduced tracer activity <25%).
definition of viability on nuclear imaging
The dysfunctional segments on cine MRI (wall motion score ≥1) were divided into four 
groups with different patterns of viability. Group I (normal perfusion/18F-FDG uptake) 
consisted of segments with normal 99mTc-tetrofosmin activity (score 0) and normal 18F-
FDG activity (score 0). Group II (perfusion/18F-FDG mismatch) consisted of segments with 
reduced 99mTc-tetrofosmin activity (score 1, 2 or 3) and preserved/relatively increased 18F-
FDG activity (18FFDG score < 99mTc-tetrofosmin score). Group III (mild perfusion/18F-FDG 
match) consisted of segments with a mild reduction in 99mTc-tetrofosmin activity (score 
1) and a concordant mild reduction in 18F-FDG activity (score 1). Finally, group IV (severe 
perfusion/18F-FDG match) consisted of segments with a moderate or severe reduction in 
99mTc-tetrofosmin activity (score 2 or 3) and a concordant reduction in 18F-FDG activity.
statistical analysis
Continuous data are expressed as means±standard deviation (SD). One-way ANOVA was 
used to compare scar score between the groups with different viability patterns. Proportions 
were compared using chi-squared (χ2) analysis. P-values <0.05 were considered statistically 
significant.
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results
patient population
Clinical data are presented in Table 1. The mean age of the study population was 65±11 years 
and 50 patients (83%) were men. All patients had evidence of coronary artery disease (CAD) 
on coronary angiography. No clinical events or interventions were reported between MRI 
and SPECT examinations.
magnetic resonance imaging
Mean LVEF in the total study population was 27±9%. The mean LVESV and mean LVEDV were 
250±110 ml and 335±114 ml, respectively. A total of 1020 segments were analysed, of which 
692 (68%) showed abnormal wall motion. Of these dysfunctional segments, 91 (13%) showed 
mild hypokinesia, 248 (36%) showed severe hypokinesia, and 298 (43%) segments were 
table 1. Clinical characteristics of the study population





Men 50 (83) 
Diabetes mellitus 16 (27) 
Hypertension 14 (23) 
Hypercholesterolaemia 23 (38) 
Smoking 25 (42) 
Previous MI 60 (100) 
Prior revascularization 34 (57) 
Percutaneous coronary intervention 20 (33) 
Coronary artery bypass grafting 14 (23) 
Extent of CAD (on coronary angiography) 
One-vessel disease 11 (18) 
Two-vessel disease 18 (30) 
Three-vessel disease 31 (52) 
Medications:
β-Blockers 48 (82) 
Calcium channel blockers 10 (17) 
ACE inhibitors 55 (92) 
Oral anticoagulants 59 (98) 
Statins 48 (80) 
Nitrates 28 (47) 
Diuretics 56 (93) 
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akinetic and 55 (8%) were dyskinetic. Of the 692 dysfunctional segments, 484 (70%) revealed 
hyperenhancement, 105 (15%) showed minor hyperenhancement (scar score 1), 107 (15%) 
had a scar score of 2, 130 (19%) a scar score of 3, and 142 (21%) a scar score of 4.
99mtc-tetrofosmin spect
Of the 692 dysfunctional segments, 182 (26%) showed normal 99mTc-tetrofosmin activity 
(score 0), 91 (13%) showed mildly reduced tracer activity (score 1), 147 (21%) showed moder-
ately reduced tracer activity (score 2), and 272 (39%) showed severely reduced tracer activity 
(score 3).
18f-fdg spect
Normal 18F-FDG activity was observed in 220 segments (32%) of the 692 dysfunctional seg-
ments. Mildly reduced tracer activity (score 1) was seen in 157 segments (23%), moderately 
reduced tracer activity (score 2) in 108 segments (16%), and severely reduced tracer activity 
(score 3) in 207 segments (30%).
viability patterns assessed with nuclear imaging
Of the 692 dysfunctional segments, 183 (26%) showed normal perfusion/18F-FDG uptake, 
145 (21%) showed perfusion/18F-FDG mismatch, 73 (11%) showed mild perfusion/18F-FDG 
match, and 291 (42%) showed severe perfusion/ 18F-FDG match. Of the 353 akinetic and 
dyskinetic segments, 40 (11%) showed normal perfusion/18F-FDG uptake, 78 (22%) showed 
perfusion/18F-FDG mismatch, 35 (10%) showed mild perfusion/18F-FDG match, and 200 
(57%) showed severe perfusion/18F-FDG match.
viability: nuclear imaging versus contrast-enhanced mrI
The mean scar scores measured in the segments grouped according to viability pattern on 
nuclear imaging are presented in Figure 1. Minimal scar tissue was observed on contrast-
enhanced MRI in segments with normal perfusion/18F-FDG uptake on nuclear imaging (scar 
score 0.4±0.8), whereas extensive scar tissue (scar score 3.1±1.0) was noted in segments 
showing severe perfusion/18F-FDG match on nuclear imaging (p <0.001). Next (Figure 2), 
the dysfunctional segments were grouped according to the transmural extent of the scar 
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tissue on contrast-enhanced MRI. The majority of segments without scar tissue on contrast-
enhanced MRI (scar score 0, Figure 2a) showed normal perfusion/18F-FDG uptake (67%) or 
perfusion/18F-FDG mismatch (24%). Considering viability, agreement in these segments was 
high (91%), since segments without scar tissue on contrast-enhanced MRI as well as seg-
ments with normal perfusion/18F-FDG uptake or perfusion/18F-FDG mismatch on nuclear 
imaging are regarded as viable tissue. Conversely, the majority (83%) of segments with trans-
mural scar tissue on contrast-enhanced MRI (scar scores 3 and 4, Figure 2c) showed severe 
99mTc-tetrofosmin activity (score 2 or 3) and a concordant
reduction in 18F-FDG activity.
Statistical analysis
Continuous data are expressed as means±standard deviation
(SD). One-way ANOVA was used to compare scar score
between the groups with different viability patterns. Propor-
tions were compared using chi-squared (χ2) analysis.
P values <0.05 were considered statistically significant.
Results
Study population
Clinical data are presented in Table 1. The mean age of the
study population was 65±11 years and 50 patients (83%)
were men. All patients had evidence of coronary artery
disease (CAD) on coronary angiography. No clinical events
or interventions were reported between MRI and SPECT
examinations.
MRI
Mean LVEF in the total study population was 27±9%. The
mean LV ESV and mean LV EDV were 250±110 ml and
335±114 ml, respectively. A total of 1020 segments were
analysed, of which 692 (68%) showed abnormal wall
motion. Of these dysfunctional segments, 91 (13%) showed
mild hypokinesia, 248 (36%) showed severe hypokinesia,
and 298 (43%) segments were akinetic and 55 (8%) were
dyskinetic. Of the 692 dysfunctional segments, 484 (70%)
revealed hyperenhancement, 105 (15%) showed minor
hyperenhancement (scar score 1), 107 (15%) had a scar
score of 2, 130 (19%) a scar score of 3, and 142 (21%) a
scar score of 4.
99mTc-tetrofosmin SPECT
Of the 692 dysfunctional segments, 182 (26%) showed
normal 99mTc-tetrofosmin activity (score 0), 91 (13%)
showed mildly reduced tracer activity (score 1), 147
(21%) showed moderately reduced tracer activity (score 2),
and 272 (39%) showed severely reduced tracer activity
(score 3).
18F-FDG SPECT
Normal 18F-FDG activity was observed in 220 segments
(32%) of the 692 dysfunctional segments. Mildly reduced
tracer activity (score 1) was seen in 157 segments (23%),
moderately reduced tracer activity (score 2) in 108 seg-
ments (16%), and severely reduced tracer activity (score 3)
in 207 segments (30%).
Viability patterns assessed with nuclear imaging
Of the 692 dysfunctional segments, 183 (26%) showed
normal perfusion/18F-FDG uptake, 145 (21%) showed
perfusion/18F-FDG mismatch, 73 (11%) showed mild perfu-
sion/18F-FDG match, and 291 (42%) showed severe perfu-
sion/18F-FDG match.
Of the 353 akinetic and dyskinetic segments, 40 (11%)
showed normal perfusion/18F-FDG uptake, 78 (22%)
showed perfusion/18F-FDG mismatch, 35 (10%) showed
mild perfusion/18F-FDG match, and 200 (57%) showed
severe perfusion/18F-FDG match.
Viability: nuclear imaging versus contrast-enhanced MRI
The mean scar scores measured in the segments grouped
according to viability pattern on nuclear imaging are
presented in Fig. 1. Minimal scar tissue was observed on
contrast-enhanced MRI in segments with normal perfu-
sion/18F-FDG uptake on nuclear imaging (scar score 0.4±
0.8), whereas extensive scar tissue (scar score 3.1±1.0) was
noted in segments showing severe perfusion/18F-FDG
match on nuclear imaging (p<0.001).
Next (Fig. 2), the dysfunctional segments were grouped
according to the transmural extent of the scar tissue on
contrast-enhanced MRI. The majority of segments without
scar tissue on contrast-enhanced MRI (scar score 0, Fig. 2a)
showed normal perfusion/18F-FDG uptake (67%) or perfu-
sion/18F-FDG mismatch (24%). Considering viability,
agreement in these segments was high (91%), since
segments without scar tissue on contrast-enhanced MRI as
well as segments with normal perfusion/18F-FDG uptake or
perfusion/18F-FDG mismatch on nuclear imaging are
regarded as viable tissue. Conversely, the majority (83%)
Fig. 1 Mean scar scores on contrast-enhanced MRI for segments
grouped according to viability pattern on nuclear imaging. (one-way
ANOVA: p<0.001). Error bars represent standard deviations
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Figure 1. Mean scar scores on contrast-enhanced MRI for segments grouped according to viability pattern on nuclear imaging. (one-way 
ANOVA: p <0.001). Error bars represent standard deviations.
of segments with transmural scar tissue on contrast-
enhanced MRI (scar scores 3 and 4, Fig. 2c) showed severe
perfusion/18F-FDG match on nuclear imaging. Accordingly,
agreement in these segments was also high (83%), since
segments with transmural scar tissue on contrast-enhanced
MRI and segments with severe perfusion/18F-FDG match
on nuclear imagi g represent nonviabl tissue. Of note, in
segments with subendocardial scar tissue on contrast-
enhanced MRI (scar scores 1 and 2, Fig. 2b), the various
viability patterns assessed with nuclear imaging were
evenly distributed, indicating that segments with subendo-
cardial scar tissue on contrast-enhanced MRI, may have
normal perfusion/18F-FDG uptake, perfusion/18F-FDG mis-
match, mild perfusion/18F-FDG match or severe perfu-
sion/18F-FDG match. Figure 3 shows an example of a
patient with subendocardial scar tissue on contrast-enhanced
MRI and perfusion/18F-FDG mismatch on nuclear imaging.
Finally (Fig. 4), the akinetic and dyskinetic segments
were analysed separately. The majority of these segments
without scar tissue on contrast-enhanced MRI (scar score 0,
Fig. 4a) showed normal perfusion/18F-FDG uptake (47%)
or perfusion/18F-FDG mismatch (39%) on nuclear imaging.
Fig. 2 Relationship between contrast-enhanced MRI and nuclear
imaging for dysfunctional segments showing the frequency of the four
viability patterns assessed with nuclear imaging in segments without
scar tissue (a), with subendocardial scar tissue (b) and with transmural
scar tissue (c) on contrast-enhanced MRI
Fig. 4 Relationship between contrast-enhanced MRI and nuclear
imaging for akinetic and dyskinetic segments showing the frequency
of the four viability patterns assessed with nuclear imaging in
segments without scar tissue (a), with subendocardial scar tissue (b)
and transmural scar tissue (c) on contrast-enhanced MRI
Fig. 3 Patient with inferior subendocardial scar tissue on contrast-
enhanced MRI (a) and a severe reduction in 99mTc-tetrofosmin activity
(b) but preserved 18F-FDG activity (c) on SPECT (perfusion/18F-FDG
mismatch), indicating ischaemically jeopardized myocardium, high-
lighting the discrepancy between information derived from contrast-
enhanced MRI and nuclear imaging
598 Eur J Nucl Med Mol Imaging (2009) 36:594–601
Figure 2. Relationship between contrast-enhanced MRI and nuclear imaging for dysfunctional segments showing the freque cy of the four 
viability patterns assessed with nuclear imaging in segments without scar tissue (a), with subendocardial scar tissue (b) and with transmural 
scar tissue (c) on contrast-enhanced MRI.
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perfusion/18F-FDG match on nuclear imaging. Accordingly, agreement in these segments 
was also high (83%), since segments with transmural scar tissue on contrast-enhanced MRI 
and segments with severe perfusion/18F-FDG match on nuclear imaging represent nonvi-
able tissue. Of note, in segments with subendocardial scar tissue on contrast-enhanced MRI 
(scar scores 1 and 2, Figure 2b), the various viability patterns assessed with nuclear imag-
ing were evenly distributed, indicating that segments with subendocardial scar tissue on 
contrast-enhanced MRI, may have normal perfusion/18F-FDG uptake, perfusion/18F-FDG 
mismatch, mild perfusion/18F-FDG match or severe perfusion/18F-FDG match. Figure 3 
shows an example of a patient with subendocardial scar tissue on contrast-enhanced MRI 
and perfusion/18F-FDG mismatch on nuclear imaging.
Finally (Figure 4), the akinetic and dyskinetic segments were analysed separately. The ma-
jority of these segments without scar tissue on contrast-enhanced MRI (scar score 0, Figure 
4a) showed normal perfusion/18F-FDG uptake (47%) or perfusion/18F-FDG mismatch (39%) 
on nuclear imaging. Consequently, agreement between the two techniques for assessment of 
viability was high (86%). Conversely, in the majority of segments with transmural scar tissue 
on contrast-enhanced MRI (scar scores 3 and 4, Figure 4c), severe perfusion/18F-FDG match 
was observed on nuclear imaging (84%). Accordingly, agreement was also high (84%) in this 
category. Of interest, in segments with subendocardial scar tissue on contrast-enhanced MRI 
(scar scores 1 and 2, Figure 4b), the viability pattern on nuclear imaging varied highly between 
normal perfusion/18F-FDG uptake, perfusion/18FFDG mismatch, mild perfusion/18F-FDG 
match and severe perfusion/18F-FDG match.
Figure 3. Patient with inferior subendocardial scar tissue on contrast-enhanced MRI (a) and a severe reduction in 99mTc-tetrofosmin activity 
(b) but preserved 18F-FDG activity (c) on SPECT (perfusion/18F-FDG mismatch), indicating ischaemically jeopardized myocardium, highlighting 
the discrepancy between information derived from contrast-enhanced MRI and nuclear imaging.
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dIscussIon
The major finding in this study is that agreement between contrast-enhanced MRI and 
nuclear imaging for assessment of viability is high in segments without scar tissue as well as 
in segments with transmural scar tissue on contrast-enhanced MRI. Disagreement between 
the two imaging modalities regarding viability assessment was observed in segments with 
subendocardial scar tissue on contrast-enhanced MRI.
Contrast-enhanced MRI has been introduced as a reliable noninvasive technique for visu-
alization of scar tissue in patients with previous MI 6,18 and in patients with clinical suspicion 
of CAD but without a history of MI 22. Kim et al. evaluated the accuracy of contrast-enhanced 
MRI for the assessment of scar tissue in dogs with previous MI and reported excellent agree-
ment between the extent of scar tissue on contrast-enhanced MRI and the histological extent 
of necrosis 23.
Subsequently, Kim et al. studied the value of scar tissue assessed with contrast-enhanced 
MRI for prediction of functional recovery after revascularization in 41 patients with chronic 
CAD 6. They reported that the majority of segments (78%) without scar tissue improved in 
function after revascularization, whereas improvement was virtually absent in segments with 
transmural scar tissue 6. Importantly, difficulties arise in segments with subendocardial scar 
tissue (transmural extent 1–50%), with only 53% of segments showing functional recovery 6.
of segments with transmural scar tissue on contrast-
enhanced MRI (scar scores 3 and 4, Fig. 2c) showed severe
perfusion/18F-FDG match on nuclear imaging. Accordingly,
agreement in these segments was also high (83%), since
segments with transmural scar tissue on contrast-enhanced
MRI and segments with severe perfusion/18F-FDG match
on nuclear imaging represent nonviable tissue. Of note, in
segments with subendocardial scar tissue on contrast-
enhanced MRI (scar scores 1 and 2, Fig. 2b), the various
viability patterns assessed with nuclear imaging were
evenly distributed, indicating that segments with subendo-
cardial scar tissue on contrast-enhanced MRI, may have
normal perfusion/18F-FDG uptake, perfusion/18F-FDG mis
match, mild perfusion/18F-FDG match or severe perfu-
sion/18F-FDG match. Figure 3 shows an example of a
patient with subendocardial scar tissue on contrast-enhanced
MRI and p rfusion/18F-FDG mismatch on ucle r imaging.
Finally (Fig. 4), the akinetic and dyskinetic segments
were analysed separately. The majority of these segments
without scar tissue on contrast-enhanced MRI (scar score 0,
Fig. 4a) showed normal perf sion/18F-FDG u take (47%)
or perfusion/18F-FDG mismatch (39%) on nuclear imaging.
Fig. 2 Relationship between contrast-enhanced MRI and nuclear
imaging for dysfunctional segments showing the frequency of the four
viability patterns assessed with nuclear imaging in segments without
scar tissue (a), with subendocardial scar tissue (b) and with transmural
scar tissue (c) on contrast-enhanced MRI
Fig. 4 Relationship between contrast-enhanced MRI and nuclear
imaging for akinetic and dyskinetic segments showing the frequency
of the four viability patterns assessed with nuclear imaging in
segments without scar tissue (a), with subendocardial scar tissue (b)
and transmural scar tissue (c) on contrast-enhanced MRI
Fig. 3 Patient with inferior subendocardial scar tissue on contrast-
enhanced MRI (a) and a severe reduction in 99mTc-tetrofosmin activity
(b) but preserved 18F-FDG activity (c) on SPECT (perfusion/18F-FDG
mismatch), indicating ischaemically jeopardized myocardium, high-
lighting the discrepancy between information derived from contrast-
enhanced MRI and nuclear imaging
598 Eur J Nucl Med Mol Imaging (2009) 36:594–601
Figur  4. Relationship between contrast-enhanced MRI and nuclear imagin  for akinetic and dyskinetic segments showing the frequency of 
the four viability patterns assessed with nuclear imaging in segments without scar tissue (a), with subendocardial scar tissue (b) and transmural 
scar tissue (c) on contrast-enhanced MRI.
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Pooling of four studies in patients (n = 132) undergoing revascularization revealed a 
high sensitivity (95%), but a relatively low specificity (45%) of contrast-enhanced MRI for 
predicting improvement in function 10. The suboptimal specificity is related to segments with 
subendocardial scar tissue (transmural extent 1–50%), that do not improve in function. These 
findings highlight the fact that contrast-enhanced MRI is an excellent technique to delineate 
scar tissue (anatomical imaging), but the technique does not provide information on the 
pathophysiological substrate of the non-scarred tissue, which results in suboptimal predic-
tion of functional recovery after revascularization.
Combined perfusion-18F -FDG imaging, as used in the current study, permits delineation 
of viability based on integration of perfusion and glucose utilization 24. This approach has 
been widely validated (both with PET and with SPECT imaging) for detection of viable myo-
cardium and prediction of functional recovery 13,25,26. Different patterns of perfusion/18F-FDG 
uptake can be observed. Dysfunctional but viable myocardium can be divided into normal 
perfusion and 18F-FDG uptake representing repetitively stunned myocardium, whereas 
reduced perfusion with preserved 18F-FDG uptake represents hibernation. Scar tissue can 
be divided (based on the concordant reduction in perfusion and 18F-FDG uptake) into 
subendocardial scar tissue and transmural scar tissue. Based on these different patterns, 
with integration of perfusion and glucose utilization (assessed by 18F-FDG imaging), it is 
possible to better characterize the substrate of the dysfunctional myocardium. Few stud-
ies have compared contrast-enhanced MRI with perfusion-18F-FDG imaging 11–14,27. Kühl et 
al. performed contrast-enhanced MRI and perfusion-18F-FDG imaging in 29 patients with 
chronic CAD 13. Comparison between the techniques showed that viable segments on 
perfusion-18F-FDG imaging contained minimal scar tissue, whereas the extent of scar tissue 
on contrast-enhanced MRI increased in parallel with the abnormalities on perfusion-18F-FDG 
imaging; segments with severe matches on perfusion-18F-FDG imaging showed transmural 
scar tissue on contrast-enhanced MRI 13.
Knuesel et al. studied 19 patients with chronic CAD who underwent 13N-ammonia PET to 
evaluate perfusion and 18F-FDG PET to evaluate glucose utilization; scar tissue was analysed 
with contrast-enhanced MRI 11. The authors reported a good correlation (ranging from r = 
0.62 to r = 0.82) between segmental 18F-FDG uptake and the transmural extent of scar tissue 
on contrast-enhanced MRI. In particular, segments with 18F-FDG uptake ≥50% corresponded 
well with small areas of subendocardial scar tissue on contrast-enhanced MRI (and extensive 
non-scar tissue, 4.5 mm of the myocardial wall, on contrast-enhanced MRI). Ten patients 
also underwent revascularization, and the segments with preserved 18F-FDG uptake and 
minimal scar tissue improved in function after revascularization; conversely, the segments 
with severely reduced 18F-FDG uptake and extensive, transmural scar tissue, did not improve 
in function.
Of interest, the segments with severely reduced 18F-FDG uptake, but non-transmural scar 
tissue on contrast-enhanced MRI, did not improve in function after revascularization. This is 
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precisely the issue highlighted in the current study. The problem is that contrast-enhanced 
MRI provides excellent information on the extent and transmural extent of scar tissue (better 
than any other imaging technique), but it does not provide information on the pathophysi-
ology of the non-scarred myocardium. As shown by Knuesel et al., segments with a small 
amount of scar tissue on contrast-enhanced MRI, but severely reduced 18F-FDG uptake do 
not improve in function 11. These observations underscore the need to better characterize 
the non-scarred myocardium, as can be done with 18F-FDG imaging (in combination with 
perfusion imaging). Indeed, the findings of the current study illustrate that segments with 
an intermediate transmural extent of scar tissue (score 1 or 2) can exhibit a wide range of 
patterns on perfusion-18F-FDG imaging (see Figure 2b).
An important limitation of the current study was the lack of outcome data after revascu-
larization, and therefore the study did not provide information on the functional fate of the 
segments after revascularization (recovery or not). Additional studies in patients undergoing 
revascularization are needed to further explore the actual outcome of segments with inter-
mediate amounts of scar tissue on contrast-enhanced MRI and different perfusion-18F-FDG 
uptake patterns.
conclusIons
Comparison of contrast-enhanced MRI and perfusion-18F-FDG imaging for assessment of 
viability in patients with severe ischaemic LV dysfunction revealed high agreement in seg-
ments without scar tissue on contrast-enhanced MRI as well as in segments with transmural 
scar tissue. However, evident disagreement was noted in segments with subendocardial 
scar tissue on contrast-enhanced MRI, illustrating that the non-enhanced epicardial rim can 
contain either normal or ischaemically jeopardized myocardium. This differentiation is 
potentially important for prediction of outcome after revascularization. Indeed, Bove et 
al. have demonstrated in 15 patients that further refinement of the non-scar tissue (in this 
particular study assessment of contractile reserve by low-dose dobutamine challenge was 
used) resulted in superior prediction of outcome after revascularization 28. Further studies, 
comparing various imaging techniques in patients undergoing revascularization including 
information on segmental functional outcome are needed to better define the contribution 
of scar tissue and viable tissue to functional recovery after revascularization.
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objectives: Surgical ventricular reconstruction has been proposed as a treatment 
option in heart failure patients with left ventricular (LV) aneurysm. The feasibility of 
this procedure has some limitations and extensive pre-operative evaluation is nec-
essary in order to give the correct indication. For this purpose, magnetic resonance 
imaging (MRI) is currently considered the gold standard, providing accurate quanti-
fication of LV shape, size, global and regional function together with the assessment 
of myocardial scar and mitral regurgitation severity. The aim of this study was to 
evaluate the accuracy of real-time three-dimensional echocardiography (RT3DE) as 
a potential alternative to MRI for this evaluation.
methods: A total of 52 patients with ischemic cardiomyopathy and LV aneurysm 
underwent a comprehensive analysis with 2D echocardiography, RT3DE and MRI.
results: Excellent correlation (r = 0.97, p <0.001) and agreement were found be-
tween RT3DE and MRI for quantification of LV volumes, ejection fraction and sphe-
ricity index; in a segment-to-segment comparison, RT3DE showed to be accurate 
also for the analysis of wall motion abnormalities (k = 0.62) and LV regional thickness 
(k = 0.56) as a marker of myocardial scar. In turn, 2D echocardiography showed to 
underestimate significantly these parameters. Furthermore, mitral regurgitant 
volume assessed by RT3DE showed excellent correlation (r = 0.93) with regurgitant 
volume measured by MRI, without significant bias (= -0.7ml/beat).
conclusions: In the management of heart failure patients with LV aneurysm, RT3DE 
provides an accurate and comprehensive assessment, including quantification of 
LV size, shape, global systolic function, regional wall motion and myocardial scar 
together with a precise evaluation of the severity of mitral regurgitation.
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IntroductIon
Left ventricular (LV) remodeling after acute myocardial infarction is defined as a progressive 
LV dilation and dysfunction, accompanied by an expansion of myocardial scar 1;2. This process 
was demonstrated to be associated with a poor prognosis 3;4 and several treatments are now 
available to attenuate or partially reverse this phenomenon. Particularly, in the presence of 
a LV aneurysm surgical ventricular reconstruction (SVR) has been proposed to improve LV 
size, shape, wall-stress and function 5. However, the feasibility of this procedure has some 
limitations and an extensive pre-operative evaluation is necessary in order to give the cor-
rect indication, to plan the operation and to estimate the peri-operative and post-operative 
mortality. In particular, accurate values of LV size, shape and function are crucial to evaluate 
the impact of surgery; precise identification of LV regional dysfunction, myocardial scar site 
and extent is also fundamental to determine the feasibility of the procedure. In addition, reli-
able quantification of mitral regurgitation is important to evaluate the possibility to perform 
concomitant mitral valve repair 6.
Magnetic resonance imaging (MRI) is currently considered the gold standard for this 
comprehensive assessment, providing highly accurate and reproducible data 6. However, this 
technique is not widely available and is not compatible with cardiac devices. As an alternative, 
conventional 2-dimensional (2D) echocardiography has been applied, although with signifi-
cant inaccuracy due to assumptions about LV cavity geometry. Real-time three-dimensional 
echocardiography (RT3DE) is now available to overcome these limitations and showed to be 
more accurate than 2D echocardiography for quantification of LV volumes 7. The aim of this 
study was therefore to evaluate, in comparison with MRI, feasibility and accuracy of RT3DE 
for the complex assessment of patients with LV aneurysm, including LV volumes, LV shape, LV 
ejection fraction, LV wall motion abnormalities, identification of myocardial scar and quanti-
fication of the severity of mitral regurgitation.
methods
The study population consisted of 60 consecutive patients with ischemic cardiomyopathy 
and LV akinetic/dyskinetic aneurysm, who were referred from July 2006 to September 2008 
to evaluate the possibility of a SVR. The evaluation included, in the same day, conventional 2D 
echocardiography, RT3DE and cardiac MRI. Using these imaging modalities, LV size and shape 
and LV global and regional systolic function were evaluated. The presence of a LV thrombus 
was also assessed. Since echocardiography can not provide a precise identification of myo-
cardial scar, RT3DE and MRI were compared for the measure of LV regional thickness, as a 
well-known marker of transmural scar. Finally, these 2 imaging modalities were compared for 
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the assessment of mitral regurgitation severity. All the variables included in the analysis are 
summarized in Table 1.
All patients gave informed consent and the protocol was approved by the institutional 
review board.
standard 2d echocardiography
Patients were imaged in the left lateral decubitus position using a commercially available 
system (iE33, Philips Medical Systems, N.A., Bothell, Washington, USA) equipped with a 
3.5-MHz transducer. LV end-systolic volume (ESV) and LV end-diastolic volume (EDV) were 
determined from the conventional apical 2- and 4-chamber views and LV ejection fraction 
(EF) was calculated using the biplane Simpson’s technique 8.
As a measure of LV shape, sphericity index (SI) was calculated by dividing LVEDV by the 
volume of a sphere whose diameter was derived from the major end-diastolic LV long-axis. 
The LV long-axis was obtained as the longest distance between the centre of the mitral an-
nulus and the endocardial apex in the 4-chamber view 6;9.
Qualitative assessment of the regional wall motion was performed according to the stan-
dard 16-segment model10 and was graded as follows: 1 = normal; 2 = hypokinetic; 3 = akinetic 
and 4 = dyskinetic. A global wall motion score index (WMSI) was calculated as the sum of 
each LV segment’s score divided by the number of visualized segments 8.
Finally, the presence of a LV thrombus, especially in the apical region, was evaluated with-
out contrast administration, using standard and off-axis views.
real-time three-dimensional echocardiography
Patients were imaged with the same system (iE33, Philips Medical Systems) equipped with an 
X3, fully sampled matrix transducer. Apical full-volume data sets were obtained combining, 
table 1. List of the measures and of the imaging modalities included in the study.
mrI rt3de 2de
Left ventricular end-diastolic volume (LVEDV) X X X
Left ventricular end-systolic volume (LVESV) X X X
Left ventricular ejection fraction (LVEF) X X X
Left ventricular sphericity index (LVSI) X X X
Left ventricular wall motion score index (LVWMSI) X X X
Left ventricular thrombus detection X X X
Left ventricular regional thickness X X -
Mitral regurgitant volume X X -
2DE:2-dimensional echocardiography, MRI: magnetic resonance imaging, RT3DE:real-time three-dimensional echocardiography
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within 1 breath-hold, 7 small real-time sub-volumes to provide a larger pyramidal volume (up 
to 101×104 degrees) and to ensure a complete capture of the LV. A 3D data set was considered 
unsuitable for analysis if >2 segments could not be visualized or if it contained visible stitch 
artefacts due to irregular heart rate or breathing movements. To assess the severity of mitral 
regurgitation, apical full-volume Color Doppler data sets were also acquired with a Nyquist 
limit set between 30 and 50 cm/sec. All 3D data sets were stored digitally and quantitative 
analysis was performed off-line using a semi-automated contour tracing algorithm (Q-Lab, 
version 6.0, Philips Medical Systems).
During post-processing of the 3D data set, the software automatically displays the apical 
4- and 2-chamber views and the parasternal short-axis view. After initial identification of the 
apex and mitral annulus with 5 reference points on the end-diastolic and end-systolic frames, 
a preconfigured ellipse is fitted to the endocardial border for each frame. A manual adjust-
ment of the endocardial border was performed if required. A LV 3D model is automatically 
generated and LV volumes and LVEF are calculated.
The SI of the LV 3D model was calculated as with 2D echocardiography; however, the use 
of 2 near-orthogonal cut-planes within the 3D dataset allowed for the exact location of the 
endocardial apex, avoiding any foreshortening (Figure 1). Furthermore, by slicing the 3D 
dataset, multiple LV short- and long-axes can be obtained (at the basal, mid-ventricular and 
apical level) and analysed to assess the 3D WMSI as for 2D echocardiography 11. With the same 
approach, the presence of a LV thrombus, particularly at the apical level, was also evaluated. 
From the same short-axis slices, the endocardial and epicardial contours were traced manu-
ally at end-diastole, with the papillary muscles included in the cavity. The traced contours 
Figure 1. Schematic example of calculation of sphericity index with RT3DE (left panel) and MRI (right panel) in a patient with LV aneurysm. 
The major end-diastolic LV long axis was obtained as the longest distance between the centre of the mitral annulus and the endocardial apex, 
identified by cropping the 3D dataset (panel A) or selecting the best slice in the MRI acquisition (panel B). Sphericity index was calculated by 
dividing LV end-diastolic volume by the volume of a sphere whose diameter was derived from the LV long-axis.
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were then used to calculate LV regional thickness according to the standard 16-segment 
model 10 (Figure 2). In particular as previously described 12, severely thinned regions (end-
diastolic thickness <6mm) were considered to be representative for transmural scar.
To evaluate the severity of mitral regurgitation, the effective regurgitant orifice area (EROA) 
was calculated 13–15. In particular, the 3D Color Doppler dataset was manually cropped by an 
image plane perpendicularly oriented to the jet direction until the narrowest cross-sectional 
area of the jet. The EROA was measured by manual planimetry of the color Doppler signal, 
tilting the image in an ‘en face’ view (Figure 3); the regurgitant volume was estimated as EROA 
multiplied by the velocity time integral of the regurgitant jet on the continuous-wave Doppler.
Image acquisition required approximately 5 min, while post processing required 10 to 15 
min, including the measurement of LV volumes, LVEF, LVSI and LV wall motion abnormalities, 
the evaluation of mitral regurgitation severity and the assessment of LV thrombus
Figure 2. An example of RT3DE assessment of LV regional thickness. After slicing the 3D dataset in 9 LV short-axes (3 at the basal, 3 at the 
mid-ventricular and 3 at the apical level), the endocardial and epicardial contours were traced manually at the end-diastolic frame. The traced 
contours were then used to calculate LV regional thickness according to the standard 16-segment model. The white arrows indicate the septum 
at mid-ventricular level that most likely contains transmural scar tissue (end-diastolic thickness <6mm). The LV apical segments are also 
significantly thinned (see right bottom panel).
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magnetic resonance imaging
Data acquisition
Data acquisition was performed on a 1.5 T scanner equipped with powertrack 6000 gradients 
(Gyroscan ACS-NT/Intera, Philips Medical Systems, Best, The Netherlands). Scout images and 
2- and 4-chamber acquisitions were performed to identify the intrinsic long-axis of the heart 
and for further planning. A cine-set of 12-16 multi-slice images were acquired in short-axis 
orientation, covering the complete LV from apex to base. Segmented gradient-turbo field 
echo was used, with parallel imaging (Sensitivity Encoding, acceleration factor 2) and steady-
state free-precession. The following imaging parameters were used: slice thickness of the 
imaging planes=10 mm, with no gap; Field-of-View=440 mm; 80% scan, scan-matrix=256 × 
256, reconstructed voxels of 1.56×1.56×10.0 mm; α=35°; TR/TE=3.6/1.7.
To evaluate the severity of mitral regurgitation, a true 3D MRI acquisition was applied with 
velocity-encoding in 3 orthogonal directions (field-of-view 370 mm, 3D volume scan with 
slab thickness 48 mm, reconstructed into 12 slices of 4 mm, TE/TR=3.3/14, α=10º, acquisi-
Figure 3. An example of RT3DE assessment of mitral effective regurgitant orifice area. The 3D dataset is manually cropped by an image plane 
perpendicularly oriented to the jet direction until the narrowest cross-sectional area of the jet. The effective regurgitant orifice area is measured 
(= 0.26 cm2) by manual planimetry of the color Doppler signal tilting the image in an ‘en face’ view.
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tion voxel size 2.9×3.8×4.0 mm3, reconstructed into 1.4×1.4×4.0 mm3, NSA 1, with 30 phases 
reconstructed, EPI factor 5) 16–18.
Data analysis
Quantification of LVESV, LVEDV and LVEF was performed on the short-axis series using MASS 
analytical software (Medis, Leiden, The Netherlands) and manual contour tracing of the 
epicardial and endocardial borders, as previously described 19.
The SI was calculated from the 4-chamber acquisition as abovementioned for 2D echo-
cardiography and RT3DE (Figure 1). Qualitative assessment of the regional wall motion was 
performed using both long- and short-axis acquisitions and the WMSI was based on a 16-seg-
ment model as for the echocardiographic analysis. From the same acquisitions, the presence 
of a LV thrombus was evaluated.
In addition, from the complete short-axis dataset 3 slices were selected representing the 
basal, mid-ventricular and apical level. From the epicardial and endocardial contours drawn 
in these slices, LV end-diastolic regional thickness was calculated according to the standard 
16-segment model 10 (Figure 4). As previously described in various studies, an end-diastolic 
thickness <6 mm was considered as a marker of transmural scar 20;21.
Figure 4. A set of MRI short-axis slices at basal, mid-ventricular and apical level acquired for the assessment of LV wall thickness (upper panel), 
using gradient-echo acquisitions, and for the analysis of myocardial scar (lower panel), using delayed contrast-enhanced images. In this 
example, the antero-septum, the anterior wall and the apex are significantly thinned and contain transmural scar (see arrows).
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To confirm the site and the extent of scar tissue, contrast-enhanced images (20-24 short-
axis slices) were acquired 15 minutes after bolus injection of gadolinium diethylenetriamine 
pentaacetetic acid (Magnevist, Schering/Berlex, Berlin, Germany; 0.15 mmol/Kg) with an 
inversion recovery gradient echo sequence (400×400 mm2 Field-of-View; 256×256 matrix 
size, 5-mm slice thickness with gap of -5mm, α=15°, TE/TR=1.36/4.53) 22. Hyperenhanced 
regions were defined by selecting a region-of-interest inside the normal myocardium and 
thresholding the window setting at 5SD above the mean signal intensity 23 (Figure 4). The 
total extent of scar, expressed as percentage of LV mass, was quantified using QMass (Medis) 
and the number of segments with transmural scar was calculated.
The 3D velocity-encoded MRI acquisitions were analyzed using in-house developed image 
processing software. The procedure was performed as previously described 17;18. In summary, 
from the velocity-encoded MRI data, the 3 velocity vector components of blood flow at 
the level of the mitral valve plane needs to be reformatted, using the LV 4- and 2-chamber 
views. The velocities measured perpendicularly to the reconstructed MV plane need to be 
corrected for the motion of the myocardium in basal/apical direction in order to obtain the 
true trans-valvular velocity of the blood flow. The trans-valvular volume flow was obtained 
by integrating the resulting velocities over the annulus area. The regurgitant volume was 
obtained by calculating the Riemann sum of backward flow during systole in the flow graph. 
The reproducibility of this analysis was also previously reported 16–18.
statistical analysis
Continuous data are presented as mean±SD; dichotomous data are presented as numbers and 
percentages. Comparison of data was performed using the paired Student t test. Pearson’s cor-
relation analysis was performed to evaluate the relation between echocardiographic and MRI 
measurements. In addition, Bland-Altman analysis was performed to evaluate the differences 
between echocardiographic and MRI measurements and the mean bias±2SD are reported. 
Agreement between these imaging techniques was assessed using weighted κ statistics (Fleiss-
Cohen weighting). The reproducibility of the RT3DE measures was assessed with Pearson’s corre-
lation and Bland-Altman analysis. A p-value <0.05 was considered to be statistically significant. A 
statistical software program SPSS16.0 (SPSS Inc, Chicago, II, USA) was used for statistical analysis.
results
Three patients (5%) did not undergo cardiac MRI because of major contraindications (atrial fi-
brillation and cardiac devices). Another 5 patients (8.5%) were excluded from further analysis 
because of inadequate RT3DE images. Clinical characteristics of the remaining 52 patients are 
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summarized in Table 2. All patients had symptoms of heart failure despite optimal medical 
therapy. The presence of a LV aneurysm (with at least 2 contiguous dyskinetic segments) was 
observed in all patients and in most of the cases (81%) involved the antero-septum, anterior 
and apical segments, as a result of a previous myocardial infarction in the LAD territory.
left ventricular size and shape
Mean values of LVEDV, LVESV and SI measured with 2D echocardiography, RT3DE and MRI are 
displayed in Table 3. According to all these techniques, a severe LV dilatation with a remodel-
ing towards a spherical shape was observed.
Considering MRI the gold standard, RT3DE showed an excellent correlation for the mea-
surements of LVEDV, LVESV and SI (r = 0.97, r = 0.98 and r = 0.96, respectively, p <0.001). 
However, Bland-Altman analysis (Figure 5) revealed a systematic bias between MRI and 
RT3DE of 21.6±40.4 ml for LVEDV, of 19.8±40.1 ml for LVESV and of 0.01±0.05 for SI (p <0.01), 
which tended to increase for larger and more spherical LV volumes.
Similarly, 2D echocardiography showed a good correlation with MRI for the measures of 
LVEDV, LVESV and SI (r = 0.94, r = 0.95 and r = 0.94, respectively, p <0.001). However, Bland-
Altman analysis showed a significantly larger bias between these 2 techniques with a mean dif-
ference of 40.9±48.8 ml for LVEDV, of 32.7±44.9 ml for LVESV and of 0.03±0.07 for SI (p <0.001).






























Time from myocardial infarction (months) 19±11
NYHA: New York Heart Association functional class
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left ventricular global and regional systolic function
Mean values of LVEF and WMSI measured with 2D echocardiography, RT3DE and MRI are dis-
played in Table 3. Considering MRI the gold standard, RT3DE showed an excellent correlation 
for the measure of LVEF (r = 0.97, p <0.001); a mean bias between MRI and RT3DE of -0.9±4.6% 
(p <0.05) was found at the Bland-Altman analysis (Figure 5). Similarly, a good correlation for 
the measure of LVEF (r = 0.96, p <0.001) was observed between 2D echocardiography and 
MRI with a mean bias of -0.7±5.2% (p <0.05).
A significant difference in the value of WMSI was found both with RT3DE and 2D echocar-
diography as compared to MRI. However, in a segment-to-segment comparison (for a total of 
821 segments that could be satisfactorily visualized by the 3 techniques) a better agreement 
was observed between RT3DE and MRI (k = 0.62) than between 2D echocardiography and 
MRI (k = 0.58).
Of note, a LV thrombus was detected by MRI in 4 (8%) patients. A LV thrombus was identi-
fied in the same 4 patients by RT3DE, while 2D echocardiography was not able to detect a 
small thrombus adjacent to the apical anterior wall in one of these patients.
Identification of lv segments with transmural scar
Using RT3DE, LV endocardial and epicardial borders could be both visualized in 779 (93%) 
segments and a mean of 6.0±1.7 segments per patient showed a thickness <6 mm and were 
considered as transmural scar. Similarly using MRI, a mean of 5.8±2.2 segments per patient 
(p <0.001) were defined as transmural scar (thickness <6 mm). In a segment-to-segment 
comparison, RT3DE and MRI showed a good agreement (k = 0.56) for the identification of 
LV segments with transmural scar, based on the measure of LV regional thickness. A good 
agreement was observed also between RT3DE and contrast-enhanced MRI (k = 0.54), which 
showed a mean of 5.1±1.9 segments per patient with a transmural scar. Of note, using 
contrast-enhanced MRI mean total scar extent was 29.9±8.2%.
table 3. Mean values of LV size and function measured by 2D echocardiography (2DE), RT3DE and MRI.
mrI rt3de 2de
LVEDV (ml) 288.4±87.2 266.8±75.3* 247.4±70.5*
LVESV (ml) 212.7±91.4† 192.9±70.8* 180.0±73.7*
LVEF (%) 28.0±12.2 29.0±10.4† 28.8±11.2†
LVSI 0.54±0.17 0.53±0.15† 0.51±0.14*
LVWMSI 2.0±0.6 2.2±0.5† 2.4±0.5*
*=p<0.001 compared to MRI.
†=p<0.05 compared to MRI 
EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic volume, LV: left ventricle, SI: sphericity index, WMSI: wall motion score index




From RT3DE analysis, the mean mitral regurgitant volume was 9.2±8.8 ml/beat, ranging from 
2 to 37 ml/beat. Similarly from the 3D velocity encoded MRI analysis, the mean mitral regur-
gitant volume was 9.8±9.4 ml/beat, ranging from 2 to 42 ml/beat. RT3DE and MRI showed 
an excellent correlation for the assessment of mitral regurgitant volume (r = 0.93, p <0.001) 




























































































Figure 5. Bland-Altman scatter plot of differences (Y-axis) in LV end-diastolic volume (EDV), LV end-systolic volume (ESV), LV ejection fraction 
(EF), LV sphericity index (SI) and mitral regurgitant volume (Rvol) between RT3DE and MRI, plotted against the average between these 
techniques (X-axis). The mean bias (full line) and the 95% limits of agreement (dotted lines) are displayed.
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and the Bland-Altman analysis (Figure 5) revealed a non significant bias between these tech-
niques (RT3DE–VE MRI = -0.7 ml/beat, limits of agreement from -7.1 to 5.8 ml/beat, p = 0.71).
reproducibility of rt3de measures
Reproducibility of RT3DE measures of LVEDV, ESV and EF were previously reported 24;25 by our 
group and were in line with other studies 26. Reproducibility of RT3DE assessment of mitral ef-
fective regurgitant orifice and regurgitant volume was also previously reported by our group 15.
Inter-observer reproducibility for SI and WMSI was obtained analyzing the 3D dataset of 15 
patients at different times by 2 independent observers, each without knowledge of the results 
obtained by the other. The agreement was good: mean bias was 0.00±0.07 (p = 0.32) and 
0.2±0.03 (p = 0.24), respectively. The correlation between the measures of the 2 observers was 
also excellent (both r = 0.97, p <0.001). Similarly, inter-observer variability for LV regional thick-
ness was tested on 7 patients (112 segments): mean bias was 0.7±0.3 mm (p = 0.11, r = 0.91).
dIscussIon
The main findings of the current study can be summarized as follows: 1) in patients with LV 
aneurysm, evaluation of LV size, shape and function by RT3DE is feasible and reproducible; 2) 
in this group of patients, RT3DE provides highly accurate quantification of LV volumes, EF, SI 
and WMSI, in a direct comparison with MRI; 3) RT3DE can be also applied for the identification 
of transmural scar and for the assessment of mitral regurgitation severity.
heart failure and lv aneurysm
Surgical treatment
Surgical ventricular reconstruction, and in particular endoventricular circular patch plasty 
(Dor procedure), has been proposed as a treatment for heart failure patients with an ex-
tensive myocardial infarction and LV aneurysm. Aim of this procedure is to restructure the 
curvature of the LV wall back to its original geometric configuration, excluding the scarred 
portion of the ventricle from the adjacent viable myocardium. Scar exclusion prompts a 
return to a systolic concentric contraction and was demonstrated to decrease LV volume and 
to increase LV systolic function 5;27;28. However, the impact of this procedure on survival is still 
controversial 27 and accurate patient selection should be performed. In particular, to set the 
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indication for SVR, accurate quantitative evaluations are necessary to determine the feasi-
bility and the impact of surgery, considering the complicated postoperative LV geometric 
changes. Accurate quantification of LV size and shape is fundamental to avoid an excessive 
volume reduction and/or cavity deformation that lead to a progressive diastolic dysfunction 
and to a restrictive filling pattern 6. Furthermore, the precise extent of myocardial scar and the 
wall motion abnormalities is crucial to evaluate whether a “viable” contractile LV cavity can be 
reshaped. Also, the presence of a LV thrombus is often a decision point for aneurysmecutomy 
and estimate of peri- and post-operative mortality is mainly based on a reliable assessment 
of LV global and regional systolic function 5. In addition, SVR is often accompanied by mitral 
valve repair and the severity of mitral regurgitation should be therefore carefully evaluated.
Use of imaging for an extensive evaluation
As mentioned above, patients with heart failure and LV aneurysm need an extensive evalua-
tion before SVR. Currently, MRI is considered the gold standard for this comprehensive analy-
sis. This imaging technique in fact was proven to be far more accurate than other techniques 
for quantification of LV shape and volumes, for the analysis of LV global systolic function and 
wall motion abnormalities, for identifying the precise extent of transmural scar and for the 
evaluation of mitral valve apparatus 6. However, MRI is not widely available, due to the high 
equipment costs and the need for special facilities, and can not be applied in the presence 
of cardiac devices and atrial fibrillation, often present in heart failure patients. Furthermore, 
MRI can not be performed at the bedside or in the operating room, where an immediate 
assessment of SVR results is of great importance. In a head-to-head comparison with MRI, 
the current study demonstrated the accuracy of RT3DE as a potential alternative technique 
for the study of heart failure patients with significantly abnormal LV geometry due to the 
presence of a LV aneurysm. In particular, excellent correlation and a good agreement were 
found between these 2 techniques for the calculation of LVEDV, ESV, EF and SI. Of note, a 
trend towards an increased disagreement between RT3DE and MRI for the measurements of 
larger LV volumes and for more spherical LV shape was noted, probably due to the challenges 
(limited sector width and lateral resolution) of obtaining an appropriate echo acquisition 
in the presence of a very dilated ventricle with geometrical alterations. In a segment-to 
segment comparison with MRI, RT3DE showed to be accurate also for the analysis of wall 
motion abnormalities and identification of non-viable segments. In turn, conventional 2D 
echocardiography showed to be less accurate, with a significant underestimation of these 
LV parameters probably due to inappropriate geometric assumptions and to the difficulty of 
obtaining true apical views.
These findings confirmed in a large population the results of initial studies 1;26;29 that ap-
plied the old free-hand 3D rotating probe or the novel real-time acquisition in small groups 
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of patients with LV aneurysm. For the first time however, RT3DE was applied in this study also 
for the calculation of WMSI and the analysis of LV regional thickness, which contains crucial 
information for the identification of myocardial transmural scar. Several studies demonstrated 
that the extent of myocardial scar, more than the type of asynergy (dyskinesia versus akine-
sia), has an important prognostic value for SVR outcomes 5,6. Furthermore, RT3DE showed to 
be an accurate approach also for the assessment of the severity of mitral regurgitation, which 
is of great prognostic importance and is necessary to plan the surgical treatment. Mitral 
regurgitant volume assessed by RT3DE showed an excellent correlation with regurgitant vol-
ume measured by 3D MRI, without a significant difference between the 2 techniques. In fact, 
color Doppler RT3DE, allowing for an unlimited plan orientation and in particular for an “en 
face” view of the mitral valve, provides a direct planimetry of the regurgitant orifice, obviating 
the geometric assumptions not applicable in patients with functional mitral regurgitation, in 
which the EROA is typically elongated along the semilunar-shaped leaflet coaptation line 13;15.
This comprehensive approach makes RT3DE particularly suitable for the management 
of heart failure patients with LV aneurysm. Further studies are needed to demonstrate the 
accuracy of RT3DE measures using the transesophageal approach, in view of a potential ap-
plication in the operating room for an immediate assessment of SVR results.
study limitations
Although the RT3DE measures showed a good reproducibility, further multi-center studies 
with larger population are needed to confirm the results of the current study. Furthermore, 
short- and long-term follow-up data are necessary to explore the accuracy and prognostic 
value of RT3DE for the assessment of progressive LV remodeling or, in case of SVR, for the 
evaluation of the surgical outcome.
conclusIons
For the management of heart failure patients with LV aneurysm and in order to determine 
the best treatment for these patients, RT3DE provides an accurate and comprehensive as-
sessment, including quantification of LV size, shape, global systolic function and extension of 
wall motion abnormalities together with the identification of transmural scar and a precise 
evaluation of the severity of mitral regurgitation.
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objectives: To validate flow assessment performed with three-dimensional (3D) 
three-directional velocity-encoded (VE) magnetic resonance (MR) imaging with 
retrospective valve tracking and to compare this modality with conventional two-
dimensional (2D) one-directional VE MR imaging in healthy subjects and patients 
with regurgitation.
methods: Patients and volunteers gave informed consent, and local medical ethics 
committee approval was obtained. Patient data were selected retrospectively and 
randomly from a database of MR studies obtained between July 2006 and July 2007. 
The 3D three-directional VE MR images were first validated in vitro and compared 
with 2D one-directional VE MR images. Mitral valve (MV) and tricuspid valve (TV) 
flow were assessed in 10 volunteers without valve insufficiency and 20 patients 
with valve insufficiency, with aortic systolic stroke volume (ASSV) as the reference 
standard.
results: Phantom validation showed less than 5% error for both techniques. In vol-
unteers, 3D three-directional VE MR images showed no bias for MV or TV flow when 
compared with ASSV, whereas 2D one-directional VE MR images showed significant 
bias for MV flow (15% overestimation, p <0.01). TV flow showed 25% overestimation; 
however, this was insignificant because of the high standard deviation. Correlation 
with ASSV was strong for 3D three-directional VE MR imaging (r = 0.96, p <0.01 for 
MV flow; r = 0.88, p <0.01 for TV flow) and between MV and TV flow (r = 0.91, p 
<0.01); however, correlation was weaker for 2D one-directional VE MR imaging (r = 
0.80, p <0.01 for MV flow; r = 0.22, p = 0.55 for TV flow) and between MV flow and TV 
flow (r = 0.34, p = 0.34). In patients (mean regurgitation fractions of 13% and 10% for 
MV flow and TV flow, respectively), correlation between MV flow and TV flow for 3D 
three-directional VE MR imaging was strong (r = 0.97, p <0.01).
conclusions: Use of 3D three-directional VE MR imaging enables accurate MV and 
TV flow quantification, even in patients with valve regurgitation.
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IntroductIon
Mitral valve (MV) and tricuspid valve (TV) regurgitation is a common complication of ischemic 
heart disease. Both the timing and the type of surgical intervention depend on the severity 
of symptoms leading to left ventricle dysfunction 1–3. Echocardiography is commonly used 
to classify the severity of MV and TV regurgitation 4–7. The quality of the acoustic window, 
attenuation from overlying structures such as ribs and lungs, and operator experience af-
fect echo Doppler image quality and can influence classification of regurgitation 8,9. Besides 
having measurement restrictions, semiquantitative approaches—such as assessment of the 
regurgitant jet area and width on color Doppler images 10,11 and the proximal isovelocity sur-
face area technique 12,13—rely on modeling assumptions, which are not valid in all subjects. 
Only flow in the same direction aligned with the ultrasound beam can be quantified, and 
the sample volume can not be adapted to the motion of the annulus 14,15, thereby limiting 
accurate quantification with echo Doppler ultrasonography.
Velocity-encoded (VE) magnetic resonance (MR) imaging is a noninvasive imaging modality 
already extensively used for blood flow assessment 15–19. In all previous attempts to quantify 
blood flow with VE MR imaging of atrioventricular valves, heart motion during contraction 
and relaxation was encountered as the main obstacle. Kayser et al 20 showed that correction 
for throughplane motion (ie, motion in the longitudinal direction through the acquisition 
plane positioned at the heart valve of interest) is indispensable for accurate transvalvular flow 
assessment. With three-directional VE MR imaging 21, intraventricular blood flow patterns can 
be assessed 22–25 to enable quantification of MV regurgitation 26. The purpose of our study was 
to validate flow assessment performed with three-dimensional (3D) three-directional VE MR 
imaging with retrospective valve tracking and to compare this modality with conventional 




Ten healthy volunteers (six men, four women; mean age, 33 years±9 and 26 years±7, re-
spectively; overall mean age, 30 years±8) with no history of cardiac disease were included 
to validate 3D three-directional VE MR imaging for simultaneous MV and TV flow quantifica-
tion. Volunteers underwent imaging between April and August 2006. Twenty patients (14 
men, six women; mean age, 64 years±12 and 60 years±15, respectively; overall mean age, 63 
years±13) with ischemic cardiomyopathy, who were suspected of having MV regurgitation, 
Nina Book.indb   339 26-09-11   12:04
Chapter 19
340
TV regurgitation, or both, were evaluated. Patient data were selected retrospectively and 
at random from a database of MR studies acquired between July 2006 and July 2007. All 
patients and volunteers gave informed consent, and local medical ethics committee approval 
was obtained.
mr imaging methods
MR images were acquired with a 1.5-T pulsar gradient system (Intera, release 11; Philips 
Medical Systems, Best, the Netherlands) with 33 mT/m amplitude, 100 mT/m/msec slew rate, 
and 0.33-msec rise time. A five-element cardiac coil placed on the chest was used for signal 
reception. After acquisition of a series of thoracic scout images that were used for planning 
purposes, two-chamber views of the left and right ventricles were obtained, and four-
chamber acquisition was performed with a steadystate free precession sequence (repetition 
time msec/echo time msec, 3.0/1.5; 350-mm field of view; 8-mm section thickness; 50° flip 
angle; 1.8 x 2.0 x 8.0-mm acquisition voxel reconstructed into a 1.4 x 1.4 x 8.0-mm voxel; one 
signal acquired; 30 phases reconstructed during one average cardiac cycle) that lasted 10–15 
seconds and covered one breath hold at end expiration.
Aortic flow was assessed with 2D one-directional VE MR imaging perpendicular to 
the ascending aorta 17; these images served as the reference standard because this flow 
acquisition was not affected by errors caused by through-plane motion. In volunteers and 
phantoms, 2D one-directional VE MR imaging was applied for comparison (8.9/5.7; 350-mm 
field of view; 8-mm section thickness; 20° flip angle; 2.7 x 3.4 x 8.0-mm acquisition voxel size 
reconstructed into a 1.4 x 1.4 x 8.0-mm voxel; two signals acquired; retrospective gating with 
10% acceptance window, with 30 phases reconstructed during one average cardiac cycle; 
150 cm/sec maximal velocity encoding, with the encoding direction perpendicular to the 
acquisition plane; in vivo free breathing was allowed). In vivo 2D one-directional E MR imag-
ing was used to assess aortic low at the ascending aorta and at the V and TV; this examination 
was performed a the location of the valve, presented in the two- and four-chamber views at 
the moment of end systole, with the acquisition plane perpendicular to the diastolic inflow 
direction.
For three-directional VE MR imaging, a true 3D MR acquisition was designed with velocity 
encoding in three orthogonal directions (14/3.3; 370-mm field of view; 3D volume imaging 
with 48-mm slab thickness reconstructed into 12 4-mm sections; 10° flip angle; 2.9 x 3.8 x 
4.0-mm acquisition voxel reconstructed into a 1.4 x 1.4 x 4.0-mm voxel; one signal acquired; 
retrospective gating with 10% acceptance window, with 30 phases reconstructed during 
one average cardiac cycle; 150 cm/sec maximal velocity encoding in all three directions). To 
reduce acquisition time, echo planar imaging 27 was used with a factor of five.
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Image processing
The 2D one-directional VE MR images were analyzed with the QFlow software package 
(Medis, Leiden, the Netherlands) by using manual contour segmentation (J.J.M.W., 13 years 
of experience in cardiac MR imaging). Segmentation took 5–10 minutes. For MV and TV flow, 
through-plane motion correction from the velocity of the myocardium was performed as 
suggested by
Kayser et al 20. In a blinded manner, the same observer compared the 3D three-directional 
VE MR images with the 2D one-directional VE MR images by using image-processing software 
developed in-house. A schematic illustration of this procedure is shown in Figure 1. First, from 
the 3D three-directional VE MR data, blood flow velocity at both locations of the valves (ie, 
MV and TV) needed to be reformatted. The left ventricular and right ventricular two- and 
four-chamber views were used as reformation guides for the MV plane and TV plane, respec-
tively. In the four-chamber view, the location of the valve was manually indicated by placing 
Figure 1. Schematic representation of the reformation of MV flow and TV flow with 3D three-directional VEMR imaging. The 3D acquisition 
volume for three -directional VE MR imaging is placed at the basal level of the heart. Special attention is paid to the position of the MV and 
TV remaining inside this 3D volume during the whole cycle. The positions of the respective valvular planes are indicated manually in each of 
the phases of the cardiac cycle in the two- and four-chamber (4CH) views. The through-plane velocities in the MV plane and the TV plane are 
reconstructed. Integration of the velocities over the annulus, subtracted by the through-plane velocity acquired in the myocardium, results in 
the flow graph of the respective valve. Arrows indicate the order in which the steps of the procedure for flow assessment at the particular valves 
are performed. LV = left ventricle, RV = right ventricle.
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a line over the annulus in each of the 30 phases. Reformation of the valvular plane needs to 
be angulated in two orthogonal directions; thus, angulation in the orthogonal direction of 
the four-chamber view (ie, the two-chamber view) is manually set and projected onto this 
two-chamber view. For each phase, all three velocity vector components were reformatted 
consecutively. Not only were velocities at the valvular plane reformatted, but also reforma-
tions of velocities at five planes (two planes on both sides and parallel to the valvular plane) 
with an interplane distance of 5 mm were constructed. In each plane, the three reformatted 
velocity components constructed velocity vectors. The through-plane velocity values per-
pendicular to the reformatted planes were determined from the dot product of the normal 
vector of these planes and the velocity vectors. The resulting through-plane velocity values 
were presented for each voxel, each phase, and each of the five reformatted planes.
The central plane (ie, the valvular plane) was generally used for analysis similar to that per-
formed with the 2D one-directional VE MR sequence, with through-plane motion correction 
from the velocity of the myocardium taken into account. When a high-velocity regurgitant jet 
occurs, phase dispersion can result in signal loss at the location of the valve 28, with possible 
underestimation of regurgitation. In such cases, phases with regurgitant flow were analyzed 
in the first or second plane next to the center plane inside the atrium. The reformatting 
procedure took 5 minutes for each valve, and subsequent image analysis took 5–10 minutes.
In vitro validation
Validation of the MR technique was performed in vitro with flow phantoms. A constant flow 
phantom setup was used (Figure 2). Water was pumped through a flexible tube (8-mm inner 
diameter) with a pump (Verder, Vleuten, the Netherlands) at five constant flow rates (5.8, 8.7, 
10.5, 12.0, and 13.7 mL/sec).
The set flow rates were checked with volumetric measurement distal to the phantom. 
The tube ran through a water tank, which was placed inside the gantry of the MR imager. 
We compared 2D one-directional VE MR imaging (with the acquisition plane perpendicular 
to the tube) with 3D three-directional VE MR imaging. In these constant flow experiments, 
cardiac synchronization to MR acquisition was turned off.
Also, flow experiments in a dynamic left ventricular flow phantom setup (Figure 2) were 
performed by using a computer-controlled pump (CardioFlow 1000; Shelley Medical Imaging 
Technologies, London, Ontario, Canada). A harmonic flow was applied to harmonically fill 
and empty a latex balloon (ie, 3-second period of motion) with the following equation: V = 20 
* sin(2πt/3), where V is volume (measured in milliliters) and t is time. The balloon was prefilled 
with 100 mL of water before sinusoidal flow was applied and placed inside a closed water tank 
that was connected to a measurement column from which the amplitude of sinusoidal flow 
was read. At the inlet of the balloon (ie, an 8-mm-diameter tube) and perpendicular to the 
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flow direction, 2D one-directional VE MR imaging and 3D three-directional VE MR imaging 
were performed. Triggering was controlled by the same computer that controlled the pump.
validation in volunteers
In a previous study 22, the net flow volume at the MV was determined in healthy volunteers 
and compared with aortic systolic stroke volume (ASSV) by using 2D one-directional and 2D 
three-directional VE MR imaging. For 2D one-directional
VE MR imaging, a significant difference of 25 mL±22 was found (p <0.01): for 2D three-
directional VE MR imaging, an insignificant difference of 5 mL±7 was found. Assuming 
similar differences for the 3D three-directional VE MR technique, comparison between the 
techniques requires 10 subjects for a power of 90% and a p-value of less than .05. In the 
current study, 10 healthy volunteers were recruited. MV flow and TV flow were measured with 
Figure 2. Schematic drawing shows the in vitro setup for MR imaging with constant flow validation (top) and inconstant flow validation 
(bottom). A pump is used to apply flow (constant flow in the top image, harmonic sinusoidal flow in the bottom image) via tubes to 
the phantom placed inside the MR gantry. In the top image, flow is determined through a straight tube and compared with volumetric 
measurement distal to the phantom. In the bottom image, harmonic flow fills and empties a balloon. The balloon is prefilled with 100 mL 
of water before sinusoidal flow is applied and placed inside a closed water tank that is connected to a measurement column from which the 
amplitude of sinusoidal flow is read. The flow is assessed with MR imaging at the inlet of the balloon.
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2D one-directional VE MR imaging and 3D three-directional VE MR imaging, respectively. The 
ASSV measured with 2D one-directional VE MR imaging in the ascending aorta was used as 
a reference standard. Correlation between stroke volumes was determined, and differences 
were studied by using Bland-Altman plots 29.Intra- and inter-observer variation of the image-
processing procedure (ie, reformatting and image analysis) was tested with repeated analysis 
by two observers (J.J.M.W., S.D.R.; 13 and 4 years of experience with cardiac MR imaging, 
respectively) with an inter-examination time of more than 1 week. Signal-to-noise ratio was 
determined in peak diastole with 2D one-directional and 3D three-directional VE MR imaging.
application in patients
Twenty patients with ischemic cardiomyopathy who were suspected of having mitral regur-
gitation, tricuspid regurgitation, or both at echocardiography were included. The net flow 
volumes per cycle (defined as stroke volume minus regurgitant flow volume) at the MV and 
TV were compared, correlation was examined, and Bland-Altman plots were used to study 
the differences. The regurgitant flow volume was determined on the basis of the flow from 
the ventricle toward the atrium during systole. The regurgitant flow fraction, representing the 
severity of regurgitation, was determined on the basis of the ratio between the regurgitant 
flow volume and the ventricular inflow volume during diastole. Possible aortic regurgitation 
was corroborated by echocardiographic findings.
statistical analysis
Continuous variables are expressed as means±standard deviations. Correlation between MR 
flow acquisitions was evaluated with the Pearson correlation coefficient (r) under the assump-
tion that data were distributed normally. This assumption was tested with the Kolmogorov-
Smirnov test. Correlation was classified as strong (r = 0.85), good (r = 0.70–0.85), or fair (r = 
0.70). p <0.05 indicated a significant difference. The approach described by Bland and Altman 
29 was used to study systematic differences. Mean signed differences and confidence intervals 
(ie, the limits of agreement) and the mean relative unsigned difference were determined, and 
significance was tested by using paired-samples t tests. Intra- and inter-observer variation 
was determined by studying not only the significance of differences between measurements 
but also the intra-class correlation for absolute agreement and the coefficients of variance 
(defined as the standard deviation of the differences between the two series of measure-
ments divided by the mean of both measurements). P-value <0.05 indicated a significant 
difference.
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results
In vitro validation
MR flow acquisition was validated at five constant flow rates (Figure 3a). Strong correla-
tion was found between both MR sequences and volumetric measurements (Table 1). The 
agreement between 3D three-directional VE MR imaging and volumetric measurements 
was lower than the agreement between 2D one-directional VE MR imaging and volumetric 
measurements, with a difference of 0.23 mL/sec (p >0.05). The confidence intervals (ie, limits 
of agreement) for 3D three-directional VE MR imaging and 2D one-directional VE MR imaging 
were similar. Figure 3b reveals that both MR sequences resulted in underestimation for low 
flow and overestimation for high flow.
The harmonic flow volume (set at 40 mL) from 2D one-directional VE MR imaging and 3D 
three-directional VE MR imaging ranged from 41.3 mL (an overestimation of 3%) to 38.7 mL 
(an underestimation of 3%), respectively.
validation in volunteers
No distortion or susceptibility artifacts caused by echo-planar imaging were seen in the 
image data. Mean signal-to-noise ratio was 187±116 for 2D one-directional VE MR imaging 
and 84±60 for 3D three-directional VE MR imaging. The signal-to-noise ratio for 3D three-
directional VE MR imaging was 55% lower than that for 2D one-directional VE MR imaging, 
but it was still sufficient for accurate image analysis.
A bias was found for 2D one-directional VE MR imaging of MV flow (overestimation, 11 
mL per cycle [15%]; p<0.01) in the healthy volunteers (Figure 4a). We found that 2D one-
tion between stroke volumes was deter-
mined, and differences were studied by
using Bland-Altman plots (29). Intra-
and interobserver variation of the im-
age-processing procedure (ie, reformat-
ting and image analysis) was tested with
repeated analysis by two observers
(J.J.M.W., S.D.R.; 13 and 4 years of
experience with cardiac MR imaging,
respectively) with an interexamination
time of more than 1 week. Signal-to-
noise ratio was determined in peak di-
astole with 2D one-directional and 3D
three-directional VE MR imaging.
Application in Patients
Twenty patients with ischemic cardio-
myopathy who were suspected of hav-
ing mitral regurgitation, tricuspid regur-
gitation, or both at echocardiography
were included. The net flow volumes
per cycle (defined as stroke volume mi-
nus regurgitant flow volume) at the MV
and TV were compared, correlation
was examined, and Bland-Altman plots
were used to study the differences. The
regurgitant flow volume was deter-
mined on the basis of the flow from the
ventricle toward the atrium during sys-
tole. The regurgitant flow fraction, rep-
resenting the severity of regurgitation,
was determined on the basis of the ratio
between the regurgitant flow volume
and the ventricular inflow volume dur-
ing diastole. Possible aortic regurgita-
tion was corroborated by echocardio-
graphic findings.
Statistical Analysis
Continuous variables are expressed as
means  standard deviations. Correla-
tion between MR flow acquisitions was
evaluated with the Pearson correlation
coefficient (r) under the assumption
that data were distributed normally.
This assumption was tested with the
Kolmogorov-Smirnov test. Correlation
was classified as strong (r  0.85), good
(r  0.70–0.85), or fair (r  0.70). P 
.05 indicated a significant difference.
The approach described by Bland and
Altman (29) was used to study system-
atic differences. Mean signed differ-
ences and confidence intervals (ie, the
limits of agreement) and the mean rela-
tive unsigned difference were deter-
mined, and significance was tested by
using paired-samples t tests. Intra- and
interobserver variation was determined
by studying not only the significance of
differences between measurements but
also the intraclass correlation for abso-
lute agreement and the coefficients of
variance (defined as the standard devia-
tion of the differences between the two
series of measurements divided by the
mean of both measurements). P  .05
indicated a significant difference.
Results
In Vitro Validation
MR flow acquisition was validated at five
constant flow rates (Fig 3a). Strong cor-
relation was found between both MR
sequences and volumetric measure-
ments (Table 1). The agreement be-
tween 3D three-directional VE MR im-
aging and volumetric measurements
was lower than the agreement between
2D one-directional VE MR imaging and
volumetric measurements, with a differ-
ence of 0.23 mL/sec (P  .05). The
confidence intervals (ie, limits of agree-
ment) for 3D three-directional VE MR
imaging and 2D one-directional VE MR
imaging were similar. Figure 3b reveals
that both MR sequences resulted in un-
derestimation for low flow and overesti-
mation for high flow.
The harmonic flow volume (set at 40
mL) from 2D one-directional VE MR
imaging and 3D three-directional VE
MR imaging ranged from 41.3 mL (an
overestimation of 3%) to 38.7 mL (an
underestimation of 3%), respectively.
Validation in Volunteers
No distortion or susceptibility artifacts
caused by echo-planar imaging were
seen in the image data. Mean signal-to-
Figure 3
Figure 3: Graphs show in vitro flow validation. (a) Flow is measured with two MR techniques (2D one-
directional VE MR imaging and 3D VE MR imaging) and compared with volumetric flow assessment. (b) Dif-
ferences between the techniques are presented on a Bland-Altman plot.
Table 1







Pearson correlation coefficient 1.00 (P  .01) 1.00 (P  .01)
Mean signed difference (mL/sec) 0.08 0.23
Mean relative unsigned difference (%) 4 4
P value* .58 .23
Confidence interval (mL/sec) 0.55, 0.72 0.50, 0.96
* P values were calculated with the paired-samples t test.
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Figure 3. Graphs show in vitro flow validation. (a) Flow is measured with two MR techniques (2D one-directional VE MR imaging and 3D VE MR 
imaging) and compared with volumetric flow assessment. (b) Differences between the techniques are presented on a Bland-Altman plot.
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directional VE MR imaging of TV flow resulted in an overestimation of 12 mL per cycle (25%); 
however, this was not significant because of the high standard deviation. Use of 3D three-
directional VE MR imaging resulted in smaller non significant bias and smaller confidence 
intervals (ie, limits of agreement) compared with use of 2D one-directional VE MR imaging for 
both MV flow and TV flow. Correlation with ASSV was strong for 3D three-directional VE MR 
imaging (for MV, r = 0.96 and p <0.01; for TV, r = 0.88 and p <0.01) and strong between MV and 
TV (r = 0.91, p <0.01) (Figure 4b). Correlation with ASSV was weaker for 2D one-directional VE 
MR imaging (for MV, r = 0.80 and p <0.01; for TV, r = 0.22 and p = 0.55) and weak between MV 
table 1. Statistics for constant flow experiments performed to compare two MR sequences for flow assessment.
statistic 2d one-directional 3d three-directional 
VE MR Imaging VE MR Imaging 
Pearson correlation coefficient 1.00 (p <0.01) 1.00 (p <0.01) 
Mean signed difference (mL/sec) 0.08 0.23 
Mean relative unsigned difference (%) 4 4 
P value* 0.58 0.23 
Confidence interval (mL/sec)  -0.55, 0.72  -0.50, 0.96 
* p- values were calculated with the paired-samples t test.
noise ratio was 187  116 for 2D one-
directional VE MR imaging and 84  60
for 3D three-directional VE MR imag-
ing. The signal-to-noise ratio for 3D
three-directional VE MR imaging was
55% lower than that for 2D one-direc-
tional VE MR imaging, but it was still
sufficient for accurate image analysis.
A bias was found for 2D one-direc-
tional VE MR imaging of MV flow (over-
estimation, 11 mL per cycle [15%]; P 
.01) in the healthy volunteers (Fig 4a).
We found that 2D one-directional VE
MR imaging of TV flow resulted in an
overestimation of 12 mL per cycle
(25%); however, this was not significant
because of the high standard deviation.
Use of 3D three-directional VE MR im-
aging resulted in smaller nonsignificant
bias and smaller confidence intervals
(ie, limits of agreement) compared with
use of 2D one-directional VE MR imag-
ing for both MV flow and TV flow. Cor-
relation with ASSV was strong for 3D
three-directional VE MR imaging (for
MV, r  0.96 and P  .01; for TV, r 
0.88 and P  .01) and strong between
MV and TV (r  0.91, P  .01) (Fig 4b).
Correlation with ASSV was weaker for
2D one-directional VE MR imaging (for
MV, r  0.80 and P  .01; for TV, r 
0.22 and P  .55) and weak between
MV and TV (r  0.34, P  .34) (Fig 5,
Table 2). Kolmogorov-Smirnov tests
showed that the data were distributed
normally. These results indicate that 3D
three-directional VE MR imaging pro-
vides accurate results for MV flow and
TV flow, whereas 2D one-directional VE
MR imaging is less accurate.
Intraobserver coefficient of varia-
tion was less than or equal to 4%, with
an intraclass correlation coefficient of
0.98 (P  .01 for both MV flow and TV
flow). Interobserver coefficient of vari-
ation was less than or equal to 8%, with
intraclass correlation coefficients of
0.94 (P  .01) and 0.93 (P  .01) for
MV flow and TV flow, respectively
(Table 3).
Application in Patients
In the 20 patients, the mean regurgitant
fraction was 13%  9 (range, 3%–32%)
for MV and 10%  6 (range, 0%–23%)
for TV. Kolmogorov-Smirnov test re-
sults proved that the data were distrib-
uted normally. Correlation between net
flow volumes at MV and TV was exam-
ined (Fig 6). The statistics are summa-
rized in Table 4.
Correlation between MV flow vol-
ume and TV flow volume at 3D three-
directional VE MR imaging was strong
and showed no significant bias. As ex-
pected, correlation between MV flow
volume and TV flow volume with ASSV
was good; however, these showed a sig-
nificant bias (15%, P  .01), as several
patients had substantial aortic valve re-
gurgitation as well, which is not ac-
counted for in the ASSV. For 3D three-
Figure 4
Figure 4: Graphs show net flow volumes measured with two techniques (2D one-directional VE MR imag-
ing and 3D VE MR imaging) at the MV and TV in healthy volunteers and compared with 2D one-directional VE
MR ASSV (a and c). Differences between the techniques are presented on Bland-Altman plots (b and d).
AOaortic valve, SVnet stroke volume.
Figure 5
Figure 5: (a) Graph shows net flow volumes measured with two techniques (2D one-directional VE MR
imaging and 3D three-directional VE MR imaging) at the MV and TV in healthy volunteers. (b) Differences
between the techniques are presented on a Bland-Altman plot. SVnet stroke volume.
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Figure 4. Graphs show net flow volumes measured with two techniques (2D o e-directional VE MR imag ng and 3D VE MR imaging) at the MV 
and TV in healthy volunteers and compared with 2D o e-directio al VE MR ASSV (a a d c). Differe ces between the techniques are presented on 
Bland- ltman plots (b and d). AO = aortic valve, SV = net stroke volume.
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and TV (r = 0.34, p = 0.34) (Figure 5, Table 2). Kolmogorov-Smirnov tests showed that the data 
were distributed normally. These results indicate that 3D three-directional VE MR imaging 
provides accurate results for MV flow and TV flow, whereas 2D one-directional VE MR imaging 
is less accurate.
Intra-observer coefficient of variation was less than or equal to 4%, with an intra-class cor-
relation coefficient of 0.98 (p <0.01 for both MV flow and TV flow). Inter-observer coefficient 
of variation was less than or equal to 8%, with intra-class correlation coefficients of 0.94 (p 
<0.01) and 0.93 (p <0.01) for MV flow and TV flow, respectively (Table 3).
noise ratio was 187  116 for 2D one-
directional VE MR imaging and 84  60
for 3D three-directional VE MR imag-
ing. The signal-to-noise ratio for 3D
three-directional VE MR imaging was
55% lower than that for 2D one-direc-
tional VE MR imaging, but it was still
sufficient for accurate image analysis.
A bias was found for 2D one-direc-
tional VE MR imaging of MV flow (over-
estimation, 11 mL per cycle [15%]; P 
.01) in the healthy volunteers (Fig 4a).
We found that 2D one-directional VE
MR imaging of TV flow resulted in an
overestimation of 12 mL per cycle
(25%); however, this was not significant
because of the high standard deviation.
Use of 3D three-directional VE MR im-
aging resulted in smaller nonsignificant
bias and smaller confidence intervals
(ie, limits of agreement) compared with
use of 2D one-directional VE MR imag-
ing for both MV flow and TV flow. Cor-
relation with ASSV was strong for 3D
three-directional VE MR imaging (for
MV, r  0.96 and P  .01; for TV, r 
0.88 and P  .01) and strong between
MV and TV (r  0.91, P  .01) (Fig 4b).
Correlation with ASSV was weaker for
2D one-directional VE MR imaging (for
MV, r  0.80 and P  .01; for TV, r 
0.22 and P  .55) and weak between
MV and TV (r  0.34, P  .34) (Fig 5,
Table 2). Kolmogorov-Smirnov tests
showed that the data were distributed
normally. These results indicate that 3D
three-directional VE MR imaging pro-
vides accurate results for MV flow and
TV flow, whereas 2D one-directional VE
MR imaging is less accurate.
Intraobserver coefficient of varia-
tion was less than or equal to 4%, with
an intraclass correlation coefficient of
0.98 (P  .01 for both MV flow and TV
flow). Interobserver coefficient of vari-
ation was less than or equal to 8%, with
intraclass correlation coefficients of
0.94 (P  .01) and 0.93 (P  .01) for
MV flow and TV flow, respectively
(Table 3).
Application in Patients
In the 20 patients, the mean regurgitant
fraction was 13%  9 (range, 3%–32%)
for MV and 10%  6 (range, 0%–23%)
for TV. Kolmogorov-Smirnov test re-
sults proved that the data were distrib-
uted normally. Correlation between net
flow volumes at MV and TV was exam-
ined (Fig 6). The statistics are summa-
rized in Table 4.
Correlation between MV flow vol-
ume and TV flow volume at 3D three-
directional VE MR imaging was strong
and showed no significant bias. As ex-
pected, correlation between MV flow
volume and TV flow volume with ASSV
was good; however, these showed a sig-
nificant bias (15%, P  .01), as several
patients had substantial aortic valve re-
gurgitation as well, which is not ac-
counted for in the ASSV. For 3D three-
Figure 4
Figure 4: Graphs show net flow volumes measured with two techniques (2D one-directional VE MR imag-
ing and 3D VE MR imaging) at the MV and TV in healthy volunteers and compared with 2D one-directional VE
MR ASSV (a and c). Differences between the techniques are presented on Bland-Altman plots (b and d).
AOaortic valve, SVnet stroke volume.
Figure 5
Figure 5: (a) Graph shows net flow volumes measured with two techniques (2D one-directional VE MR
imaging and 3D three-directional VE MR imaging) at the MV and TV in healthy volunteers. (b) Differences
between the techniques are presented on a Bland-Altman plot. SVnet stroke volume.
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Figure 5. (a) Graph shows net flow volumes measured with two techniques (2D one-directional VE MR imaging and 3D three-directional VE MR 
imaging) at the MV and TV in healthy volunteers. (b) Differences between the techniques are presented on a Bland-Altman plot. SV = net stroke 
volume.
table 2. Statistics for transvalvular flow volumes assessed in healthy volunteers with two MR techniques
mv vs ao tv vs ao mv vs tv
Statistic 2D 1-Dir 3D 3-Dir 2D 1-Dir 3D 3-Dir 2D 1-Dir 3D 3-Dir
 VE MRI  VE MRI VE MRI VE MRI VE MRI VE MRI












Mean signed difference (mL) 11 1 12 -2 1 -1
Mean relative unsigned difference (%) 15 4 25 7 18 4
p-value* <0.01 0.60 0.13 0.46 0.92 0.72
Confidence interval (mL) -10, 32 -8, 10 -33, 57   -20, 16 -44, 45 -11, 10
Note. AO = aortic valve. 
* p-values were calculated with the paired-samples t test.




In the 20 patients, the mean regurgitant fraction was 13%±9 (range, 3%–32%) for MV and 
10%±6 (range, 0%–23%) for TV. Kolmogorov-Smirnov test results proved that the data were 
distributed normally. Correlation between net flow volumes at MV and TV was examined 
(Figure 6). The statistics are summarized in Table 4.
Correlation between MV flow volume and TV flow volume at 3D three-directional VE MR 
imaging was strong and showed no significant bias. As expected, correlation between MV 
flow volume and TV flow volume with ASSV was good; however, these showed a significant 
bias (15%, p <0.01), as several patients had substantial aortic valve regurgitation as well, 
which is not accounted for in the ASSV. For 3D three-directional VE MR imaging in 20 patients 
and 10 volunteers, mean examination time was 4.2 minutes±0.8 at an average heart rate of 
67 beats per minute±12.
table 3. Statistics for intra- and inter-observer study for transvalvular flow volume assessed with 3D three-directional VE MR imaging.
Intra-observer Inter-observer
Statistic MV TV MV TV








Mean signed difference (mL) 1 1 1 3
Mean relative unsigned difference (%) 3 3 6 6
p-value* 0.61 0.28 0.60 0.27
Confidence interval (mL) -6, 5 -6, 9 -11, 12 -17, 12
Coefficient of variance (%) <3 <4 <6 <8
* p-values were calculated with the paired-samples t test.
directional VE MR imaging in 20 patients
and 10 volunteers, mean examination
time was 4.2 minutes  0.8 at an average
heart rate of 67 beats per minute  12.
Discussion
The main findings of the current study
are as follows: First, both 2D one-direc-
tional VE MR imaging and 3D three-
directional VE MR imaging are accurate
for in vitro flow assessment when the
plane of interest remains fixed in the
same location and no through-plane mo-
tion is present. Second, in vivo 2D one-
directional VE MR imaging shows 15%
and 25% overestimation of MV flow and
TV flow, respectively. Third, 3D three-
directional VE MR imaging yields accu-
rate MV flow and TV flow values in the
presence of valve regurgitation, with
smaller limits of agreement when com-
pared with 2D one-directional VE MR
imaging.
The severity of regurgitation, ex-
pressed in the regurgitation fraction de-
termined from the quotient between the
regurgitant backward flow during sys-
tole and diastolic inflow, is an important
determinant of mortality in patients
with ischemic cardiomyopathy (30);
therefore, knowledge about the severity
of regurgitation is desired for optimal
surgical decision making. The value of
indirect quantification of regurgitation
by measuring left and right ventricular
end-systolic and end-diastolic volumes
(31) is limited to assessment of isolated
valve regurgitation. The use of 2D one-
directional VE MR imaging (18–20) for
consecutive flow assessment of MV and
TV is routine in clinical practice, al-
though this technique has been proved
to be in ccurate (22). Our in vitro vali-
dation study has shown that the accu-
racy of 2D one-directional VE MR imag-
ing is comparable to that of 3D three-
directional VE MR imaging when flow
assessment takes place at a plane that
does not show through-plane motion. In
vivo, 2D one-dir ctional VE MR imagi g
does not adapt to heart motion during
relaxation. Thus, with this technique,
flow acquisition does not take place at
the valve of interest for the complete
Figure 6
Figure 6: (a) Graph shows net flow volumes measured with two techniques (2D one-directional VE MR
imaging and 3D three-directional VE MR imaging) in patients with valve regurgitation assessed at the MV (MV
SV) and TV (TV SV). (b) Differences between the techniques are presented on a Bland-Altman plot. SVnet
stroke volume.
Table 2
Statistics for Transvalvular Flow Volumes Assessed in Healthy Volunteers with Two MR Techniques














Pearson correlation coefficient .80 (P  .01) .96 (P  .01) .22 (P  .55) .88 (P  .01) .34 (P  .34) .91 (P  .01)
Mean signed difference (mL) 11 1 12 2 1 1
Mean relative unsigned difference (%) 15 4 25 7 18 4
P value* .01 .60 .13 .46 .92 .72
Confidence interval (mL) 10, 32 8, 10 33, 57 20, 16 44, 45 11, 10
Note.—AO  aortic valve.
* P values were calculated with the paired-samples t test.
Table 3
Statistics for Intra- and Interobserver Study for Transvalvular Flow Volume Assessed
with 3D Three-Directional VE MR Imaging
Intraobserver Interobserver
Statistic MV TV MV TV
Intraclass correlation coefficient 0.98 (P  .01) 0.98 (P  .01) 0.94 (P  .01) 0.93 (P  .01)
Mean signed difference (mL) 1 1 1 3
Mean relative unsigned difference (%) 3 3 6 6
P value* .61 .28 .60 .27
Confidence interval (mL) 6, 5 6, 9 11, 12 17, 12
Coefficient of variance (%) 3 4 6 8
* P values were calculated with the paired-samples t test.
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Figure 6, (a) Graph shows net flow volumes measured with two techniques (2D one-directional VE MR imaging and 3D three-directional VE MR 
imaging) in patients with valve regurgitation assessed at the MV(MV SV) and TV (TV SV). (b) Differences between the techniques are presented 
on a Bland-Altman plot. SV = net stroke volume.
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dIscussIon
The main findings of the current study are as follows: First, both 2D one-directional VE MR 
imaging and 3D three-directional VE MR imaging are accurate for in vitro flow assessment 
when the plane of interest remains fixed in the same location and no through-plane motion 
is present. Second, in vivo 2D one-directional VE MR imaging shows 15% and 25% overesti-
mation of MV flow and TV flow, respectively. Third, 3D three-directional VE MR imaging yields 
accurate MV flow and TV flow values in the presence of valve regurgitation, with smaller 
limits of agreement when compared with 2D one-directional VE MR imaging.
The severity of regurgitation, expressed in the regurgitation fraction determined from the 
quotient between the regurgitant backward flow during systole and diastolic inflow, is an 
important determinant of mortality in patients with ischemic cardiomyopathy 30; therefore, 
knowledge about the severity of regurgitation is desired for optimal surgical decision 
making. The value of indirect quantification of regurgitation by measuring left and right 
ventricular end-systolic and end-diastolic volumes 31 is limited to assessment of isolated 
valve regurgitation. The use of 2D one-directional VE MR imaging 18–20 for consecutive flow 
assessment of MV and TV is routine in clinical practice, although this technique has been 
proved to be inaccurate 22. Our in vitro validation study has shown that the accuracy of 2D 
one-directional VE MR imaging is comparable to that of 3D three-directional VE MR imaging 
when flow assessment takes place at a plane that does not show through-plane motion. In 
vivo, 2D one-directional VE MR imaging does not adapt to heart motion during relaxation. 
Thus, with this technique, flow acquisition does not take place at the valve of interest for the 
complete cardiac cycle, whereas with 3D three-directional VE MR imaging, flow at the valve 
can be assessed with retrospective adaptation of the reformation plane to the valvular plane.
In a previous study, MV flow was measured with a 2D three-directional VE MR protocol 
by using a radial stack of acquisition planes positioned on the left ventricle 22. The current 
approach with 3D three-directional VE MR imaging shows two important improvements 
to the 2D three-directional VE MR imaging approach with radial acquisition stack: The first 
table 4. Statistics for transvalvular flow volume assessment with 3D three-directional VE MR imaging in patients.
statistic mv vs ao tv vs ao mv vs tv 






Mean signed difference (mL)  -11  -11 1 
Mean relative unsigned difference (%) 15 15 5 
p-value*  <0.01  <0.01 0.58 
Confidence interval (mL)  -33, 11  -37, 15  -7, 8 
Note.AO = aortic valve.
* p-values were calculated with the paired-samples t test.
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improvement is that in-plane data sampling is almost isotropic over the MV and TV an-
nuli, with sufficient spatial resolution to ensure accurate flow acquisition over the annuli 
18, whereas radial sampling implies dense sampling at the center of the annulus but sparse 
sampling at the outside region, resulting in underestimation of eccentric regurgitant jets. The 
second improvement is that MV flow and TV flow are assessed with one acquisition, thereby 
excluding possible inter-examination variation in heart rate, whereas 2D three-directional 
VE MR imaging with radial sampling requires a repeated acquisition when both valves are 
studied. Retrospective gating 32 was used for both flow acquisition techniques. Arrhythmia, 
often present in patients with ischemic heart disease, has a degrading effect on the overall 
image quality and therefore on the accuracy of the flow acquisitions. Arrhythmia rejection 
was used during data acquisition (with an acceptance window of 10% from the value chosen 
in advance). This prolonged acquisition time but had a positive effect on accuracy. Data ac-
quisition was performed during free breathing. This also degraded image quality compared 
with that achieved with breathhold techniques or navigator-based acquisitions 33. However, 
navigator-based techniques require prospective triggering, which is not suitable when ac-
quisition at both systole and diastole is required with sufficient temporal resolution.
In this study, 20 patients with ischemic cardiomyopathy and suspected of having mitral 
regurgitation, tricuspid regurgitation, or both were examined. MV flow and TV flow measured 
with 3D three-directional VE MR imaging were in agreement. Regurgitant fractions ranged 
from 3% to 32% for MV and from 0% to 23% for TV. This information is essential for surgical 
decision making. At our institute, 3D three-directional VE MR imaging is now routinely used 
to test valvular insufficiency in patients eligible for the procedure described by Dor et al 34.
Our study had some limitations. Echo-planar imaging was used with the 3D three-
directional VE MR sequence and an echo-planar imaging factor of five to accelerate image 
acquisition and to make this examination clinically applicable. No distortions or suscepti-
bility artifacts were seen, and although signal-to-noise ratio was 55% lower with 3D three-
directional VE MR imaging than with 2D one-directional VE MR imaging, this technique was 
still sufficient for accurate image analysis. Background phase correction was not performed 
35, but by correcting for through-plane motion by subtracting the mean velocity from nearby 
myocardium from the velocity through the annulus, it can be assumed that local phase offset 
errors are eliminated. These errors may introduce systematic errors in flow assessment with 
some MR imagers, and these are also more pronounced in short breath-hold acquisitions 
28. In this study, 2D one-directional VE MR imaging was performed without acceleration, 
3D three-directional VE MR imaging was performed with an echo-planar imaging factor of 
five, and both examinations were performed with free breathing. Both MR sequences were 
validated extensively in phantoms, and the volunteer data did not indicate systematic differ-
ences between MV flow and TV flow.
The image processing needed for assessment of MV flow and TV flow with 3D three-direc-
tional VE MR imaging (ie, reformatting and image analysis) still requires manual interaction, 
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but it showed good reproducibility. MV flow showed 4% or less variation, and TV flow showed 
8% or less variation, which is considered acceptable in clinical practice. Compared with the 
time required for reformatting in 2D one-directional VE MR imaging, another technique in 
which manual image analysis is mandatory, additional time for the reformatting procedure in 
3D three-directional VE MR imaging is 5 minutes per valve.
In healthy volunteers, ASSV was used as the reference standard to compare MV and TV 
stroke volumes. There was some underestimation with ASSV because of the distensibility 
of the aorta and the coronary flow. Also, possible variation in heart rate between 2D one-
directional VE MR imaging in the ascending aorta, 2D one-directional VE MR imaging at the 
MV and TV, and 3D three-directional VE MR imaging, respectively, was a potential source of 
error.
We tested and applied 3D three-directional VE MR imaging in relatively small groups of 
volunteers and patients within a small age range. A larger study should be performed to 
prove the accuracy and reproducibility of this technique.
conclusIons
3D three-directional VE MR imaging is a noninvasive quantification tool used to assess the 
severity of regurgitation at multiple valves in a single acquisition.
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objectives: Accurate grading of mitral regurgitation (MR) severity is crucial for 
appropriate patient management, but remains challenging. Velocity-encoded mag-
netic resonance imaging (MRI) with three-dimensional (3D) 3-directional acquisition 
has been recently proposed as the reference method. Aim of this study was to evalu-
ate feasibility and accuracy of real-time 3D echocardiography for quantification of 
MR, in a head-to-head comparison with velocity-encoded MRI.
methods: A total of 64 patients with functional MR were included. A 3D 3-direc-
tional velocity-encoded MRI acquisition was applied to quantify mitral regurgitant 
volume (Rvol). Color Doppler 3D-echocardiography was applied for direct measure-
ment, in ‘en face’ view, of mitral effective regurgitant orifice area (EROA); Rvol was 
subsequently calculated as EROA multiplied by the velocity-time integral of the re-
gurgitant jet on the continuous-wave Doppler. To assess the relative potential error 
of the conventional approach, color Doppler 2D-echocardiography was performed: 
vena contracta width was measured in the 4-chamber view and EROA calculated as 
circular (EROA-4CH); EROA was also calculated as elliptical (EROA-elliptical), measur-
ing vena contracta also in the 2-chamber view. From these 2D measurements of 
EROA, the regurgitant volumes were also calculated.
results: the EROA measured by 3D-echocardiography was significantly higher than 
EROA-4CH (p<0.001) and EROA-elliptical (p<0.001) with a significant bias between 
these measurements (0.10 cm2 and 0.06 cm2, respectively). Rvol measured by 
3D-echocardiography showed excellent correlation with Rvol measured by MRI (r 
= 0.94) without a significant difference between these techniques (mean difference 
= -0.08 ml/beat). Conversely, 2D echocardiographic approach from the 4-chamber 
view significantly underestimated Rvol (p=0.006) as compared to MRI (mean differ-
ence = 2.9 ml/beat). The 2D elliptical approach demonstrated a better agreement 
with MRI (mean difference = -1.6 ml/beat, p=0.04).
conclusions: Quantification of EROA and Rvol of functional MR using 3D-echocar-
diography is feasible and accurate as compared to 3D 3-directional velocity-encoded 
MRI; the currently recommended 2D-echocardiographic approach significantly 
underestimate both EROA and Rvol.
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IntroductIon
Functional mitral regurgitation (MR) is a common and serious complication in patients with 
global and/or regional left ventricular (LV) dilatation and dysfunction, and is associated with 
relatively high morbidity and mortality 1–4. Consequently, timely diagnosis and accurate grading 
of MR severity are crucial for appropriate patient management and timing of surgical interven-
tion 2,5,6. However, quantitative assessment of MR remains challenging, and different echocar-
diographic modalities or semiquantitave angiographic grading have been proposed, but a true 
gold standard technique is still lacking 7,8. Evaluation of the effective regurgitant orifice area 
(EROA) and regurgitant volume (Rvol) is currently recommended, applying 2-dimensional (2D) 
echocardiography with the proximal isovelocity surface area (PISA) or pulsed Doppler quantita-
tive flow methods 8. However, both methods have several limitations due to indirect measure-
ments based on imprecise hemodynamic assumptions and multiple computational steps 9–12.
In addition, an accepted direct assessment of EROA is the vena contracta width (VCW), 
as the narrowest cross-section of the regurgitant jet 8,13,14. However, this method assumes 
the orifice as nearly circular and the exact shape and size may not be accurately assessed 
due to the limited scan plane orientation of 2D echocardiography. Real-time 3-dimensional 
echocardiography (RT3DE) is now available to overcome this limitation, which is particularly 
relevant in patients with functional MR, in whom EROA geometry is usually complex and 
asymmetric 15,16. In fact, RT3DE provides unlimited image plane orientation and, using color 
Doppler, allows for a direct EROA quantification 15,17,18.
Recently, velocity encoded magnetic resonance imaging (MRI) has been proposed as 
a reference method for transvalvular flow quantification 19,20; in particular, the use of a 3D 
3-directional acquisition showed to be able to optimize the conventional 2D one-directional 
acquisition 21–24, providing independent MR flow quantification. Therefore, the aim of the 
current study was to explore in patients with functional MR, the feasibility and the accuracy 
of direct measurement of EROA and quantification of Rvol with RT3DE, in a head-to-head 
comparison with VE MRI. To assess the relative potential error of 2D echocardiography for 
these measurements, 2D echocardiography was also performed in the same patient cohort.
methods
patient population and protocol
The patient population consisted of 70 consecutive patients who were clinically referred for 
cardiac MRI and had functional mild-to-severe MR on color Doppler echocardiography. Func-
tional MR was defined as leaflet tethering and incomplete leaflet coaptation in the presence 
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of normal mitral valve anatomy and regional or global LV remodeling 25.
Patients with atrial fibrillation, irregular heart rhythm or absolute contraindications (in-
cluding cardiac devices) for MRI were excluded. The standard MRI protocol was applied to 
assess LV size and function. A 3D 3-directional velocity encoded MRI acquisition was added to 
quantify MR. On the same day, patients underwent also 2D color Doppler echocardiography 
and RT3DE to quantify MR and for comparison with MRI measurements. All patients gave 
informed consent and the protocol was approved by the institutional review board.
magnetic resonance imaging
Data acquisition
Data acquisition was performed on a 1.5T MRI scanner equipped with Powertrack 6000 
gradients (ACS-NT15 Intera, Philips Medical Systems, Best, The Netherlands; software release 
11), using a 5-element cardiac coil placed on the chest for signal reception. LV volumes were 
determined by planimetry from a series of short-axis acquisitions covering the complete 
LV from apex to base, following a standardized protocol described previously 26. The spatial 
resolution of the acquired images was 1.56 × 1.56 mm2.
For 3-directional velocity encoded MRI, a true free breathing 3D MRI acquisition was designed 
with velocity encoding in 3 orthogonal directions (field-of-view 370 mm, 3D volume scan with 
slab thickness 48 mm, reconstructed into 12 slices of 4 mm, TE 3.3 ms, TR 14 ms, α 10º, acquisi-
tion voxel size 2.9×3.8×4.0 mm3, reconstructed into 1.4×1.4×4.0 mm3, NSA 1, Venc 150 cm/s in 
all 3 directions) and with 30 phases reconstructed during one average cardiac cycle from the 
retrospectively gated acquisition (temporal resolution between 25 and 40ms, depending on 
the patient’s heart rate). To reduce acquisition time, echo planar imaging was used with EPI 
factor 5. Scan time was less than 5 minutes, depending on the subject’s heart rate.
LV volumes and function analysis
Quantification of LV end-systolic and end-diastolic volumes and ejection fraction was per-
formed on the short-axis series using MASS analytical software (Medis, Leiden, the Nether-
lands) and manual contour segmentation of the epicardial and endocardial borders. In the 
presence of significant mitral regurgitation, LV ejection fraction does not represent the true 
systolic stroke volume. To correct for this effect, the ‘‘forward LV ejection fraction’’ was cal-
culated as the ratio of the forward stroke volume (obtained from aortic flow measurements 
derived from velocity encoded MRI) and LV end-diastolic volume 27.
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Mitral valve flow quantification
The 3D 3-directional velocity encoded MRI acquisitions were analyzed using in-house devel-
oped image processing software. The procedure was performed as previously described 24 
and is schematically illustrated in Figure 1. In summary, from the MRI data, the 3 velocity vec-
tor components of blood flow at the level of the mitral valve plane needs to be reformatted, 
using the LV 4- and 2-chamber views; this procedure required 5 to 10 minutes. The velocities 
measured perpendicularly to the reconstructed mitral valve plane need to be corrected for 
the motion of the myocardium in basal/apical direction in order to obtain the true trans-
valvular velocity of the blood flow 21. Therefore, the through-plane velocity of the mitral valve 
annulus was determined in the lateral wall and subtracted from the through-plane MV flow 
velocities. The trans-valvular volume flow was obtained by integrating the resulting veloci-
ties over the annulus area. The regurgitant volume (Rvol-MRI) was obtained by calculating 
the Riemann sum of backward flow during systole in the flow graph. This analysis required 
approximately 5 minutes and its reproducibility was previously reported 24: intraobserver 
variation was less than 3%, while inter-observer variation was less than 6%.
Figure 1. Reformat procedure of mitral valve flow from 3-dimensional (3D) 3-directional velocity encoded magnetic resonance imaging 
data. Schematic representation of reformat procedure of mitral valve flow from 3-dimensional (3D) 3-directional velocity encoded magnetic 
resonance imaging data. The acquisition is performed in a volume positioned at the basal level of the heart (left panel), covering the full 
excursion of the mitral valve during contraction and relaxation. From the 3D velocity vector field, the trans-mitral flow is retrospectively 
quantified by multi-planar reformatting of mitral valve in 2- and 4-chamber views (second panel). The through-plane velocity is constructed 
from the dot product with the normal vector (third panel). During systole, regurgitant flow can be identified and quantified. During diastole, 
mitral valve inflow is acquired. Through-plane motion correction is performed from the longitudinal velocity measured in the lateral wall (green 
lines). The regurgitant volume was obtained by calculating the Riemann sum of backward flow during systole in the flow graph (right panel).





Patients were imaged in the left lateral decubitus position using a commercially available 
system (iE33, Philips Medical Systems, N.A., Bothell, Washington, USA) equipped with a 3.5-
Mhz transducer. VCW was measured as the narrowest portion of the MR color Doppler jet 
in a zoomed optimized apical 4-chamber (4CH) view. In addition, VCW was also measured 
in the apical 2-chamber (2CH) view to allow a more accurate calculation in case of asym-
metric EROA. The systolic frame with the most relevant lesion size was selected for the 
measurement. Nyquist limits were always set between 30 and 50 cm/sec to avoid any over- 
or under-estimation and a color gain was used that just eliminates random color speckles 
from non-moving regions. From the VCW measurements, estimates of EROA were obtained 
as circular (EROA-4CH = [π x (VCW-4CH/2)]2) as well as biplane elliptical (EROA-elliptical = 
[π x (VCW-4CH/2) x (VWC-2CH/2)]) 15. The Rvol can be estimated as EROA multiplied by the 
velocity time integral of the regurgitant jet on the continuous-wave Doppler.
Real-time 3-dimensional echocardiography
RT3DE was performed using the same ultrasound system and with an X3, fully sampled matrix 
transducer. Apical full-volume color Doppler datasets were obtained within 1 breath hold, 
combining 7 small real-time sub-volumes in a larger pyramidal volume (approximately 60 x 
60 degrees). Nyquist limits (aliasing velocity) and color gain were set as for 2D echocardiog-
raphy. Analysis of the 3D images was performed off-line (Q-Lab, version 6.0, Philips Medical 
Systems). To measure EROA (-3D), the 3D dataset was manually cropped by an image plane 
perpendicularly oriented to the jet direction until the narrowest cross-sectional area of the 
jet 15,18 (Figure 2). EROA-3D was measured by manual planimetry of the color Doppler signal, 
tilting the image in an ‘en face’ view and selecting the systolic frame with the most relevant 
lesion size (Figure 2) . The Rvol (-3D) was derived as for 2D echocardiography. On the cropped 
images, the ratio of the longest and shortest diameter of EROA (L/S) was also calculated as an 
index of orifice shape 28. The image post-processing required 3 to 5 minutes.
Twenty patients were randomly identified to evaluate the inter- and intra-observer agree-
ment for the EROA-3D. According to the Bland-Altman analysis, inter-observer agreement 
was good: EROA-3D mean difference (±2SD) = 0.06±0.04 cm2 (p = 0.43). The intra-observer 
agreement was also good with a mean difference (±2SD) of 0.04±0.04 cm2 (p = 0.55).
Nina Book.indb   360 26-09-11   12:04
361
Mitral regurgitation severity assessed by RT3DE
Figure 2. Real-time 3-dimensional (3D) echocardiographic technique for assessment of vena contracta area (EROA-3D). The 3D dataset is 
manually cropped by an image plane perpendicularly oriented to the jet direction until the narrowest cross-sectional area of the jet. EROA-3D is 
measured by manual planimetry of the color Doppler signal tilting the image in an ‘en face’ view. Panel A: example of a patient with moderate 
functional mitral regurgitation (MR) and asymmetric EROA-3D (= 0.23 cm2) elongated along the leaflet coaptation line. Panel B: example of a 
patient with severe functional MR and extremely irregular EROA-3D (= 0.48 cm2), for which geometric assumptions may not be applicable.




Continuous data are presented as mean±standard deviation (the range, when of interest). 
Categorical data are presented as absolute numbers or percentages. T-test and χ2-test were 
used for appropriate comparisons. For Rvol and EROA, that were not normally distributed as 
evaluated by the Kolmogorov-Smirnov test, a log-transformation has been performed. Pear-
son’s correlation analysis was performed to evaluate the relation between velocity encoded 
MRI, RT3DE and 2D echocardiographic measurements of EROA and Rvol. Bland-Altman analy-
sis was performed to evaluate the differences in Rvol and EROA assessed with MRI, RT3DE and 
2D echocardiography. The mean differences, trends and limits of agreement are reported. A 
p-value <0.05 was considered to be statistically significant. A statistical software program 
SPSS 16.0 (SPSS Inc, Chicago, II, USA) was used for statistical analysis.
results
Six patients (8.5%) were excluded from further analysis because inadequate RT3DE color 
Doppler images. Among the remaining 64 patients (44 men, 60±11 years), 48 (75%) were 
referred because of ischemic cardiomyopathy with a previous myocardial infarction (31 pa-
tients with anterior myocardial infarction and 17 with infero-posterior myocardial infarction) 
and 16 (25%) patients because of idiopathic dilated cardiomyopathy.
MRI analysis revealed severe LV dilatation (mean LV end-diastolic volume 273±66 ml), with 
depressed LV systolic function (mean forward LV ejection fraction 29±10%). From the 3-di-
rectional velocity encoded MRI analysis, the mean mitral Rvol was 12.9±12.6 ml/beat, ranging 
from 2 to 63 ml/beat. No significant (more than mild) regurgitation of the other cardiac valves 
was detected by 3-directional velocity encoded MRI.
rt3de versus 2d echocardiography
The mean values and the ranges of the EROA measurements with 2D echocardiography and 
RT3DE are displayed in Table 1. EROA-3D was significantly higher than EROA-4CH (p <0.001) 
and EROA-elliptical (p <0.001), and Bland-Altman analysis confirmed a significant systematic 
bias between these measurements (Table 2).
From the RT3DE analysis, EROA was considered significantly asymmetric when the L/S ratio 
was >1.5 28. In patients with an asymmetric orifice shape (18, 28%), 4CH was significantly 
smaller as compared to patients with L/S ≤1.5 (p = 0.02, Table 1), indicating a regurgitant 
orifice elongated along the leaflet coaptation line with the 4CH view representing the nar-
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rowest and the 2CH view the widest VCW. EROA-elliptical and EROA-3D however, were not 
significantly different between patients with asymmetric or non-asymmetric EROA (Table 1).
rt3de versus ve-mrI
The mean Rvol-3D was 12.8±12.7 ml/beat, ranging from 2 to 67 ml/beat. The mean Rvol-4CH 
was 10.1±11.9 ml/beat (from 1 to 51 ml/beat) and Rvol-elliptical was 11.3±12.1 ml/beat (from 
1 to 55 ml/beat).
Rvol-3D showed an excellent correlation with Rvol-MRI (r = 0.94, Figure 3) and the Bland-
Altman analysis revealed a non significant bias between these techniques (Figure 3): mean 
table 1. Mean values and range (minimum-maximum) of EROA measured by 2 different 2D echocardiographic approaches (from the 4CH 
view and with the elliptical formula) and measured by RT3DE, in the total population and among patients with (L/S >1.5) and without (L/S 
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* = p <0.05 between patients with L/S >15 and with L/S ≤1.5.
† = p <0.001 between 2D echocardiography and RT3DE.
EROA: effective regurgitant orifice area; elliptical: elliptical formula; L/S: ratio of the longest and shortest diameter of EROA-3D; SD: standard 
deviation; 2D: 2-dimensional; 4CH: 4 chamber view: RT3DE: real-time 3-dimensional echocardiography
table 2. Summary of the results of the Bland-Altman analysis applied for the EROA and Rvol measurements performed with 2D 
echocardiography (4CH view and elliptical approaches), RT3DE and 3D 3-directional velocity encoded MRI. The mean difference and the limits of 
agreements are reported.
rt3de: eroa-3d, cm2
2D echo: EROA-4CH, cm2 -0.10 (-0.26 to 0.08)*
2D echo: EROA-elliptical, cm2 -0.06 (-0.17 to 0.04)*
MRI: Rvol, ml/beat
2D echo: Rvol-4CH, ml/beat   -2.9 (-18.0 to 12.5)†
2D echo: Rvol-elliptical, ml/beat -1.6 (-11.9 to 8.8)†
RT3DE: Rvol-3D, ml/beat -0.08 (-7.7 to 7.6)
* = p <0.001
† = p <0.05
MRI: magnetic resonance imaging; Rvol: regurgitant volume. For other abbreviations see Table 1.
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difference (RT3DE – MRI) = -0.08 ml/beat (p = 0.87), limits of agreement from -7.7 to 7.6 ml/
beat (Table 2).
Conversely, the 2D echocardiographic approach from the 4CH view (Rvol-4CH) significantly 
underestimated Rvol (p = 0.006) as compared to MRI (Rvol-MRI) (Table 2). However, the 2D el-
liptical approach demonstrated a better agreement with MRI: mean difference (Rvol-elliptical 
– Rvol-MRI) = -1.6 ml/beat (p = 0.04), limits of agreement from -11.9 to 8.8 ml/beat (Table 2).
dIscussIon
The main findings of the current study can be summarized as follows: 1) in patients with 
functional MR direct assessment of EROA by RT3DE was feasible and reproducible; 2) 2D 
echocardiography systematically underestimated the EROA as compared to RT3DE and the 
difference between these 2 techniques was more accentuated in the presence of an asym-
metric regurgitant orifice; 3) a strong correlation was observed between RT3DE and MRI for 
the measurement of Rvol, with no significant bias between these 2 techniques; conversely, 
2D echocardiography significantly underestimated Rvol as compared to MRI.
Quantification of mitral regurgitation
RT3DE versus 2D echocardiography
Accurate grading of MR severity is an important but still controversial issue. Currently, con-
ventional 2D echocardiography is the method of choice for the assessment of MR 8, although 
y = 0.9243x - 0.247






































Figure 3. Comparison between mitral regurgitant volume (Rvol) assessed with real-time 3-dimensional echocardiography (RT3DE, Rvol-3D) 
and by 3-directional velocity encoded magnetic resonance imaging (MRI, Rvol-MRI). Left panel: correlation between mitral regurgitant volume 
(Rvol) assessed with real-time 3-dimensional echocardiography (RT3DE, Rvol-3D) and by 3-directional velocity encoded magnetic resonance 
imaging (MRI, Rvol-MRI). Right panel: Bland-Altman scatter plot of differences in Rvol between RT3DE and MRI and the average Rvol between 
the 2 techniques: Rvol-3D is 0.08 ml/beat lower than Rvol-MRI (p = 0.87), limits of agreement from -7.7 to 7.6 ml/beat.
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the limitations of this technique are well known. One of the most commonly used measures 
is the ratio between the regurgitant jet area and the left atrial area. However, this method is 
semiquantitative and rather subjective. In turn, quantitative approaches, such as PISA and 
pulsed Doppler quantitative flow methods, are limited by hemodynamic and geometric 
assumptions that introduce inaccuracies, and by complicated and time-consuming acquisi-
tions and calculations 8–11. For estimation of MR severity, 2D echocardiographic measurement 
of VCW has also been proposed as a direct representation of the EROA 8,13,14. This approach 
assumes the EROA shape to be either circular or elliptical. However, these assumptions may 
not be applicable when mitral valve geometry is significantly altered 29 and the regurgitant 
orifice shows an irregular shape. Particularly in patients with functional MR, EROA is typi-
cally elongated along the semilunar-shaped leaflet coaptation line, which contributes to a 
significant underestimation of the regurgitant orifice when measured from the 4-chamber 
or parasternal long-axis views 15,16. In this group of patients, lower thresholds to define se-
vere MR and to identify patients with poor prognosis have been proposed (EROA ≥0.2 cm2 
instead of 0.4 cm2 and Rvol ≥30 ml/beat instead of ≥60 ml/beat) 2,3,30. This difference may be 
explained by the changes in LV and left atrium function and compliance 2,3, but the difference 
is probably also related to a significant underestimation of MR severity by conventional 2D 
echocardiographic methods in the presence of an asymmetric regurgitant orifice.
Color Doppler RT3DE, allowing for an unlimited plan orientation and in particular for an 
“en face” view of the mitral valve, provides a direct assessment of size and shape of regurgi-
tant orifice, obviating the geometric assumptions applied by 2D echocardiography 15,17,18,28. 
Initial studies showed the incremental value of RT3DE measurements of EROA over 2D PISA 
and VCW. In particular, the studies by Iwakura et al 28 and Kahlert et al 15 emphasized the 
importance of a 3D approach in patients with functional MR, in whom 2D echocardiography 
significantly underestimated the size of the regurgitant orifice. Similarly, in the current study 
a significant difference in the measurement of EROA was observed between RT3DE and 2D 
echocardiography (-0.10 cm2 for EROA-4CH and -0.06 cm2 for EROA-elliptical); also, 2D echo-
cardiography underestimated EROA particularly in patients with an asymmetric regurgitant 
orifice (L/S >1.5). Thus far, a true validation study of RT3DE measurement of EROA is lacking, 
since previous studies were limited to comparisons between different echocardiographic 
techniques or used semiquantitative angiographic grading as a reference 15,18,28. The present 
study is the first systematic comparison between RT3DE and velocity encoded MRI, which has 
been recently proposed as the reference method for quantification of MR.
RT3DE versus VE MRI
Velocity encoded MRI is particularly suitable for determining trans-valvular blood flow, pro-
viding quantitative information on moving spins 31, and has been recently proposed as a ref-
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erence method 19,20. However, conventional single-slice one-directional velocity encoded MRI 
showed some limitations 21, in particular due to the fact that the acquisition plane can not be 
adapted to the motion of the valve, and currently the most accurate approach is considered 
the 3D 3-directional velocity encoded MRI with retrospective valve tracking. This technique 
is able to cover the complete velocity vector field of the blood flow and to correct for the 
through-plane myocardial motion in the apical-basal direction 22,23. Furthermore, it has been 
validated in vitro with flow phantoms and in vivo, and showed excellent reproducibility 24.
In the current study, RT3DE measurement of Rvol was compared against 3D 3-directional 
velocity encoded MRI. An excellent correlation between the 2 techniques was found without 
a significant bias. The residual non-significant difference between RT3DE and MRI may be 
explained by 2 sources of errors: the fixed position and the eventual misalignment of the 
continuous-wave Doppler ultrasound beam to the flow direction. Furthermore, imaging the 
region of interest with RT3DE can be complicated by acoustic attenuation from cardiac and 
thoracic structures.
The currently recommended 2D approach, providing a less accurate measurement of the 
EROA and presenting the same limitations of the Doppler acquisitions, showed a significant 
underestimation of the Rvol when compared to 3D 3-directional velocity encoded MRI. In 
particular, a mean bias between these 2 techniques of -2.9 ml/beat (p<0.05, limits of agree-
ment from -18.0 to 12.5 ml/beat) may easily lead to a misdiagnosis of the severity of MR (mild 
instead of moderate or moderate instead of mild).
clinical implications
The presence of functional MR has important prognostic value and accurate assessment of its 
severity is crucial for risk stratification and clinical decision making 1–6. In the present study, 
quantification of Rvol by RT3DE demonstrated to be feasible and highly accurate compared 
to 3D 3-directional velocity encoded MRI and, consequently, may be proposed as a better 
alternative to conventional 2D echocardiographic measurements. In addition, RT3DE will 
probably overcome the need for 2 different cut-off values to define severity of organic and 
functional MR, providing direct and accurate quantification of the EROA. Further multi-center 
studies are needed to confirm the present results and follow-up data are necessary to explore 
the prognostic implications of these measures.
Of note, RT3DE technology is in continuous progress and will lead to further improvement 
in the image quality (allowing for a direct assessment of the regurgitant orifice without Color 
Doppler) and in the temporal resolution (higher frame rate).
Nina Book.indb   366 26-09-11   12:04
367
Mitral regurgitation severity assessed by RT3DE
conclusIons
Quantification of the regurgitant orifice and volume of functional MR using RT3DE is feasible 
and accurate and demonstrated to be superior to the currently recommended 2D echocar-
diographic approach in a head-to-head comparison with 3D 3-directional velocity encoded 
MRI.
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objectives: Left ventricular (LV) twist and untwisting rate are emerging as global 
and thorough parameters for assessment of LV function. This study explored differ-
ences of LV twist and untwisting rate in patients with acute myocardial infarction 
(AMI) and patients with ischemic and nonischemic chronic heart failure (HF).
methods: Fifty patients with AMI, 49 with ischemic HF, and 38 with nonischemic HF 
were studied. As a control group, 28 subjects without evidence of structural heart 
disease were included. Speckle-tracking analysis was applied to LV short-axis im-
ages at basal and apical levels. LV twist was defined as the net difference of apical 
and basal rotations at isochronal time points. The first time derivative of LV untwist 
was defined as the LV untwisting rate.
results: Compared with control subjects, peak LV twist was decreased in patients 
with AMI and extremely decreased in those with HF (p <0.001, analysis of variance). 
A strong correlation (r = 0.87, p <0.001) was found between peak LV twist and LV 
ejection fraction in the overall study population. LV untwisting rate was progres-
sively decreased in patients with AMI and HF compared with control subjects (p 
<0.001, analysis of variance). A moderate correlation (r = 0.56, p <0.001) was noted 
between peak LV untwisting rate and grade of diastolic dysfunction in the overall 
study population.
conclusions: LV twist and untwisting rate are strongly related to LV systolic and 
diastolic functions, respectively. Impairment of LV function observed in patients 
with AMI and HF is associated with a decrease of LV twist and untwisting rate.
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IntroductIon
Recently, a novel speckle-tracking analysis has become available as a simple echocardio-
graphic method to assess left ventricular (LV) twist and untwisting rate. This technique has 
been validated against sonomicrometry and tagged magnetic resonance imaging, which are 
currently considered the gold standards for assessment of rotational parameters 1,2. Initial 
studies evaluated LV twist and untwisting rate in patients with myocardial infarction (MI) 
and heart failure (HF) 3–5, but thus far, the impact of these different diseases on rotational 
mechanics has never been systematically evaluated.
The present study assessed differences of LV twist and untwisting rate between patients 
with acute MI (AMI) and chronic HF.
methods
One hundred thirty-seven consecutive patients were enrolled; 50 patients had AMI, 49 
had chronic ischemic HF, and 38 had nonischemic HF. Diagnosis of AMI was based on the 
presence of symptoms consistent with myocardial ischemia lasting ≥30 minutes and ≥2-
mm ST-segment elevation in ≥2 contiguous electrocardiographic leads 6. All patients with 
AMI underwent urgent coronary angiography, followed by primary percutaneous coronary 
intervention, and echocardiographic examination was performed within 48 hours after AMI. 
Cause of HF was considered ischemic in the presence of significant coronary artery disease 
(>50% stenosis in ≥1 major epicardial coronary artery) on coronary angiogram and/or history 
of AMI or previous revascularization.
In addition, 28 subjects without evidence of structural heart disease, matched for age 
and gender, were included as a control group. Clinical echocardiographic analysis included 
standard 2-dimensional echocardiography to assess LV systolic and diastolic functions. Fur-
thermore, speckle-tracking analysis was applied to assess LV rotational parameters (twist and 
untwisting rate).
All patients were imaged in the left lateral decubitus position with a commercially available 
system (Vingmed Vivid 7, General Electric Medical Systems, Milwaukee, Wisconsin) equipped 
with a 3.5-MHz transducer. Standard 2-dimensional images and Doppler and color Doppler 
data acquired from parasternal and apical views (2, 3, and 4 chambers) were digitally stored 
in cine-loop format; analyses were subsequently performed off-line using EchoPac 7.0.0 
(General Electric Medical Systems).
LV end-diastolic volume (EDV) and end-systolic volume (ESV) were measured according to 
the Simpson biplane method and LV ejection fraction (EF) was calculated as ([EDV – ESV]/end-
diastolic volume) X 100 7. Transmitral and pulmonary vein (PV) pulse-wave Doppler tracings, 
obtained in accordance to recommendations of the American Society of Echocardiography 
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8, were used to classify diastolic function as (1) normal, when the E/A ratio was equal to 0.9 
to 1.5, deceleration time was equal to 160 to 240 ms, and PV systolic velocity ≥PV diastolic 
velocity; (2) diastolic dysfunction grade 1 (mild), when the E/A ratio <0.9, deceleration time 
>240 ms, and PV systolic velocity was >> PV diastolic velocity; (3) diastolic dysfunction grade 
2 (moderate), when the E/A ratio was equal to 0.9 to 1.5, deceleration time was equal to 160 
to 240 ms, and PV systolic velocity was <PV diastolic velocity; (4) diastolic dysfunction grade 
3 (severe), when the E/A ratio >2.0, deceleration time <160 ms, and PV systolic velocity was 
<<PV diastolic velocity; or (5) diastolic dysfunction grade 4 (severe), when the E/A ratio >2.5, 
deceleration time <130 ms, and PV systolic velocity was <<PV diastolic velocity 9.
Speckle-tracking analysis is based on tracking of natural acoustic markers, or speckles, on 
standard gray-scale images. This novel technique is angle independent and permits evalua-
tion of myocardial contraction/relaxation along the circumferential, longitudinal, and radial 
directions 10,11.
In the present evaluation, speckle-tracking analysis was applied to determine the LV twist 
and LV untwisting rate. Parasternal short-axis images were acquired at 2 distinct levels: (1) 
basal level, identified by the mitral valve, and (2) apical level, defined as the smallest cavity 
achievable distal to the papillary muscles (moving the probe down and slightly laterally, if 
needed). The frame rate was 45 to 100 frames/s and 3 cardiac cycles for each parasternal 
short-axis level were stored in cine-loop format for off-line analysis. The endocardial border 
was traced at an end-systolic frame and the region of interest was chosen to fit the entire 
myocardium. The software allows the operator to check and validate the tracking quality 
and to adjust the endocardial border or modify the width of the region of interest, if needed. 
Furthermore, each short-axis image was automatically divided into 6 standard segments, 
i.e., septal, anteroseptal, anterior, lateral, posterior, and inferior. Subsequently, the speckle-
tracking software calculated LV rotation from the apical and basal short-axis images as the 
average angular displacement of the 6 standard segments referring to the ventricular cen-
troid, frame by frame. Counter-clockwise rotation was marked as a positive value and clock-
wise rotation as a negative value when viewed from the LV apex. The software automatically 
calculated LV twist, defined as the net difference (in degrees) of apical and basal rotations at 
isochronal time points. The opposite rotation after LV twist was defined as LV untwist and the 
time derivative of LV untwist was defined as LV untwisting rate (degrees per second; Figure 1).
The following measurements were obtained: (1) peak apical and basal rotations, (2) peak 
LV twist and peak LV untwisting rate, (3) time to peak apical and basal rotations, and (4) time 
to peak LV twist and untwisting rate. A pulse-wave Doppler tracing obtained from the LV 
outflow tract was used to identify timing of aortic valve opening and closure. All timings were 
expressed as percent systolic phase.
To assess the reproducibility of peak LV twist and peak LV untwisting rate measurements, 
20 patients were randomly selected. Bland-Altman analysis was performed to evaluate 
intra- and inter-observer agreements, repeating the analysis 1 week later by the same ob-
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server and by a second independent observer. Bland-Altman analysis demonstrated good 
intra-observer and inter-observer agreements, with a small bias not significantly different 
from 0. Mean differences±2 SDs for peak LV twist and peak LV untwisting rate were 0.05±0.43 
and -1.93±15.97°/s for intra-observer agreement and 0.17±1.51 and -3.97±35.63°/s for inter-
observer agreement.
Figure 1 Left ventricular twist and untwisting rate in a normal control (Panel A), patient with AMI (Panel B), patient with ischemic HF (Panel 
C) and a patient with nonischemic HF(Panel D). Apical rotation (upper green line), apical rotation rate (lower green line), basal rotation (upper 
purple line), basal rotation rate (lower purple line), LV twist/untwist (upper white line), and LV twisting/untwisting rate (lower white line) are 
displayed.
AVC = aortic valve closure; AVO = aortic valve opening.
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Continuous variables are expressed as mean±SD. Categorical data are presented as abso-
lute numbers and percentages. One-way analysis of variance test was used to assess differ-
ences in continuous variables across different groups of patients; if the result of the analysis 
was significant, Bonferroni post hoc test was applied. Differences in categorical variables 
were analyzed using chi-square tests or Fischer’s exact tests, as appropriate. Linear regression 
analysis was used to determine relations between peak LV twist and LVEF, between peak LV 
untwisting rate and grade of diastolic dysfunction, and between peak LV untwisting rate and 
LVESV. To identify independent determinants of peak LV untwisting rate, a multivariable lin-
ear regression analysis was performed including LVESV and grade of diastolic dysfunction as 
covariates. All statistical tests were 2-sided, and a p-value <0.05 was considered statistically 
significant. Statistical analysis was performed using SPSS 14.0 (SPSS, Inc., Chicago, Illinois).
results
Table 1 presents clinical and echocardiographic characteristics of the different patient groups 
and the control group.
Compared with controls, patients with AMI had significantly lower values of LV apical rota-
tion (9.8±3.0 vs 7.6±3.8°, p = 0.007), LV basal rotation (-6.3±2.4 vs -4.9±2.1°, p = 0.04), and LV 
twist (15.7±3.1 vs 11.6±3.8°, p <0.001).
LV rotational parameters were not significantly different between patients with ischemic 
HF and those with nonischemic HF but were significantly impaired compared with patients 
with AMI; peak apical rotations were 2.5±1.9 and 2.4±1.8°, respectively (p <0.001 compared 
with patients with AMI) and peak basal rotations were -3.4±2.0 and -2.8±2.2°, respectively (p 
= 0.003 and p <0.001, respectively, compared with patients with AMI). Consequently, peak LV 
twists were 5.2±2.2 and 4.0±2.9°, respectively (p <0.001 compared with patients with AMI; 
Table 1).
Figure 2 shows the progressive decrease of peak LV twist and LVEF among the 4 different 
groups. In particular, a strong correlation (r = 0.87, p <0.001) was found between peak LV 
twist and LVEF (Figure 3) and between peak LV apical rotation and LVEF (r = 0.79, p <0.001) 
in the overall study population; conversely, only a modest relation was found between peak 
LV basal rotation and LVEF (r = -0.48, p <0.001). Furthermore, time to peak LV twist occurred 
sooner in patients with AMI, ischemic HF, and nonischemic HF compared with controls (p 
<0.001, analysis of variance; Table 1).
Peak LV untwisting rate was not significantly different between patients with ischemic 
HF and those with nonischemic HF, with lower values compared with patients with AMI 
(-58±34°/s in patients with ischemic HF, p = 0.018; -59±32°/s in patients with nonischemic HF, 
p = 0.036; Table 1).
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table 1. Clinical, echocardiographic and rotational parameters of controls and patients with acute myocardial infarction, ischemic heart 












anova   
p-value
Age (years) 60±11 60±11 64±11 65±13 0.084
Gender male, n (%) 21 (75) 38 (76) 43 (88) 28 (74) 0.16
LVEDV (ml) 87±26* 103±28* 179±67 214±74¶ <0.001
LVESV (ml) 34±11* 55±21* 130±52 164±61¶ <0.001
LVEF (%) 62±6‡ 47±10* 28±5 24±6¶ <0.001
Diastolic function, n (%)
   Grade 0
   Grade 1
   Grade 2























Peak LV twist (°) 15.7±3.1‡ 11.6±3.8* 5.2±2.2 4.0±2.9 <0.001
Peak LV untwisting rate (°/s) -108±30*§ -75±35ǁ¶ -58±34 -59±33 <0.001
Time peak LV twist (% systole) 98±8‡§ 83±14 83±19 75±27 <0.001
Time peak LV untwisting (% systole) 114±9 118±17 116±17 116±23 0.75
* p <0.001; 
† p <0.01 versus ischemic and nonischemic HF.
‡ p <0.001 versus AMI, ischemic HF, and nonischemic HF.
§ p <0.01 versus AMI.
ǁ p <0.05 versus ischemic HF.
¶ p <0.05 versus nonischemic HF.
ANOVA = analysis of variance; AMI = acute myocardial infarction; EDV = end-diastolic volume; EF = ejection fraction; ESV = end-systolic 
volume; HF = heart failure; LV = left ventricular.
the American Society of Echocardiography,8 were used to
classify diastolic function as (1) normal, when the E/A ratio
was equal to 0.9 to 1.5, deceleration time was equal to 160
to 240 ms, and PV systolic velocity  PV diastolic velocity;
(2) diastolic dysfunction grade 1 (mild), when the E/A ratio
0.9, deceleration time 240 ms, and PV systolic velocity
was  PV diastolic velocity; (3) diastolic dysfunction
grade 2 (moderate), when the E/A ratio was equal to 0.9 to
1.5, deceleration time was equal to 160 to 240 ms, and PV
systolic velocity was  PV diastolic velocity; (4) diastolic
dysfunction grade 3 (severe), when the E/A ratio 2.0,
deceleration time 160 ms, and PV systolic velocity was
 PV diastolic velocity; or (5) diastolic dysfunction grade
4 (severe), when the E/A ratio 2.5, deceleration time
130 ms, and PV systolic velocity was  PV diastolic
velocity.9
Speckle-tracking analysis is based on tracking of natural
acoustic markers, or speckles, on standard gray-scale im-
ages. This novel technique is angle independent and permits
evaluation of myocardial contraction/relaxation along the
circumferential, longitudinal, and radial directions.10,11
In the present evaluation, speckle-tracking analysis was
applied to determine the LV twist and LV untwisting rate.
Parasternal short-axis images were acquired at 2 distinct
levels: (1) basal level, identified by the mitral valve, and (2)
apical level, defined as the smallest cavity achievable distal
to the papillary muscles (moving the probe down and
slightly laterally, if needed). The frame rate was 45 to 100
frames/s and 3 cardiac cycles for each parasternal short-axis
level were stored in cine-loop format for off-line analysis.
The endocardial border was traced at an end-systolic frame
and the region of interest was chosen to fit the entire myo-
cardium. The software allows the operator to check and
validate the tracking quality and to adjust the endocardial
border or modify the width of the region of interest, if
needed. Furthermore, each short-axis image was automati-
Figure 2. Peak LV twist (left) and LVEF (right) in controls, patients with AMI, patients with ischemic HF, and patients with nonischemic HF. ANOVA 
analysis of variance.
Table 1
Clinical, echocardiographic, and rotational parameters of controls and patients with acute myocardial i farction, ischemic heart failure, and nonischemic
heart failure










(n  50) (n  49) (n  38)
Age (yrs) 60  11 60  11 64  11 65  13 0.084
Men 21 (75%) 38 (76%) 43 (88%) 28 (74%) 0.16
LV end-diastolic volume (ml) 87  26* 103  28* 179  67¶ 214  74 0.001
LV end-systolic volume (ml) 34  12* 55  21* 130  52¶ 164  61 0.001
LV ejection fraction (%) 62  6‡ 47  10* 28  5¶ 24  6 0.001
Diastolic function ‡ † 0.001
Grade 0 28 (100%) 7 (14%) 0 0
Grade 1 0 19 (38%) 12 (24%) 8 (21%)
Grade 2 0 14 (28%) 13 (26%) 6 (16%)
Grade 3–4 0 10 (20%) 24 (49%) 24 (63%)
Peak LV twist (°) 15.7  3.1‡ 11.6  3.8* 5.2  2.2 4.0  2.9 0.001
Peak LV untwisting rate (°/s) 107  29*§ 78  35¶ 58  34 59  32 0.001
Time peak LV twist (percent systole) 98  8‡§ 83  14 83  19 75  27 0.001
Time peak LV untwisting (percent systole) 114  9 18  17 116  17 116  23 0.75
* p 0.001; † p 0.01 versus ischemic and nonischemic HF.
‡ p 0.001 versus AMI, ischemic HF, and nonischemic HF.
§ p 0.01 versus AMI.
 p 0.05 versus ischemic HF.
¶ p 0.05 versus nonischemic HF.
ANOVA  analysis of variance; AMI  acute myocardial infarction; HF  heart failure; LV  left ventricular.
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Figure 2. Peak LV twist (left) and LVEF (right) in controls, patients with AMI, patients with ischemic HF, and patients with nonischemic HF.
ANOVA = analysis of variance.
Nina Book.indb   379 26-09-11   12:04
Chapter 21
380
Peak LV untwisting rate and grade of diastolic dysfunction among the 4 groups are 
shown in Figure 4. A moderate correlation (r = 0.56, p <0.001) was noted between peak LV 
untwisting rate and grade of diastolic dysfunction in the overall study population (Figure 5). 
Furthermore, peak LV untwisting rate was significantly related to LVESV (r = 0.42, p <0.001). 
At multivariable linear regression analysis LVESV (beta 0.16, p = 0.047) and grade of diastolic 
dysfunction (beta 0.47, p <0.001) were independently related to peak LV untwisting rate.
No significant differences were found among the different groups for time to peak LV 
untwisting rate (Table 1).
cally divided into 6 standard segments, i.e., septal, antero-
septal, anterior, lateral, posterior, and inferior.
Subsequently, the speckle-tracking software calculated
LV rotation from the apical and basal short-axis images as
the average angular displacement of the 6 standard seg-
ments referring to the ventricular centroid, frame by frame.
Counterclockwise rotation was marked as a positive value
and clockwise rotation as a negative value when viewed
from the LV apex. The software automatically calculated
LV twist, defined as the net difference (in degrees) of apical
and basal rotations at isochronal time points. The opposite
rotation after LV twist was defined as LV untwist and the
time derivative of LV untwist was defined as LV untwisting
rate (degrees per second; Figure 1).
The following measurements were obtained: (1) peak
apical and basal rotations, (2) peak LV twist and peak LV
untwisting rate, (3) time to peak apical and basal rotations,
and (4) time to peak LV twist and untwisting rate. A pulse-
wave Doppler tracing obtained from the LV outflow tract was
used to identify timing of aortic valve opening and closure. All
timings were expressed as percent systolic phase.
To assess the reproducibility of peak LV twist and peak
LV untwisting rate measurements, 20 patients were ran-
domly selected. Bland-Altman analysis was performed to
evaluate intra- and interobserver agreements, repeating the
analysis 1 week later by the same observer and by a second
independent observer. Bland-Altman analysis demonstrated
good intraobserver and interobserver agreements, with a
small bias not significantly different from 0. Mean differ-
ences  2 SDs for peak LV twist and peak LV untwisting
rate were 0.05  0.43 and 1.93  15.97°/s for intr ob-
server agreement and 0.17  1.51 and 3.97  35.63°/s for
interobserver agreement.
Continuous variables are expressed as mean  SD. Cat-
egorical data are presented as absolute numbers and per-
centages. One-way analysis of variance test was se to
assess differences in continuous variables across different
groups of patients; if the result of the analysis was signifi-
cant, Bonferroni post hoc test was applied. Differences in
categorical variables were analyzed using chi-square tests or
Fischer’s exact tests, as appropriate. Linear regression anal-
ysis was used to determine relations between peak LV twist
and LVEF, between peak LV untwisting rate and grade of
diastolic dysfunction, and between peak LV untwisting rate
and LVESV. To identify independent determinants of peak
LV untwisting rate, a multivariable linear regression anal-
ysis was performed including LVESV and grade of diastolic
dysfunction as covariates. All statistical tests were 2-sided,
and a p value 0.05 was considered statistically significant.
Statistical analysis was performed using SPSS 14.0 (SPSS,
Inc., Chicago, Illinois).
Results
Table 1 presents clinical and echocardiographic character-
istics of the different patient groups and the control group.
Compared with controls, patients with AMI had sig-
nificantly lower values of LV apical rotation (9.8  3.0
vs 7.6  3.8°, p  0.007), LV basal rotation (6.3  2.4
vs 4.9  2.1°, p  0.04), and LV twist (15.7  3.1 vs
11.6  3.8°, p 0.001).
LV rotational parameters were not significantly different
between patients with ischemic HF and those with nonisch-
emic HF but were significantly impaired compared with
patients with AMI; peak apical rotations were 2.5  1.9 and
2.4  1.8°, respectively (p 0.001 compared with pa-
tients with AMI) and peak basal rotations were 3.4 
2.0 and 2.8  2.2°, respectively (p  0.003 and p 
0.001, respectively, compared with patients with AMI).
Consequently, peak LV twists were 5.2  2.2 and 4.0 
2.9°, respectively (p 0.001 compared with patients with
AMI; Table 1).
Figure 2 shows the progressive decrease of peak LV
twist and LVEF among the 4 different groups. In particular,
a strong correlation (r  0.87, p 0.001) was found be-
tween peak LV twist and LVEF (Figure 3) and between
peak LV apical rotation and LVEF (r  0.79, p 0.001) in
the overall study population; conversely, only a modest
relation was found between peak LV basal rotation and
LVEF (r  0.48, p 0.001). Furthermore, time to peak
LV twist occurred sooner in patients with AMI, ischemic HF,
and nonischemic HF compared with controls (p 0.001, anal-
ysis of variance; Table 1).
Figure 3. Correlation between LVEF and peak LV twist in the entire study population including controls (white triangles), patients with AMI (black
triangles), patients with ischemic HF (white circles), and patients with nonischemic HF (black circles).
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Figure 3. Correlation between LVEF and peak LV twist in the en ire study population including ontrols (white triangles), patients with AMI 
(black triangles), patients with ischemic HF (white circles), and patients with nonischemic HF (black circles).
Compared with controls, patients with AMI had signifi-
cantly lower values of peak LV untwisting rate (107  29
vs 78  35°/s, p  0.002).
Peak LV untwisting rate was not significantly different
between patients with ischemic HF and those with nonisch-
emic HF, with lower values compared with patients with
AMI (58  34°/s in patients with ischemic HF, p 
0.018; 59  32°/s in patients with nonischemic HF, p 
0.036; Table 1).
Peak LV untwisting rate and grade of diastolic dys-
function among the 4 groups are shown in Figure 4. A
moderate correlation (r  0.56, p 0.001) was noted
between peak LV untwisting rate and grade of diastolic
dysfunction in the overall study population (Figure 5).
Furthermore, peak LV untwisting rate was significantly
related to LVESV (r  0.42, p 0.001). At multivariable
linear regression analysis LVESV (beta 0.16, p  0.047)
and grade of diastolic dysfunction (beta 0.47, p 0.001)
were independently related to peak LV untwisting rate.
No significant differences were found among the
different groups for time to peak LV untwisting rate
(Table 1).
Figure 4. (Left) A decreased peak LV untwisting rate is observed in patients with AMI, those with ischemic HF, and those with nonischemic HF compared
with controls. (Right) Distribution of normal diastolic function (white bars) and grades 1 (light gray bars), 2 (dark gray bars), and 3 to 4 (black bars) of
diastolic dysfunction in controls and patients with AMI, ischemic HF, and nonischemic HF.
Figure 5. Correlation between grades of diastolic dysfunction (see definition in text) and peak LV untwisting rate in controls (white triangles), patients with
AMI (black triangles), patients with ischemic HF (white circles), and patients with nonischemic HF (black circles).
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Figure 4. (Left) A decreased peak LV untwisting rate is observed in patients with AMI, those with ischemic HF, and those with nonischemic HF 
compared with controls. (R ght) Distribution of normal diastolic function (white bars) and grades 1 (light gray bars), 2 (dark gray bars), and 3 to 
4 (black bars) of diastolic dysfunction in controls and patients with AMI, ischemic HF, and nonischemic HF.
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dIscussIon
The present study comprehensively evaluated differences in LV twist and untwisting rate in 
patients with AMI, ischemic HF, and nonischemic HF, providing new insight in the relation 
between LV rotational mechanics and LV function. The main findings can be summarized 
as follows: (1) LV twist is strongly related to LV systolic function and LV untwisting rate is 
modestly, but significantly, related to diastolic function; (2) impairment of LV function is as-
sociated not only with a decrease of LV twist and untwisting rate but also with an earlier peak 
of LV twist during systole.
As previously demonstrated in a mathematical model, LV twist distributes equally LV fiber 
stress and shortening across the LV wall 12. Accordingly, LV twist increases the efficiency of 
sarcomere shortening and improves myocardial deformation during LV ejection 12. In the 
present study, a significant impairment of LV twist was observed in patients with AMI and 
HF compared with controls. Moreover, a strong relation between degree of impairment of LV 
twist and observed impairment of LVEF was noted, confirming previous findings demonstrat-
ing a relation between LV twist and LVEF 4,5,13. The strong correlation found between LV apical 
Compared with controls, patients with AMI had signifi-
cantly lower values of peak LV untwisting rate (107  29
vs 78  35°/s, p  0.002).
Peak LV untwisting rate was not significantly different
between patients with ischemic HF and those with onisch-
emic HF, with lower values compared with patients with
AMI (58  34°/s in patients with ischemic HF, p 
0.018; 59  32°/s in patients with nonischemic HF, p 
0.036; Table 1).
Peak LV untwisting rate and grade of diastolic dys-
function among the 4 groups are shown in Figure 4. A
moderate correlation (r  0.56, p 0.001) was noted
between peak LV untwisting rate and grade of diastolic
dysfunction in the overall study population (Figure 5).
Furthermore, peak LV untwisting rate was significantly
related to LVESV (r  0.42, p 0.001). At mult variable
linear regression analysis LVESV (beta 0.16, p  0.047)
and grade of diastolic dysfunction (beta 0.47, p 0.001)
were independently related to peak LV untwisting rate.
No significant differences were found among the
different groups for time to peak LV untwisting rate
(Table 1).
Figure 4. (Left) A decreased peak LV untwisting rate is observed in patients with AMI, those with ischemic HF, and those with nonischemic HF compared
with controls. (Right) Distribution of normal diastolic function (white bars) and grades 1 (light gray bars), 2 (dark gray bars), and 3 to 4 (black bars) of
diastolic dysfunction in controls and patients with AMI, ischemic HF, and nonischemic HF.
Figure 5. Correlation between grades of diastolic dysfunction (see definition in text) and peak LV untwisting rate in controls (white triangles), patients with
AMI (black triangles), patients with ischemic HF (white circles), and patients with nonischemic HF (black circles).
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Figure 5. Correlation between grades of diastolic dysfunction (see definition in text) and peak LV untwisting rate in controls (white triangles), 
patients with AMI (black triangles), patients with ischemic HF (white circles), and patients with nonischemic HF (black circles).
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rotation and LVEF is not surprising, because LV apical rotation contributes more to LV twist 
than LV basal rotation 14. The different effects of AMI and long-term LV remodeling (in HF) 
on LV twist were also explored. LV twist was more decreased in patients with chronic HF 
compared with AMI. These findings may be explained by different mechanisms underlying 
a decrease in LV twist. In patients with HF, LV twist impairment is probably the result of a 
long-lasting process, with a rearrangement of LV myofibers with a consequent loss of the 
specific LV architecture responsible for the wringing motion 4,15,16. Conversely, in patients with 
AMI the decrease of LV twist may result from an acute impairment in rotation of the LV region 
involved in the infarction 3,17. Severity of this impairment appears related to transmurality of 
the infarction and to extent of dysfunctional myocardial segments13,18.
Intriguingly, time to peak LV twist occurred sooner in patients with AMI and those with 
HF compared with controls. The impaired LV rotational mechanics observed in AMI and 
HF most likely explains this finding; less time is needed to reach peak LV twist because of 
the decreased contraction and rotation of LV myofibers. In addition, diseased LV myofibers 
are not able to fully counteract systolic ventricular pressure, preventing further myocardial 
shortening and, consequently, leading to sooner peak LV twist 18.
LV systolic twist consists of a deformation of the interstitial matrix resulting in storage of 
potential energy; the rapid release of potential energy stored during systole in isovolumic 
relaxation time leads to LV untwisting 19. In turn LV untwisting generates an intraventricular 
pressure gradient facilitating diastolic LV filling 19. Indeed, LV untwisting rate is emerging as 
an index of diastolic function 20–22. In particular, LV untwisting rate was related to the time 
constant of LV pressure decay (tau) and the intraventricular pressure gradient 21. In the 
present study, a good relation between LV untwisting rate and global diastolic function 
was observed. The relation was not perfect, probably because LV untwisting rate is a marker 
of diastolic suction rather than global diastolic function. LV untwisting rate was also inde-
pendently related to LVESV; however, on multivariable linear regression analysis, grade of 
diastolic dysfunction was the strongest determinant of LV untwisting rate.
A significant impairment of LV untwisting rate was observed in patients with AMI and 
HF compared with control subjects. In patients with AMI, impairment in LV untwisting rate 
may be related to increased ventricular stiffness and consequent diastolic dysfunction due 
to recent acute ischemia and infarction 23. In patients with HF, LV untwisting rate was even 
more decreased compared with patients with AMI. This observation may be explained by the 
presence of extensive, diffuse LV fibrosis as encountered in patients with HF, which is not (yet) 
present soon after AMI 24.
Although groups of patients with different grades of diastolic dysfunction were studied, 
no significant differences in time to peak LV untwisting rate were noted. This finding is in line 
with previous experimental and clinical studies in which only peak of untwisting rate but not 
time to peak untwisting rate was affected by grade of diastolic dysfunction 21,25.
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As limitations, acquisition of LV apical short-axis images (highly dependent on the acoustic 
window) and through-plane motion, particularly at the basal level, could have affected the 
accuracy of the measurement of LV rotational parameters.
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objectives: Left ventricular (LV) twist is emerging as a comprehensive index of LV 
function. This study explored the effects of cardiac resynchronization therapy (CRT) 
on LV twist, particularly in relation to LV lead position.
methods: Eighty heart failure (HF) patients were included. 2D-echocardiography 
was performed at baseline, immediately after CRT, and at 6 months follow-up. 
Speckle-tracking analysis was applied to assess LV twist. LV lead was placed pref-
erably in a (postero-)lateral vein and at fluoroscopy, the position was classified as 
basal, mid-ventricular or apical. Response to CRT was defined as reduction of LV 
end-systolic volume ≥15% at 6 months follow-up. A control group comprised 30 
normal subjects.
results: Peak LV twist in HF patients was 4.8±2.6º compared to 15.0±3.6º of the 
controls (p <0.001). At 6 months follow-up, peak LV twist significantly improved only 
in responders (56%), from 4.3±2.4º to 8.5±3.2º (p <0.001). The strongest predictor 
of response to CRT was the improvement of peak LV twist immediately after CRT 
(odds ratio 1.899, 95% confidence intervals 1.334-2.703, p <0.001). Furthermore, LV 
twist significantly improved in patients with an apical (from 4.3±3.1º to 8.6±3.0º, p = 
0.001) and mid-ventricular (from 4.8±2.2º to 6.4±3.9º, p = 0.038) but not with a basal 
(5.0±3.3 vs. 4.1±3.2, p = 0.28) LV lead position. Similarly LVEF significantly increased 
in patients with an apical (from 26±7% to 37±7%, p <0.001) and mid-ventricular 
(from 26±6% to 33±8%, p <0.001) but not with a basal (26±5% vs. 28±8%, p = 0.30) 
LV lead position.
conclusions: An immediate improvement of LV twist after CRT predicts LV reverse 
remodeling at 6 months follow-up.
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IntroductIon
The human heart has a specific helical arrangement of the myofibers with a right-hand orien-
tation from the base towards the apex in the endocardial layers and a left-hand orientation 
in the epicardial layers. This spiral architecture of the myofibers leads to a left ventricular (LV) 
systolic wringing motion as a result of an opposite rotation of LV apex and base 1, 2. The gradi-
ent between apex and base in the rotation angle along LV longitudinal axis is called twist 
and contributes significantly to LV systolic function, in addition to myocardial shortening and 
thickening 3–5.
In heart failure (HF) patients, LV twist is significantly reduced 6. Cardiac resynchronization 
therapy (CRT) is considered a major therapeutic breakthrough for HF patients, and recent 
large randomized trials have shown that CRT has beneficial effects on HF symptoms, LV 
systolic function and survival 7, 8. At present, minimal data are available about the effect of 
CRT on LV twist 9, 10.
In the current study, the effect of CRT on LV twist was assessed using speckle-tracking 
echocardiography. Furthermore, the relationship between the change in LV twist and LV 
reverse remodeling at 6 months follow-up was investigated. Finally, the influence of the LV 
lead position on the improvement in LV twist and response to CRT was explored.
methods
patient population and protocol
A total of 87 consecutive HF patients scheduled for CRT were prospectively included. Ac-
cording to current guidelines, the inclusion criteria were: New York Heart Association (NYHA) 
functional class III-IV, sinus rhythm, LV ejection fraction (LVEF) ≤35%, QRS duration ≥120 
ms 11. Etiology of HF was considered ischemic in the presence of significant coronary artery 
disease (>50% stenosis in ≥1 major epicardial coronary artery) on coronary angiography and/
or a history of myocardial infarction or revascularization.
The clinical evaluation consisted of: 1) assessment of clinical status: NYHA functional class, 
quality of life (using the Minnesota Living with Heart Failure questionnaire) 12 and 6-minute 
walk distance13 at baseline and 6 months follow-up; 2) assessment of LV volumes, function, 
dyssynchrony and twist, using standard echocardiography and speckle-tracking analysis at 
baseline, within 48 hours (immediately after CRT) and at 6 months follow-up.
In addition, 30 subjects without evidence of structural heart disease, frequency-matched 
for age, gender and body surface area, were included as a normal control group, selected 
Nina Book.indb   389 26-09-11   12:04
Chapter 22
390
from an echocardiographic data base. These subjects were referred for the echocardiographic 
evaluation because of atypical chest pain, palpitations or syncope without murmur.
standard echocardiography
All patients were imaged in left lateral decubitus position using a commercially available 
system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, USA). Standard 
2-dimensional images were obtained using a 3.5-MHz transducer and digitally stored in 
cine-loop format; the analysis was performed offline using EchoPAC version 6.0.1 (General 
Electric-Vingmed).
From the standard apical views (4- and 2-chamber) LV volumes and LVEF were calculated 
according to the American Society of Echocardiography guidelines 14. At 6 months follow-up, 
patients were classified as echocardiographic responders based on a reduction ≥15% of LV 
end-systolic volume (LVESV) 15.
Segmental wall motion was assessed according to American Society of Echocardiography 
in order to evaluate the presence of scarred segments within ischemic HF patients 14. Akinetic 
and diskinetic segments (wall motion score 3 and 4) were classified as scarred segments 16.
speckle-tracking analysis
The speckle-tracking software tracks frame-to-frame the movement of natural myocardial 
acoustic markers, or speckles, on standard gray scale images. Speckles are randomly distrib-
uted and each region of the myocardium has a distinguishing pattern, a fingerprint. Further-
more, speckle-tracking analysis is angle independent and allows the evaluation of myocardial 
contraction/relaxation along the circumferential, longitudinal and radial direction 17, 18.
In the current study, speckle-tracking analysis was applied to evaluate LV dyssynchrony 
(based on radial strain analysis) and LV twist. Parasternal short-axis images were acquired at 3 
distinct levels: 1) basal level, identified by the mitral valve; 2) papillary muscle level; 3) apical 
level (the smallest cavity achievable distally to the papillary muscles, moving the probe down 
and slightly laterally, if needed). Frame rate ranged from 45 to 100 frame/s and 3 cardiac cycles 
for each parasternal short-axis level were stored in cine-loop format for the offline analysis 
(EchoPAC). The endocardial border was traced at an end-systolic frame and the region of 
interest (ROI) was chosen to fit the whole myocardium. The software allows the operator to 
check and validate the tracking quality and to adjust the endocardial border or modify the 
width of the ROI, if needed. Furthermore, each short-axis image was automatically divided 
into 6 standard segments: septal, anteroseptal, anterior, lateral, posterior, and inferior.
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Aortic valve opening and closure were identified on pulsed-wave Doppler tracings ob-
tained from the LV outflow tract.
LV dyssynchrony analysis
LV dyssynchrony was derived from the radial strain curves obtained from the papillary muscle 
short-axis view. As previously described, LV dyssynchrony was defined as the time difference 
of peak radial strain between the anteroseptal and posterior segments 19.
LV twist analysis
The speckle-tracking software calculates LV rotation from the apical and basal short-axis 
images as the average angular displacement of the 6 standard segments referring to the 
ventricular centroid, frame by frame. Counterclockwise rotation was marked as positive value 
and clockwise rotation as negative value when viewed from the LV apex. LV twist was defined 
as the net difference (in degrees) of apical and basal rotation at isochronal time points. 
For the calculation of LV twist, averaged apical and basal rotation data were exported to a 
spreadsheet program (Excel 2003; Microsoft Corporation, Redmond, Washington) (Figure 1) 
20, 21. The following measurements were derived: peak apical and basal rotation, peak LV twist.
reproducibility
Reproducibility of LV end-diastolic volume (LVEDV), LVESV, LVEF and peak LV twist was as-
sessed on 20 randomly selected HF patients. Bland-Altman analysis was performed to evalu-
ate the intra- and inter-observer agreement repeating the analysis few days later by the same 
observer and by a second independent observer. The results were expressed as absolute 
mean difference±2 standard deviation (SD).
The intra-observer agreement for LVEDV, LVESV, LVEF and peak LV twist were 7.4±11.2 ml, 
7.0±10.1 ml, 1.9±4.4%, and 0.2±0.3º, respectively.
The inter-observer agreement for LVEDV, LVESV, LVEF and peak LV twist were 12.9±14.7 ml, 
11.3±13.9 ml, 2.5±4.9%, and 0.7±0.8º, respectively.
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Figure 1 (Assessment of LV twist). Examples of left ventricular (LV) twist in normal control (panel A) and in heart failure patient (panel B). In 
both panels, the upper parts represent apical and basal rotations and the lower parts represent LV twist calculation after exporting the data to a 
spreadsheet program (Excel 2003; Microsoft Corporation, Redmond, Washington). AVC: aortic valve closure. AVO: aortic valve opening.
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crt implantation
All patients received a biventricular pacemaker with cardioverter-defibrillator function 
(Contak Renewal 4RF, Boston Scientific St. Paul, Minnesota; or InSync Sentry, Medtronic Inc. 
Minneapolis, Minnesota; Lumax 340 HF-T, Biotronik, Berlin). The right atrial and ventricular 
leads were positioned conventionally. All LV leads were implanted transvenously, and posi-
tioned preferably in a (postero)lateral vein. A coronary sinus venogram was obtained using a 
balloon catheter, followed by the insertion of the LV pacing lead. An 8-F guiding catheter was 
used to place the LV lead (Easytrak, Boston Scientific, or Attain-SD, Medtronic, or Corox OTW 
Biotronik) in the coronary sinus.
LV lead position
Target veins were lateral or postero-lateral veins. The LV lead position was determined using 
biplane fluoroscopy classification 22. In the right anterior oblique view and/or in the postero-
anterior view, the distance between the coronary sinus/mitral plane and the cardiac apex was 
divided in 3 parts and the LV lead position was classified in 3 groups: basal, mid-ventricular 
and apical.
statistical analysis
All continuous variables had a normal distribution (as evaluated with Kolmogorov-Smirnov 
tests). Summary statistics for these data are therefore presented as mean±SD. Categorical 
data are presented as numbers and percentages. Paired T test was used for the comparison 
between continuous variables at baseline and immediately after CRT and between baseline 
and at 6 months follow-up. Unpaired T test was performed to compare continuous variables 
between normal controls and HF patients and between CRT responders and non-responders. 
Chi-square/Fischer’s exact tests were computed to test for differences in categorical variables. 
Linear regression analysis was performed to determine the relations between LV twist, LVEF 
and LV dyssynchrony. In order to identify independent determinants of LV twist, a multivari-
able linear regression analysis using the enter model was performed including as covariates 
LVEF and LV dyssynchrony. Linear regression analysis was used to assess the relation between 
the ∆ (difference between immediately after CRT and baseline) peak LV twist and ∆ LVEF. 
The differences in peak LV twist during follow-up in responders and non-responders were 
assessed using ANOVA for repeated measurements. In order to identify variables related to a 
positive response to CRT, univariable and multivariable logistic regression analysis were per-
formed including clinical (age, gender, etiology, QRS duration at baseline and 6-minute walk 
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distance at baseline) and echocardiographic (LVESV at baseline, ∆LVESV, LV dyssynchrony 
at baseline, ∆LV dyssynchrony, peak LV twist at baseline, ∆peak LV twist) characteristics of 
the patients. Only, significant (p <0.05) univariable predictors were entered as covariates in 
the multivariable logistic regression analysis which was performed using the enter model. 
Odds ratio (OR) and 95% confidence intervals (CI) were calculated. Model discrimination was 
assessed using c-statistic and model calibration was assessed using Hosmer-Lemeshow sta-
tistic. The differences in peak LV twist and LVEF between the groups of patients with different 
LV lead position were assessed by one-way ANOVA. All statistical tests were 2-sided, and a 
p-value <0.05 was considered significant. A statistical software program SPSS 14.0 (SPSS Inc, 
Chicago, IL, USA) was used for statistical analysis.
results
patient population
Reliable speckle-tracking for rotation analysis was obtained in all normal controls and in 80 
(92%) HF patients. Consequently, 7 (8%) patients were excluded from the study. Of the 80 HF 
patients enrolled, 9 did not complete the 6 months follow-up; 3 patients died of worsening 
HF, 1 had LV pacing switched off due to intolerable phrenic stimulation, 1 had CRT device 
explantation secondary to infection, and 4 were lost to follow-up. Therefore, data at baseline 
and immediately after CRT were collected for 80 patients and data at 6 month follow-up were 
collected for 71 patients. Baseline characteristics of normal controls and the HF patients are 
listed in Table 1.
lv twist baseline
As shown in Table 1, peak apical rotation, peak basal rotation and peak LV twist were se-
verely reduced in HF patients compared to normal controls: 2.4±1.8º vs. 9.4±3.2º (p <0.001), 
-3.3±2.0º vs. -6.1±2.4º (p <0.001) and 4.8±2.6º vs. 15.0±3.6º (p <0.001), respectively.
A significant relation (r = 0.53, p <0.001) was observed between peak LV twist and LVEF in 
HF patients. This relation was stronger in non-ischemic (r = 0.60, p <0.001) than in ischemic 
HF patients (r = 0.34, p = 0.020) (Figure 2A). Moreover, a modest relation (r = -0.33, p = 0.003) 
was observed between peak LV twist and LV dyssynchrony in HF patients. At multivariable 
linear regression analysis, LVEF (β = 0.47, p <0.001) and LV dyssynchrony (β = -0.21, p = 0.032) 
were independent determinants of LV twist.
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table 1. Baseline characteristics of normal controls and heart failure (HF) patients. 
normal controls  
(n = 30)
hf patients
 (n = 80)
p-value
Age (years) 61±11 64±11 0.091
Gender (male/female) 22/8 61/19 0.46
NYHA class - 3.0±0.4 -
QoL - 34±20 -
6-minute walk distance (m) - 321±109 -
QRS duration (ms) 91±9 148±30 <0.001
Etiology, n (%)
      Ischemic








      ACE Inhibitors
      ß-blockers
      Diuretics and/or










LVEDV (ml) 86±26 196±74 <0.001
LVESV (ml) 34±11 146±60 <0.001
LVEF (%) 62±7 26±6 <0.001
LV dyssynchrony (ms) 14±9 146±81 <0.001
Peak apical rotation (°) 9.4±3.2 2.4±1.8 <0.001
Peak basal rotation (°) -6.1±2.4 -3.3±2.0 <0.001
Peak LV twist (°) 15.0±3.6 4.8±2.6 <0.001
LVEDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume, NYHA: New York 
Heart Association, QoL: Score on the Minnesota Living with Heart Failure Questionnaire
LV twist baseline. As shown in Table 1, peak apical
rotation, peak basal rotation, and peak LV twist were
severely reduced in HF patients compared with normal
control subjects: 2.4  1.8° versus 9.4  3.2° (p  0.001),
3.3  2.0° versus 6.1  2.4° (p  0.001), and 4.8  2.6°
versus 15.0  3.6° (p  0.001), respectively.
A significant relation (r  0.53, p  0.001) was observed
between peak LV twist and LVEF in HF patients. This
relation was stronger in nonischemic (r  0.60, p  0.001)
than in ischemic HF patients (r  0.34, p  0.020) (Fig. 2A).
Moreover, a modest relation (r  0.33, p  0.003) was
observed between peak LV twist and LV dyssynchrony in HF
patients. At multivariable linear regression analysis, LVEF
(beta  0.47, p  0.001) and LV dyssynchrony (beta 
0.21, p  0.032) were independent determinants of LV
twist.
LV twist after CRT. IMMEDIATELY AFTER CRT. Immedi-
ately after CRT, peak LV twist increased from 4.8  2.6° to
5.9  3.2° (p  0.007). In particular,  peak LV twist was
strongly related to LVEF (r  0.83, p  0 .001), and this
relation was good in both nonischemic (r  0.85, p 
0.001) and ischemic HF patients (r  0.82, p  0.001) (Fig.
2B). Furthermore, the relations between  peak LV twist
and LV dyssynchrony (r  0.57, p  0.001) and
between LV dyssynchrony and LVEF (r  0.63, p 
0.001) were good but less strong than the previous relation
between  peak LV twist and LVEF.
SIX-MONTH FOLLOW-UP. At 6-month follow-up, 40 of 71
(56%) patients were classified as echocardiographic re-
sponders to CRT (defined as a decrease in LVESV 15%).
No significant differences in the baseline clinical character-
istics were found between responders and nonresponders
(Table 2). At 6-month follow-up, significant improvement in
NYHA functional class (from 3.0  0.5 to 2.0  0.7, p 
0.001), quality of life (from 35  23 to 20  20, p  0.001),
and 6-min walk distance (from 306  106 m to 363  109 m,
p  0.001) were observed in CRT responders only (Table 2).
Baseline echocardiographic characteristics were also sim-
ilar between the 2 groups, except for LV dyssynchrony
(Table 3), which was larger in responders compared with
nonresponders (182  71 ms vs. 116  83 ms, p  0.003).
A trend toward lower values of peak LV twist were noted in
responders as compared with nonresponders (4.3  2.4° vs.
5.4  2.9°, p  0.072). At 6-month follow-up, LV
dyssynchrony improved in CRT responders (from 182  71
ms to 60  45 ms, p  0.001), whereas in nonresponders
LV dyssynchrony did not change (116  83 ms vs. 136 
89 ms, p  0.30) (Table 3). Importantly, within ischemic
HF patients, CRT responders presented a significantly
lower number of scarred segments at 2-dimensional echo-
cardiography as compared with nonresponders (2.7  0.9
vs. 4.2  2.2, p  0.016).
Figure 2 LV Twist and LV Systolic Function
(A) Correlation between baseline peak left ventricular (LV) twist and left ventric-
ular ejection fraction (LVEF) in heart failure (HF) patients (ischemic: open
circles, and nonischemic: solid circles). (B) Correlation between  peak LV
twist and LVEF immediately after cardiac resynchronization therapy in HF
patients (ischemic: open circles, and nonischemic: solid circles).




(n  31) p Value
Age (yrs) 66  10 66  11 0.88
Sex (male/female) 32/8 20/11 0.18
Medication, n (%)
ACE inhibitors 37 (92) 29 (93) 0.77
Beta-blockers 35 (87) 27 (86) 0.82
Diuretics and/or
spironolactone
34 (84) 26 (84) 0.82
Etiology, n (%)
Ischemic 20 (50) 18 (58)
Nonischemic 20 (50) 13 (42) 0.63
QRS duration (ms) 149  32 149  30 0.97
NYHA functional class
Baseline 3.0  0.5 3.0  0.5 0.92
6-month follow-up 2.0  0.7* 2.7  0.6† 0.001
QoL
Baseline 35  23 32  15 0.51
6-month follow-up 20  20* 29  19 0.065
6-min walk distance (m)
Baseline 306  106 330  107 0.34
6-month follow-up 363  109* 327  110 0.17
*p  0.001 baseline versus 6-month follow-up; †p  0.05 baseline versus 6-month follow-up.
Abbreviations as in Table 1.
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LV twist baseline. As shown in Table 1, peak apical
rotation, peak basal rotation, and peak LV twist were
severely reduced in HF patients compared with normal
control subjects: 2.4  1.8° versus 9.4  3.2° (p  0.001),
3.3  2.0° versus 6.1  2.4° (p  0.001), and 4.8  2.6°
versus 15.0  3.6° (p  0.001), respectively.
A significant relation (r  0.53, p  0.001) was observed
between peak LV twist and LVEF in HF patients. This
relation was stronger in nonischemic (r  0.60, p  0.001)
than in ischemic HF patients (r  0.34, p  0.020) (Fig. 2A).
Moreover, a modest relation (r  0.33, p  0.003) was
observed b tween peak LV twist and LV dyssynchrony in HF
patients. At multivariable linear regression analysis, LVEF
(beta  0.47, p  0.001) and LV dyssynchrony (beta 
0.21, p  0.032) were independent determinants of LV
twist.
LV twist after CRT. IMMEDIATELY AFTER CRT. Immedi-
ately after CRT, peak LV twist increased from 4.8  2.6° to
5.9  3.2° (p  0.007). In particular,  peak LV twist was
strongly related to LVEF (r  0.83, p  0 .001), and this
relation was go d i both nonischemic (r  0.85, p 
0.001) and ischemic HF patients (r  0.82, p  0.001) (Fig.
2B). Further ore, the relations between  peak LV twist
and LV dyssynchrony (r  0.57, p  0.001) and
between LV dyssynchrony and LVEF (r  0.63, p 
0.001) were good but less strong than the previous relation
between  peak LV twist and LVEF.
SIX-MONTH FOLLOW-UP. At 6-month follow-up, 40 of 71
(56%) patients were classified as echocardiographic re-
sponders to CRT (defined as a decrease in LVESV 15%).
No significant differences in the baseline clinical character-
istics were found between responders and nonresponders
(Table 2). At 6-month follow-up, significant improvement in
NYHA functional class (from 3.0  0.5 to 2.0  0.7, p 
0.001), quality of life (from 35  23 to 20  20, p  0.001),
and 6-min walk distance (from 306  106 m to 363  109 m,
p  0.001) were observed in CRT responders only (Table 2).
Baseline echocardiographic characteristics were also sim-
ilar between the 2 groups, except for LV dyssynchrony
(Table 3), which was larger in responders compared with
nonresponders (182  71 ms vs. 116  83 ms, p  0.003).
A trend toward lower values of peak LV twist were noted in
responders as compared with nonresponders (4.3  2.4° vs.
5.4  2.9°, p  0.072). At 6-month follow-up, LV
dyssynchrony improved in CRT responders (from 182  71
ms to 60  45 ms, p  0.001), whereas in nonresponders
LV dyssynchrony did not change (116  83 ms vs. 136 
89 ms, p  0.30) (Table 3). Importantly, within ischemic
HF patients, CRT responders presented a significantly
lower number of scarred segments at 2-dimensional echo-
cardiography as compared with nonresponders (2.7  0.9
vs. 4.2  2.2, p  0.016).
Figure 2 LV Twist and LV Systolic Function
(A) Correlation between baseline peak left ventricular (LV) twist and left ventric-
ular ejection fraction (LVEF) in heart failure (HF) patients (ischemic: open
circles, and nonischemic: solid circles). (B) Correlation between  peak LV
twist and LVEF immediately after cardiac resynchronization therapy in HF
patients (ischemic: open circles, and nonischemic: solid circles).




(n  31) p Value
Age (yrs) 66  10 66  11 0.88
Sex (male/female) 32/8 20/11 0.18
Medication, n (%)
ACE inhibitors 37 (92) 29 (93) 0.77
Beta-blockers 35 (87) 27 (86) 0.82
Diuretics and/or
spironolactone
34 (84) 26 (84) 0.82
Etiology, n (%)
Ischemic 20 (50) 18 (58)
Nonischemic 20 (50) 13 (42) 0.63
QRS duration (ms) 149  32 149  30 0.97
NYHA functional class
Baseline 3.0  0.5 3.0  0.5 0.92
6-month follow-up 2.0  0.7* 2.7  0.6† 0.001
QoL
Baseline 35  23 32  15 0.51
6-month follow-up 20  20* 29  19 0.065
6-min walk distance (m)
Baseline 306  106 330  107 0.34
6-month follow-up 363  109* 327  110 0.17
*p  0.001 baseline versus 6-month follow-up; †p  0.05 baseline versus 6-month follow-up.
Abbreviations as in Table 1.
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Figure 2 (LV twist and LV systolic function). Panel A: Correlation between baseline peak LV twist and LVEF in heart failure patients (ischemic, 
white circles, and non-ischemic, black circles). Panel B: Correlation between ∆ peak LV twist and ∆ LVEF immediately after CRT in heart failure 
patients (ischemic, white circles, and non-ischemic, black circles).
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lv twist after crt
Immediately after CRT
Immediately after CRT, peak LV twist increased from 4.8±2.6º to 5.9±3.2º (p = 0.007). In par-
ticular, ∆ peak LV twist was strongly related to ∆ LVEF (r = 0.83, p <0.001) and this relation was 
good in both non-ischemic (r = 0.85, p <0.001) and ischemic HF patients (r = 0.82, p <0.001) 
(Figure 2B). Furthermore, the relations between ∆ peak LV twist and ∆ LV dyssynchrony (r = 
-0.57, p <0.001) and between ∆ LV dyssynchrony and ∆ LVEF (r = -0.63, p <0.001) were good 
but less strong than the previous relation between ∆ peak LV twist and ∆ LVEF.
Six months follow-up
At 6 months follow-up, 40 of 71 (56%) patients were classified as echocardiographic respond-
ers to CRT (defined as a decrease in LVESV ≥15%).
No significant differences in the baseline clinical characteristics were found between 
responders and non-responders (Table 2). At 6 months follow-up, significant improvement in 
table 2. Clinical characteristics of responders vs. non-responders at baseline and 6 months follow-up. 
responders 
(n = 40)
non-responders    
(n = 31)
 p-value
Age (years) 66±10 66±11 0.88
Gender (male/female) 32/8 20/11 0.18
Medication, n (%)
      ACE Inhibitors
      ß-blockers
      Diuretics and/or











      Ischemic

































* = p <0.001 baseline vs. 6 month follow-up; † = p<0.05 baseline vs. 6 month follow-up. Abbreviations see Table 1.
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NYHA class (from 3.0±0.5 to 2.0±0.7, p <0.001), quality of life (from 35±23 to 20±20, p <0.001), 
and 6-minute walk distance (from 306±106 m to 363±109 m, p <0.001) were observed in CRT 
responders only (Table 2).
Baseline echocardiographic characteristics were also similar between the 2 groups, except 
for LV dyssynchrony (Table 3) that was larger in responders compared to non-responders 
(182±71 ms vs. 116±83 ms, p = 0.003). A trend towards lower values of peak LV twist were 
noted in responders as compared to non-responders (4.3±2.4º vs. 5.4±2.9º, p = 0.072). At 6 
months follow-up, LV dyssynchrony improved in CRT responders (from 182±71 ms to 60±45 
ms, p <0.001), whereas in non-responders LV dyssynchrony did not change (116±83 ms vs. 
136±89 ms, p = 0.30) (Table 3). Importantly, within ischemic HF patients, CRT responders pre-
sented significantly lower number of scarred segments at 2D-echocardiography as compared 
to non-responders (2.7±0.9 vs. 4.2±2.2, p = 0.016).
Concerning the rotational parameters, in responders peak LV twist progressively improved 
during follow-up (ANOVA p-value <0.001), whereas in non-responders a progressive dete-
rioration of peak LV twist was noted (ANOVA p-value <0.001) (Figure 3). Particularly, both 
apical and basal rotation significantly improved in responders (from 2.3±1.7º to 5.0±3.0º, p 
<0.001 and from -3.2±2.2º to -4.3±1.9º, p = 0.006), whereas only basal rotation significantly 
deteriorated in non-responders (from -3.5±1.7 to -2.1±2.2, p = 0.001) (Table 3).






























































* = p <0.001 baseline vs. 6 month follow-up; † = p <0.01 baseline vs. 6 month follow-up; ‡ = p<0.05 baseline vs. 6 month follow-up. 
Abbreviations see Table 1.
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prediction of lv reverse remodeling
At univariable logistic regression, LV dyssynchrony at baseline, ∆ LV dyssynchrony, ∆ LVESV 
and ∆ peak LV twist were significantly related to LV reverse remodeling at 6 months follow-up 
(Table 4). At multivariable logistic regression analysis, ∆ peak LV twist was the strongest pre-
dictor of response to CRT at 6 months follow-up (OR = 1.899, 95%CI = 1.334-2.703, p <0.001) 
(Table 4).
Table 4. Univariable and multivariable logistic regression analysis for prediction of response to CRT (defined as reduction in LVESV ≥15%).
dependent variable: univariable analysis multivariable analysis
Response to CRT at 6 months follow-up OR (95% CI) p-value OR (95% CI) p-value
Independent variables
Age 1.003 (0.958-1.050) 0.90
Female gender 2.198 (0.756-6.404) 0.15
Ischemic etiology 0.722 (0.281-1.858) 0.50
QRS width at baseline 1.000 (0.985-1.016) 0.97
6 minutes walking test at baseline 0.998 (0.993-1.002) 0.34
LVESV at baseline 0.998 (0.990-1.005) 0.56
∆ LVESV immediately after CRT 0.949 (0.915-0.984) 0.005 0.998 (0.950-1.049) 0.94
LV dyssynchrony at baseline 1.013 (1.005-1.021) 0.002 1.011 (1.001-1.022) 0.037
∆ LV dyssynchrony immediately after CRT 0.992 (0.986-0.998) 0.010 1.007 (0.996-1.017) 0.21
Peak LV twist at baseline 0.844 (0.698-1.019) 0.078
∆ peak LV twist immediately after CRT 1.837 (1.378-2.449) <0.001 1.899 (1.334-2.703) <0.001
c-statistic: 0.885
CI: confidence intervals; CRT: cardiac resynchronization therapy; LV: left ventricular; LVEF: left ventricular ejection fraction; LVESV:  left ventricular 
end-systolic volume; OR: odds ratio.
Concerning the rotational parameters, in responders peak
LV twist progressively improved during follow-up
(ANOVA p  0.001), whereas in nonresponders a progres-
sive deterioration of peak LV twist was noted (ANOVA
p  0.001) (Fig. 3). Particularly, both apical and basal
rotation significantly improved in responders (from 2.3 
1.7° to 5.0  3.0°, p  0.001 and from 3.2  2.2° to 4.3
 1.9°, p  0.006), whereas only basal rotation significantly
deteriorated in nonresponders (from 3.5  1.7 to 2.1 
2.2, p  0.001) (Table 3).
Prediction of LV reverse remodeling. At univariable lo-
gistic regression, LV dyssynchrony at baseline, LV dys-
synchrony, LVESV, and  peak LV twist were signifi-
cantly related to LV reverse remodeling at 6-month
follow-up (Table 4). At multivariable logistic regression
analysis,  peak LV twist was the strongest predictor of
response to CRT at 6-month follow-up (odds ratio:
1.899, 95% confidence interval: 1.334 to 2.703, p 
0.001) (Table 4).
LV twist in relation to LV lead position. Considering the
71 patients with 6-month follow-up, 68 patients had the
LV lead placed in a (postero)lateral vein and 3 in an anterior
vein. The 3 patients with the LV lead positioned in an
anterior vein were nonresponders at 6-month follow-up. Of
the remaining 68 patients, the LV lead position was
classified (from the right anterior oblique/postero-anterior
view on fluoroscopy) as basal in 17 (25%), midventricular in
34 (50%), and apical in 17 (25%) patients. At baseline, peak
LV twist was not significantly different between patients
with apical, midventricular, and basal LV lead position
(ANOVA p  0.68). However, at 6-month follow-up, peak
LV twist showed a significant improvement in patients with
apical (from 4.3  3.1° to 8.6  3.0°, p  0.001) and
midventricular (from 4.8  2.2° to 6.4  3.9°,
p  0.038) LV lead position, whereas in patients with a
basal LV lead position, peak LV twist did not change
significantly (5.0  3.3° vs. 4.1  3.2°, p  0.28) (Fig. 4A).
Similarly, LVEF increased significantly in patients with an
apical (from 26  7% to 37  7%, p  0.001) and
midventricular (from 26  6% to 33  8%, p  0.001) but not
with a basal (26  5% vs. 28  8%, p  0.30) LV lead position
(Fig. 4B).
Figure 5 shows an example of a responder with the LV
lead placed in an apical position of a postero-lateral vein and
significant improvement in peak LV twist and LVEF after
CRT (both immediately after CRT implantation and at
6-month follow-up).
Discussion
The current study evaluated the effects of CRT on LV twist
and provides new insights on the relationship between LV
rotational mechanics, CRT response, and LV lead position.
The main findings can be summarized as follows: 1) LV
twist was significantly reduced in HF patients; 2) LV twist
improved in responders and worsened in nonresponders to
CRT; 3) the strongest predictor of LV reverse remodeling at
6-month follow-up was  peak LV twist (immediate
change in LV twist after CRT); and 4) an LV lead placed in
a (postero-)lateral vein with apical or midventricular posi-
tion was associated with the greatest improvement of LV
twist after CRT and with the highest response rate to CRT.
Figure 3 LV Twist in Responders and Nonresponders
Peak left ventricular (LV) twist in responders and nonresponders at baseline,
immediately after cardiac resynchronization therapy (CRT), and at 6-month fol-
low-up. ANOVA  analysis of variance.
Standard Echocardiographic Variables andRotational Parameters in Responders VersusN nresponders t Baseline and 6-Month Follow-Up
Table 3
St ndard Echo ar iographic Variables and
Rotational Parameters in Responders Versus









Baseline 144  58 153  67 0.56
6-month follow-up 110  43* 164  72† 0.001
LVEF (%)
Baseline 26  6 26  6 0.91
6-month follow-up 37  7* 26  6 0.001
LV dyssynchrony (ms)
Baseline 182  71 116  83 0.003
6-month follow-up 60  45* 136  89 0.001
Peak apical rotation (°)
Baseline 2.3  1.7 2.8  2.1 0.32
6-month follow-up 5.0  3.0* 2.1  2.3 0.001
Peak basal rotation (°)
Baseline 3.2  2.2 3.5  1.7 0.51
6-month follow-up 4.3  1.9‡ 2.1  2.2‡ 0.001
Peak LV twist (°)
Baseline 4.3  2.4 5.4  2.9 0.072
6-month follow-up 8.5  3.2* 3.3  2.2* 0.001
*p  0.001 baseline versus 6-month follow-up; †p  0.05 baseline versus 6-month follow-up;
‡p  0.01 baseline versus 6-month follow-up.
Abbreviations as in Table 1.
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Figure 3 (LV twist in responders and non-responders). Peak LV twist in responders and non-responders at baseline, immediately after CRT and 
at 6 months follow-up.
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lv twist in relation to lv lead position
Considering the 71 patients with 6 months follow-up, 68 patients had the LV lead placed in a 
(postero-)lateral vein and 3 in an anterior vein. The 3 patients with the LV lead positioned in 
an anterior vein were non-responders at 6 months follow-up. Of the remaining 68 patients, 
the LV lead position was classified (from the right anterior oblique/postero-anterior view on 
fluoroscopy) as basal in 17 (25%), mid-ventricular in 34 (50%), and apical in 17 (25%) pa-
tients. At baseline, peak LV twist was not significantly different between patients with apical, 
mid-ventricular and basal LV lead position, (ANOVA p-value = 0.68). However, at 6 months 
follow-up, peak LV twist showed a significant improvement in patients with apical (from 
4.3±3.1º to 8.6±3.0º, p = 0.001) and mid-ventricular (from 4.8±2.2º to 6.4±3.9º, p = 0.038) LV 
lead position, whereas in patients with a basal LV lead position, peak LV twist did not change 
significantly (5.0±3.3º vs. 4.1±3.2º, p = 0.28) (Figure 4A). Similarly, LVEF increased significantly 
in patients with an apical (from 26±7% to 37±7%, p <0.001) and mid-ventricular (from 26±6% 
to 33±8%, p <0.001) but not with a basal (26±5% vs. 28±8%, p = 0.30) LV lead position (Figure 
4B). Figure 5 shows an example of responder with the LV lead placed in an apical position of 
a postero-lateral vein and significant improvement in peak LV twist and LVEF after CRT (both 
immediately after CRT implantation and at 6 months follow-up).
dIscussIon
The current study evaluated the effects of CRT on LV twist and provides new insights on the 
relationship between LV rotational mechanics, CRT response and LV lead position. The main 
findings can be summarized as follows: 1) LV twist was significantly reduced in HF patients; 
Relationship between LV twist and LV function. Several
techniques have been applied for the assessment and quan-
tification of LV twist. For this purpose, tagged cardiac
magnetic resonance imaging and sonomicrometry are con-
sidered the gold standard, but the most recent speckle-
tracking echocardiographic technique, used in the present
study, demonstrated a good agreement with these imaging
modalities (20,21). Previous studies, using both tagged
cardiac magnetic resonance imaging and speckle-tracking
analysis, suggested an important relation between LV twist
and LVEF (4,9). Similarly, in the current study, the relation
between LV twist and LV systolic function was good (r 
0.53, p  0 .001), illustrating the potential role of LV twist
as a comprehensive index of LV systolic function. Further-
more, the results of the present study highlight that the relation
between LV systolic function and LV twist was stronger in
nonischemic patients as compared with ischemic patients. A
possible reason may be the presence of regional myocardial
damage in ischemic patients, involving specifically the apex or
the base with a different effect on LV twist (23).
Finally, LV twist was modestly related to LV dyssyn-
chrony (r  0.33, p  0 .001), but at multivariable linear
regression analysis, LV dyssynchrony was still independently
related to LV twist. This finding points out that LV twist not
only is a sensitive and thorough parameter of LV function, but
also it may reflect the extent of LV (dys)synchrony.
Relationship between LV twist and CRT response. The
effects of CRT on torsional mechanics were different in
responders and nonresponders. A trend toward more re-
duced LV twist at baseline in responders as compared with
nonresponders was observed. In the present study, a signif-
icant improvement of LV twist was observed in CRT
responders and a significant worsening in nonresponders. In
contrast, a previous study by Zhang et al. (10) did not show
any significant increase of LV twist in responders to CRT.
Figure 4 LV Twist and LVEF in Relation to LV Lead Position
(A) Peak LV twist at baseline and 6-month follow-up in patients with basal, mid-
ventricular, and apical LV lead position. Significant improvement was observed in
patients with an apical or midventricular LV lead position but not in patients with
basal LV lead position. (B) LVEF at baseline and 6-month follow-up in patients with
basal, midventricular, and apical LV lead position. Significant improvement was
observed in patients with an apical or midventricular LV lead position but not in
patients with basal LV lead position. Abbreviations as in Figure 2.
Univariable and Multivariable LogisticRegression A alysis for Prediction of Response to CRT*Table 4 Univariable and Multivariable LogisticRegression Analysis for Prediction of Response to CRT*
Univariable Analysis Multivariable Analysis
OR (95% CI) p Value OR (95% CI) p Value
Dependent variable
Response to CRT at 6-month follow-up
Independent variables
Age 1.003 (0.958–1.050) 0.90
Female sex 2.198 (0.756–6.404) 0.15
Ischemic etiology 0.722 (0.281–1.858) 0.50
QRS width at baseline 1.000 (0.985–1.016) 0.97
6-min walking test at baseline 0.998 (0.993–1.002) 0.34
LVESV at baseline 0.998 (0.990–1.005) 0.56
LVESV immediately after CRT 0.949 (0.915–0.984) 0.005 0.998 (0.950–1.049) 0.94
LV dyssynchrony at baseline 1.013 (1.005–1.021) 0.002 1.011 (1.001–1.022) 0.037
LV dyssynchrony immediately after CRT 0.992 (0.986–0.998) 0.010 1.007 (0.996–1.017) 0.21
Peak LV twist at baseline 0.844 (0.698–1.019) 0.078
 peak LV twist immediately after CRT 1.837 (1.378–2.449) 0.001 1.899 (1.334–2.703) 0.001
c-statistic  0.885. *Defined as reduction in LVESV 15%.
CI  confidence interval; CRT  cardiac resynchronization therapy; OR  odds ratio; other abbreviations as in Table 1.
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Relationship between LV twist and LV function. Several
techniques have been applied for the assessment and quan-
tification of LV twist. For this purpose, tagged cardiac
magnetic resonance imaging and sonomicrometry are con-
sidered the gold standard, but the most recent speckle-
tracking echocardiographic technique, used in the present
study, demonstrated a good agreement with these imaging
modalities (20,21). Previous studies, using both tagged
cardiac magnetic resonance imaging and speckle-tracking
analysis, suggested an important relation between LV twist
and LVEF (4,9). Similarly, in the current study, the relation
between LV twist and LV systolic function was good (r 
0.53, p  0 .001), illustrating the potential role of LV twist
as a comprehensive index of LV systolic function. Further-
more, the results of the present study highlight that the relation
between LV systolic function and LV twist was stronger in
nonischemic patients as compared with ischemic patients. A
possible reason may be the presence of regional myocardial
damage in ischemic patients, involving specifically the apex or
t e base with a diffe ent effect n LV twist (23).
Finally, LV twist was modestly related to LV dyssyn-
chrony (r  0.33, p  0 .001), but at multivariable linear
regression analysis, LV dys ynchrony was still independently
related to LV twist. This finding points out that LV twist not
only is a sensitive and thorough parameter of LV function, but
also it may reflect the extent of LV (dys)synchrony.
Relationship between LV twist and CRT response. The
effects of CRT on torsional mechanics were different in
responders and nonresponders. A trend toward more re-
duced LV twist at baseline in responders as compared with
nonresponders was observed. In the present study, a signif-
icant improvement of LV twist was observed in CRT
responders and a significant worsening in nonresponders. In
contrast, a previous study by Zhang et al. (10) did not show
any significant increase of LV twist in responders to CRT.
Figure 4 LV Twist and LVEF in Relation to LV Lead Position
(A) Peak LV twist at baseline and 6-month follow-up in patients with basal, mid-
ventricular, and apical LV lead position. Significant improvement was observed in
patients with an apical or midventricular LV lead position but not in patients with
basal LV lead position. (B) LVEF at baseline and 6-month follow-up in patients with
basal, midventricular, and apical LV lead position. Significant improvement was
observed in patients with an apical or midventricular LV lead position but not in
patients with basal LV lead position. Abbreviations as in Figure 2.
Univariable and Multivariable LogisticRegression A alysis for Prediction of Response to CRT*Table 4 Univariable and Multivariable LogisticRegression Analysis for Prediction of Response to CRT*
Univariable Analysis Multivariable Analysis
OR (95% CI) p Value OR (95% CI) p Value
Dependent variable
Response to CRT at 6-month follow-up
Independent variables
Age 1.003 (0.958–1.050) 0.90
Female sex 2.198 (0.756–6.404) 0.15
Ischemic etiology 0.722 (0.281–1.858) 0.50
QRS width at baseline 1.000 (0.985–1.016) 0.97
6-min walking test at baseline 0.998 (0.993–1.002) 0.34
LVESV at baseline 0.998 (0.990–1.005) 0.56
LVESV immediately after CRT 0.949 (0.915–0.984) 0.005 0.998 (0.950–1.049) 0.94
LV dyssynchrony at baseline 1.013 (1.005–1.021) 0.002 1.011 (1.001–1.022) 0.037
LV dyssynchrony immediately after CRT 0.992 (0.986–0.998) 0.010 1.007 (0.996–1.017) 0.21
Peak LV twist at baseline 0.844 (0.698–1.019) 0.078
 peak LV twist immediately after CRT 1.837 (1.378–2.449) 0.001 1.899 (1.334–2.703) 0.001
c-statistic  0.885. *Defined as reduction in LVESV 15%.
CI  confidence interval; CRT  cardiac resynchronization therapy; OR  odds ratio; other abbreviations as in Table 1.
1323JACC Vol. 54, No. 14, 2009 Bertini et al.
September 29, 2009:1317–25 Effects of CRT on LV Twist
Relationship between LV twist and LV function. Several
techniques have been applied for the assessment and quan-
tification of LV twist. For this purpose, tagged cardiac
magnetic resonance imaging and sonomicrometry are con-
sidered the gold standard, but the most recent speckle-
tracking echocardiographic technique, used in the present
study, demonstrated a good agreement with these imaging
modalities (20,21). Previous studies, using both tagged
cardiac magnetic resonance imaging and speckle-tracking
analysis, suggested an important relation between LV twist
and LVEF (4,9). Similarly, in the current study, the relation
between LV twist and LV systolic function was good (r 
0.53, p  0 .001), illustrating the potential role of LV twist
as a comprehensive index of LV systolic function. Further-
more, the results of the present study highlight that the relation
between LV systolic function and LV twist was stronger in
nonischemic patients as compared with ischemic patients. A
possible reason may be the presence of regional myocardial
damage in ischemic patients, involvi g specifically the apex or
the base with a different effect on LV twist (23).
Fin lly, LV twist was modestly related to LV dyssyn-
chrony (r  0.33, p  0 .001), but at multivariable linear
regression analysis, LV dyssynchrony was still independently
related to LV twist. This finding points out that LV twist not
only is a sensitive and thorough parameter of LV function, but
also it may reflect the extent of LV (dys)synchrony.
Relationship between LV twist and CRT response. The
effects of CRT on torsional mechanics were different in
responders and nonresponders. A trend toward more re-
duced LV twist at baseline in responders as compared with
nonresponders was observed. In the present study, a signif-
icant improvement of LV twist was observed in CRT
responders and a significant worsening in nonresponders. In
contrast, a previous study by Zhang et al. (10) did not show
any significant increase of LV twist in responders to CRT.
Figure 4 LV Twist and LVEF in Relation to LV Lead Position
(A) Peak LV twist at baseline and 6-month follow-up in patients with basal, mid-
ventricular, and apical LV lead position. Significant improvement was observed in
patients with an apical or midventricular LV lead position but not in patients with
bas l LV lead position. (B) LVEF at baseline and 6-month follow-up in patients with
basal, midventricular, and apical LV lead position. Significant improvement was
observed in patients with an apical or midventricular LV lead position but not in
patients with basal LV lead position. Abbreviations as in Figure 2.
Univariable and Multivariable LogisticRegression A alysis for Prediction of Response to CRT*Table 4 Univariable and Multivariable LogisticRegression Analysis for Predicti n of Response to CRT*
Univari ble Analysis Multivariable A alysis
OR (95% CI) p Value OR (95% CI) p Value
Dependent variable
R sponse to CRT at 6-month follow-up
Independent variables
Age 1.003 (0.958–1.050) 0.90
Female sex 2.198 (0.756–6.404) 0.15
Ischemic etiology 0.722 (0.281–1.858) 0.50
QRS width at baseline 1.000 (0.985–1.016) 0.97
6-min walking test at baseline 0.998 (0.993–1.002) 0.34
LVESV at baseline 0.998 (0.990–1.005) 0.56
LVESV immediately after CRT 0.949 (0.915–0.984) 0.005 0.998 (0.950–1.049) 0.94
LV dyssynchrony at baseline 1.013 (1.005–1.021) 0.002 1.011 (1.001–1.022) 0.037
LV dyssyn hrony immediately after CRT 0.992 (0.986–0.998) 0.010 1.007 (0.996–1.017) 0.21
Peak LV twist at baseline 0.844 (0.698–1.019) 0.078
 peak LV twist immediately after CRT 1.837 (1.378–2.449) 0.001 1.899 (1.334–2.703) 0.001
c-statistic  0.885. *Defined as reduction in LVESV 15%.
CI  confidence interval; CRT  cardiac resynchronization therapy; OR  odds ratio; other abbreviations as in Table 1.
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Figure 4 (LV twist and LVEF in relation to LV lead position). Panel A. Peak LV twist at bas lin  nd 6 onths follow-up in pati nts with basal, 
mid-ventricular and apical LV lead position. Significant improvement was observed in atients with an apical or mid-ventricular LV lead position 
but not in patients with basal LV lead position. Panel B. LVEF at baseline and 6 months follo -up in patients with basal, mid-ventricular and 
apical LV lead position. Significant improvement was observed in patients with an apical or mid-ventricular LV lead positio  but not in patients 
with basal LV lead position.
LV: left ventricular; LVEF: left ventricular ejection fraction
Nina Book.indb   399 26-09-11   12:04
Chapter 22
400
2) LV twist improved in responders and worsened in non-responders to CRT; 3) the strongest 
predictor of LV reverse remodeling at 6 months follow-up was ∆ peak LV twist (immediate 
change in LV twist after CRT); 4) an LV lead placed in a (postero-)lateral vein with apical or 
mid-ventricular position was associated with the greatest improvement of LV twist after CRT 
and with the highest response rate to CRT.
relationship between lv twist and lv function
Several techniques have been applied for the assessment and quantification of LV twist. For 
this purpose, tagged cardiac magnetic resonance imaging and sonomicrometry are consid-
ered the gold standard, but the most recent speckle-tracking echocardiographic technique, 
used in the present study, demonstrated a good agreement with these imaging modalities 
20, 21. Previous studies, using both tagged cardiac magnetic resonance imaging and speckle-
tracking analysis, suggested an important relation between LV twist and LVEF 4, 9. Similarly, in 
the current study the relation between LV twist and LV systolic function was good (r = 0.53, 
p <0.001), illustrating the potential role of LV twist as comprehensive index of LV systolic 
function. Furthermore, the results of the present study highlight that the relation between LV 
Figure 5. Example of a CRT responder with LV lead in an apical position. Panel A. Peak LV twist improved from 3.9º at baseline to 9.7º 
immediately after CRT implantation. Peak LV twist further improved at 6 months follow-up (peak LV twist 10.9º). AVC: aortic valve closure. Panel 
B. Biplane fluoroscopy: the left anterior oblique (LAO) view shows the LV lead in a posterolateral cardiac vein; in the postero-anterior (PA) view 
the distance between the coronary sinus/mitral plane and the cardiac apex was divided (dotted lines) in 3 parts (basal, mid-ventricular and 
apical).
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systolic function and LV twist was stronger in non-ischemic patients as compared to ischemic 
patients. A possible reason may be the presence of regional myocardial damage in ischemic 
patients, involving specifically the apex or the base with a different effect on LV twist 23.
Finally, LV twist was modestly related to LV dyssynchrony (r = -0.33, p <0.001), but at mul-
tivariable linear regression analysis, LV dyssynchrony was still independently related to LV 
twist. This finding points out that LV twist not only is a sensitive and thorough parameter of 
LV function, but also it may reflect the extent of LV (dys)synchrony.
relationship between lv twist and crt response
The effects of CRT on torsional mechanics were different in responders and non-responders. 
A trend towards more reduced LV twist at baseline in responders as compared to non-
responders was observed. In the present study, a significant improvement of LV twist was 
observed in CRT responders and a significant worsening in non-responders. In contrast, a 
previous study of Zhang et al. did not show any significant increase of LV twist in responders 
to CRT 10. The different results may be related to sample size and population characteristics.
In the multivariable model, baseline LV dyssynchrony and an immediate improvement in 
LV twist after CRT were the only predictors of LV reverse remodeling at 6 months follow-up. 
The predictive value of LV dyssynchrony has been shown already in previous studies 19, 24. The 
novelty of the present study is that CRT may (partially) restore LV twist, possibly by providing 
a more physiologic electrical depolarization and mechanical contraction of the myofibers. 
Specifically, CRT partially restored LV torsional behavior in responders, by not only improving 
apical rotation but also basal rotation. In non-responders, the deterioration of LV twist was 
mainly due to worsening of the basal rotation underscoring the influence of the basal level 
on LV twist 25.
relationship between lv twist and lv lead position
Previous studies showed that HF patients treated with CRT showed the best hemodynamic 
improvement when the LV pacing lead was positioned in (postero) lateral veins 26. In the 
current study, 3 patients had the LV lead placed in an anterior vein, and none of them re-
sponded to CRT. The remaining 68 patients had the LV lead positioned in the (postero-)lateral 
vein. In these patients, the optimal position of LV lead inside the target vein was explored. 
Patients with a mid-ventricular or apical position had the largest systolic improvement, and 
showed a significant increase in LV twist, whereas patients with a basal LV lead position did 
not improve systolic function and decreased in LV twist, confirming that pacing site may 
influence torsional behavior of the LV 27. Similarly, a recent study by Helm et al.28 reported 
Nina Book.indb   401 26-09-11   12:04
Chapter 22
402
that the optimal site of stimulation (although in a canine model of HF) was the LV free wall 
centered over the mid-apical part. This finding may be related to the fact that normal cardiac 
depolarization is directed from the apex towards the base 29, and an earlier activation of 
the LV basal region, altering the normal contraction pattern of the myofibers, may lead to a 
significant deterioration of LV twist. Another explanation for the findings may be related to 
the fact that the myocardial wall is thinner towards the apex 30, 31; therefore, the epicardial LV 
lead in this position is closer to the Purkinje network. Consequently, pacing from this position 
may generate a cardiac pulse which spreads faster to the entire myocardium with a more 
physiological activation 32–34.
conclusIons
LV twist is reduced in HF patients and improves in patients who respond to CRT. Particularly, 
the change in LV twist immediately after CRT predicts LV reverse remodeling at 6 months 
follow-up.
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objectives: Functional mitral regurgitation (MR) is a common finding in heart 
failure (HF) patients with dilated cardiomyopathy, and has important prognostic 
implications. However, the increased operative risk of these patients may result in 
low referral or high denial rate for mitral valve surgery. Cardiac resynchronization 
therapy (CRT) showed to have a favorable effect on MR. Aims of this study were 
to: 1) evaluate CRT as a therapeutic option in HF patients with functional MR and 
high operative risk; and 2) investigate the effect of MR improvement after CRT on 
prognosis.
methods: A total of 98 consecutive patients with moderate-severe functional MR 
and high operative risk underwent CRT according to current guidelines. Echocar-
diography was performed at baseline and 6-month follow-up; severity of MR was 
graded according to a multi-parametric approach. Significant improvement of 
MR was defined as a reduction ≥1 grade. All cause-mortality was assessed during 
follow-up (median 32 [6.0-116] months).
results: Thirteen (13%) patients died before 6 months follow-up. In the remaining 
85 patients, significant reduction in MR was observed in all evaluated parameters. In 
particular, 42 (49%) patients improved ≥1 grade of MR and were considered MR im-
provers. Survival was superior in MR improvers as compared to MR non-improvers, 
log rank p <0.001. MR improvement was an independent prognostic factor for 
survival (HR 0.35, C.I. 0.13-0.94, p = 0.043).
conclusions: CRT is a potential therapeutic option in HF patients with moderate-
severe functional MR and high risk for surgery. Improvement in MR results in supe-
rior survival after CRT.
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IntroductIon
Functional mitral regurgitation (MR) is a common finding in heart failure patients with isch-
emic or non-ischemic dilated cardiomyopathy 1, 2. More importantly, the presence of MR has 
important prognostic implications in these patients 1, 3. The initial strategy of treating MR is 
optimization of medical therapy (afterload reduction and treatment of fluid load). However, 
in many patients significant functional MR persists and surgery may be the final option to 
reduce the extent of MR. The main surgical technique for treatment of functional MR is 
restrictive annuloplasty, with or without additional surgical left ventricular (LV) remodeling. 
In many of the patients however, the increased operative mortality risk may result in either a 
low referral, or high denial rate for mitral valve surgery. A recent study by Bach et al reported 
a non-referral or denial rate for surgery as high as 84% in patients with moderate-to-severe 
or severe functional MR 4. Moreover, it is currently unclear whether mitral valve surgery 
improves prognosis in this specific group of patients 5. As a result, indications for mitral valve 
surgery in heart failure patients with functional MR are not well defined by any (currently 
available) guideline 6.
Conversely, cardiac resynchronization therapy (CRT) showed to have a favorable effect 
on functional MR. There are several studies that demonstrated a reduction in extent of 
functional MR after CRT 7–12. Most of these studies however, were performed in patients with 
only mild-moderate MR and therefore less is known about the effects of CRT in patients with 
moderate-severe functional MR. Furthermore, these studies were limited to changes at mid-
term (6 months) follow-up and therefore no data exist with regard to the potential beneficial 
effects of reduction in MR on long-term prognosis. Consequently, the aims of this study were: 
1) to evaluate the role of CRT as an alternative therapeutic option in heart failure patients 
with moderate-severe functional MR and high operative risk; and 2) to investigate the effect 
of reduction in severity of MR after CRT on long-term prognosis.
methods
patient population and data collection
A total of 98 consecutive patients with moderate-severe functional MR and high operative 
risk were included. These patients are part of an ongoing registry and were referred for CRT 
according to the current guidelines 13. Patient data were prospectively collected in the de-
partmental Cardiology Information System (EPD-Vision®, Leiden University Medical Center, 
Leiden, the Netherlands).
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Etiology of heart failure was considered ischemic in the presence of significant coronary 
artery disease (≥50% stenosis in 1 or more of the major coronary arteries) and/or a history 
of myocardial infarction or prior revascularization. The protocol was as follows: in all patients 
clinical status was assessed before implantation and at 6 months follow-up. Extensive echo-
cardiography was performed at baseline and repeated 6 months after CRT to: 1) quantify 
LV volumes and function; and 2) evaluate the severity of MR. After the 6 months follow-up, 
patients were scheduled for regular visits to the outpatient clinic.
clinical evaluation
In all patients, evaluation of heart failure symptoms according to the New York Heart Associa-
tion (NYHA) classification was performed. Assessment of quality of life was performed using 
the Minnesota Living with Heart Failure Questionnaire (high scores indicating poor quality 
of life) 14 and when possible, exercise capacity was measured using the 6-minute walk test 
15. In addition, operative risk was assessed by means of the logistic Euroscore 16. Estimated 
glomerular filtration rate (eGFR) was calculated using the standard formula by Cockcroft 
and Gault and expressed in ml/min/1.73m2 17. Finally, outcome data were collected by chart 
review, device interrogation and telephone contact. Primary end point during long-term 
follow-up was death from any cause.
echocardiography
All patients underwent echocardiography in the left lateral decubitus position before and 
6 months after CRT implantation. Imaging was performed using a commercially available 
echocardiographic system (VIVID 7, General Electric Vingmed Ultrasound, Milwaukee, USA). 
Images were obtained using a 3.5 MHz transducer, at a depth of 16 cm in the parasternal and 
apical (2-, 3- and 4-chamber) views. All images were recorded digitally in cine-loop format 
and analyzed offline with commercial software (EchoPac 108.1.5, General Electric Vingmed 
Ultrasound, Milwaukee, USA).
LV volumes and function analysis
LV end-diastolic (LVEDV) and LV end-systolic (LVESV) volumes were determined from the con-
ventional apical 2- and 4-chamber views and LV ejection fraction (LVEF) was calculated using 
the biplane Simpson’s technique 18. Volumetric response to CRT was defined as a reduction 
≥15% in LVESV at 6 months follow-up 19.
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Assessment of MR severity
According to the current guidelines 20,  21, the severity of MR was assessed using a multi-
parametric approach, which combined the following measurements: 1) vena contracta width 
(VCW), measured as the narrowest portion of the MR color Doppler jet in a zoomed optimized 
parasternal long-axis view or in the apical 4-chamber view; 2) the ratio of the jet area to the 
left atrium (LA) area measured by planimetry in the 4-chamber view; 3) the effective regurgi-
tant orifice area (EROA) calculated with the proximal isovelocity surface area (PISA) method. 
The color Doppler images were acquired using a Nyquist limit of 30-60 cm/sec, and a color 
gain that just eliminates random color speckle from non-moving regions. Severity of MR was 
defined using a multi-parametric approach, according to current guidelines 21, and graded 
on a four-point scale: mild = 1+, moderate = 2+, moderate-severe = 3+ and severe = 4+. 
Improvement in MR was defined as a reduction ≥1 grade, 6 months after CRT. In addition, as 
a measure of MV deformation, valvular tenting area was measured from the parasternal long-
axis view at mid-systole as the area enclosed between the annular plane and mitral leaflets. 
LA volumes were measured form the 2- and 4-chamber views using the biplane Simpson’s 
technique. Finally, estimated systolic pulmonary artery pressure (SPAP) was derived from the 
right ventricular to right atrial pressure gradient or tricuspid regurgitant jet gradient and 
calculated with the modified Bernoulli equation 22.
statistical analysis
Continuous data are presented as mean±SD, and dichotomous data are presented as numbers 
and percentages. Comparison of data at baseline and 6 months follow-up was performed 
with the paired-samples t test. Comparison of data between patient groups was performed 
using the independent-samples t test for continuous data. Fisher’s exact tests or χ2 tests 
were used as appropriate to compare dichotomous data. Analysis of variance for repeated 
measurements, including interaction between group and time, was applied for comparison 
of data between patient groups at baseline and 6 months follow-up. The (event-free) survival 
of patients was evaluated with the Kaplan-Meier method and the log rank test. The effect of 
improvement in MR on (event-free) survival, adjusted for other variables, was investigated 
using the Cox proportional hazards model. Variables that showed a statistically significant 
effect in the univariate analyses were entered in the multivariate Cox proportional hazards 
model. The proportional hazards assumption was checked for continuous variables by visual 
inspection of scaled Schoenfeld residuals and for categorical variables by visual inspection 
of log-log plots. All analyses were performed with SPSS for Windows, version 16.0 (SPSS, 
Chicago, IL). All statistical tests were two-sided. A p-value <0.05 was considered statistically 
significant.





Baseline characteristics of the patient population are presented in Table 1. The majority of 
patients were male (74%) and the underlying cause of heart failure was ischemic cardiomy-
opathy in 62 (63%) patients. All patients had moderate-severe MR (63% grade 3+ and 37% 
grade 4+) with a central jet secondary to significant LV dilatation and dysfunction. Further-
more, all patients were characterized by a high operative risk (logistic Euroscore 26±13%, 
mean eGFR 51±22 ml/min/1.73m2, diabetes in 19% of cases). Optimal medical therapy was 
administered in all patients, if tolerated. Implantation of a CRT device was successful in all pa-
tients and no procedure-related complications were observed. All devices were programmed 
to simultaneous biventricular pacing during the first 6 months of follow-up. Before the 6 
Table 1: Patient characteristics (n = 98)
Age (years) 71±7
Male gender (n) 72 (74%)
Etiology of heart failure
  Ischemic 62 (63%)
  Non-ischemic 36 (37%)
QRS duration (ms) 166±29
eGFR (ml/min/1.73m2) 51±22
Diabetes (n, %) 18 (18%)
Logistic Euroscore (%) 26±13
NYHA class 3.2±0.4






  Anticoagulants 93 (95%)
  Diuretics 86 (88%)
  ACE-inhibitors 86 (88%)
  Β-blockers 57 (58%)
  Spironolactone 49 (50%)
6 MWT = 6-minute walk test; ACE = angiotensin-converting enzyme; eGFR = estimated glomerular filtration rate; LVEDV = left ventricular end-
diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; NYHA = New York Heart Association; QoL 
= quality of life
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months follow-up, 13 patients died (10 patients died due to heart failure, 2 patients died due 
to severe infection and 1 patient died because of a malignancy). Therefore, further analysis 
(baseline versus follow-up) was performed in the remaining 85 patients. Of note, patients 
that died before the 6 months follow-up had a higher logistic Euroscore (34±15 vs. 24±12), 
lower eGFR (40±15 ml/min/1.73m2 vs. 53±23 ml/min/1.73m2) and were in higher NYHA class 






















































































p < 0.001 p < 0.001 p = 0.001






Figure 1: Changes in severity of MR at 6 months follow-up. Improvement in severity of MR at 6 months follow-up was observed in all evaluated 
parameters. Error bars represent standard deviation. EROA = effective regurgitant orifice area; LA = left atrium; SPAP = systolic pulmonary 
artery pressure; VCW = vena contracta width.
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clinical and lv functional changes after 6 months crt
At 6 months follow-up, mean NYHA class improved from 3.1±0.3 to 2.1±0.7 (p <0.001). In ad-
dition, quality of life score decreased from 38±18 to 24±17 (p <0.001), while distance covered 
in the 6-minute walk test increased from 283±109 m to 368±120 m (p <0.001). Significant 
LV reverse remodeling was observed at 6 months follow-up, as evidenced by a decrease in 
LVEDV from 261±88 ml at baseline to 233±81 ml at follow-up and a decrease in LVESV from 
205±81 ml to 166±72 ml (both p <0.001). Furthermore, an increase in LVEF from 23±7% at 
baseline to 30±9% at follow-up was noted (p <0.001). Volumetric response to CRT (reduction 
≥15% in LVESV at 6 months follow-up) was observed in 54 (55%) patients.
A B
C D
Figure 2: Example of a patient with a significant improvement in MR at 6 months follow-up. At baseline, the MR jet area exceeded 80% of the 
left atrium area and the effective regurgitant orifice area (EROA) was 0.61 cm2 (Panels A [4-chamber view] and B [parasternal long-axis view]). 
At 6 months follow-up, the jet area decreased to 10% of the left atrium area and the EROA was 0.19 cm2 (Panels C [4-chamber view] and D 
[parasternal long-axis view]).
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changes in mr severity after 6 months crt
Severity of MR improved significantly according to all evaluated parameters (Figure 1). The 
VCW decreased from 0.74±0.15 cm at baseline to 0.59±0.21 cm at follow-up (p <0.001), 
whereas the EROA decreased from 0.51±0.16 cm2 to 0.43±0.18 cm2 (p = 0.001). Tenting area 
decreased from 7.2±2.0 cm2 at baseline to 6.2±2.0 cm2 at follow-up (p <0.001), and the LA 
volume decreased from 103±38 ml to 91±32 ml (p <0.001). Finally, the regurgitant jet area 
ratio decreased from 51±14% at baseline to 41±18% at follow-up (p <0.001) and mean SPAP 
decreased from 35±10 mmHg to 31±10 mmHg (p = 0.001). An example of significant im-
provement in severity of MR is displayed in Figure 2.
mr improvers versus mr non-improvers after crt
At 6 months follow-up, MR improvement (reduction ≥1 grade of MR as previously described) 
was noted in 42 (49%) patients. These patients were therefore considered MR improvers. 
Baseline clinical characteristics were comparable between MR improvers and MR non-
improvers. However, ischemic etiology of heart failure was more frequently observed among 
MR non-improvers (Table 2). In addition, MR improvers had slightly less symptomatic heart 
failure (according to the NYHA functional class).
Comparison of clinical and echocardiographic data between MR improvers and non-im-
provers, both at baseline and 6 months follow-up, is displayed in Table 3. At 6 months follow-
table 2: Clinical characteristics of MR improvers and non-improvers
variable mr improvers (n = 42) mr non-improvers (n = 43) p-value
Age (years) 70±8 70±7 0.914
Men/Women 28/14 34/9 0.229
Etiology of heart failure
  Ischemic 20 (48%) 32 (74%) 0.015
  Non-ischemic 22 (52%) 11 (26%)
QRS duration (ms) 165±33 165±28 0.942
eGFR (ml/min/1.73m2) 55±23 51±23 0.432
Diabetes (n) 5 (12%) 10 (23%) 0.255
Medication (n)
  Anticoagulants 40 (95%) 41 (95%) 0.981
  Diuretics 38 (90%) 39 (91%) 0.972
  ACE-inhibitors 35 (83%) 38 (88%) 0.505
  Β-blockers 25 (60%) 25 (58%) 0.897
  Spironolactone 20 (48%) 24 (56%) 0.450
6 MWT = 6-minute walk test; ACE = angiotensin-converting enzyme; eGFR = estimated glomerular filtration rate; LVEDV = left ventricular 
end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; NYHA = New York Heart 
Association; QoL = quality of life
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up, both MR improvers and MR non-improvers had an improvement in clinical characteristics. 
However, these improvements were more outspoken in MR improvers. All baseline echocar-
diographic parameters were comparable between MR improvers and non-improvers. At 6 
months follow-up, reductions in LV volumes and an increase in LVEF were observed in both 
groups. Of note, 39 (93%) MR improvers also had significant LV volumetric response, versus 
only 15 (35%) patients in the MR non-improvers group (p <0.001). By definition, MR improv-
ers had a significant decrease in MR grade from 3.3±0.5 to 1.8±0.6, and this was evidenced by 
significant improvement in all evaluated parameters. Conversely, MR non-improvers showed 
(by definition) no improvement in MR grade from 3.3±0.5 to 3.4±0.6.
Improvement in mr and long-term prognosis after crt
To evaluate whether improvement in MR has prognostic importance after CRT, MR improve-
ment was investigated in relation to all-cause mortality during long-term follow-up (median 
32 [6.0-116] months). During this follow-up period, 34 (40%) patients died. Survival was 
superior in MR improvers as compared to MR non-improvers, log rank p <0.001 (Figure 3).
Respective 1- and 2-year survival rates were 97% and 92% in MR improvers as compared 
with 88% and 67% in MR non-improvers (log rank p = 0.117 for comparison at 1 year follow-up 
and log rank p = 0.013 at 2 years follow-up). Additionally, MR improvement was tested as an 











  Baseline Follow-up   Baseline Follow-up
NYHA class 3.0±0.2 1.9±0.7‡ 3.2±0.4 2.3±0.6‡ 0.005 0.117
6 MWT (m) 299±113 407±121* 266±105 329±106‡ 0.022 0.061
QoL score 35±17 19±16* 42±18 28±17* 0.019 0.783
LVEDV (ml) 255±84 214±78‡ 267±93 252±81* 0.174 0.004
LVESV (ml) 201±80 146±69‡ 208±83 187±70† 0.151 <0.001
LVEF (%) 23±7 33±10‡ 23±6 27±7† 0.039 <0.001
VCW (cm) 0.73±0.14 0.44±0.16† 0.74±0.17 0.73±0.13 <0.001 <0.001
EROA (cm2) 0.51±0.16 0.31±0.12* 0.52±0.16 0.54±0.16 0.002 <0.001
TA (cm2) 7.1±2.1 5.5±1.7‡ 7.4±1.9 7.1±2.0* 0.033 <0.001
LA volume (ml) 102±43 78±27‡ 104±32 104±32 0.050 <0.001
Jet area / LA area (%) 51±14 29±15* 52±14 53±13 <0.001 <0.001
SPAP (mmHg) 34±10 25±6* 37±9 38±9 <0.001 <0.001
MR grade 3.3±0.5 1.8±0.6* 3.3±0.5 3.4±0.6 <0.001 <0.001
6 MWT = 6-minute walk test; EROA = effective regurgitant orifice area; LA = left atrium; LVEDV = left ventricular end-diastolic volume; LVEF = 
left ventricular ejection fraction; LVESV = left ventricular end-diastolic volume; MR = mitral regurgitation; NYHA = New York Heart Association; 
QoL = quality of life; SPAP = systolic pulmonary artery pressure; TA = tenting area; VCW = vena contracta width
* p <0.05, baseline vs. follow-up, † p = 0.001, baseline vs. follow-up, ‡ p <0.001, baseline vs. follow-up.
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independent predictor for all-cause mortality using a multivariate Cox proportional hazards 
model. In univariate analysis, MR improvement reached a crude hazard ratio (HR) of 0.21 (95% 
Confidence Interval 0.09-0.49, p <0.001). After correction for other significant variables in the 
univariate analysis, MR improvement remained a strong independent predictor of survival 
after CRT, with a corrected HR of 0.35 (95% Confidence Interval 0.13-0.94, p = 0.043, Table 4).
dIscussIon
The findings of the present study can be summarized as follows: (1) CRT reduces severity of 
MR at 6 months follow-up in heart failure patients with moderate-severe functional MR and 
at high risk for MV surgery; and (2) improvement in MR results in superior survival during 
long-term follow-up.




















Figure 3: Kaplan-Meier survival curves for time to all-cause mortality in MR improvers versus MR non-improvers. During long-term follow-up, 
survival was superior in MR improvers as compared to MR non-improvers, log rank p <0.001. Respective 1- and 2-year survival rates were 97% 
and 92% in MR improvers as compared with 88% and 67% in MR non-improvers.
table 4: Uni- and multivariate Cox proportional hazards models for time to all-cause mortality
univariate multivariate
HR (95%-C.I.) p-value HR (95%-C.I.) p-value
Age (years) 1.01 (0.97-1.05) 0.539
Male gender 1.10 (0.57-2.12) 0.784
Ischemic etiology 1.56 (0.85-2.89) 0.154
NYHA class IV vs. III 2.42 (1.23-4.78) 0.011 1.01 (0.40-2.55) 0.981
Diabetes 1.63 (0.83-3.22) 0.156
QRS duration (ms) 1.00 (0.99-1.01) 0.947
eGFR (ml/min/1.73m2) 0.98 (0.97-0.99) 0.002 0.98 (0.97-1.00) 0.025
MR improvement 0.21 (0.09-0.49) <0.001 0.35 (0.13-0.94) 0.043
LVESV response 0.25 (0.12-0.50) <0.001 0.42 (0.18-0.97) 0.042
C.I. = confidence interval; eGFR = estimated glomerular filtration rate; HR = hazard ratio; LVESV = left ventricular end-systolic volume; MR = 
mitral regurgitation; NYHA = New York Heart Association
Nina Book.indb   417 26-09-11   12:04
Chapter 23
418
functional mr in heart failure
In heart failure patients with impaired LV systolic function, MR is a frequent finding. It is 
estimated that nearly half of these patients have some degree of MR, and in around 30% 
of these cases, extent of MR can be graded as moderate or severe 1,3,23. In most patients, a 
structurally normal mitral valve is present, but the regurgitation is secondary to changes in 
LV geometry caused by LV remodeling (dilatation). This specific type of MR is referred to as 
“functional MR” 6,23. There have been several studies which evaluated the effect of mitral valve 
surgery in patients with heart failure and functional MR 24–26. Wu et al studied 682 patients 
with significant MR and LV systolic dysfunction 24. Out of these 682 patients, 419 were consid-
ered candidates for surgical correction. Surprisingly, only 126 of these patients (30%) eventu-
ally underwent mitral valve repair. Mentioned reasons for non-referral or denial for surgery 
included cardiogenic shock, renal failure, significant valvular lesion other than MR and the 
fact that patients felt to be too weak to undergo surgery after evaluation by cardiac surgeon 
or cardiologist. Other reasons included the coexistence of conditions that increased the risk 
of cardiac surgery. During long-term follow-up, 112 patients (38%) who were not referred or 
denied for surgery died, versus 61 (48%) of those who had undergone MV surgery (p = NS). It 
was therefore concluded that there was no significant survival benefit in the surgical group. 
The finding that 70% of patients were either not referred or denied for mitral valve surgery 
was confirmed by another recent study from the same group 4.
effects of crt on functional mr
Contrasting the abovementioned results on surgery for functional MR, previous studies on 
the effects of CRT have not only demonstrated improved survival 27, but also a significant 
reduction in extent of functional MR after CRT 7–12. Most of the studies on changes in MR after 
CRT were single-center studies with limited numbers of patients. Nonetheless, results among 
these studies are consistent and several explanations for improvement in MR, including the 
acute effect of resynchronization and improvement of LV contraction (inducing synchronized 
mechanical activation of papillary muscle insertion sites) 8,10, and the more delayed effect 
of favorable changes in MV geometry (LV reverse remodeling) 10,11 have been proposed. 
Moreover, in the CARE-HF trial, which randomized 813 patients to receive either biventricular 
pacing in addition to optimized medical therapy, or optimized medical therapy alone, there 
was a significantly greater reduction in MR (measured by the regurgitant jet area ratio) in 
patients that received CRT as compared to patients on optimized medical therapy alone, 3 
moths after CRT (difference in means 5,1%, p <0.001) 27. Finally, pooled data from several 
major studies including 357 patients implanted with a CRT device, with a follow-up of at least 
6 months, showed a reduction in functional MR (measured by the regurgitant jet area) of 
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30–40% after CRT 28. The abovementioned results clearly demonstrate the beneficial effects 
of CRT on (functional) MR.
Several contributing factors to non-response to CRT, such as inappropriate LV lead posi-
tioning and, in patients with ischemic cardiomyopathy, the extent and location of scar tissue, 
have been previously reported 29–32. These factors might also have a significant effect on the 
changes in MR after CRT. Positioning the LV pacing lead at the optimal site (latest activated 
myocardial segment) may improve MR during CRT by any of the 2 mechanisms described 
above (synchronized mechanical activation of papillary muscle insertion sites and LV reverse 
remodeling during follow-up). Conversely, the presence of significant scar tissue may limit 
the extent of LV reverse remodeling after CRT and therefore also prevent the improvement 
in MR. In addition, positioning the LV lead at the level of a non-viable myocardial segment 
may significantly hamper the beneficial effect of CRT on LV remodeling and MR. Specific stud-
ies are needed to further explore the relationship between these different factors and the 
improvement of MR after CRT.
Improvement in mr versus long-term follow-up
In the current study, eGFR, LVESV response and MR improvement were all independently 
associated with improved long-term outcome (survival) after CRT. Previously, several studies 
have shown that a (significant) reduction in LVESV at 6 months follow-up resulted in superior 
long-term survival after CRT 33, 34. Yu et al reported that patients with a reduction in LVESV 
≥10% after CRT had significantly better survival as compared to patients with LVESV reduc-
tion <10%, while a more recent study by Ypenburg et al even related the extent of LV reverse 
remodeling to long-term prognosis after CRT. These observations are confirmed by the cur-
rent findings, where patients with a volumetric response after CRT (defined as a reduction 
≥15% in LVESV at 6 months follow-up) had significantly better long-term prognosis. A novel 
finding in the current study is that in addition to this significant LV reverse remodeling, a 
reduction of ≥1 grade of MR, 6 months after CRT (MR improvement), also resulted in supe-
rior survival during long-term follow-up (log rank p <0.001). Specifically, the 1- and 2-year 
survival rates were 97% and 92% in MR improvers as compared with 88% and 67% in MR 
non-improvers. More importantly, this beneficial survival effect of MR improvement was 
independent of other characteristics, including LVESV response at 6 months follow-up. This 
is the first study to establish a relation between improvement in MR at 6 months follow-up 
and superior survival during long-term follow-up after CRT. Possible explanations for this 
improved survival can be the (further) decrease in afterload induced by the reduction in MR 
or the interplay between reduction in MR and LV reverse remodeling. However, the survival 
benefit of MR improvement was independent of LVESV response at 6 months follow-up.




The observations in the present study indicate that CRT improves severity of MR at 6 months 
follow-up in heart failure patients with moderate-severe functional MR, who are at high risk 
for MV surgery. Applying CRT in this specific group may yield a new therapeutic option for 
MR. More importantly, patients with a reduction ≥1 grade of MR (MR improvers) had superior 
survival during long-term follow-up. This implicates a sustained survival benefit of CRT for 
heart failure patients with moderate-severe functional MR.
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objectives: Decreased cerebral blood flow is frequently observed in patients with 
heart failure and this may be the result of impaired cardiac systolic function. Cardiac 
resynchronization therapy (CRT) improves cardiac function and heart failure symp-
toms in selected patients. The effects of CRT on cerebral blood flow have not been 
evaluated before.
methods: In this study, left ventricular (LV) systolic function and cerebral blood 
flow were assessed in 35 heart failure patients, before and 6 months after CRT. 
Additionally, 15 heart failure patients, not being candidates for CRT were included 
as a control group. Peak-systolic velocity (PSV), end-diastolic velocity (EDV), mean 
velocity and pulsatility index (PI = [PSV-EDV] / mean velocity) were obtained with 
the use of transcranial Doppler (TCD) from the right middle cerebral artery from the 
temporal window in all subjects. Response to CRT was defined as a reduction in LV 
end-systolic volume (LVESV) ≥15%.
results: At 6 months follow-up, PSV significantly increased from 83±20 cm/s to 
100±20 cm/s (p=0.001), EDV increased from 29±7 cm/s to 37±8 cm/s (p <0.001) 
and mean velocity increased from 47±10 cm/s to 58±11 cm/s (p <0.001), only in 
responders to CRT. Conversely, no significant changes in cerebral blood flow were 
observed in non-responders and controls.
conclusions: CRT induces an increase in cerebral blood flow in heart failure 
patients. This increase in cerebral blood flow is related to the improvement in LV 
systolic function.
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IntroductIon
Transcranial Doppler (TCD) has been validated as a reliable non-invasive technique to mea-
sure cerebral blood flow and is widely used 1–4. In the current study, cerebral blood flow was 
measured with TCD in heart failure patients before CRT implantation and at 6 months follow-
up. The aim of the study was to evaluate whether cerebral blood flow is altered after CRT, 
and whether changes in cerebral blood flow are related to improvement in cardiac systolic 
function after CRT.
methods
Thirty-five patients scheduled for cardiac resynchronization therapy (CRT) were evaluated in 
this study. The study was approved by the local ethics committee and written informed con-
sent was obtained in all patients. The selection criteria for CRT included advanced symptoms 
of heart failure (New York Heart Association [NYHA] functional class III or IV), left ventricular 
ejection fraction (LVEF) <35%, sinus rhythm and a wide QRS complex (>120 ms) 5. Patients 
with recent myocardial infarction (<3 months), decompensated heart failure, history of isch-
emic stroke/transient ischemic attack or known carotid stenosis were not included. Etiology 
of heart failure was considered ischemic in the presence of significant coronary artery disease 
(>50% stenosis in 1 or more of the major epicardial coronary arteries) and/or a history of 
myocardial infarction or prior revascularization.
Before CRT device implantation, clinical status including NYHA class, 6-minute walking 
distance and Minnesota Living with Heart Failure Questionnaire (MLHFQ] score was assessed. 
Cognitive function was specifically evaluated with the psychometric sub-score of the MLHFQ 
(MLHFQ-PS). This psychometric properties sub-score has recently been validated against the 
more extensive Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) 6, 7.
In addition, left ventricular (LV) volumes and LVEF were measured using real-time three-
dimensional echocardiography (RT3DE). Cerebral blood flow was evaluated with the use of 
TCD. At 6 months follow-up, the abovementioned measurements were repeated to assess the 
effect of CRT on cerebral blood flow, cognitive function and LV performance. Patients with 
a reduction ≥15% of LV end-systolic volume (LVESV), reflecting improvement in LV systolic 
function, were considered responders to CRT 8, 9.
Finally, 15 heart failure patients matched for age, gender, NYHA class and LV function, 
not being candidates for CRT according to current guidelines (QRS duration <120 ms), were 
included as a control group. These patients underwent the same clinical, echocardiographic 
and transcranial Doppler assessment as the CRT recipients. All patients were on stable heart 
failure medication and medical therapy was unchanged during the study.
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Complete echocardiographic methods have been described previously 10. In brief, patients 
were imaged in the left lateral decubitus position with a commercially available system (iE33, 
Philips Medical Systems, N.A., Bothell, Washington, USA) equipped with a X3, fully sampled 
matrix transducer. RT3DE data sets were stored digitally and quantitative analysis of the 3D 
dataset was performed off-line using a semi-automated contour tracing algorithm (Q-Lab, 
version 6.0, Philips Medical Systems) over a complete heart cycle.
LV systolic performance was quantified by measuring the LV outflow-tract velocity-time 
integral (LVOT VTI) using pulsed-wave Doppler, during end-expiratory apnea.
Transcranial Doppler images were acquired after the patient was in supine position for a 
minimum of 10 minutes, with the same system used for the echocardiographic examinations 
(iE33, Philips Medical Systems, N.A., Bothell, Washington, USA), equipped with a broadband 
pure wave S5-1 transducer. All TCD measurements were taken from the right middle cerebral 
artery from the temporal window. Blood flow velocities were measured by placing a sample 
volume of 2.5 mm in the bloodstream at a depth (range 40 – 65 mm) giving the highest 
values. The software (HighQ) automatically calculated peak-systolic velocity (PSV), end-
diastolic velocity (EDV), mean velocity and pulsatility index (PI = [PSV-EDV] / mean velocity) 
using automatic trace of the Doppler spectrum. For each patient, blood flow velocities were 
obtained from a minimum of 10 cardiac cycles.
table 1: Baseline characteristics of the study population (n = 46).
variable patients (n = 32) controls (n = 14) p-value
Men/Women 25/7 11/3 0.648
Age (years) 68±10 66±10 0.583
Etiology of heart failure
  Ischemic 16 (50%) 10 (71%) 0.153
  Non-ischemic 16 (50%) 4 (29%)
QRS duration (ms) 152±25 110±8 <0.001
Systolic blood pressure (mmHg) 123±15 121±12 0.696
Diastolic blood pressure (mmHg) 71±10 73±7 0.349
NYHA class 3.0±0 2.9±0.3 0.132
Medication
  ACE-inhibitors/AII-blockers 30 (94%) 13 (93%) 1.000
  Β-blockers 24 (75%) 13 (93%) 0.240
  Diuretics 29 (91%) 10 (71%) 0.176
  Spironolactone 20 (63%) 6 (43%) 0.333
Echocardiography
Heart rate 70±17 68±13 0.558
LV end-diastolic volume (ml) 189±68 158±32 0.272
LV end-systolic volume (ml) 137±55 109±24 0.073
LV ejection fraction (%) 29±6 32±4 0.101
LV outflow-tract VTI (cm) 13±4 14±3 0.510
ACE: angiotensin converting enzyme, LV: left ventricular, NYHA: New York Heart Association, VTI: velocity time integral
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Continuous data are presented as mean±SD, and dichotomous data are presented as 
numbers and percentages. Comparison of continuous data between 2 groups was per-
formed using the Mann-Whitney U-test. For comparison between more than 2 groups, the 
Kruskal-Wallis test with manual Bonferroni post-hoc testing was performed. Fisher’s exact 
tests or χ2 tests were used to compare dichotomous data. Comparison of continuous data 
within patient groups (at baseline and 6 months follow-up) was performed with the Wilcoxon 
test. Additionally, linear regression analysis was performed to evaluate the relation between 
reduction in LVESV and increase in mean TCD velocity. All analyses were performed with SPSS 
for Windows, version 16.0 (SPSS, Chicago, IL). A p-value <0.05 was considered statistically 
significant.
table 2: Clinical and echocardiographic characteristics of responders and non-responders (n = 32).
variable responders (n = 16) non-responders (n = 16) p-value
Men/Women 12/4 13/3 1.000
Age (years) 67±10 69±10 0.317
Etiology of heart failure
  Ischemic 12 (75%) 4 (25%) 0.012
  Non-ischemic 4 (24%) 12 (75%)
QRS duration (ms) 159±25 145±24 0.105
NYHA class 3.0±0 3.0±0 1.000
MLHFQ
    baseline 31±12 35±20 0.755
    follow-up 16±12* 32±24 0.088
MLHFQ-PS
    baseline 6.8±4.4 7.4±6.2 0.909
    follow-up 3.6±3.3* 6.1±6.3 0.413
Echocardiography
LV end-diastolic volume (ml)
    baseline 188±67 190±70 0.836
    follow-up 186±74 180±59 0.880
LV end-systolic volume (ml)
    baseline 148±65 126±43 0.429
    follow-up 114±55‡ 127±46 0.214
LV ejection fraction (%)
    baseline 28±8 30±4 0.557
    follow-up 40±8‡ 30±4 <0.001
LV outflow-tract VTI (cm)
    baseline 12±3 14±4 0.187
    follow-up 14±4† 14±4 0.598
MLHFQ: Minnesota Living with Heart Failure Questionnaire, MLHFQ-PS: Minnesota Living with Heart Failure Questionnaire - Psychometric Sub-
score. Rest of abbreviations as in Table 2.
* p <0.05, baseline vs. follow-up, † p = 0.001, baseline vs. follow-up, ‡ p <0.0001, baseline vs. follow-up.




Adequate visualization of the middle cerebral artery was not feasible in 3 patients in the 
CRT group and in 1 control patient. These patients were excluded from further analysis and 
therefore the final study population consisted of 32 CRT recipients and 14 control patients. 
Baseline characteristics of the study population are summarized in Table 1. By definition, CRT 
patients and controls were comparable in terms of age, gender, NYHA class and LV function. 
Control patients had a significantly shorter QRS duration (110±8 ms vs. 152±25 ms, p <0.001). 
No differences in baseline TCD measurements (depth, number of samples, PSV, EDV, mean 
velocity and PI) were observed between CRT patients and controls.
At 6 months follow-up, mean NYHA class improved in the CRT group from 3.0±0 to 2.3±0.7 
(p <0.001). In addition, MLHFQ score decreased from 32±16 to 24±20 (p = 0.010) and MLHFQ-
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Figure 1: Changes from baseline to follow-up in cerebral blood flow; responders, non-responders and controls. A significant increase in peak 
systolic velocity (PSV, panel A), end diastolic velocity (EDV, panel B) and mean velocity (panel C) was observed in responders, while no changes 
were observed in both non-responders and control patients. Provided p-values are from the Kruskal-Wallis test for comparison of follow-up data 
between the 3 groups.
* p = 0.027, responders vs. non-responders
† p <0.01, responders vs. non-responders and controls
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from 333±89 m to 374±114 m (p = 0.024). Furthermore, a significant LV reverse remodeling 
was observed with a decrease in LVESV from 137±55 ml to 120±50 ml (p = 0.001) and an im-
provement in LVEF from 29±6% to 35±8% (p <0.0001). Finally, there was a significant increase 
in LVOT-VTI from 13±4 cm to 14±4 cm (p = 0.027).
In contrast, control patients did not show any change in echocardiographic parameters 
(LVESV from 109±24 ml to 111±25 ml [p = 0.314], LVEF from 32±4% to 32±3% [p = 0.810] and 
LVOT-VTI from 14±3 cm to 15±2 cm [p = 0.180]).
Figure 2: Example of improvement in cerebral blood flow after 6 months CRT.
(Upper panel) Before CRT, velocities are low and a dicrotic waveform can be seen. (Lower panel) After 6 moths CRT, the dicrotic waveform is still 
present, but velocities have increased significantly, indicating increase in cerebral blood flow.
EDV: end-diastolic velocity, PI: pulsatility index, PSV: peak-systolic velocity. SV: sample volume, TCD: transcranial Doppler.
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At 6 months follow-up, 16 patients (50%) demonstrated response to CRT. There were no dif-
ferences in baseline clinical characteristics between responders and non-responders, except 
for non ischemic etiology of heart failure, which was more frequently observed in responders. 
Baseline echocardiographic characteristics were comparable between the 2 groups (Table 2). 
Only responders showed a significant decrease in both the MLHFQ (from 31±12 to 16±12, p 
= 0.005) and the MLHFQ-PS (from 6.8±4.4 to 3.6±3.3, p = 0.043) reflecting an improvement in 
quality of life and cognitive functions.
At follow-up, responders demonstrated not only a significant reduction in LVESV (by defini-
tion) when compared to non-responders, but also a significant increase in LVEF and LVOT VTI, 
indicating improvement in cardiac performance (Table 2).
Insonation depth and number of samples acquired for TCD assessment were comparable 
between baseline and follow-up in responders, non-responders and controls. At follow-up, 
peak-systolic velocity significantly increased in responders from 83±20 cm/s to 100±20 
cm/s (p = 0.001). Similarly, EDV increased from 29±7 cm/s to 37±8 cm/s and mean velocity 
increased from 47±10 cm/s to 58±11 cm/s (both p <0.001, Figure 1). The mean value of PI 
showed no significant change from baseline to follow-up.
Conversely, in non-responders and controls, no significant changes in any of the TCD ve-
locities were observed (Figure 1). An example of a CRT patient that demonstrated a marked 
improvement in cerebral blood flow is shown in Figure 2. Linear regression analysis revealed 
a strong correlation (r = 0.78, p <0.001) between reduction in LVESV and increase in mean 
TCD velocity, demonstrating that improvement in cardiac function resulted in a significant 
increase in cerebral blood flow (Figure 3).
























Figure 3: Relation between change in LVESV and chance in mean TCD velocity (y = -3.3 – 1.1x, n = 32, r = 0.78, p <0.0001). LVESV: left 
ventricular end-systolic volume, TCD: transcranial Doppler.
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dIscussIon
The findings of the present study can be summarized as follows: 1) cardiac resynchronization 
therapy improves cerebral blood flow in patients with heart failure; and 2) this improvement 
in cerebral blood flow is related to the improvement in LV systolic function following CRT.
Cerebral blood flow is decreased in symptomatic heart failure patients and this may con-
tribute to the impaired cognitive performance frequently observed in these patients 11–13. 
Choi et al reported significantly lower values for cerebral blood flow in 52 patients with heart 
failure secondary to idiopathic dilated cardiomyopathy, in comparison to 10 healthy controls 
13. Additionally, Vogels and co-workers noted reduced cerebral blood flow in 43 heart failure 
patients in comparison to 33 patients with a history of ischemic cardiac disease without 
symptoms of heart failure and an LVEF >55%, and 22 healthy controls 12. Cardiac resynchro-
nization therapy improves heart failure symptoms, quality of life, LV systolic function, and 
prognosis in patients with moderate or severe heart failure 14–16. More recent studies have also 
linked the improvement in LV systolic function to systemic improvements 17, 18. The first study 
to show an association between CRT and improvement in cognitive function was reported 
by Conti and co-workers 19. The authors found significant improvements in quantitative neu-
rocognitive measures of attention and information processing at 3 months follow-up in 10 
heart failure patients treated with CRT (Digit Span increased from 50±5 to 57±7, p = 0.04 and 
Symbol Digit from 39±9 to 49±15, p = 0.04). Although, the precise mechanism underlying 
this improvement is not clear, it could be related to increase in cerebral blood flow as result 
of the increased cardiac systolic function.
An increase in cerebral blood flow has been previously reported in patients undergoing 
heart transplantation 2, 20. Gruhn et al studied 12 healthy controls and 12 patients with severe 
heart failure (NYHA class III-IV) of whom 5 underwent cardiac transplantation 20. In the patients 
who underwent transplantation, cerebral blood flow normalized to the level of the controls 
at 1 month follow-up. Similar findings were described by Massaro and co-workers in a series 
of 14 patients who underwent cardiac transplantation 2. The currently observed improve-
ment of 23.4% in mean cerebral blood flow is a significant improvement, which may translate 
into a substantial clinical benefit in these patients 21. The MLHFQ and the MLHFQ-PS scores 
reduced significantly only in patients that showed response to CRT, probably related to the 
significant increase in cerebral blood flow observed in these patients. The last observation 
further strengthens the assumption that in patients with heart failure, increase in cerebral 
blood flow is the key mechanism in improvement in cognitive function.
A limitation of this study is the single-centre, non randomized, observational design. To 
counterbalance the absence of randomization, a control group with similar baseline charac-
teristics, but without an indication for CRT (since these control patients did not have a wide 
QRS complex) was included. Still, a multi-centre, randomized trial should be performed to 
confirm the current findings. Second, the study sample was relatively small, and finally, no 
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other neurological tests were performed besides the MLHFQ-PS. Therefore, a direct relation 
between improvement in cerebral blood flow and improvement in cognitive function could 
not be shown.
Nina Book.indb   434 26-09-11   12:04
435
Effect of cardiac resynchronization therapy on cerebral blood flow
references
 1. Bishop CC, Powell S, Rutt D, Browse NL. Transcranial Doppler measurement of middle cerebral 
artery blood flow velocity: a validation study. Stroke 1986;17:913-915.
 2. Massaro AR, Dutra AP, Almeida DR, Diniz RV, Malheiros SM. Transcranial Doppler assessment of 
cerebral blood flow: effect of cardiac transplantation. Neurology 2006;66:124-126.
 3. Brass LM. Reversed intracranial blood flow in patients with an intra-aortic balloon pump. Stroke 
1990;21:484-487.
 4. Lindegaard KF, Lundar T, Wiberg J, Sjoberg D, Aaslid R, Nornes H. Variations in middle cerebral 
artery blood flow investigated with noninvasive transcranial blood velocity measurements. 
Stroke 1987;18:1025-1030.
 5. Strickberger SA, Conti J, Daoud EG et al. Patient selection for cardiac resynchronization therapy: 
from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias 
and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration 
with the Heart Rhythm Society. Circulation 2005;111:2146-2150.
 6. Supino PG, Borer JS, Franciosa JA et al. Acceptability and psychometric properties of the Min-
nesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: 
validation and comparison with SF-36. J Card Fail 2009;15:267-277.
 7. McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. 
Psychometric and clinical tests of validity in measuring physical and mental health constructs. 
Med Care 1993;31:247-263.
 8. Bleeker GB, Bax JJ, Fung JW et al. Clinical versus echocardiographic parameters to assess response 
to cardiac resynchronization therapy. Am J Cardiol 2006;97:260-263.
 9. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial. 
Circulation 2008;117:2608-2616.
 10. Marsan NA, Bleeker GB, Ypenburg C et al. Real-time three-dimensional echocardiography as 
a novel approach to assess left ventricular and left atrium reverse remodeling and to predict 
response to cardiac resynchronization therapy. Heart Rhythm 2008;5:1257-1264.
 11. Roman GC. Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res 2004;26:454-
458.
 12. Vogels RL, Oosterman JM, Laman DM et al. Transcranial Doppler blood flow assessment in pa-
tients with mild heart failure: correlates with neuroimaging and cognitive performance. Congest 
Heart Fail 2008;14:61-65.
 13. Choi BR, Kim JS, Yang YJ et al. Factors associated with decreased cerebral blood flow in congestive 
heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006;97:1365-1369.
 14. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl 
J Med 2002;346:1845-1853.
 15. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an 
implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
 16. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and 
mortality in heart failure. N Engl J Med 2005;352:1539-1549.
 17. Fung JW, Szeto CC, Chan JY et al. Prognostic value of renal function in patients with cardiac 
resynchronization therapy. Int J Cardiol 2007;122:10-16.
 18. Boerrigter G, Costello-Boerrigter LC, Abraham WT et al. Cardiac resynchronization therapy im-
proves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail 
2008;14:539-546.
Nina Book.indb   435 26-09-11   12:04
Chapter 24
436
 19. Conti JB, Sears SF. Cardiac resynchronization therapy: can we make our heart failure patients 
smarter? Trans Am Clin Climatol Assoc 2007;118:153-164.
 20. Gruhn N, Larsen FS, Boesgaard S et al. Cerebral blood flow in patients with chronic heart failure 
before and after heart transplantation. Stroke 2001;32:2530-2533.
 21. Zuccala G, Onder G, Marzetti E et al. Use of angiotensin-converting enzyme inhibitors and varia-
tions in cognitive performance among patients with heart failure. Eur Heart J 2005;26:226-233.
Nina Book.indb   436 26-09-11   12:04
chapter 25
Cardiac resynchronization therapy in 
patients with ischemic versus non-
ischemic heart failure: Differential effect 
of optimizing interventricular pacing 
interval
n ajmone marsan, G B Bleeker, R J van Bommel, C JW Borleffs, M Bertini, E R 
Holman, E E van der Wall, M J Schalij, and J J Bax
Am Heart J 2009;158:769-76.




objectives: Whether sequential biventricular pacing provides substantial benefits 
over conventional simultaneous stimulation remains unclear, particularly regarding 
the differences between ischemic and non-ischemic patients. The purpose of this 
study was to evaluate the acute effect of inter-ventricular pacing interval (V-V) opti-
mization on left ventricular (LV) systolic performance and dyssynchrony in ischemic 
versus non-ischemic patients.
methods: 69 consecutive patients underwent cardiac resynchronization therapy. 
Within 3 days after implantation, V-V was optimized by measuring (every 20ms 
interval) LV systolic performance (LV outflow-tract velocity-time-integral, LVOT-VTI) 
and LV dyssynchrony (using tissue Doppler imaging). Optimal pacing configuration 
was the one achieving maximal increase in LVOT-VTI.
results: Optimized sequential pacing provided a significant improvement in LVOT-
VTI compared to simultaneous stimulation (from 138±42 mm to 163±38 mm, p 
<0.001) and was associated with a significant reduction in LV dyssynchrony (from 
33±31 ms to 19±24 ms, p <0.001). The increase in LVOT-VTI and LV ejection fraction 
after implantation was greater in non-ischemic as compared to ischemic patients 
(p <0.001). However, V-V optimization yielded a larger improvement in LV systolic 
performance in ischemic patients (p = 0.03). Consequently, the 2 groups showed 
comparable response after V-V optimization. A significant correlation was observed 
between LV scar tissue and optimal V-V interval (r = 0.58, p <0.001), with a larger 
extent of scar related to a larger level of LV pre-activation, probably reflecting slow 
intra-LV conduction.
conclusions: Optimized sequential biventricular pacing further increased LV 
systolic performance as compared to simultaneous stimulation, particularly in 
ischemic patients where the presence of a large scar was correlated with a larger LV 
pre-activation.
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IntroductIon
Cardiac resynchronization therapy (CRT) is currently considered an important breakthrough 
in the treatment of selected patients with drug-refractory heart failure and has rapidly 
evolved from the experimental stage into an established treatment modality 1.
In the first generations of CRT devices both left ventricular (LV) and right ventricular (RV) 
pacing leads were activated simultaneously in order to resynchronize LV contraction. A novel 
feature on the more recent generations of CRT devices allows separate (sequential) timing 
of activation of the LV and RV pacing leads through a programmable inter-ventricular (V-V) 
pacing interval. Since this option is available, several studies have focused on the possibility 
of further enhancing the beneficial effects of CRT through optimization of the V-V pacing 
interval. Preliminary data have demonstrated that optimized sequential CRT, rather than 
simultaneous CRT, is able to further improve LV systolic performance, as measured by LV 
stroke volume or dP/dt 2–9. In contrast, other studies demonstrated no or only limited ad-
ditional clinical or echocardiographic benefits of V-V optimization compared with “standard” 
simultaneous CRT 10,11. Moreover, the effect of V-V optimization on LV dyssynchrony has not 
been extensively studied and no data are available on the potential advantage of sequential 
CRT in patients with ischemic heart failure (who may demonstrate a less favorable response 
to CRT in absence of V-V optimization12) as compared to patients with non-ischemic heart 
failure. Accordingly, the purpose of this study was to evaluate the acute effects of varying 
degrees of RV or LV pre-activation on both LV hemodynamic profile and LV dyssynchrony. 
In addition, the beneficial effects of V-V optimization were compared between patients with 
ischemic and non-ischemic heart failure.
methods
patient population
Sixty-nine consecutive heart failure patients, scheduled for implantation of a biventricular 
pacemaker, were included in this study. Patients were selected for CRT based on the fol-
lowing characteristics: LV ejection fraction (LVEF) ≤35%, QRS duration >120 ms and NYHA 
functional class III or IV, despite optimal medical treatment. Etiology was considered ischemic 
in the presence of significant coronary artery disease (>50% stenosis in ≥1 major epicardial 
coronary artery) on coronary angiography and/or history of myocardial infarction or previous 
revascularization. Patients with a recent myocardial infarction (<3 months) or decompen-
sated heart failure were excluded.




The LV pacing lead was inserted transvenously via the subclavian route. First, a coronary sinus 
venogram was obtained using a balloon catheter. Next, the LV pacing lead (Easytrak 4512-80, 
Guidant Corp., or Attain-SD 4189, Medtronic Inc) was inserted through the coronary sinus, 
using an 8Fr-guiding catheter, and positioned in the lateral or postero-lateral vein. The right 
atrial and ventricular leads were positioned conventionally. The 3 leads were connected to 
a biventricular pacing device and, when an indication for an internal defibrillator existed, a 
combined device was implanted (Contak CD or Renewal, Guidant Corp., or Insync III-CD or 
Marquis, Medtronic Inc). These devices have two separate channels for RV and LV pacing with 
a programmable V-V interval. In all patients the implantation of the CRT device was successful 
without major complications.
study protocol
Before CRT, echocardiography was performed to evaluate LV dimensions and systolic func-
tion, whereas the extent of LV mechanical dyssynchrony was derived from tissue Doppler 
imaging (TDI). Within 3 days after implantation pacemaker settings were optimized. The 
atrio-ventricular interval was adjusted to maximize mitral inflow duration, as assessed with 
pulsed-wave Doppler echocardiography using the “iterative” method 13. Next, V-V interval was 
modified by advancing LV or RV pacing by 20 ms intervals. For each patient seven different 
V-V intervals were examined: simultaneous biventricular pacing (= 0 ms), LV pre-activation 
(LV60 = 60 ms, LV40 = 40 ms and LV20 = 20 ms) and RV pre-activation (RV60 = 60 ms, RV40 
= 40 ms and RV20 = 20 ms). For each combination, LV systolic function and the extent of LV 




Patients were imaged in the left lateral decubitus position using a commercially available 
system (Vingmed Vivid Seven, General Electric Healthcare, Horten, Norway). Images were 
obtained using a 3.5-Mhz transducer, at a depth of 16 cm in the apical views. For the TDI 
images, the sector width was adjusted to obtain a frame rate of at least 100 frames/second; 
pulse repetition frequencies were between 500 Hz and 1 kHz, resulting in aliasing velocities 
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between 16 and 32 cm/s. To minimize variability between examinations, all echocardio-
graphic recordings were performed by the same operator. During the pulsed-wave Doppler 
acquisitions, an effort was made to maintain the same position of the sample throughout 
the investigation. All images were recorded digitally in cine-loop format and analyzed of-
fline with commercial software Echopac 6.1 (General Electric-Vingmed). Off-line analysis was 
performed by a different observer and was blinded to the pacing mode. Each parameter was 
measured and averaged over three consecutive beats during sinus rhythm.
Analysis of LV systolic function and LV dyssynchrony
LV end-systolic and end-diastolic volumes were determined from the conventional apical 2- 
and 4-chamber views and LV ejection fraction (EF) was calculated using the biplane Simpson’s 
technique. During V-V optimization, LV systolic function and the extent of LV dyssynchrony 
were assessed for each interval. As previously described 6,9, the acute changes in LV systolic 
performance were quantified by measuring the LV outflow-tract velocity-time integral (LVOT 
VTI), using pulsed-wave Doppler during end-expiratory apnea. After the optimization of the 
pacemaker, patients were maintained in the individually optimized sequential biventricu-
lar pacing configuration that was defined as the setting with the highest LVOT VTI and LV 
volumes and EF were recalculated. An absolute increase in LVEF ≥5% was considered as a 
significant positive response to CRT 14.
To quantify the extent of LV dyssynchrony, the maximum delay in peak velocity between 
the earliest and the latest activated segments within the basal segments of septum, inferior, 
anterior and lateral wall was calculated 15. From previous observations, a delay ≥65 ms was 
considered to represent significant LV dyssynchrony 15. Inter-observer agreement and intra-
observer agreement for assessment of LV dyssynchrony were 90% and 96% respectively 16.
statistical analysis
Continuous data are presented as mean±SD; dichotomous data are presented as numbers 
and percentage. Student t test and χ2 test were used for appropriate comparisons. Sequential 
data measurements, in the total population and in the groups of patients with and without 
ischemic cardiomyopathy, were analyzed by repeated measures analysis of variance (ANOVA) 
followed by post hoc Scheffe’s correction for multiple tests. A two-way ANOVA analysis was 
performed for comparison of time trends between patients with and without ischemic 
cardiomyopathy. Simultaneous biventricular pacing was considered as the reference pacing 
configuration to compare all sequential configurations and to assess the correlation between 
the change in LVOT VTI and LV dyssynchrony. Pearson’s correlation coefficient was used to 
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quantify correlations between quantitative variables. Agreement for the optimal V-V interval 
between LVOT VTI and LV dyssynchrony was assessed using weighted κ statistics. A p-value 
<0.05 was considered to be statistically significant. A statistical software program SPSS 12.0 
(SPSS Inc, Chicago, II, USA) was used for statistical analysis.
results
pre-implantation data
Sixty-nine patients were included (58 men; mean age 66±10 years). Baseline patient charac-
teristics are summarized in Table 1. Most patients were in NYHA class III (88%), and 41 (59%) 
patients had ischemic heart failure.  Echocardiography revealed severe LV dilatation and 
dysfunction (mean LV end-diastolic volume 251±74 ml, mean LVEF 22.9±7.8%). The mean 
extent of LV dyssynchrony was 75±24 ms.
simultaneous and sequential crt
After CRT implantation, simultaneous CRT (V-V interval = 0 ms) resulted in a significant im-
provement of the cardiac output: LVOT VTI increased from 118±36 mm at baseline to 138±42 
table 1. Baseline patient characteristics (n = 69)
age, years 66±10
Gender, M/F 58/11
NYHA class, n (%)
    III 61 (88)
    IV 8 (12)
QRS duration, ms 163±32
Rhythm, n (%)
    Sinus rhythm 57 (83)
    Atrial fibrillation 12 (17)
Etiology, n (%)
    Ischemic 41 (59)




LVOT VTI, mm 118±36
LV dyssynchrony, ms 75±24
LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVOT VTI = 
left ventricular out-flow tract velocity-time integral.
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mm (p <0.001) after CRT; LVEF improved from 22.9±7.8% to 28.7±5.6% (p <0.001). A total of 
34 (49%) patients showed a significant increase (≥5%) in LVEF. In addition, compared with 
baseline, simultaneous CRT significantly reduced LV dyssynchrony from 75±24 ms to 33±31 
ms (p <0.001).
The LV systolic performance was further improved by optimizing the V-V interval, with the 
LVOT VTI increasing from 138±42 mm during simultaneous CRT to 163±38 mm (p <0.001) 
during sequential CRT and LVEF improving from 28.7±5.6% to 34.3±6.9% (p <0.001). In addi-
tion, LV dyssynchrony decreased from 33±31 ms to 19±24 ms (p <0.001). The percentage of 
significant response to CRT increased from 49% to 74% (51 patients).
In 18 patients (26%) the highest LVOT VTI was achieved during simultaneous CRT. In the 
remaining 51 patients (74%), LV pre-activation was the optimal setting in 38 patients (55%), 
with LV60 in 11 patients (16%), LV40 in 11 patients (16%) and LV20 in 16 patients (23%). For 
13 patients (19%) RV pre-activation was the optimal setting, with RV60 in 1 patient (2%) and 
RV20 in 12 patients (17%); no patient had an optimal cardiac output at RV40 (Figure 1).
The concordance between V-V intervals yielding the highest LVOT VTI and the lowest LV 
dyssynchrony was excellent ( weighted kappa = 0.88, p <0.001) (Figure 2 and Table 2). In 
addition, the absolute changes in LV dyssynchrony, showed a significant correlation (r = 0.58; 
p <0.001) with the absolute changes in LVOT VTI. Figure 3 shows an example of a patient 




(according to LVOT VTI) 









LV60 LV40 LV20 0 RV20 RV40 RV60
Figure 1. Distribution of optimal V-V interval configuration resulting in highest left ventricular cardiac output (LVOT VTI). LV = left ventricle; RV 
= right ventricle; SIM = simultaneous.
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After implantation, simultaneous CRT (V-V interval = 0 ms) resulted in a significant improve-
ment of LVOT VTI and LVEF (p <0.01) both in ischemic and non-ischemic patients (Table 3). 
However, this improvement (change from baseline to simultaneous CRT) was larger in non-
ischemic patients (with a relative increase in LVOT VTI of 29±30 mm and in LVEF of 8.1±6.2%) 
as compared to ischemic patients (with a relative increase in LVOT VTI of 14±14 mm and 
in LVEF of 3.4±5.5%, p <0.001 versus non-ischemic patients). Consequently, among non-
ischemic patients, 19 (68%) patients showed an increase ≥5% in LVEF, while among ischemic 
patients, only 14 (34%) patients had a significant response to CRT.
In turn, V-V optimization yielded a larger improvement of LVOT VTI and LVEF (change from 
simultaneous CRT to optimized sequential stimulation) in ischemic patients (Table 3); a rela-
tive increase in LVOT VTI of 34±25 mm in ischemic patients versus a relative increase of 16±15 
mm in non-ischemic patients (p = 0.03 ischemic versus non-ischemic patients); a relative 
increase in LVEF of 7.6±6.1% versus 4.4±5.9% in ischemic patients (p = 0.02 ischemic versus 
Patients (%)
Optimal V-V interval
(according to LV dyssynchrony)







LV60 LV40 LV20 0 RV20 RV40 RV60
Figure 2. Distribution of optimal V-V interval configuration resulting in least left ventricular dyssynchrony. LV = left ventricle; RV = right 
ventricle; SIM = simultaneous.
table 2: Kappa statistic for LVOT VTI-optimized V-V interval vs. LV dyssynchrony-optimized V-V interval. 
lvot vtI
lv dyssynchrony
lv60 lv40 lv20 0 rv20 rv40 rv60 total
LV60 9 0 1 1 2 0 0 13
LV40 0 11 0 0 0 0 0 11
LV20 1 0 11 1 0 0 0 13
0 1 0 2 15 2 0 0 20
RV20 0 0 2 0 7 0 0 9
RV40 0 0 0 1 1 0 0 2
RV60 0 0 0 0 0 0 1 1
Total 11 11 16 18 12 0 1 69
Weighted Kappa = 0.88, p <0.001; LVOT VTI = left ventricular out-flow tract velocity-time integral
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LV60 LV40 LV20 RV20 RV40 RV60
Figure 3. An example of patient with optimal V-V interval of LV60. A: LV dyssynchrony and LV out-flow-tract velocity-time integral (LVOT VTI) at 
V-V interval of LV60. B: LV dyssynchrony and LVOT VTI during simultaneous CRT. C: changes of LV dyssynchrony and LVOT VTI during V-V interval 
optimization.
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non-ischemic patients). Consequently, the percentage of ischemic patients that showed a 
significant improvement in LVEF (≥5%) increased from 34% to 71% (29 patients), while in 
non-ischemic patients this percentage increased from 68% to 78% (22 patients). Importantly, 
after V-V optimization the percentage of CRT responders was similar between ischemic and 
non-ischemic patients.
v-v pacing interval versus the extent of scar tissue
In 24 patients (58%) with ischemic heart failure, a nuclear perfusion study was obtained 
during the clinical course, using single-photon emission computed tomography (SPECT, 
triple head camera system, GCA 9300/HG, Toshiba Corp.) and technetium-99m tetrofosmin. 
To quantify the extension of the scar tissue, tracer uptake was analyzed quantitatively using 
a standard 17-segment model and categorized on a 4-point scale: 0, tracer activity > 75% 
(normal, viable); 1, tracer activity = 50%-75% (minimal scar); 2, tracer activity = 25%-50% 
(moderate scar); 3, tracer activity < 25% (extensive scar) 17. Summation of the segmental 
scores yielded the total scar score, with the higher scores indicating more scar tissue (reflect-
ing the extent of damage per patient).
Extensive regions of scar tissue were present, as indicated by a total scar score of 16.3±6.0 
per patient. A significant correlation (r = 0.89; p <0.001) was observed between the SPECT 
total scar score and the optimal V-V interval. Figure 4 indicated that a higher scar score (repre-
senting more scar tissue), is associated with a higher level of pre-activation of the LV (patients 
with an optimal V-V interval of LV60 had a mean scar score of 22±3, whereas patients with an 
optimal V-V interval of LV20 had a mean scar score of 13±3).
table 3. Left ventricular out-flow tract velocity-time integral (LVOT VTI) and left ventricular ejection fraction (LVEF) at baseline, during 








  LVOT VTI (mm)
Baseline 116±34 120±39 NS
Simultaneous CRT 129±41* 149±41* <0.001














 *: p <0.01 (two-way ANOVA)
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-80 -60 -40 -20 0 20 40
SPECT tot scar score
Optimal V-V interval
LV60 LV40 LV20 RV20
Figure 4. Correlation between the SPECT total scar score and the optimal V-V interval. r = 0.89, p <0.001, y = -0.19x + 10.68
dIscussIon
The findings of the current study can be summarized as follows: 1) Optimized sequential 
CRT provides a significant improvement in LV hemodynamic performance compared to con-
ventional simultaneous stimulation. This hemodynamic improvement was associated with a 
significant reduction of LV dyssynchrony; 2) the increase in LVOT VTI and LVEF after implanta-
tion (simultaneous CRT) was significantly greater in non-ischemic as compared to ischemic 
heart failure patients. However, V-V interval optimization yielded to a larger improvement 
of LVOT VTI and LVEF in patients with ischemic heart failure and resulted in a comparable 
percentage of CRT responders in ischemic and non-ischemic heart failure patients; 3) a direct 
relation was observed between the extent of scar tissue and the optimal V-V interval, with a 
larger extent of scar tissue related to a higher level of LV pre-activation.
simultaneous versus sequential crt
CRT is now considered an important therapeutic option in the treatment of patients with 
end-stage heart failure1, but still up to 30% of patients do not have a favorable response 
to CRT 18. Since the new pacemakers allow a separate activation of the ventricular leads, 
several studies have investigated whether the tailored programming of V-V interval could 
decrease the percentage of non-responders or convert non-responders to partial or com-
plete responders. In fact, a recent multi-center study showed that almost 50% of patients 
who did not exhibit a positive response to CRT had inadequate device settings (temporary 
VVI back-up setting) 19 and that improved LV filling and systolic function could be achieved 
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by optimizing the pacemaker settings. In addition, V-V optimization may also further increase 
the hemodynamic benefit of CRT in patients with a positive response to CRT.
Preliminary data from small single-center studies, demonstrated that optimized sequential 
CRT, rather than simultaneous CRT, can further improve different short-term outcomes of LV 
systolic performance, such as stroke volume, dP/dt, LV filling time, myocardial performance 
index etc 2–8. Only few data are available on the effect of V-V optimization on LV dyssynchrony. 
Three trials further investigated whether there is a significant difference between optimized 
sequential CRT and simultaneous CRT in long-term outcome 9–11. The InSync III study 9 showed 
in 397 patients that stroke volume at short-term follow-up and exercise capacity at long-
term follow-up could be improved by echocardiographic optimization of the V-V interval. 
The DECREASE-HF trial 10 evaluated 306 patients and did not reveal a significant difference 
between sequential and simultaneous CRT in the improvement of LV size and function after 
6 months of CRT. However, the V-V interval was programmed on the basis of intrinsic inter-
ventricular conduction measured from intracardiac electrocardiograms at the time of the 
implantation and was not individually optimized according to the hemodynamic response. 
The RHYTHM II ICD study 11 evaluated in 121 patients the improvement in clinical end-points, 
such as NYHA class and 6-minute walking distance, after echocardiographic optimization of 
the V-V interval with standard simultaneous CRT. No additional benefit was demonstrated, 
but the potential favorable effect on LV remodeling and function was not evaluated. These 
inhomogeneous results may be explained by different factors: 1) different parameters have 
been used to optimize the V-V interval, which included intrinsic conduction from the intra-
cardiac electrocardiogram, invasive and non-invasive dP/dt, stroke volume, LV filling time, 
LV dyssynchrony and other echocardiographic parameters. No large studies have pointed 
out the superiority of one method of V-V optimization over another; 2) different end-points 
(clinical improvement versus echocardiographic improvement) have been used to evaluate 
the effects of V-V optimization, 3) it is possible that V-V interval optimization has a clear 
advantage over simultaneous CRT only in specific subgroups of patients such as those with 
a slow inter- and intra-ventricular conduction (e.g. after myocardial infarction with extensive 
scar formation).
v-v interval optimization in ischemic and non-ischemic cardiomyopathy
Recent data have suggested a slower and more attenuated response to CRT in patients with 
ischemic cardiomyopathy as compared to non-ischemic cardiomyopathy, probably related 
to repetitive episodes of ischemia or to the presence of scar tissue 12. Initial single-center 
studies suggested that the amount and distribution of myocardial scar may be important 
determinants of response to CRT, limiting LV reverse remodeling and improvement of systolic 
function 20,21. However, in these patients the best mechanical efficiency may be achieved us-
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ing different pacemaker settings (and in particular the inter-ventricular activation) that might 
compensate for the conduction abnormalities due to the presence of ischemic and/or scar 
tissue.
In the current study, immediately after implantation (simultaneous pacing) a significantly 
better response to CRT was observed in non-ischemic patients (68% of patients with an 
increase ≥5% in LVEF as compared to 34% of ischemic patients). However, additional V-V 
optimization in patients with ischemic heart failure increased the percentage of patients with 
significant response to CRT from 34% to 71%. These results may be explained by the fact that 
the extent of myocardial scar tissue has an influence on the optimal V-V interval setting. In 
the current study, the presence of large areas of scar tissue was indeed related to a larger 
level of LV pre-activation, probably as a compensation for slow intra-ventricular conduction 
caused by scar tissue within the left ventricle. These findings are in line with data reported by 
van Gelder et al7 showing that the mean V-V interval was significantly longer and more often 
with LV pre-excitation in patients with ischemic cardiomyopathy.
study limitations
The patient cohort in the current study is relatively small, and larger populations are needed 
to confirm these results, particularly regarding the differences between ischemic and non-
ischemic patients. In addition, the benefit of V-V interval optimization was observed acutely 
after CRT implantation, but the long-term effect of V-V optimization on clinical and echocar-
diographic outcome was not evaluated. In particular, the acute benefit of V-V optimization 
on LV systolic performance was assessed using LVOT VTI and LVEF; these measures were not 
supported by an invasive measurement but, although with a certain beat-to-beat variability, 
they have been previously demonstrated to be reliable and reproducible. Furthermore, in 
the study protocol atrio-ventricular delay optimization was not repeated after V-V delay 
optimization since there is no consensus so far on its potential usefulness.
conclusIons
Optimized sequential CRT provides a significant improvement of LV hemodynamic perfor-
mance as compared to conventional simultaneous CRT, which is associated with a further 
reduction in LV dyssynchrony. Particularly in patients with ischemic heart failure, V-V interval 
optimization increased the response rate from 39% to 73% acutely after CRT and a larger 
extent of scar tissue was related to a larger level of LV pre-activation.
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objectives: Time course of the effects of cardiac resynchronization therapy (CRT) 
on left ventricular (LV) systolic function and reverse remodeling is still unknown 
and was the subject of this study. In particular, whether the acute benefit of CRT 
translates in late response was explored. Furthermore, the time course of response 
was compared between ischemic and non-ischemic patients.
methods: A total of 222 consecutive heart failure patients (135 ischemic) scheduled 
for CRT, were included. Standard echocardiography was performed before, immedi-
ately after CRT and at 6 months follow-up (6MFU) to measure LV end-systolic (ESV) 
and end-diastolic (EDV) volume, and ejection fraction (EF).
results: Immediately after CRT, a significant improvement in LVEF (from 25±8% 
to 31±9%, p <0.001) and LVESV (from 163±68ml to 149±63ml, p <0.001) was ob-
served, followed by an additional improvement at 6MFU (to 34±9% and 132±62ml 
respectively, both p <0.001). Significant reduction in LVEDV was observed only at 
6MFU (from 217±73ml to 194±72ml, p <0.001). An acute reduction in LVESV of 6% 
could predict response to CRT at 6MFU (defined as a reduction ≥15% in LVESV) with 
a sensitivity and specificity of 79% and 75%. Time course of response to CRT was 
similar in ischemic and non-ischemic patients, but reduction in LVESV and LVEDV 
was significantly greater in non-ischemic patients (p <0.001).
conclusions: The beneficial effect of CRT on LV systolic function occurs immediately 
after CRT, with additional improvement at 6MFU. The acute reduction in LVESV can 
predict response to CRT at 6MFU. Non-ischemic patients show a significantly greater 
LV reverse remodeling compared to ischemic patients.
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IntroductIon
The precise time course of improvement in left ventricular (LV) function and reduction in LV 
volumes after cardiac resynchronization therapy (CRT) is currently unknown and was subject 
of the current study. For this purpose, 230 patients underwent sequential echocardiography 
before, 1 day and 6 months after CRT implantation. Moreover, the current study explored 
whether it could be possible that an acute improvement in systolic function predicts reverse 
remodeling at late follow-up. Finally, the time course of improvement in systolic function 
and reverse remodeling may be different between patients with ischemic and non-ischemic 
cardiomyopathy and this was also evaluated in the current study.
methods
A total of 230 consecutive heart failure patients, scheduled for implantation of a CRT device, 
were included. Traditional selection criteria for CRT were applied 1, including: New York Heart 
Association (NYHA) functional class III or IV, despite optimal medical therapy; LV ejection frac-
tion (EF) ≤35% and QRS duration ≥120 ms. Patients with a recent myocardial infarction (<3 
months) or decompensated heart failure were excluded. Clinical status, including assessment 
of NYHA class, Minnesota quality-of-life score and 6-minute walk test, was assessed before 
pacemaker implantation and at 6-months follow-up. QRS duration was measured at baseline, 
immediately after CRT and at 6 months follow-up from the surface ECG using the widest 
QRS complex from the leads II, V1 and V6. Moreover, 2D echocardiography was performed 
before and immediately after pacemaker implantation and repeated at 6 months follow-up 
to evaluate LV volumes and LVEF.
Patients were imaged in the left lateral decubitus position using a commercially available 
system (Vingmed Vivid Seven, General Electric Healthcare, Horten, Norway). Images were 
obtained using a 3.5-MHz transducer, at a depth of 16 cm in the standard apical views. All 
images were recorded digitally in cine-loop format and analyzed offline with commercial 
software Echopac 7.0.0 (GE Healthcare). LV end-systolic volume (ESV) and LV end-diastolic 
volume (EDV) were determined from the conventional apical 2- and 4-chamber views and 
LVEF was calculated using the biplane Simpson’s technique 2. Inter- and intra-observer agree-
ment for assessment of LV function and volumes were 90% and 96% respectively 3.
Echocardiographic response was defined as an improvement ≥15% in LVESV 4. Response 
was determined acutely after CRT implantation and at 6 months follow-up.
The LV pacing lead was inserted transvenously via the subclavian route. First, a coronary 
sinus venogram was obtained using a balloon catheter. Next, the LV pacing lead was inserted 
through the coronary sinus, using an 8Fr-guiding catheter, and positioned as far as possible 
in the venous system, preferably in the (postero-) lateral vein. The right atrial and ventricular 
Nina Book.indb   455 26-09-11   12:04
Chapter 26
456
leads were positioned conventionally. When an indication for an internal defibrillator existed, 
a combined device was implanted (Contak CD or Renewal, Guidant Corp.; Insync III-CD or 
Marquis, Medtronic Inc.). In all patients the implantation was successful without major 
complications. Two types of LV leads were used (Easytrak 4512-80, Guidant Corp., or Attain-
SD 4194, Medtronic Inc.). For each patient, the AV interval was adjusted to maximize mitral 
inflow duration with pulsed-wave Doppler echocardiography 5.
Continuous data are presented as mean±standard deviation; dichotomous data are pre-
sented as numbers and percentage. Comparison of data was performed using the paired 
or unpaired Student t test or χ2 test when appropriate. For the LVESV and LVEDV, that were 
not normally distributed, a log-transformation has been performed. Sequential data mea-
surements, in the total population and in the groups of patients with and without ischemic 
cardiomyopathy, were analyzed by repeated measures analysis of variance (ANOVA). A two-
way ANOVA analysis was performed for comparison of time trends between patients with 
and without ischemic cardiomyopathy. To determine the relationship between immediate 
changes in LVESV after CRT and response to CRT at late follow-up (defined as a reduction 
≥15% in LVESV), multivariable logistic regression analysis was applied including patient’s 
clinical and echocardiographic characteristics at baseline (odds ratios with their correspond-
ing 95% confidence intervals [CI] are reported). Receiver operating characteristic (ROC) 
curve analysis was also applied to obtain a cut-off value for the acute percentage change in 
LVESV (acute delta LVESV) that can be used in clinical practice to predict echocardiographic 
response to CRT at late follow-up. The ‘optimal’ threshold was defined as the value for which 
the sum of sensitivity and specificity to distinguish between echocardiographic responders/
non-responders was maximized. Statistical significance was set a two tailed p-value <0.05. 
A statistical software program SPSS 12.0 (SPSS Inc, Chicago, II, USA) was used for statistical 
analysis.
results
A total of 8 (3.5%) patients died before the 6-month follow-up was completed. Baseline char-
acteristics of the remaining 222 patients (180 men, mean age 66±10 years) are summarized 
in Table 1. Most patients (94%) were in NYHA class III. Echocardiographic evaluation revealed 
LV dilatation with depressed LVEF.
A significant improvement in clinical status was observed at 6 months follow-up. In par-
ticular, NYHA class improved significantly from 3.1±0.3 to 1.9±0.7 (p <0.01). A total of 71% 
of patients exhibited a reduction in NYHA class of 1 score or more. Furthermore, the Minne-
sota quality-of-life score improved from 33±19 to 24±19 (p <0.01) and the 6-minute walking 
distance increased from 324±106 m to 392±108 m (p <0.01). QRS duration at baseline was 
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153±26 ms and decreased to 136±26 ms (p <0.01) immediately after CRT implantation, which 
remained unchanged at 6 months follow-up (136±28 ms).
Acutely after CRT implantation, a significant reduction in LVESV was observed (from 
163±68 ml to 149±63 ml, p <0.001), with a significant improvement in LVEF (from 25±8% to 
31±9%, p <0.001). LVEDV remained unchanged (217±77 ml at baseline vs. 216±76 ml after 
CRT implantation, p = NS).
At 6 months follow-up, a further reduction in LVESV to 132±62 ml (p <0.001 vs. baseline 
and immediate follow-up) was noted, with an additional improvement in LVEF to 34±9% (p 
<0.001 vs. baseline and immediate follow-up). LVEDV also showed a significant reduction to 
194±72 ml (p <0.001 vs. baseline and immediate follow-up) at 6 months follow-up.
When a reduction in LV end-systolic volume ≥15% was used to define response to CRT, 
40% of patients exhibited an immediate response to CRT, with an additional 23% of patients 
showing response at 6 months follow-up, resulting in a total of 63% echocardiographic 
responders to CRT.
Table 2 shows the results of the multivariable logistic regression analysis applied to identify 
whether the acute changes in LVESV after CRT and the baseline clinical and echocardiographic 
variables were related to response to CRT at late follow-up. After correction for the covariates, 
the only variables that remained significantly correlated with late response to CRT were the 
etiology of cardiomyopathy (OR = 0.28, 95%CI 0.13-0.63, p = 0.002) and the acute percentage 




      III 208 (94%)
      IV 14 (6%)
6-minutes walk test (m) 328±107
Quality of life score 31±19
QRS duration (ms) 153±26
Rhythm
     Sinus rhythm 211 (95%)
     Atrial fibrillation 11 (5%)
Etiology
     Ischemic 135 (61%)
     Non-ischemic 87 (39%)
Left ventricular ejection fraction (%) 25±8
Left ventricular end-diastolic volume (ml) 217±77
Left ventricular end-systolic volume (ml) 163±68
Medication
    ACE inhibitors 194 (87%)
    ß-blockers 173 (78%)
    Diuretics and/or spironolactone 214 (96%)
    Amiodarone 47 (21%)
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change in LVESV (acute delta LVESV, OR = 1.21, 95%CI 1.14-1.26, p <0.001). Furthermore, ROC 
curve analysis revealed that a cut-off value of 6% for acute delta LVESV yielded a sensitivity of 
79% with a specificity of 75% to predict echocardiographic response to CRT (area under the 
curve = 0.85, p <0.001) (Figure 1).
Of the 222 patients included, 135 (61%) patients had ischemic cardiomyopathy and 87 
(39%) had non-ischemic cardiomyopathy. No significant differences in the baseline charac-
teristics were noted between the 2 groups (Table 3). The immediate changes after CRT in LV 
volumes and LVEF in patients with ischemic cardiomyopathy are shown in Figure 2 (panels A 
to C). Immediately after CRT implantation, a significant reduction in LVESV (from 163±65 ml 
to 150±61 ml, p <0.001) and an improvement in LVEF (from 25±8% to 31±9%, p <0.001) were 
observed. LVEDV remained unchanged (217±74 ml vs. 217±73 ml, p = NS).
At 6 months follow-up, a further reduction in LVESV to 139±59 ml (p <0.001 vs. baseline 
and immediate follow-up) was detected (Figure 2, panel A). Similarly, a further improvement 
table 2. Multivariable logistic regression analysis: estimates of correlation between the baseline clinical and echocardiographic 
characteristics (including the acute changes in left ventricular end-systolic volume) and response to cardiac resynchronization therapy, defined 
as a reduction ≥15% of left ventricular end-systolic volume at 6 month follow-up.
odds ratio (95% cI) p-value
Age 0.99 (0.95-1.03) 0.74
Male gender 1.28 (0.48-3.41) 0.62
6-minute walk test 1.00 (0.99-1.00) 0.95
QRS duration 0.98 (0.97-1.01) 0.075
Ischemic etiology 0.28 (0.13-0.63) 0.002
Left ventricular ejection fraction 0.99 (0.94-1.04) 0.75
Left ventricular end-diastolic volume 0.99 (0.99-1.00) 0.56
Acute delta left ventricular end-systolic volume 1.21 (1.14-1.26) <0.001









Figure 1. Optimal cut-off value of the percentage change in left ventricular end-systolic volume immediately after CRT (acute delta LVESV 
= [(LVESVat baseline – LVESVacutely after CRT)/LVESVat baseline] x 100) to predict echocardiographic response to CRT at late follow-up, 
determined by ROC curve analysis. AUC = area under the curve.
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in LVEF to 33±10% (p <0.001 vs. baseline and immediate follow-up) was noted (Figure 2, 
panel B). In addition, a reduction in LVEDV to 202±68 ml was observed (p <0.001 vs. baseline 
and immediate follow-up) (see Figure 2, panel C).
In 32% of patients with ischemic cardiomyopathy, an acute reduction in LVESV ≥15% was 
noted; at 6 months follow-up, an additional 22% showed a significant reduction in LVESV, 
resulting in a total of 54% echocardiographic responders to CRT out of 135 patients with 
ischemic cardiomyopathy.
The immediate changes after CRT in LV volumes and LVEF in patients with non-ischemic 
cardiomyopathy are displayed in Figure 2 (panels A to C). Immediately after CRT implanta-
tion, a significant improvement in LVESV (from 163±74 ml to 146±68 ml, p <0.001) and LVEF 
(from 25±8% to 32±8%, p <0.001) were observed. LVEDV remained unchanged (217±82 ml 
vs. 215±81 ml, p = NS).
At 6 months follow-up, a further reduction in LVESV to 122±64 ml (p <0.001 vs. baseline 
and immediate follow-up) was detected (Figure 2, panel A). Similarly, a further improvement 
in LVEF to 35±8% (p <0.001 vs. baseline and immediate follow-up) was noted (Figure 2, panel 
B). In addition, a reduction in LVEDV to 184±78 ml was observed (p <0.001 vs. baseline and 
immediate follow-up) (Figure 2, panel C).
In 53% of patients with non-ischemic cardiomyopathy an acute reduction in LVESV ≥15% 
was noted (p <0.05 vs. 32% of acute responders with ischemic cardiomyopathy); at 6 months 
follow-up, an additional 25% of patients showed a significant reduction in LVESV, resulting 
in a total of 78% echocardiographic responders to CRT out of 87 patients with non-ischemic 
cardiomyopathy (p <0.05 vs. 54% of late responders with ischemic cardiomyopathy).
A significant difference in time course after CRT implantation between ischemic and non-
ischemic patients was observed for LVESV and LVEDV (Figure 2): the improvement over time 
of these parameters was more outspoken in patients with non-ischemic cardiomyopathy, 
particularly at late follow-up (two-way ANOVA p <0.001). No significant difference was found 
for the changes over time of LVEF between the 2 groups (Figure 2).





Age (years) 65±10 67±17
Male/Female 57/3 28/7
QRS duration (ms) 143±28 153±33
NYHA class III/IV (n) 62/3 34/1
Left ventricular ejection fraction (%) 25±8 25±8
Left ventricular end-diastolic volume (ml) 217±74 217±82
Left ventricular end-systolic volume (ml) 163±65 163±74




Thus far, most of the studies addressed the effects of CRT on LV systolic function and LV 
reverse remodeling at mid- or long-term follow-up 6. Both an absolute increase >5% in LVEF 
and a reduction ≥15% in LVESV have been used to define a favorable response to CRT 4,6,7. 
Few studies focused on the acute effects of CRT 8–13. Breithardt et al 8 demonstrated a sig-
nificant increase in dP/dtmax immediately after CRT, while Dohi and coworkers 
9 defined acute 
































Figure 2. Comparison of the time course of changes in left ventricular (LV) volumes and function after CRT in patients with ischemic and non-
ischemic cardiomyopathy.
Panel A. Both in patients with ischemic and non-ischemic cardiomyopathy, LV end-systolic volume (ESV) improved immediately after CRT 
(ACUTE) and at 6 months follow-up (LATE). The reduction in LVESV was significantly larger in patients with non-ischemic cardiomyopathy.
Panel B. Both in patients with ischemic and non-ischemic cardiomyopathy, LV ejection fraction (EF) improved significantly immediately after 
implantation and at 6 months follow-up; the LVEF at 6 months follow-up was not significantly different between patients with ischemic and 
non-ischemic cardiomyopathy.
Panel C. Both in patients with ischemic and non-ischemic cardiomyopathy, LV end-diastolic volume (LVEDV) did not change acutely after CRT, 
but revealed a significant reduction at 6 months follow-up, which was significantly larger in patients with non-ischemic cardiomyopathy.
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of acute response as a reduction ≥15% in LVESV 12,13, but did not include information on long-
term follow-up.
Accordingly, the precise time course of response to CRT is currently unknown. It is unclear 
whether improvement of LV systolic function after CRT implantation is a gradual process or 
whether this improvement occurs immediately and then remains unchanged, or whether 
some patients may not respond acutely, but do respond at later stage.
The current study evaluated the precise time course of response to CRT, systematically 
looking at parameters of LV systolic function (LVEF, LVESV) and LV remodeling (LVEDV, LVESV). 
Acutely after implantation, a significant increase in LVEF and a decrease in LVESV were ob-
served, followed by an additional improvement in these parameters at 6 months follow-up. 
Of note, significant reduction in LVEDV only occurred at late follow-up. The acute improve-
ment after CRT implantation probably indicates a pure effect of CRT on cardiac systolic 
performance, reflected in the changes in LVEF and LVESV (but not in LVEDV). Conversely, 
late improvement is the result of significant LV reverse remodeling (with a reduction in both 
LVEDV and LVESV) with a further improvement in LV systolic function. Indeed, the beneficial 
effect of CRT on LV remodeling (with changes in cardiac structure and geometry) needs more 
time to occur.
In clinical practice, it is important to identify whether a patient responds to CRT or not, 
particularly in terms of LV systolic function. In fact, an improvement in LV systolic function 
is most likely the base for a clinical improvement and it has been demonstrated to be the 
best predictor of improved survival after CRT 14. Furthermore, the possibility to predict a 
significant improvement in LV systolic function (i.e. response to CRT) at long-term follow-up 
through the evaluation of the acute effects of CRT may be of great interest, with important 
implications for patient management. In the current study, the acute percentage change in 
LVESV was found to be an independent predictor of response to CRT at long-term follow-up, 
defined as a reduction ≥15% in LVESV. In particular, a reduction of 6% in LVESV immediately 
after implantation could predict response to CRT at late follow-up with a sensitivity of 79% 
and specificity of 75%.
The difference in response to CRT between patients with ischemic and non-ischemic 
cardiomyopathy has been a matter of debate. Additional analyses from the MUSTIC and 
MIRACLE 15,16 trials revealed that at mid- and long-term follow-up after CRT, the improvement 
in LV systolic function and LV reverse remodeling are significantly greater in patients with 
non-ischemic cardiomyopathy as compared to patients with ischemic cardiomyopathy.
In the present study, the time course of response to CRT was evaluated in patients with 
ischemic and non-ischemic cardiomyopathy. Both groups showed a similar trend over time 
with an immediate improvement in LVESV and LVEF, followed by an additional improvement 
at late follow-up, and a reduction of LVEDV only at late follow-up. However, the reduction in 
LVESV and LVEDV was significantly greater in patients with non-ischemic cardiomyopathy 
as compared to patients with ischemic cardiomyopathy, particularly at late follow-up. This 
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finding is probably related to the presence of more myocardial scar tissue in patients with 
ischemic cardiomyopathy that may limit the extent of LV reverse remodeling 17–19.
According to the abovementioned definition of response to CRT, patients with non-ischemic 
cardiomyopathy also showed a significantly higher percentage of responders both at acute 
(53% vs. 32%) and late (78% vs. 54%) follow-up. Furthermore, etiology of cardiomyopathy 
was found to be an independent predictor of response to CRT at long-term follow-up at the 
multivariable logistic regression analysis.
In the current study, the acute and late effects of CRT on LV diastolic function and on 
right ventricular remodeling and function were not analyzed. Furthermore, the results on LV 
volumes and function need to be confirmed in larger multi-center studies and eventually in 
comparison with a control group.
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The general introduction of the thesis outlines the current and future role of advanced cardiac 
imaging modalities, such as RT3DE, myocardial deformation imaging, contrast-enhanced 
echocardiography and CMR, in the diagnostic process and for clinical decision-making. The 
main applications are described in heart failure patients referred for CRT, in patients with 
acute myocardial infarction and in patients with functional mitral regurgitation.
part I
The first part of the thesis evaluates the incremental value of RT3DE over conventional echo-
cardiography for the quantification of cardiac chambers size and function. part Ia focuses on 
the use of this technique for the assessment of LV volumes and EF and for the quantification of 
LV dyssynchrony. In heart failure patients, acquisition and analysis of RT3DE dataset is shown 
to be feasible and reproducible even in patients with severely dilated LV, and provides quan-
titative information on both LV volumes and LV dyssynchrony in one single analysis. This is 
of great importance particularly in patients candidate for CRT, in whom accurate and reliable 
assessment of changes in LV size and function is crucial for the evaluation of therapy success 
(mainly as LV reverse remodeling). In addition, direct echocardiographic assessment of LV 
dyssynchrony might improve CRT patient selection over traditional selection criteria, based 
on which approximately 30% of patients do no show favorable response after implantation. 
Using RT3DE, LV dyssynchrony measurement is based on the analysis of regional volumetric 
changes over time and quantified as the standard deviation of the time to minimum systolic 
volume of 16 standard LV segments (expressed as percentage of the cardiac cycle - systolic 
dyssynchrony index, SDI). This LV dyssynchrony index was shown to be a good predictor of 
echocardiographic response to CRT, with high sensitivity and specificity (see Chapter 3 but 
also Chapter 9, Part IB). Main advantages of this approach are also represented by a good 
reproducibility, due to the semi-automated analysis, and by the possibility of simultaneous 
evaluation of all myocardial segments with a rapid identification of the area of latest activa-
tion. The measure of SDI was also found to correlate well with LV dyssynchrony measured 
by gated myocardial perfusion single photon emission computed tomography (GMPS) with 
phase analysis (Chapter 4), which is also a 3D nuclear imaging technique previously validated 
for assessment of LV dyssynchrony.
For a better interpretation and application of different indices of LV dyssynchrony, normal 
reference values for the measurements obtained by RT3DE (but also TDI and CMR) are pro-
vided in Chapter 5. It appears that for all LV segments, longitudinal peak systolic velocity and 
strain rate are early systolic events, while peak systolic longitudinal displacement and strain 
occur in late systole, or in 20-30% of segments, during isovolumic relaxation time (similarly 
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to minimum systolic volume and maximum myocardial thickness). These measures therefore 
reflect different cardiac mechanical events and can be combined to provide more robust 
information on LV dyssynchrony.
A 3D dataset can also be displayed in a tri-plane modality, with simultaneous visualiza-
tion of the 3 apical views. This approach can therefore also be used for the calculation of LV 
volumes and EF (with more accurate measures as compared to the bi-plane method) and for 
the assessment of LV dyssynchrony. Tri-plane TDI can in fact measure LV dyssynchrony as the 
standard deviation of time to peak myocardial systolic velocity in 12 LV segments (Ts-SD-12), 
which demonstrated a good correlation with GMPS (Chapter 6) and to predict LV reverse re-
modeling 6 months after CRT with good sensitivity and specificity (Chapter 7). This approach 
also showed to be able to rapidly identify the area of latest activation, which is of importance 
for the evaluation of the effect of CRT in the presence of a match with the LV pacing lead 
position (assessed by multi detector computer tomography, Chapter 8).
In part Ib, RT3DE is proposed as a novel, reliable technique for the assessment of left 
atrial size and function, providing unique information about phasic changes of left atrium 
volumes during the cardiac cycle. In patients undergoing CRT, RT3DE showed significant left 
atrium reverse remodeling after implantation, together with an improvement in left atrium 
total emptying fraction, conduit and reservoir function (Chapter 9). In patients undergoing 
radiofrequency catheter ablation for atrial fibrillation, RT3DE demonstrated that 3 months 
after the procedure, a significant reduction in left atrium volumes and a clear improvement 
in left atrium active contraction and reservoir function occurred only in patients without 
recurrences of atrial fibrillation (Chapter 10).
part II
In this part of the thesis, a large group of patients was studied with contrast-enhanced 
echocardiography within 48 hours after admission for acute myocardial infarction and per-
cutaneous coronary intervention. Since safety data on the use of this technique in acutely 
and critically ill patients is lacking, we reported that major adverse events were not observed, 
whereas minor events occurred in 4% of patients (Chapter 11). However, larger patient co-
horts are needed to confirm these findings.
In addition, RT3DE acquisitions were performed with and without contrast, demonstrating 
that the administration of contrast agents in these patients is of incremental value, improving 
endocardial border visualization and reproducibility of LV function assessment (Chapter 12).
Finally, this technique also allows for the evaluation of myocardial perfusion and therefore 
of myocardial infarction extension, which is a fundamental parameter to take into account 
in the evaluation of cardiac mechanics at short- and long-term follow-up after myocardial 
infarction. In fact, LV function immediately after infarction was demonstrated to be inde-
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pendently associated with infarct size, but also with LV dyssynchrony and LV twist (with a 
reduction of both basal and apical rotations). In particular, impairment of LV twist early after 
acute myocardial infarction was significantly and independently related to the occurrence of 
LV remodeling at 6-month follow-up, representing a sensitive global parameter of LV systolic 
performance after infarction.
part III
In this part of the thesis, novel applications of CMR are evaluated in patients with heart failure 
and in patients with functional mitral regurgitation. In part IIIa, different approaches for 
the measure of LV dyssynchrony using CMR are proposed. Velocity-encoded CMR, commonly 
used to perform flow measurements, can be applied for myocardial velocity analysis, similar 
to TDI. A strong correlation was found between TDI and velocity-encoded CMR for the as-
sessment of myocardial peak systolic and diastolic velocities and their respective timings, 
with a small bias between the 2 techniques. Importantly, a strong agreement between the 2 
techniques was also observed when patients were categorized according to the severity of LV 
dyssynchrony and LV diastolic function (using the E/E’ ratio) (Chapter 15).
Another potential approach to quantify LV dyssynchrony is applied in patients referred for 
CRT using a standard cine-set of short-axis slices (therefore without specific acquisitions), 
in which endocardial and epicardial contours are identified and the changes in myocardial 
radial thickness over time (= myocardial deformation) are evaluated. The standard deviation 
of 16 segments time-to-maximum wall thickness (SDt-16) showed to be an important predic-
tor of significant LV reverse remodeling after CRT, together with the extension of myocardial 
infarction. This is therefore the first study to evaluate the relative merits of these 2 important 
parameters (both measured by CMR) to improve CRT patient selection (Chapter 16).
CMR represents a unique approach for a comprehensive evaluation of heart failure pa-
tients, including quantification of cardiac chamber size and function and the assessment of 
LV dyssynchrony and myocardial viability (as demonstrated also in comparison with 99mTc-
tetrofosmin and 18F-fluorodeoxyglucose single photon emission computed tomography, 
Chapter 17). It is therefore considered the reference technique for patients with LV aneurysm 
referred for surgical ventricular reconstruction, since accurate measures of LV shape, size, 
and global and regional function, together with the assessment of myocardial scar and mitral 
regurgitation severity are necessary to give the correct indication and plan the surgical 
procedure. RT3DE showed to be a potential accurate alternative imaging modality for this 
evaluation (Chapter 18).
In part IIIb, 3D 3-directional velocity encoded CMR is applied in 64 patients with functional 
mitral regurgitation in a head-to-head comparison with RT3DE. A strong correlation was ob-
served between RT3DE and CMR for the measurement of mitral regurgitant volume, with no 
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significant bias between these 2 techniques; conversely, 2D echocardiography significantly 
underestimated regurgitant volume as compared to CMR. These results are related to the fact 
that conventional echocardiography measures the effective regurgitant orifice area (EROA) 
based on the assumption of a circular shape. However, in patients with functional mitral 
regurgitation, the orifice is typically elongated along the semilunar-shaped leaflet coapta-
tion line, leading to a significant underestimation when measured from the 4-chamber or 
parasternal long-axis views.
part Iv
Novel physiopathological aspects in CRT patients are studied in the last part of the thesis 
using advanced echocardiographic imaging modalities. The effect of CRT on LV rotational 
mechanics was evaluated in 80 heart failure patients (Chapter 22). A substantial improve-
ment in LV twist was observed immediately after implantation only in patients who showed 
significant LV reverse remodeling at long-term follow-up, and therefore it strongly predicted 
favourable response to CRT. In addition, LV twist significantly improved in patients with an 
apical and midventricular, but not with a basal LV lead position. These results suggest that 
CRT may (partially) restore LV twist, possibly by providing a more physiological electrical 
depolarization (directed from the apex toward the base) and mechanical contraction of the 
myofibers.
CRT might also be considered as a potential therapeutic option in patients with heart 
failure and severe functional mitral regurgitation, who are not referred or denied for surgery 
due to their high operative risk. We were able to demonstrate in fact that when these patients 
are referred to CRT, a significant improvement of mitral regurgitation can be observed in 
approximately 50% of the cases, and that the improvement in mitral regurgitation resulted in 
superior long-term survival after CRT (Chapter 23).
Cerebral blood flow is decreased in symptomatic patients with heart failure, and it might 
contribute to the impaired cognitive performance frequently observed in these patients. We 
studied the effect of CRT on cerebral blood flow using transcranial Doppler in 35 patients 
before and 6 months after implantation, and in a control group of 15 heart failure patients 
who were not referred for CRT. A significant increase in cerebral blood flow was observed 
after CRT and it was strongly correlated with the improvement in LV function (Chapter 24).
Whether sequential biventricular pacing provides substantial benefits over conventional 
simultaneous stimulation was also explored in this part of the thesis, including ischemic 
and non-ischemic heart failure patients referred to CRT. Optimized sequential pacing pro-
vided a significant improvement in LV systolic performance and a significant reduction in 
LV dyssynchrony as compared to simultaneous stimulation. Although the absolute increase 
in LV EF after implantation was greater in non-ischemic as compared to ischemic patients, 
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inter-ventricular (V-V) interval optimization yielded a larger improvement in LV systolic per-
formance in ischemic patients. In particular, a significant correlation between LV scar tissue 
and optimal V-V interval was observed, with a larger extent of scar related to a larger level of 
LV pre-activation, probably reflecting a compensation for a slow intra-LV conduction caused 
by scar tissue (Chapter 25).
In the last Chapter of the thesis, the time course of the effect of CRT on LV systolic function 
and reverse remodeling was evaluated in ischemic and non-ischemic heart failure patients. 
The beneficial effect of CRT on LV systolic function was observed immediately after CRT, but 
with additional improvement at 6-month follow-up. In particular, an acute decrease in LV 
end-systolic volume could predict echocardiographic response to CRT at 6-month follow-up 
with good sensitivity and specificity. Time course of response to CRT was similar between the 
2 groups, but LV reverse remodeling was greater in non-ischemic as compared to ischemic 
patients, in whom it was probably limited by the presence of significant scar tissue.
conclusIons
Advanced cardiac imaging modalities play a crucial role in the diagnostic process and clinical 
management of patients with different cardiac diseases, including heart failure, valvular heart 
disease, myocardial infarction and atrial fibrillation. RT3DE has made an important transition 
from a research tool to a clinically applicable imaging technique and has been demonstrated 
to provide important advantages over conventional 2D echocardiography, such as a more 
accurate quantification of cardiac chamber size and function and the possibility of unlimited 
image plane orientations for better understanding of valvular heart diseases. Therefore, it is 
likely that RT3DE will become a routine part of most echocardiographic examinations.
Contrast-enhanced echocardiography should be performed in every patient with subop-
timal acoustic window, especially with RT3DE. Importantly, in patients underwent primary 
percutaneous coronary intervention, perfusion analysis can provide an accurate estimate of 
myocardial infarction size, which is crucial information for the patient management, together 
with more sophisticated assessment of LV mechanics. Myocardial deformation imaging has 
witnessed an enormous development in the last years and is now considered an accurate tool 
for a more sensitive assessment of LV regional and global function and for a more detailed 
assessment of LV mechanics and dyssynchrony.
CMR represents the reference imaging modality for the quantification of LV volumes and 
function and for the identification of myocardial scar/fibrosis. It should be therefore con-
sidered for a comprehensive evaluation of heart failure patients, including more novel and 
sophisticated assessments of transvalvular flow and LV dyssynchrony.
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Advanced cardiac imaging modalities can be applied in heart failure patients referred for 
CRT to explore novel physiopathological aspects, such as the effect on LV rotation mechanics, 
on functional mitral regurgitation and cerebral blood flow.
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In de introductie van dit proefschrift wordt een overzicht gegeven van de huidige en toe-
komstige rol van geavanceerde beeldvormende technieken, in het bijzonder RT3DE, strain 
analyse, contrast echocardiografie en cardiale MRI, zowel voor diagnostiek als klinische 
besluitvorming. De voornaamste toepassingen worden beschreven bij patiënten met hart-
falen die zijn verwezen voor CRT, patiënten met een acuut myocard infarct en patiënten met 
functionele mitralis insufficiëntie.
deel I
In het eerste deel van dit proefschrift wordt de toegevoegde waarde van RT3DE boven con-
ventionele echocardiografie voor de bepaling van de grootte en functie van de verschillende 
hartkamers geëvalueerd.
deel Ia richt zich voornamelijk op het gebruik van deze techniek voor de beoordeling van 
LV volumes en EF en voor het kwantificeren van LV dissynchronie. In patiënten met hartfalen 
is de acquisitie en analyse van een RT3DE dataset uitvoerbaar en reproduceerbaar, zelfs in 
patiënten met een zeer gedilateerde LV. Deze RT3DE dataset geeft kwantitatieve informatie 
over zowel LV volumes als LV dissynchronie in één enkele analyse. Dit is in het bijzonder 
van belang voor patiënten die in aanmerking komen voor CRT, aangezien hier een accurate 
en betrouwbare bepaling van veranderingen in LV grootte en functie van cruciaal belang is 
om het effect van de therapie te evalueren. Verder zou echocardiografische bepaling van 
LV dissynchronie de selectie van patiënten voor CRT kunnen verbeteren boven de huidige 
selectie criteria, aangezien onder deze criteria ongeveer 30% van de patiënten geen goede 
response heeft na implantatie. Met RT3DE wordt de mate van LV dissynchronie gebaseerd op 
de analyse van lokale volumeveranderingen in de tijd, gekwantificeerd als de standaarddevi-
atie van de tijd tot kleinste systolische volume van 16 standaard LV segmenten en uitgedrukt 
als een percentage van de hartcyclus (systolische dissynchronie index, SDI). Deze index blijkt 
een goede voorspeller van echocardiografische response op CRT, met een hoge sensitiviteit 
en specificiteit (zie ook Hoofdstuk 9, Deel 1B). De grootste voordelen van deze methode zijn 
verder de hoge reproduceerbaarheid als gevolg van de semigeautomatiseerde analyse, en 
de mogelijkheid tot gelijktijdige beoordeling van alle segmenten met een eenvoudige iden-
tificatie van het laatst geactiveerde segment. De mate van SDI bleek ook goed te correleren 
met LV dissynchronie gemeten met een andere gevalideerde 3D techniek voor het bepalen 
van LV dissynchronie: “gated myocardial perfusion single photon emission computed to-
mography” (GMPS) met fase analyse (Hoofdstuk 4). Voor een betere interpretatie van deze 
indexen van LV dissynchronie worden normaalwaarden verstrekt voor de verschillende me-
tingen met RT3DE, maar ook met TDI and cardiale MRI. Het blijkt dat voor alle LV segmenten, 
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longitudinale piek systolische snelheid en strain rate vroeg in de systole plaatsvinden, daar 
waar piek systolische longitudinale verplaatsing en strain laat in de systole geschieden, of (bij 
20-30% van alle segmenten) gedurende de isovolumetrische relaxatie tijd, zoals ook het mi-
nimaal systolische volume and maximale myocard dikte. Deze metingen reflecteren daarom 
verschillende cardiale mechanische gebeurtenissen en kunnen gecombineerd worden om 
een gedetailleerder beeld van LV dissynchronie te verkrijgen.
Een 3D dataset kan ook worden weergegeven in een tri-plane vorm, waarbij er gelijktijdig 
informatie verkregen wordt vanuit de 3 apicale vensters. Daarom kan deze aanpak worden 
gebruikt voor het berekenen van LV volumes en EF (met meer nauwkeurigheid vergeleken 
met de bi-plane methode) en voor het bepalen van LV dissynchronie. Met tri-plane TDI kan 
zelfs LV dissynchronie berekend worden als de standaarddeviatie van de tijd tot piek systoli-
sche snelheid van 12 LV segmenten (Ts-SD-12). Dit liet eerder een goede correlatie zien met 
GMPS (Hoofdstuk 6) and bleek tevens een voorspeller van gunstige verkleining in LV volumes 
na 6 maanden CRT, met goede sensitiviteit en specificiteit (Hoofdstuk 7). Met deze techniek 
kan ook snel het laatst geactiveerde segment worden geïdentificeerd, wat van belang is voor 
het evalueren van het effect van CRT in geval van een corresponderende positie van de LV 
pacemakerdraad (zoals vastgesteld met multi detector computer tomografie, Hoofdstuk 8).
In deel Ib wordt RT3DE besproken als een nieuwe, betrouwbare techniek voor de 
beoordeling van linker atrium grootte en functie. RT3DE geeft belangrijke informatie over 
veranderingen in linker atrium volumes gedurende de hartcyclus.
In patiënten behandeld met CRT demonstreerde RT3DE significante gunstige verkleining 
van het linker atrium na implantatie, evenals een verbetering in linker atrium ledigingfractie 
en reservoir functie. In patiënten die radiofrequente katheter ablatie hebben ondergaan voor 
boezemfibrilleren werd met RT3DE gedemonstreerd dat er alleen een significatie reductie in 
linker atrium volumes en een duidelijke verbetering in linker atrium contractie en reservoir 
functie optrad in patiënten vrij van episodes van boezemfibrilleren na de procedure.
deel II
In dit deel van het proefschrift werd een grote groep patiënten bestudeerd door middel van 
contrast echocardiografie binnen 48 uur na opname met een acuut myocard infarct waar-
voor percutane coronair interventie. Aangezien getallen over de veiligheid van deze techniek 
bij kritiek zieke patiënten ontbreken hebben we gerapporteerd dat grote complicaties zich 
niet hebben voorgedaan en kleine complicaties optraden in slechts 4% van alle patiënten. 
Studies in grotere patiëntengroepen moeten deze resultaten echter bevestigen. De RT3DE 
acquisities werden verricht met, en zonder contrast, waarmee gedemonstreerd werd dat de 
toevoeging van contrast in deze patiënten van toegevoegde waarde is doordat de endocar-
diale begrenzing beter gevisualiseerd kan worden en leidt tot een hogere reproduceerbaar-
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heid van LV functie bepaling. Tenslotte kan met deze techniek ook cardiale perfusie worden 
geëvalueerd en daarmee de uitgebreidheid van infarcering, wat een belangrijke parameter is 
voor het beloop van cardiale functie op korte en lange termijn na een myocard infarct. Linker 
kamer functie direct na een infarct bleek niet alleen onafhankelijk geassocieerd met infarct 
grootte, maar ook met LV dissynchronie en LV twist (met een reductie van zowel basale als 
apicale rotatie. Voornamelijk afname van LV twist direct na een myocard infarct was signi-
ficant en onafhankelijk geassocieerd met het optreden van ongunstige LV vergroting na 6 
maanden. Dit betekent dat het een gevoelige globale parameter is van LV systolische functie 
na infarcering.
deel III
In dit deel van het proefschrift worden nieuwe toepassingen van cardiale MRI in patiënten 
met hartfalen en functionele mitralis insufficiëntie geëvalueerd.
In deel IIIa worden verschillende manieren besproken om LV dissynchronie met cardiale 
MRI te bepalen. Snelheid gecodeerde cardiale MRI, gewoonlijk gebruikt om bloedstroom 
metingen mee te verrichten, kan ook worden gebruikt om de snelheden van het bewegende 
myocard mee te analyseren, vergelijkbaar met TDI. Er werd een sterke correlatie gevonden 
tussen TDI en snelheid gecodeerde cardiale MRI voor de bepaling van cardiale piek systoli-
sche en diastolische snelheden met corresponderende timings, met een kleine bias tussen 
de 2 technieken. Er werd bovendien ook een sterke overeenkomst gevonden tussen de 2 
technieken wanneer patiënten werden gecategoriseerd naar ernst van LV dissynchronie en 
LV diastolische functie (met gebruik van de E/E’ ratio). Een andere mogelijke methode om 
LV dissynchronie te bepalen wordt toegepast in patiënten die zijn verwezen voor CRT. Deze 
techniek gebruikt standaard korte as opnames waarbij endocardiale en epicardiale contouren 
wordt geïdentificeerd en de verandering van myocard dikte in de tijd (strain) wordt geëvalu-
eerd. De standaarddeviatie van de tijd tot maximale wanddikte van 16 segmenten (SDt-16) 
bleek een belangrijke voorspeller van gunstige verkleining in LV volumes na CRT, evenals 
de uitgebreidheid van een eerder myocard infarct. Dit is de eerste studie die de waarde van 
deze 2 belangrijke parameters (beide gemeten met cardiale MRI) heeft aangetoond in de 
verbetering van patiënt selectie voor CRT.
Cardiale MRI is een unieke manier om patiënten met hartfalen te evalueren. Het combineert 
de kwantificering van de hartkamer grootte en functie met de bepaling van LV dissynchronie 
en cardiale viability (zoals ook gedemonstreerd in vergelijking met 99mTc-tetrofosmin and 
18F-fluorodeoxyglucose SPECT, Hoofdstuk 17). Daarom is het tevens de aangewezen techniek 
voor de evaluatie van patiënten met een LV aneurysma die in aanmerking komen voor chirur-
gische reconstructie, aangezien nauwkeurige metingen van LV grootte, vorm, en globale en 
regionale functie, samen met de bepaling van cardiaal littekenweefsel en ernst van eventuele 
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mitralis insufficiëntie, noodzakelijk zijn om de juiste indicatie te stellen en de procedure te 
plannen. RT3DE blijkt een mogelijk nauwkeurige alternatieve beeldvormende methode voor 
deze analyse (Hoofdstuk 18).
In deel IIIb werd 3D 3 richtingen snelheid gecodeerde cardiale MRI direct vergeleken met 
RT3DE in 64 patiënten met functionele mitralis insufficiëntie. Er werd een sterke overeen-
komst gevonden tussen RT3DE en cardiale MRI voor de bepaling van het mitralis insufficiënte 
volume, zonder significatie bias tussen deze 2 technieken. 2D echocardiografie onderschatte 
echter het mitralis insufficiënte volume in vergelijking met cardiale MRI. Dit wordt mede 
veroorzaakt door het feit dat conventionele echocardiografie de “effective regurgitant orifice 
area” (EROA) baseert op de aanname dat het een perfecte cirkelvorm is. In patiënten met 
functionele mitralis insufficiëntie is het echter vaker geelongeerd langs de halvemaanvor-
mige coaptatie lijn. Dit resulteert in een onderschatting wanneer dit gemeten wordt vanuit 
een 4-kamer venster of een parasternaal lange as.
deel Iv
In het laatste deel van dit proefschrift worden nieuwe pathosfysiologische aspecten in CRT 
patiënten bestudeerd met behulp van geavanceerde echocardiografische technieken. Het 
effect van CRT op LV rotatie werd geëvalueerd in 80 patiënten met hartfalen. Er werd direct 
na implantatie een substantiële verbetering in LV twist geobserveerd, echter alleen in patiën-
ten met een gunstige verkleining in LV volumes na 6 maanden CRT. Daarom lijkt het een zeer 
goede voorspeller van response op CRT. Verder verbeterde LV twist in patiënten met een api-
caal en midventriculair geplaatste LV draad, maar niet in patiënten met een basaal geplaatste 
LV draad. Deze resultaten suggereren dat CRT LV twist (gedeeltelijk) kan herstellen, mogelijk 
doordat er een meer fysiologische elektrische depolarisatie (van de apex richting basaal) en 
mechanische contractie van het myocard wordt bewerkstelligd. CRT kan ook als mogelijke 
therapie gezien worden in patiënten met hartfalen en ernstige mitralis insufficiëntie, die niet 
in aanmerking komen, of worden afgewezen voor chirurgische correctie vanwege het zeer 
hoge operatierisico. We konden laten zien dat als deze patiënten worden verwezen voor CRT, 
er een significante verbetering in de ernst van de mitralis insufficiëntie wordt geobserveerd 
in ca. 50% van alle gevallen. Deze verbetering na CRT leidt tot een betere overleving.
Cerebrale doorbloeding is verminderd in patiënten met symptomatisch hartfalen, en dit 
kan mogelijk bijdragen tot (frequent geobserveerde) verminderde cognitieve vermogens. 
We bestudeerden het effect van CRT op cerebrale doorbloeding met behulp van transcra-
niele Doppler in 35 patiënten voor, en 6 maanden na implantatie, en vergeleken dit met 15 
patiënten met hartfalen die niet in aanmerking kwamen voor CRT. Er werd een significante 
verbetering in cerebrale doorbloeding gevonden na CRT en dit was sterk gecorreleerd aan de 
verbetering in LV functie. Of sequentieel biventriculair pacen betere resultaten kan bereiken 
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dat simultaan biventriculair pacen werd ook verkend in dit deel van het proefschrift, in patiën-
ten verwezen voor CRT met zowel ischemisch als niet-ischemisch hartfalen. Geoptimaliseerde 
sequentieel biventriculair pacen gaf een significante verbetering in LV systolische functie en 
een significante reductie in LV dissynchronie in vergelijking met simultaan biventriculair pa-
cen. Hoewel de absolute verbetering in LVEF na implantatie groter was in patiënten met niet-
ischemisch hartfalen, leidde inter-ventriculaire (V-V) interval optimalisatie tot een grotere 
relatieve verbetering in LV systolische functie in patiënten met ischemisch hartfalen. Er werd 
een significantie relatie gevonden tussen LV litteken weefsel en een optimaal V-V interval, 
waar een grotere hoeveelheid litteken weefsel gerelateerd was aan meer LV pre-activatie. Dit 
reflecteert waarschijnlijk een compensatie voor de langzamer verlopende intra-LV geleiding 
veroorzaakt door het litteken weefsel.
In het laatste Hoofdstuk van het proefschrift werd het effect van CRT op systolische func-
tie en gunstige verkleining in LV volumes in patiënten met ischemisch en niet-ischemisch 
hartfalen in de tijd geëvalueerd. Er werd een directe verbetering gezien in LV systolische 
functie na CRT, maar met een aanvullende verbetering na 6 maanden. Met name een acute 
afname in LV eind-systolisch volume bleek voorspellend voor echocardiografische response 
na 6 maanden, met een goede sensitiviteit en specificiteit. Het tijdsbeloop van verbetering 
in LV systolische functie was gelijk voor beide groepen, maar de gunstige verkleining in LV 
volumes was meer uitgesproken in niet-ischemische patiënten dan in ischemische patiënten, 
in wie significante hoeveelheden litteken weefsel waarschijnlijk verdere verbetering belem-
merde.
conclusIes
Geavanceerde beeldvormende technieken spelen een cruciale rol in de diagnostiek en klini-
sche besluitvorming van patiënten met verschillende cardiale ziekten, waaronder hartfalen, 
acuut myocard infarct en boezemfibrilleren.
RT3DE heeft een belangrijke overgang gemaakt van onderzoeksinstrument tot een klinisch 
toepasbare techniek en heeft bewezen voordelen boven conventionele 2D echocardiografie. 
Dit zijn onder andere een meer accurate kwantificering van de grootte en functie van de 
verschillende hartkamers en de mogelijkheid van oneindig veel oriëntaties voor een beter 
begrip van klepafwijkingen. Het is daarom aannemelijk dat RT3DE een routine onderdeel zal 
worden van veel echocardiografische onderzoeken.
Contrast echocardiografie zou toegepast moeten worden in elke patiënt met een subopti-
maal akoestisch venster, zeker met RT3DE. In patiënten die een primaire percutane coronair 
interventie hebben ondergaan kan perfusie analyse een accurate inschatting maken van in-
farct grootte, wat samen met een meer complexe evaluatie van LV functie cruciale informatie 
verschaft voor patiënt management.
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Samenvatting en Conclusies
Strain analyse heeft een enorme ontwikkeling doorgemaakt de laatste jaren en wordt 
nu gezien als een bruikbaar instrument voor een gevoeligere bepaling van LV regionale en 
globale functie en voor een meer gedetailleerde evaluatie van LV functie in LV dissynchronie.
Cardiale MRI is de gouden standaard voor de bepaling van LV volumes en voor de identifi-
catie van litteken weefsel en fibrose. Het moet daarom gezien worden als een zeer compleet 
instrument voor de evaluatie van patiënten met hartfalen, waarbij er complexe bepalingen 
van bloedstroming door de kleppen en LV dissynchronie mogelijk zijn.
Geavanceerde beeldvormende technieken kunnen worden toegepast bij patiënten met 
hartfalen die zijn verwezen voor CRT voor de evaluatie van nieuwe pathosfysiologische 
aspecten, waaronder het effect op LV twist, functionele mitralis insufficiëntie en cerebrale 
doorbloeding.
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